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INTRODUCTORY REMARKS
Ladies and Gentlemen,
Let me first express our sincere thanks to you for ac­
cepting our invitation and for participating in the present 
meeting in this small, quiet university town which some of you 
may have never heard of before. Our colleagues are often com­
plaining that the huge international congresses and even the 
smaller national gatherings tend to be more and more costly and 
formal day by day. Therefore, the participants have less and 
less opportunity for intimate discussions.
One of our motives for organizing this meeting was to 
create quiet conditions and a calm atmosphere for exchanging 
ideas of mutual interest. This explains why we decided to 
invite only a small number of participants and to cover at 
least the expenses of their stay. The latter became possible 
with the generous help of the Hungarian Biochemical Society 
and some Hungarian pharmaceutical factories (REANAL and 
CHXNOIN, Budapest; BIOGAL, Debrecen) to whom thanks are due.
Proteinases can be listed among the classical objects of 
biochemistry or rather among those of enzymology. Some of them, 
particularly the extracellular pancreatic enzymes had been 
described in detai1 by the late 1960s. The intracellular en­
zymes, however, were investigated with much less intensity.
As regards the importance of the latter enzymes, this situa­
tion seems to be inconsistent because Schoenheimer reported 
in 1935 already that a very intensive protein metabolism is 
continuously going on in the cells. Since then Schoenheimer's 
discovery has been treated in textbooks and manuals as a 
principle of biochemistry. It is obvious that protein turnover
V
can hardly go on without the participation of proteolytic 
enzymes.
The renaissance of the study of proteinase action began 
some 15 years ago. Nowadays proteolytic enzymes are investi­
gated with a different aspect in view. They are known, for 
example, to play an important role in biological regulation 
either in a direct way by activating inactive proteins and 
inactivating active ones, or in an indirect manner by releasing 
biologically active peptides. The role played by proteolytic 
enzymes in the release of secretory proteins from the cells is 
also commonly known. The keen interest excited by the subject 
is therefore obvious.
The rapid growth in the knowledge of proteolytic enzymes 
has been promoted greatly by the development of research 
techniques. In addition, the integration of techniques applied 
in other fields of research, e.g., in physics, mathematics, 
chemistry, etc., into biochemical studies also enriched the 
technical inventory of protein research in the last decades.
The new methods have opened up new territories and made re­
search more fruitful. This enabled us to attempt to elucidate 
such delicate issues that could not even be thought of 10-15 
years ago.
The topics covered by the papers presented at this meeting 
will also indicate this situation. We were lucky enough to 
bring together a colourful spectrum of papers covering a wide 
field of proteinase research. The speakers will sum up their 
most recent data on the mechanism of proteinase action in 
viruses, plants and in man in health and disease as well. In 
the days ahead we will have a chance to discuss topics ranging 
from the submolecular mechanism of proteinase action to the 
application of these results in the everyday practice, e.g., 
in diagnostics and treatment of patients.
I wish you a pleasant time at our meeting and a useful 
exchange of ideas, opinions which, hopefully, will stimulate 
our future research activities.
Thank you for your attention.
P. Elődi
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GENERAL- PROBLEMS OF PROTEOLYTIC MEC HANI SM 
ANTONOV, V.K.
M.M. Shemyakin Institute of Bioorganic Chemistry 
Academy of Sciences 
Moscow, USSR
Proteolytic enzymes constitute one of the largest classes 
of biocatalysts. Despite their great diversity, these enzymes 
can be classified according to the structure of their catalytic 
apparatus, into four main groups, namely, serine-,thiol-, car­
boxylic- and metal-dependent proteases. Latest advances in 
X-ray crystallography have shed much light on the mechanism of 
action of proteolytic enzymes. However, some aspects common 
for all of them still need thorough investigation.
In this report I would like to bring your attention to 
the following questions:
1 . / What is the function of catalytic groups of proteases, 
that is, do they act as covalent or as general base catalysts 
at the stage of nucleophilic attack of the substrate carbonyl?
2. / Does enzymatic hydrolysis of amides proceed through 
the tetrahedral intermediates?
3. / Is the formation of a productive enzyme-substrate 
complex and the dissociation of the reaction products a one- 
or a multistep process?
4. / What is the structure of the substrate in a productive 
complex?
All these problems are directly related to the efficiency 
and specificity of proteolysis.
The first problem concerning the function of catalytic 
groups of proteases can be formulated otherwise, namely does 
the enzyme form covalent intermediate with the substrate frag­
ments? There is no unequivocal answer to this question yet,
3
at least as far as amide hydrolysis is concerned, since in 
this case the intermediates are not accumulated in the system.
Recently a number of approaches have been developed in 
our laboratory which are aimed at identification of covalent 
intermediates and which allow to establish the type of cataly­
tic action of various proteases (Antonov et al., 1978, 1979,
1981).
Both the nucleophilic catalysis (1) giving rise to a 
covalent intermediate and the general base catalysis (2) that 
is not completed by this intermediate formation, differ by a
stage involving water. _
E-X + RCONHR2
(1 ) R2NH2 Transpeptidation
R k, R k R© I ' I © 2 IE-X + C=0 ■ » E-X-C-0 -j- • * E-X-C=0 + H0NR.I \  | 2 1
NHR1 -1 NHR1 - 2
h 2# 'k3 j[ K-:
E-X^ + RCO*H 
Hydrolysis
(2) E-X + RC*NHR„
R2NH2
H R k. R k„ I* RCOOH© I I ’ I Q 2 QE-Xw + H-« + C=C g- E-XH • H#-C-(j * E-X ■
I k I k
NHR1 -1  NHR1 - 2  R 1NH2I
R1NH2 + E-X + RCOOH
When the reaction is performed with heavy oxygen-labelled 
water it becomes possible to differentiate between these two 
mechanisms. During general base catalysis, when the rate of 
formation of the tetrahedral intermediate is higher than that
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of its degradation, the heavy oxygen label will be incorporated 
into the substrate. When the reaction is in a thermodynamic 
equilibrium, the rate of the heavy oxygen incorporation into 
the substrate should be close to that of the amine product in­
corporation, irrespective of the rates ratio of the tetrahedral
intermediate formation and degradation (Lyakisheva et al.,
1 81973). Only in case of general base catalysis will the 0 
label be incorporated into the amide group of the transpeptida- 
tion or acyl transfer product. And, finally, the rate of the 
heavy oxygen exchange at the carboxyl of the acyl product would 
be increased by the amine product due to the synthesis and 
hydrolysis of the corresponding peptide, provided that the re­
action occurs via a general base mechanism.
It should be mentioned that when the nucleophilic group 
is represented by a carboxyl ion of the enzyme, the cleavage 
of the "acyl" or "amino" enzyme at protein carbonyl moiety 
will result in heavy oxygen incorporation into the enzyme. To 
test this assumption we have elaborated a special procedure 
(Antonov, 1977; Antonov et al., 1980). After completion of 
the reaction in the heavy oxygen-labelled water the enzyme is 
subjected to the action of specific inhibitors (3) which form 
ester bonds with the active center carboxyls. The next step 
is mild alkaline hydrolysis and separation of the hydroxy- 
compounds where the heavy oxygen content is determined. In ex­
periments with pepsin no label was detected in the enzyme.
^C 00° s ,COOCOR Ho« co«e z yC0*CH,CH(0H)RCi. ---* L  ^ E E
COOH sCONHR1 C0#H NCO*CH CONHR
e0 3300oh” +
H*CH2CH(OH)R2
nCOOH H«CH2CONHR3 (
1 8Data from 0 incorporation into the substrates and trans- 
peptidation products, for all the four protease groups tested 
are shown in Table 1. It can be seen that the amide bond hyd­
rolysis catalyzed by serine and thiol proteases occurs via a 
nucleophilic mechanism. However, carboxylic proteases as well
5
Table 1
180 Content of the transpeptidation products and 
non-hydrolyzed substrates
Enzyme Reaction studied
18o
in
Content 
atom. %
, trans­sub- , . ,
strate ' product
Chymotrypsin AcPheGlyNH2 t AcPheOH+GlyNH2 0
2LeuLeuNH2 J LeuLeuLeu+LeuNH2+NH3 0 0
Papain ZGlyNH2+LeuGly t ZGlyLeuGly+NH3 0
ZGlyOMe+LeuGly t ZGlyLeuGly+MeOH 0
Pepsin 2LeuTyrNH2 J LeuLeu+2TyrNH2 13±4 65±12
Leucine amino- 
peptidase 2LeuNH2 t LeuLeuNH2+NH 
2 [18o] LeuNH2 Z [18o]LeuLeuNH2+NH3
46+5 48±3
55±5
Thermolysin 2LeuLeuNH2 Z LeuLeu+2LeuNH2 52+5 47+5
Table 2
Rates of oxygen exchange
Enzyme Substrate and additions
180 content 
in atan. %
Maximal rate 
of exchange
-1 . -1M min
Vs
Vs+a
Chymotrypsin AcPheOH 35±3 1.8*10-8
AcPheOH +AlaNH 2 22±3 0.8-10-5 0.45
AcPheOH+GlyNH2 16±2 1.0*10~5 0.63
Pepsin AcPheOH 13±2 2.5-10" 5
AcPheOH+PheAlaAlaOMe 29±3 5.6-10“ 5 2 .2
Leucine amino- 
Peptidase LeuOH
LeuOH+NH4Cl
21 ±1 
19±1
1.6 -10” 3
1.5-10" 3 0.9
LeuOH+LeuNH(CH2> 20H 40±2 3.5-10" 3 1.95
Carboxypep- 
tidase A AcPheOH
AcPheOH+PheOH
18±2
40±3
7.9-10-6  
1.8 -10-5 2.3
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as metal-dependent endo- and exopeptidases act as general base 
catalysts and do not form covalent intermediates with the sub­
strate fragments. The same results have been obtained in the 
study of the rates of heavy oxygen exchange in the acyl products 
in the presence and absence of amines (Table 2).
Thus, according to their mechanism of action the enzymes 
uncer study and, probably, other enzymes hydrolyzing carboxylic 
acid derivatives, may be subdivided into two groups. To the 
first group we may relate serine and thiol proteases which act 
as nucleophilic or covalent catalysts, to the second one - car­
boxylic and metal-dependent enzymes functioning as general base 
catalysts.
It might be expected that in the case of the second group 
enzymes the heavy oxygen incorporation into the non-hydrolyzed 
substrate will point to the formation of a tetrahedral inter­
mediate. However, a detailed analysis of the kinetics of this 
process corroborated our expectations (Kapitannikov, 1983). 
Indeed, it was found that in case of leucine aminopeptidase 
(Fig. 1) and pepsin the heavy oxygen incorporation occurs 
simultaneously and in a comparable degree with incorporation 
of labelled amine reaction product into the substrate. Presum­
ably, the oxygen exchange is due to the acyl transfer to the 
amino product formed during hydrolysis. These data suggest that 
the commonly accepted viewpoint that the heavy oxygen incor­
poration into the substrate is inevitably associated with the 
formation of a tetrahedral intermediate cannot be applied to 
enzymatic hydrolysis. However, these results do not exclude 
the possibility of such formation.
Using quantum-chemical approaches, S. Alexandrov in our 
laboratory calculated the pK values for the leaving amino 
group at different stages of the planar amide conversion into 
a tetrahedron. It appeared that this value becomes comparable 
to that of the proton acceptor, imidazole, long before the 
completion of the tetrahedron formation (Fig. 2). Therefore, 
the reaction of amide hydrolysis is likely to occur, at least 
partly, via a SN2 mechanism (Komiyama and Bender, 1979).
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1 8Fig. 1: Kinetic of 0 incorporation into the leucine amide 
catalyzed by leucine aminopeptidase. A: Dependence 
of the exchange on the degree of the substrate hyd­
rolysis [S] :0.3 M. B : Dependence of the exchange 
on the substrate concentration at 80 % of hydrolysis. 
Arrow indicates the exchange in the presence of 
0.15 M of 1 (Circle - oxygen; triangle - nitrogen).
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Fig. 2: Relation between the degree of pyramidalyzation of 
the amide bond and pKa of the amino-leaving group. 
Calculated by S. Alexandrov (CNDO-2 method, pro­
gramme GEOMO).
The observation that the enzymes incapable to form co­
valent intermediates can catalyze the transfer and transpep- 
tidation reactions provides evidence for some important con­
clusions .
First, the nucleophilic "entrapment", an approach common­
ly employed in enzymology as a proof of the covalent nature 
of the reaction intermediates, seems to be inadequate in this 
case, because the transfer to the nucleophilic moiety may take 
place in the absence of covalent bond between the enzyme and 
the substrate fragment.
Second, here it is the nature of the enzyme complexes 
with the reaction products that comes to the foreground. The 
stability of the enzyme complexes with the reaction products 
whose dissociation constants can easily and directly be meas­
ured by routine methods, is incompatible with the high rates
2 * 9
observed during transpeptidation reaction (Antonov, 1980). The 
only possible explanation is that the dissociation of the 
reaction product occurs stepwise and that transpeptidation 
affects the "internal" (E^ P) enzyme-product complex (4).
E + S E S o E S P P E Po
+ P (4)
In such a system the equilibrium is usually shifted 
toward the "external" complex (EqP) and the apparent value 
for the reaction product coincides with the true of the 
external complex. The formation of the internal complex res­
ponsible for transpeptidation will be effective only during 
substrate conversion into the reaction product, while its 
formation from the free enzyme and the reaction product will 
be limited by the low rate of the external complex conversion 
into the internal one (k_4) - This hypothesis provides satis­
factory explanation for the basic differences between trans­
peptidation and resynthesis.
Naturally, the internal enzyme-product complex is form­
ed from the corresponding enzyme-substrate complex (E^S), i.e. 
in this case the formation of the enzyme-substrate complex 
occurs in at least two stages, a situation similar to that 
observed during dissociation of the reaction products. This 
finding can be confirmed by numerous data from literature 
(for references see Antonov, 1980).
Now a question arises as what the structural differences 
between the internal and external complexes are. It is hardly 
likely that a complementarity between the enzyme and its sub­
strate can be achieved in a one-step diffusion-controlled 
reaction. It seems more reasonable to assume that the sub­
strate is at first "anchored" by the enzyme which thus reveals 
its primary specificity and only thereafter interacts with the 
secondary sites of the substrate to form a productive complex 
(Fig. 3).
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Fig. 3: Schematic representation of the stepwise binding of 
a substrate and dissociation of a product in the 
course of enzymic hydrolysis.
These suggestions allow to understand why the specificity 
of some enzymes is manifested either in the maximal rates or 
in the values of the binding constants. Both these parameters 
depend on the equilibrium between the external and internal 
enzyme-substrate complexes (see Scheme 4):
V
k0K. 3. P1+K and Km (a p p )
K
T+T~ where V KP k-2 + V
When this equilibrium is shifted toward the external complex
(K <1), the value of catalytic constant is changed while that Pof Michaelis constant is not, provided that the primary speci­
ficity of the enzymes (Kg) for all the substrate tested is the 
same. When the equilibrium is shifted toward the internal com­
plex (K >1), the specificity is reflected on the values of the P
Michaelis constants. This assumption is in good agreement with 
the data obtained by comparing the apparent Km and kcat values 
for the structurally similar substrates of three different 
proteases (Fig. 4).
Although the data mentioned above clearly demonstrate 
the specificity of proteases, they fail to provide sufficient 
explanation of their efficiency. As the hypothesis on "charge
11
relay system" is not valid for serine proteases, and in case 
of carboxylic or metal-dependent proteases the substrate- 
attacking molecule is water, the nucleophility of catalytic 
groups of proteases is too low to explain the high rates of 
the reactions.
-1 0 1 2 3 4 5
leg kcat/k°cat
Fig. 4: Plots of log K (rel.) vs. log kcat (rel.) for 
series of substrates of carboxypeptidase A (1), 
Chymotrypsin (2) and pepsin (3). Data and re­
ferences see Antonov (1980).
It is known (cf. Fastrez, 1977) that the main cause of 
the amide resistance to nucleophilic attack is the resonance 
stabilization. Evidence from X-ray crystallography obtained 
in the last few years suggest that in some protease-inhibitor 
complexes the potentially hydrolyzable amide bond is destabi­
lized due to pyramidalization (Table 3). It might be assumed 
that partial destabilization of the hydrolyzable bond also 
takes place in productive enzyme-substrate complexes. The 
results of quantum-chemical analysis show that the degree of 
amide pyramidalization depends on the nature of the nucleo­
philic group and can rather be prominent, even when the nucleo-
12
phil is a long distance off the substrate carbonyl carbon 
(Fig. 5).
Table 3
Pyramidalization of the amide bond
/ C^ Y / 4 ' °
Enzyme Ligand Bond A,8 * Refer-encesKX
Chymotrypsin BPTI t 15 A1 16 Lys -Ala 0.38 a
Trypsin BPTI T 15 .. 16 Lys -Ala 0.28 b
- BPTI(free) T 15 16 Lys -Ala 0.008 c
Elastase CF3COLysAlaNHC6H4CF3-p CF3CO-NH 0.042 d
Carboxypep- 
tidase A GlyTyr CO-NH 0.012 e
Thermolysin CLH_(CHJ COPheOHD D 2 2 CONH 0.06 f
x Calculated from the atomic coordinates of the complexes.
XXSource of the atomic coordinates: a.) D. Blow, personal 
communication; b.) R. Huber et al. (1974); c.) R. Huber, 
personal communication; d.) D. Hughes et al. (1982); 
e.) F. Quiocho et al. (1971); f.) W. Kester, B. Matthews 
(1 977) .
If the resonance destabilization of the amide group in 
the enzyme-substrate complex does take place, any further 
nucleophilic attack will occur at very low activation barrier 
(Fig. 6 ) .
In conclusion, I would like to emphasize that the concept 
presented here explains the efficiency of catalysis in terms 
other than strain or transition state stabilization. If we con­
sider chemical transformation of a substrate as an elementary 
act, we will need to select the same structural forms of the
13
Fig. 5: Dependence of the degree of pyramidalvzation of the
amide bond on the distance between the carbonyl carbon 
of the substrate and the nucleophyl for CH3OH (1), 
CHjO- (2), CH3S- (3) and H20-HC00" system (4). Cal­
culated by CNDO-2 method.
O '-  n u c le o p h j l  diatuunoe ( I )
Fig. 6 : Change of the energy at the nucleophilic attack of
MeCONHMe by MeOH (1) and MeO- (2). The initial state 
of the CONH corresponds to that shown in Fig. 5. for 
3 fi distance. Calculated by S. Alexandrov (CNDO-2 
method, programme GEOMO).
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substrate in the ground state of the enzymatic and non-enzy- 
matic reactions. In a non-enzymatic reaction the resonance-de­
stabilized form of the substrate exists in solution at very 
low concentration. The enzyme can stabilize a highly reactive 
but energetically unfavourable form of the substrate. The activ­
ation barrier of the elementary step of chemical transformation 
for an enzymatic reaction may be the same as the barrier of 
transformation of the reactive form of substrate in solution. 
Hence, the reactive form of the substrate is not subjected to 
any strain when binding to the enzyme; nor does the enzyme 
stabilize the transition state of substrate (cf. Karpeiskii 
et al., 1980).
We believe that experimental verification of these ideas 
will be a step forward in establishing a general theory of en­
zymatic hydrolysis of carboxylic acid derivatives.
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INTRODUCTION
The basic features of the mechanism of action of serine 
proteinases, like Chymotrypsin and subtilisin, are illustrated 
in Fig. 1. It is seen that the nucleophilic attack by the
Acylation---------------------►
r-Im r-Im
H X X
n * r _ p -- ^ n_r _ p
--- /  0 ___ /  i
♦ HX
O-C-R
/ "-> O
Deacylation
Fig. 1. X stands for OR' or NHR' group in acylation 
and for OH group in deacylation
serine hydroxyl group on the carbonyl carbon atom of the sub­
strate is catalyzed by a histidine residue as a general base. 
This leads to the formation of a tetrahedral intermediate and 
an imidazolium ion. The intermediate breaks down by general 
acid catalysis to an acyl-enzyme, an imidazole base and alcohol 
or amine. The acyl-enzyme is hydrolyzed through the reverse 
reaction pathway of acylation. The tetrahedral intermediates 
formed during acylation and deacylation are transition-state-
Abbreviation: ATTE: N-acetyl-L-tyrosine ethyl ester
17
like species (Robertus et al., 1972; Polgár, 1972). The stabi­
lization of the negatively charged oxygen by hydrogen bonds 
from the protein was postulated on the basis of low Hammett p 
values (Williams, 1970) and of X-ray diffraction studies (Hen­
derson, 1970; Robertus et al., 1972). The oxyanion binding 
site was observed in all serine proteinases whose three-dimen­
sional structure has been determined (Kraut, 1977; James,
1 980) .
Cysteine proteinases, like papain and chymopapain, form 
an acyi-enzyme intermediate, a thiol ester, which builds up 
and breaks down through a tetrahedral adduct. On the basis of 
X-ray diffraction studies, an oxyanion binding site was pro­
posed to be involved also in the catalysis by cysteine pro­
teinases (Drenth et al., 1976).
To obtain experimental evidence on the importance of the 
oxyanion binding site in the catalysis by both serine and 
cysteine proteinases, we have synthesized thiono ester sub­
strates containing a sulfur in place of the carbonyl oxygen 
atom, and compared the catalytic constants with those found 
with the corresponding oxygen esters. It was assumed that 
replacement of the carbonyl oxygen by the sulfur atom, which 
is larger and has reduced hydrogen bondihg ability, should 
seriously affect the enzymatic reaction if oxyanion binding is 
indeed important in the catalysis.
RESULTS AND DISCUSSION
Comparison of the alkaline hydrolysis of thiono and the 
corresponding oxygen esters. To interpret the effect of oxygen- 
sulfur exchange in the enzymatic reactions, first the reactiv­
ity change in the substrates should be delineated. Therefore, 
alkaline hydrolysis of esters and thiono esters used in this 
study were examined. The rate constants obtained are shown in 
Table 1. It is seen that the ester and the corresponding thiono 
ester bonds are hydrolyzed at similar rates. Thus large dif­
ferences in the enzymatic reactions cannot arise from the dif­
ferent chemical reactivities of the substrates but rather from 
their different interactions with the oxyanion binding site.
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Table 1
Base-catalyzed hydrolysis of oxygen and corresponding
thiono esters9
Oxygen ester Thiono ester 
k (M  ^s ^) k ( M ^ s ^ )
Methyl
N-benzoylglycinate 1.9 ± 0.2 2.710.4
Ethyl
N-acetylphenylalaninate 0.4 +0.1 0.4 ± 0.1
Ethyl N-Z-phenyl-
alanylglycinate 0.3 ±0.1 0.4 ±0.1
aln 0.2 M KC1, 3 % acetonitrile at 25°C; determined 
at least at three different pH-values between 10.0 
and 11.5; ester concentration range: 0.3-3 mM
Reaction of oxygen esters and thiono esters with serine 
proteinases. The second-order rate constants for acylation of 
Chymotrypsin and subtilisin are shown in Table 2 and Table 3, 
respectively. It is seen that the thiono esters are not hydro­
lyzed by either serine proteinase at a measurable rate (the 
data represent upper limits). Particularly in the case of the 
better substrate (the phenylalanine derivative), the differences 
in the rate constants for the oxygen and thiono compounds are 
considerable, more than four orders of magnitude, with both 
Chymotrypsin and subtilisin. Since the acylation rate constant 
(k = k2 /Ks> is a complex constant which involves binding, the 
binding constants (K or ) were also determined as seen in 
Tables 2 and 3. Their values clearly show that binding is not 
significantly affected by the oxygen to sulfur change, as the 
respective constants are within a factor of 2. Accordingly, 
the substantial difference in the acylation rate constants may 
be attributed to poor catalysis with thiono esters rather than 
to the impediment of the formation of the enzyme-substrate com-
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Table 2
Kinetic parameters of the reaction of Chymotrypsin with oxygen
and corresponding thiono esters3
Oxygen ester Thiono ester
k (M-1s~1) K (mM) k(M~1s_1)> K (mM)
Methyl
N-benzoylglycinate 31±1b,d 4±0.5f,g,h < -|b,e 4+0.5f'g'h
Ethyl N-acetyl- 
phenylaläninate 15 000+1000b,f 7.4j < -|C,e 4±0.5f'g'i
a; in 0.2 M KC1, 3 % acetonitrile at pH 7.5, at 2 5°C; the
second-order rate constants were determined under pseudo first- 
order conditions by dividing the first-order rate constants by 
the enzyme concentration; b: substrate concentration (0.5-5)x10_ M^; 
c: substrate concentration (1-3)x10~3 M; d: enzyme concentra­
tion 10“4 M; e: enzyme concentration 1 0“ 3 M; f: enzyme concentra­
tion 10"7 M; g: Kp values on N-acetyl-L-tyrosine ethyl ester 
(ATEE) hydrolysis, ATEE concentration (0 .5-2 )x1 0 _ 3 M; h: sub­
strate concentration (1 — 1 0 )x10 — 3 M; i: substrate concentration 
( 0 . 2 - 2 ) x 1 0 - 3 M; j: Ks value from Zerner et al. (1964).
plex. The similar binding constants of esters and thiono esters 
with their extremely different behavior in enzymatic reactions 
strongly suggest that substrate binding in the oxyanion bind­
ing site is critical in the transition state (tetrahedral 
adduct) while it is less important in the ground state (Michae­
lis complex) of the reaction.
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Table 3
Kinetic parameters of the reaction of subtilisin with oxygen
and corresponding thiono esters5
Oxygen ester Thiono ester
- 1 “Ik (M s ') K (mM) k(M- 1s~1) K (mM)
Methyl
N-benzoylglycinate 18±0.5c,i g±3e,f,g <o.6d'3 7±3e,f,g
Ethyl N-acetyl- 
phenylalaninate 25 000±1000e' 20±4e,i <2d,k 11±4e, '^k
a: in 0.2 M KC1, at pH 8.5, at 25 C, in 3 % acetonitrile; b: in 
8 % acetonitrile; c: enzyme concentration 10- 4 M; d: enzyme con­
centration 10~3 M; e: enzyme concentration 1 0~7 M; f: values
on ATEE hydrolysis, ATEE concentration (0.5-2)x10“3 M; g: sub­
strate concentration (2-15)x10"3 M; h: substrate concentration 
( 1 - 6 ) x 1 0 - 3 M; i: K value determined by the added nucleophile 
method (Bender et ll., 1964; Berezin et al., 1971); substrate 
concentration (5-15)x10“3 M, 1,4-butanediol concentration 0.11 
and 0.22 M; j: substrate concentration (0.5-5)x10- 4 M; k: sub­
strate concentration (1-3)x10“3 M.
Hydrolysis of oxygen and thiono esters by cysteine pro- 
teinases. A stereochemical mechanism for the action of papain, 
which was based on X-ray diffraction (Wolthers et al., 1970) 
and kinetic investigations (cf. Lowe and Yuthavong, 1971), 
suggested that the oxyanion of the tetrahedral intermediate was 
in a sterically non-restricted environment, i.e. without hydro­
gen bonding to papain (Lowe and Yuthavong, 1971). In contrast, 
from the three-dimensional structure of papain derivative form­
ed with a specific chloromethyl ketone inhibitor, the existence 
of an oxyanion binding site was deduced (Drenth et al., 1976). 
In order to clarify this contradiction, we measured the second- 
order acylation rate constants for the papain reactions 
<k = kcat/Km ) with the oxygen and thiono pairs of methyl N-ben- 
zoyl-glycinate and the more specific ethyl N-benzyloxycarbonyl- 
phenylalanyl-glycinate. It is seen from Table 4 that with the
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Table 4
Kinetic parameters of the reaction of papain with oxygen and
corresponding thiono esters5
Oxygen Thiono ester
k ^cat K k m ^cat Km
(M 1 s 1 ) (s_1) (mM) (M  ^s  ^) (s_1 ) (mM)
Methyl N-ben- 
zoylglycinate 1 20d 8.5d 72d 100e 0.1 5® 1 .5®
Ethyl N-Z-phe-
nylalanylglyci-
nate 360000f 1 1f 0.03f 15000g 1 . 5g 0 .1g
a: in 0.2 M KCl, pH 6.0, at 25°C, the second-order rate con­
stants were calculated from the kcat and Km values; b: in 16 % 
acetonitrile; c: in 0.5 % acetonitrile; d: substrate concentra­
tion 0.01-0.13 M, enzyme concentration 6x10-6 M; e: substrate 
concentration (0.5-10)x10“3 M, enzyme concentration 2x10-5 M; 
f: substrate concentration (1-10)x10-5 M, enzyme concentration 
5x10-8 M; g: substrate concentration (1-10)x10-5' M, enzyme 
concentration 1 0 - 6 M.
less specific substrate the oxygen and thiono derivatives exhib­
it similar rate constants, whereas with the specific substrate 
the thiono derivative is less reactive than the oxygen one, but 
the difference is much less (24-fold) than in the case of the 
specific substrates of serine proteinases (more than four or­
ders or magnitude).
Table 4 also shows the k , values, which in the case ofcat
the dipeptide derivatives is practically equal to the first- 
order deacylation rate constant, since the added nucleophile 
method (Bender et al., 1964) showed that the first-order 
acylation rate constant is at least 10 times as high as the 
deacylation constant. Thus, deacylation being rate-determining, 
its rate constant approaches the overall rate constant, kcat. 
Since the tetrahedral intermediate is formed also in deacyla­
tion, its stabilization at the oxyanion binding site is ex­
pected to be comparable to the stabilization of the tetrahedral 
adduct formed in the acylation step. In fact, the 7-fold dif-
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ference between the rate constants for the oxygen and thiono 
substrates is consistent with this assumption. Behause the de­
acylation rate constant is a simple kinetic constant not com­
plicated by binding, it is more meaningful with respect to the 
transition state stabilization than the composite acylation 
rate constant. In the case of the serine proteinases the de­
acylation could not be estimated, because the acyl-enzyme was 
not formed with the thiono substrates.
Table 5
Acylation and deacylation of thiol proteinases by the oxygen 
and thiono esters of N-benzyloxycarbonyl-phenylalanylglucinea
Oxygen ester Thiono ester
k k . K x1 05 k k , K x1 05cat m cat m
(M~1s_1) (s_1) (M) (M_1s_1) (s_1) (M)
Chymopapain-s'3 3 400C 0.25C 7.3° 540d 0.06 6d 1 2d
Papaya pepti­
dase Ae 1 27 ooof 6 .3f 5 f 15 500g 0.59g 3.8g
Ficin 53 ooof 5.6f 1 0.5f 10 ooog 1 .1g 1 1g
a: in 0.2 M KC1, at pH 6.0, at 25°C, substrate concentration 
(1-10)x10~5 M; b: enzyme purified according to Khan and Polgár 
(1983); c: enzyme concentration 5x10~ 7 M; d: enzyme concentra­
tion 5x10“® M; e: enzyme isolated according to Polgár (1981); 
f; enzyme concentration 2x1 0“7 M; g: enzyme concentration 
2x10“ 6 M.
By the same method we also tested cysteine proteinases 
other than papain. The results obtained with chymopapain, 
papaya peptidase and ficin are shown in Table 5. From the data 
one can conclude that replacement of sulfur for the oxygen atom 
does not seriously affect either the acylation or the deacyla­
tion with either cysteine proteinase.
A comparison of our results obtained with the serine and 
cysteine proteinases is presented in Table 6 showing the ratios 
of the second-order rate constants for the oxygen and the cor­
responding thiono substrates.
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Table 6
Acylation of serine and cysteine protelnases: ratios of the 
second-order rate constants of the oxygen and the 
corresponding thiono esters
Serine Proteinases Cysteine Proteinases
Chymo­
trypsin
Subti-
lisin Papain
Chymo-
papain-S
Fapaya
pepti-
dase-A
Ficin
Non-specific
substrate
Methyl N-benzoyl- 
glycinate >30 >30 1 . 2 0.4 - -
Specific
substrate
Ethyl N-acetyl- 
phenylalaninate >10 000 >10 000 - - - -
Ethyl N-Z-phenyl- 
alanylglycinate - 24 6.3 8 . 2 5.3
It is seen that with the specific substrates of serine 
proteinases the ratios are more than four orders of magnitude 
whereas with cysteine proteinases they are only one order of 
magnitude. This implies the importance of oxyanion binding in 
the catalysis by serine proteinases but not in the catalysis 
by cysteine proteinases, which appears to be an important dif­
ference in the mechanisms of the two types of proteinases. 
Since most of the mechanistic features of the serine and cys­
teine proteinases are common, it is usual to assume that they 
operate via the same mechanism. We have already pointed out a 
significant difference, i.e., with serine proteinases the nuc­
leophilic attack on the substrate is a general-base catalyzed 
process whereas with cysteine proteinases it is not catalyzed 
(Polgár, 1973). By comparing the reactions of oxygen and 
thiono esters, we presented here another important difference 
in oxyanion binding.
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DISCUSSION
BARRETT:
The serine and cysteine groups of proteinases each consists 
of more than one homologous group. You have shown that the 
serine proteinases of the trypsin/chymotrypsin and sub- 
tilisin families are similar, but all the cysteine pro­
teinases were from the papain superfamily. Would it be 
worth trying some others, like clostripain or strepto­
coccal cysteine proteinase?
POLGÁR:
We didn't study thiol proteinases evolved in a different 
way as those of the papain family. However, since the 
active site appears to be alike in the most important 
respects, it seems probable that all cystein proteinases 
lack oxyanion binding.
STEPANOV:
Have you tested the thionoesters as inhibitors of serine 
proteinases?
POLGÁR:
Yes, thionoesters depending on their binding constant can 
be good inhibitors. They may become a new type of pro­
teinase inhibitors.
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ELŐDI:
It was recently described by Powers and his associates 
(McRae et al., Biochemistry, ^0, 7196, 1981) that peptide- 
thlolesters are fairly good substrates for thrombin. 
According to your data on Chymotrypsin and subtilisin, 
O-esters are much more favourable than S-esters. Is this 
finding characteristic of proteinases? If not, how would 
you interpret the contradiction between your and Power's 
data?
POLGÁR:
Thiolesters are better substrates than alkylesters since 
they have better leaving groups. They are actually inter­
mediates between alkyl and nitrophenyl esters.
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SUBSTRATE AND SOLVENT ISOTOPE EFFECTS AND "PROTON INVENTORIES" FOR THE ELUCIDATION OF CATALYTIC STRATEGIES OF SERINE PROTEASES*
KOVACH, I.M. and SCHOWEN, R.L.
Department of Chemistry, University of Kansas,
Lawrence
Kansas, USA
Our investigations of serine protease enzymes have been 
conducted in the perspective of revealing underlying catalytic 
strategies, that is an assembly of interactions between sub­
strate and dynamically vital functional groups on the enzyme, 
used in their innate biological functions. Through careful se­
lection of a series of molecular structures, the chemical con­
straints imposed on catalytic efficiency of each particular 
enzyme can be discerned (Fersht, 1977). To comply with biolo­
gical and chemical constraints enzymes have to evolve to an 
optimal distribution of transition state (TS) stabilization 
between V/K terms and V terms (Stein et al., 1983). An econom­
ical use of the free energy released upon binding of the tran­
sition state for the uncatalyzed reaction to the enzyme may 
be a major, albeit not the only determinant in catalytic ac­
celeration (Gandour and Schowen, 1978 Ch. 2; Jencks, 1975). 
Other factors are reduction of stable and intermediate state 
stabilization.
Serine protease enzymes have achieved, in the course of 
evolution, a remarkable level of catalytic acceleration (MO 9 
fold) (Zerner et al., 1964) for the release of the acyl frag­
ment of the substrate. The catalytic entity operating with 
such efficiency includes in addition to the serine a chain of 
general acid-base residues (ABCE); His, Asp, and perhaps
This research was supported by the National Institutes of 
Health through Research Grant GM20198 from the National 
Institute of General Medical Sciences.
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others. The dynamics of this machinery is the subject of our 
inquiry. We obtain information on the nature of the transition 
state through our kinetic studies, which is often different 
from conclusions that might be drawn from measurements on the 
resting state of the enzyme (Polgar and Halász, 1982).
A dual approach has been taken to the mechanistic details 
of protease catalysis. The acid-base catalytic chain contains 
exchangeable hydrogenic sites, which, if active in catalysis, 
should manifest this in solvent isotope effects (SIE). The 
number of protonic sites contributing to the overall solvent 
isotope effect can also be estimated from studies of reactions 
in mixtures of isotopic water, a method dubbed "proton inven­
tory" (PI) (Gandour and Schowen, 1978, Ch.6 ; Schowen and 
Schowen, 1983). In a mixture of H^O and D2O, populations of 
isotopically substituted subspecies exist (the substrate has 
either exchangeable sites or a mixture of isotopically dif­
ferent solvates). The concept of fractionation factors, a 
ratio of deuterium enrichment relative to protium in a par­
ticular site of a molecule in a mixture of H^0:D..0=1 :1 (Eq.(1))
has been introduced to quantitate isotopic content of a site.
SH + LOD SD + LOH
[sd] [loh]
<)> = ----— ---— (inverse of SIE*) (1)
[shj [lodJ
The populations of various sub-species can be related, with 
appropriate assumptions, to fractionation factors of TSs(j)T>, 
to those of the reactants (<j>R) , and to the mole fraction (n) 
of D2O in H2O according to the Gross Buttler equation (2)
VTk n (1-n + n<f> . )
= ^ -----------  (2)IT (1-n + n<f>R)
(kQ = rate constant in pure H20 )
*The SIE = 1.64±0.04 at pH - 6.00 is more precise than the 
value obtained from the pH independent kcat values (1.40±0.14) 
This discrepancy, if real, may arise from a further shift of 
the rate limiting step from the chemical steps towards phy­
sical rearrangements.
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Quite frequently, (j>R%1 , consequently Eq. (2) then reduces to 
the numerator, which can take linear, quadratic or other poly­
nomial forms. An exponential dependence can be derived and ob­
served if generalized solvation or subtle enzyme conformational 
changes give rise to isotope effects. These are generated from 
a large number of very small effects.
A complementary investigation of the TS status at the 
carbonyl and surrounding atoms (core) by the use of a and ß 
deuterium secondary isotope effects has further expanded our 
insight into the mechanism of protease action. A structural 
plasticity of the core region can be inferred from such sub­
strate isotope effects. Direct deductions of characteristics 
of the force field in the transition state, near the isotopic 
center, can be made from substrate isotope effects (Gandour and 
Schowen, 1978, Ch. 5). The force fields, on the other hand, 
can be related to the positions of the atoms (B = Pauling Bond 
order) in these TSs by using vibrational analysis methods (Hogg 
et al., 1980; Kovach et al., 1980).
In acyl transfer reactions through the addition elimina­
tion mechanism, D-substitution on the carbon adjacent to car­
bonyl is expected to increase the rate. The reason for this is 
a certain degree of loss, at the quasi-tetrahedral TS preceding 
and succeeding the tetrahedral intermediate, of the hypercon­
jugation from the ß-CH(D) bond into the pi orbital of the car­
bonyl that stabilizes the trigonal ground state. This increases 
electron density in the bonds at the TS and strengthens them 
leading to an inverse isotope effect. The limiting effect cal­
culated from comparable equilibria , K /Kn = 0.955 per D, for 
complete conversion of an sp carbon to sp (at carbonyl) 
(Kovach et al., 1980a, b; Kovach, 1982). A single measure of 
tetrahedrality is expressed by Eq. (3),
kH/kD = ‘W 1 <3)
where I is the fractional progress towards tetrahedrality.
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A variety of enzyme and substrate combinations have been 
studied by these tools to assess the extent to which the TS 
status of proton translocation is correlated with the progress 
of heavy atom reorganization at the core TS.
Utilization of the proton relay system
In a systematic approach to the resolution evolutionary 
of constraints to catalysis by serine proteases, initial 
studies included minimal substrates that lack most of the 
structural features of the natural substrate. In this circum­
stance, the enzyme is deprived of subsite interactions with 
substrate derived structural units in the catalytic TS. These 
systems exhibit one proton catalysis. The enzymes, presumably, 
rely on the proximal hydrogen bridge of the ABCE, in the manner 
of nonenzymic protolytic catalysts. Proton inventories of the 
deacylation of acetyl-chymotrypsin, acetyl-elastase and acetyl 
trypsin are good examples with SIE-s 2.4, 2.45,and 1.4 res­
pectively (Elrod et al., 1980). The first two are similar to 
SIEs for general catalysis in organic reactions. The value of 
1 .4 is too low even for a single proton solvation bridge and 
may indicate a partial nucleophilic attack by histidine fol­
lowed by an N-0 transacylation and hydrolysis. Hubbard and 
Kirsch (1972) found their data for acylation of a-chymotrypsin 
by reactive esters to be consistent with such a model.
A non-linear proton inventory for the acylation of a-lytic 
protease by p-nitrophenyl acetate (PNPA) has also been observed 
(Quinn et al., 1980). The simplest interpretation of this pro­
file is that both reactant and TSs contribute subunit frac­
tionation factors, i.e, have loosely bound protons. The best 
fit to this model gives <|> = 0.39 + 0.01 and <f>R = 0.81±0.01.
The value 0.8 calculated from this model can be compared with 
<j)R = 0.6, which is suggested by the pKa difference in 1^0 and 
D2O taken <f>R to be ”v1 for the protonated enzyme. It might be 
conjured then that the ionized enzyme has a single protonic 
site with an unusually "loose" potential, which becomes in­
volved in catalysis and then the bond gets weaker at the TS. 
Alternatively (0.8) = 0.6 so that two protonic sites, which
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are generated on conversion of EH to E, may be available one 
of which participates in catalysis.
A transition toward more natural substrates such as oligo­
peptide analogs can be shown through a series of examples. The 
first two of these are with truncated substrates that, however, 
contain a Ca-chain (Elrod et al., 1980). One of these reactions 
is the acylation of elastase by N-CbzAla-p-nitrophenyl ester 
(N-CbzAlaONP). A linear proton inventory with a single protonic 
site generating a SIE of 1.75 emerges from this study. The 
other case is linear proton inventories with substantial SIE-s 
of ^3.0 for deacylation reactions of N-benzoyl-Arg-thrombin and 
trypsin.
One of our more recent endevours is the investigation of 
the acylation by N-CbzGly-ONP and the ensuing deacylation of 
the bacterial serine protease, subtilisin BPN. Fig. 1 portrays 
the pL (L=H,D) profile of acylation where the SIE stays close 
to unity throughout the pH range studied. The pH-s of the free
Fig. 1: Bi-molecular rate constants (10~5 kcat/Km , M"^s_1) 
for acylation of subtilisin BPN by N-CbzGlyONP as 
a function of pL (L=H,D) at 25.Ű+0.1OC, and y=0.27.
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enzyme are 7.4+0.1 in H20 and 8.00+0.15 in D2<D and the limiting 
velocities for the bimolecular reaction between enzyme and sub­
strate are (1.62 + 0.15)x10^ M "'s  ^ in H.O and (1 .51 + 0.20) x1 0®
- 1 - 1  Z M s D20 calculated from regressional analysis fit of the
data to Eq. (4) .
k = kllm Ka/(Ka + aH)
k = k . or k /K cat cat m
(4)
The values obtained in H20 are in good agreement with those 
reported by Philipp et al. (1979).
Fig. 2: Unimolecular rate constants (k t, s 1) for de­
acylation of N-CbzGly-subtilisin BPN, as a func­
tion of pL (L=H,D) at 25.0+0.1 °C and y=0.27.
In Fig. 2 the pL profile of the deacylation step is pre­
sented with SIEs 'vl.5 at points of identical fraction of the 
catalytically active unprotonated subtilisin. The pKs are
6.85+0.03 and 7.45+0.02 in H„0 and D_0 respectively. The pH
Z Z -1independent values of kcat are 105 + 9 s in H2<D and 73.5±6 s 
in £>2° ’ Thus, the apparent pK of the ES complex is ^0.4 unit
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lower than that of the free enzyme, while the ApK of 0.6 be­
tween H^O and D20 is preserved as close as can be inferred 
from the data. Such substrate dependent change in the pK of an 
enzyme upon binding of a substrate may be attributed to confor­
mational changes. Cleland (1982) pointed out the possibility of 
a partially rate limiting product release from the enzyme in 
cases when the pK shift occurs outward on the pH-k . profile. 
Nonproductive binding may also result in artificial pK values 
(Fastrez and Ferst, 1973).
Fig. 3:
PI. Rates of deacylation of 
N-CbzGly-subtilisin BPN as 
a function of n, the mol 
fraction of D2O in H2O at 
25.0±0.1 oc, pH = 6 .00 (and 
equivalent phosphate buffer), 
and y=0.27.
“ '“0 0.5 1
n
A PI has also been carried out and is given in Fig.3 for 
the deacylation of N-CbzGlyONP at pH=6.00* This may be another 
example of a "bulging up" curve, although the quality of data 
and the small size of the SIE do not permit a clear distinction 
between a linear one site model with tJ>T = 0.64±0.03 as the 
dashed line indicates and various two site models. We find the 
most consistent with the aforementioned pK shift of the kcat
term, the curved proton inventory, and our 6DIE results, vide 
infra, a consecutive two step model in which partially rate 
limiting product release follows a partially rate limiting 
breakdown of the tetrahedral adduct of water and the acyl en­
zyme. Such a scheme is consistent with the kinetic expression 
of Eq. (5)
kncat
kn kn 1 2
k -1 + k 2
(5)
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with two sequential TSs (cj>T1 and <|> 2) . The proton inventory 
data fit to such scheme is accounted for in Eq. (6), which 
simplifies to Eq. (7) in the case of <|> = 1 as for an isotopi-
cally insensitive or physical step (w^  and w2 are weighting
kn (1-n + n<|>T 1)(1-n + n<J>T2)
k° w^ (1-n + nct>T 1) + w2 (1-n + n<J>T2)
(6 )
Rn (1 -n + n4>T1 )
k° w (1 -n + n<t>T1) + (1-w)
(7)
factors K^/(k_^ + k2) and k2 /(k_^ + k2> respectively and their 
sum - 1) . The curve on Fig. 3 has been generated with <f>T  ^ =
0.33+0.02, and w 1 = 0.7±0.06 through nonlinear least squares 
fit of our data. Consequently, the contribution of the acid 
base catalytic TS is ^0.3 followed by a TS with a weight of
0.7 and a SIE 'vl. SIEs of 3.0 have been observed in the proto- 
lytically assisted deacylation of subtilisin Carlsberg by Pol­
gar and Bender (1979) and Matta et al. (1975) with a variety 
of acyl moieties. It is an unanticipated finding that the 
minor structural differences between the two species of sub­
tilisin can result in such a shift towards a rate limiting step 
other than the bond breaking and making steps.
A much stronger response is elicited from a-chymotrypsin 
to the presence of even a single feature of the natural sub­
strate such as the first peptide unit in N-CbzGlyONP (Stein 
et al. , 1 983). Fig. 4 shows comparative Pis for the deacylation 
of acetyl a-chymotrypsin and porcine elastase and their CbzGly 
analogs. Both acetyl enzymes demonstrate one proton catalysis 
with SIEs ^2.4. N-CbzGly-elastase retains this character, 
whereas N-CbzGly-chymotrypsin shows curvature of the PI plot, 
which is best described by two proton catalysis with two sites 
of identical fractionation factors (1/1 .8 ) contributing.
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Fig. 4:
PI. The straight line 
represents combined 
data for reactions of 
acetyl-chymotrypsin, 
-elastase, and 
N-CbzGly-elastase, the 
curved line represents 
deacylation rates of 
N-CbzGly-chymotrypsin 
as a function of n, 
the mol fraction of 
D20 in H20 at pH = 4.7, 
and for 25.0±0.1 oc. 
The dashed line 
connects the point 
n=0 with that for 
n=1. (Reproduced with 
permission from 
Stein et al., 1983.)
It might be noted that the manifestation of the catalytic 
proton relay network is considerably different in the inter­
action of Chymotrypsin, elastase, and subtilisin with the de­
acylation TSs of their N-CbzGly-derivatives.
Two or multiproton catalysis has been observed in other 
cases of protease reactions when some element of the evolu- 
tionarily anticipated structure was provided. Addition of the 
Ca-side chain as in CgHj-Cf^CH^COO-NP resulted in a concave 
proton inventory for the deacylation of Chymotrypsin with 
4>Ti = 1/1.9 and <j>T2 = 1/1.5 as best fit (Elrod et al., 1 980).
A paradigm of multiproton catalysis is the reaction of trypsin 
with the oligopeptide BzPheValArg-p-nitroanilide (ONA). Fig. 5 
presents a comparison of Pis of trypsin reactions with PNPA, 
BzArg-ethyl ester, and BzPheValArg-ONA. The progression toward 
larger SIEs (1.4, 3.0 and 4.3 respectively) as well as to two 
proton catalysis is obvious. The contributing sites to the
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Fig. 5:
PI. Rates of acylation of 
trypsin by N-BzPheValArg-PNA 
and of deacylation of N-BzArg- 
and acetyl trypsin as a func­
tion of mol fraction of D2O 
in H2O at pH=8.00 and 
25.0±0.1 °C. The dashed line 
connects points n = 0 and n=1 
for the acylation reaction.
Fig. 6 :
A schematic structure of the 
ES complex of trypsin, which 
occurs after C-N bond breakage. 
The dark circles symbolize 
the acetyl group attached to 
the serine arm. Addition of 
the heavy circles depicts the 
position of a truncated sub­
strate. Inclusion of all 
these and the shaded circles 
describe orientation to an 
oligopeptide substrate. The 
acid-base catalytic chain 
begins at the histidine in 
the upper left corner and 
extends leftwards.
(Reproduced with permission 
from Schowen and Schowen,
1981.)
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BzPheValArg-ONA reaction have SIEs of 2.1 each actually ap­
proaching the values obtained in model reactions. A specula­
tive structure of the trypsin complex with peptide analogs is 
presented in Fig. 6 . The core, i.e. the three atom fragment is 
shown in dark circles and is attached to the serine arm. 
Inclusion of the heavy circles aids in envisioning the orien­
tation of a truncated substrate. Further addition of elements 
indicated as shaded circles to the rest of the structure com­
pletes the portrayal of probable interactions between trypsin 
and oligopeptides (Schowen and Schowen, 1981).
Structural variations at the transition state of the core
Secondary a and ß-deuterium isotope effects (a or ßDIE) 
have found great utility in the assessment of structural plas­
ticity of the TS in nucleophilic reactions (do Amaral et al., 
1979; Kovach et al., 1980a, b; Kovach, 1982; Kovach and Quinn, 
1983). Table 1 features ßDIEs of two fundamental reactions of 
phenyl acetate and formate; nucleophilic attack of hydroxide
Table 1
Secondary isotope effects in nonenzymic acyl transfer
System in
kH/kD TaH20, 25°C I
nucleophilic catalysis
HO + PNPA 0 .98(ß-D^) 0. 15
proteolytic catalysis
four examples of 0.81 3-0.833(a-D) 0.58-0.66
hydrolysis of aryl 
formates and acetates 0.914 (ß-D3) 0.65
aFor a-D effects, I = log(kn/kD)/lpg 0.73 (do Amaral 
et al. , 1 979); for 8 - 0 3 effects, I = log(kH/k£)) log 0.87 
(Kovach et al., 1980)
ion with a small progress toward tetrahedrality and the general 
base catalyzed reaction of acetate ion with a quasi-tetrahedral 
TS more than half way developed. This latter process is remini-
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scent of the enzymic deacylation. The I values indicate the 
significant quantitative difference in progress along the re­
action coordinate of the two reactions. Yet, the free energy 
difference between the two TS-s, calculated from the rate con­
stants is only 3.6 kcal/mol. This bespeaks of a great flexi­
bility of the TS structure on the expense of just a small 
energy. The implication of this phenomenon to biological evolu­
tion is nontrivial, since an acyl transfer enzyme may take 
advantage of a chemical opportunity with a modest expenditure.
Table 2
Secondary isotope effects in the deacylation of 
serine protease acyl enzymes
System in 
H20, 25°C kB/kD ia
LCO-Chymot ryps in 0.87 0 + 0.023b 0.44
CL3CO-Chymotrypsin 0.940 ± 0 . 0 1 0 0.44
CbzNHCL2C0 -Chymotrypsin 0.925 + 0.009 0.84
PhCH2CL2CO-Chymotrypsin 0.950 + 0 .0 1 0c 0.54
CL3CO-Elastase 0.975 + 0.007 0.27
CbzNHCL2CO-Elastase 0.961 + 0 . 0 1 0 0.43
CbzNHCL2C00Hp + 
Subtilisin
0.963 + 0.013 0.40
CbzNHCL2CO-Subtilisin 1 .01 ± 0.03
i n  o  1
0 . 0
bLehrman et al., 1980. cFujihara et al., unpublished.
Table 2 lists results of a and ßDIEs of reactions of pro­
tease enzymes (Stein et al., 1983; Fujihara et al., unpublish­
ed; Lehrmann et al., 1980). With minimal substrates, the de­
acylation of both Chymotrypsin and elastase have TS-s less 
tetrahedral in character than the nonenzymic analog (1=0.44 
and 0.27). The difference between the two enzymes is also 
marked. Both acetyl-enzymes exert an "explosive" effect, 
lengthening the bond between the carbonyl cargon and the atom, 
which interacts with the protonic bridging of the ABCE.ßDIEs for 
the CgHj-Ci^CL^CO and N-CbzGly-enzymes are more inverse with 
Chymotrypsin and elastase. Compression of these structures
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toward sp hybridization with respect to the acetyl analogs is 
expressed in the changes of the values of Í; 0.44 -► 0.54-0.84 
for Chymotrypsin and 0.27 -» 0.43 for elastase. The latter is 
still slightly exploded relative to the nonenzymic TS, whereas 
N-CbzGly-chymotrypsin has a more compressed TS. The main dif­
ference between the structure of these two enzymes lies in the 
specificity pocket "south" of the serine residue (Fig. 6 ). 
Chymotrypsin has a large open hydrophobic cavity, while elastase 
has only a small depression where not more than a Ca-methyl 
side chain is anticipated. In other words, a small substrate 
offers much less in terms of interactions than expected by 
Chymotrypsin but not that much less than what elastase can 
accomodate anyway.
The acylation TS of subtilisin is mostly like the base 
line TS (I = 0.5), which fact together with a SIE of unity 
seems to be compliant with the proposition of a protolytically 
unassisted nucleophilic attack by the histidine of subtilisin,
much like the case, that Hubbard and Kirsh (1972) reported.2A negligible alteration of the sp hybridized structure at the 
TS of CbzGly-subtilisin deacylation can be surmised from the 
absence of ßDIE. This is consistent with the picture that 
emerged, vide supra, from the SIE studies. If the TS for pro­
tonic reorganization and (coupled) heavy atom rearrangement 
is only 0.3 fraction of the highest energy barrier along the 
reaction path, the most inverse ßDIE to be realized is 
1x0.7 h 0.91x0.3 - 0.975. Moreover, such a TS might well be 
quite late preceding a high energy product state as suggested 
in structure I and therefore be quasi-trigonal or product-like.
NH •H- - - - - 0  8------H —  n h-c h2-
1-0 0.0
0T = 0.33 L
(I)
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Correspondence between proton transfer and heavy atom 
rearrangement in proteases
An attractive interpretation of the combined results of 
the two diagnostic probes of protease mechanism is that serine 
proteases use a mechanical leverage on the serine arm and on 
the carbonyl oxygen of the substrate to explode the carbonyl 
structure (Scheme I; Schowen et al., 1981). The polypeptide 
tail via hydrogen bonding interactions can exert a compressive
P O S S I B L E  
E X P L O S I V E  
I N T E R A C T I O N S  
( S E R I N E  A R M  ; 
O X Y A N I O N  C E N T E R )
P I V O T I N G  
B L O C K I N G  
L E V E R A G E  O R  
O T H E R
I Ca S I D E  -  C H A I N I
Scheme I: Proposed interactions of various elements of a 
substrate with catalytically vital subunits of 
serine proteases. (Reproduced with permission 
from Schowen, et al., 1982.)
force across the proton relay chain. A balancing role of the 
Ca-side chain to proportionate the two effects is evident for 
Chymotrypsin, where the lack of it results in "overshooting"
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compression at the carbonyl structure as well as at the proton 
relay apparatus as it is the case when only N-acyl interactions 
are present. The compressive effect is less in elastase where 
the active site is more rigid since a substantial Ca-side chain 
pivot cannot be accomodated.
A comparison with amidohydrolases
Amidohydrolases, a group of enzymes very similar in their 
catalytic makeup to serine proteases, have also been studied 
by the two-fold approach described (Quinn et al., 1980). High­
lights of PI results in this connection are the observation 
of two or multiproton catalysis by asparaginases from E.coli, 
Proteus vulgaris and Erwinia coratovora in the rate determining 
expulsion of NH^+ from the ES complex, both from the reaction 
with the natural substrate, Asn, and with Erwinia coratovora, 
the reaction with succinamate ion (Eq. (8)).
RCH2CONH2 + E-OH +— +• RCH2COO-E + NH4 +
RCH2COO-E + H20  * RCH2COO_ + EOH (8)
SIE-s in all four cases are 2.6-3.3 with contribution of the 
two sites each 1.6-1.8. When, however, TS complementarity to 
the active site is removed, recruitment of the full acid-base 
catalytic capacity of the enzyme falls short. This was the 
case with glutamine as a substrate for two asparaginases that 
showed single site general acid participation. Reactions of 
Asn and succinamate ion with Erwinia asparaginase are being 
studied in our laboratory currently (Paborji et al., unpublish­
ed). A 8DIE = 0.95 and a SIE =1.5 for the succinamate ion 
suggests a rate determining nucleophilic attack by the enzymic 
hydroxyl assisted by a single proton catalysis. Asn also shows 
a single proton catalysis with SIE = 1.4 akin to the one site 
of the two proton processes. Rates and SIE-s are the same for 
Asn and succinamate ion for the expulsion of NH4 + from the 
tetrahedral adduct (ES). ßDIEs for this step with several sub­
strates and all three asparaginase enzymes are greater than
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3 2one, indicative of a sp sp rehybridization as in rate de­
termining breakdown of a tetrahedral intermediate. Such inter­
mediate is expected to accumulate under saturating conditions. 
These results are supportive of a weak specificity requirement 
in the catalysis by some asparaginases.
CONCLUSIONS
Serine proteases generally have a greatly variable struc­
ture at the active site. In response to the specific substrate 
structure, reaction conditions such as temperature, pH and salt 
concentration, any one enzyme can select from an arsenal of 
pathways and rate determining steps the one with the lowest 
energy cost. The accessible pathways can converge into one as 
the physiological substrate structure is approached, i.e. the 
complementarity between substrate and enzyme is fulfilled.
A speculative suggestion is that serine proteases can 
achieve mechanical deformations through sufficient leverage 
(Schowen et al., 1981). Such deformations can serve in inter­
mediate stabilization an extreme case of which is generation 
of a covalent acyl intermediate. It may be that such deforma­
tion is necessary to permit the formation of the optimal TS 
structure involving the proton relay. The coupling of this 
hydrogen bond chain to the heavy atom rearrangement can provide 
the ideal length between the carbonyl carbon and the atom 
partially bonded to it to give the energetically correct acid- 
base property at the TS.
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DISCUSSION
POLGÁR:
Did you measure the deacylation rate in the pH independent 
region?
KOVACH:
Proton inventories have been measured in the pH independ­
ent region of the respective parameter in every case 
except for the deacylation reaction of Cbz-Gly-subtilisin. 
In the latter case the solvent-isotope effect had been 
shown to remain 1-5 throughout the pH range studied, thus 
the proton inventory was measured at pH 6.00 for conven­
ience, i.e. greater precision.
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PROTEINASES AS TOOLS IN PEPTIDE SYNTHESIS, SYNTHESIS OF SUBSTRATES FOR PROTEINASE ASSAY
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Proteolytic enzymes including those produced by micro­
organisms have found application in various fields. One of the 
most recent trends consists in their use to catalyse the syn­
thesis of peptide bonds. This line of research might be easily 
traced until late thirties, but only recently revival of old 
ideas on the basis of modern enzymology have lead to develop­
ment of preparatively valuable synthetic procedures.
Among numerous advantages of enzymatic peptide synthesis 
the most obvious are:
- synthesis at very mild conditions;
- stereoselectivity and the absence of racemization danger;
- structural selectivity that allows to avoid in many 
cases the protection of functional groups, etc.;
- tolerance towards many admixtures including those found 
in commercially available starting materials;
- essential absence of by products.
Of course, one should not overlook rather strong limita­
tions imposed by very nature of this approach. Without going 
into detailed discussion of this matter, one might point out 
the following ones:
- the methods used to shift the equilibrium toward syn­
thesis are rather limited. Precipitation of the product, its 
selective transfer to organic phase, the use of the solvents 
with low water content, the excess of one of the reactants, as 
well as the application of specifically activated derivatives 
are predominantly used to this end. Obviously, new ways are
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to be searched, e.g., selective sorption of the product or the 
coupling of the synthesis with other reactions;
- the specificities of the enzymes used do not provide 
free choise of the peptide structures to be synthesised. To 
overcome this problem the use of enzymes side specificities 
might be tried, but substantial broadening of the enzyme col­
lection used for the synthesis appears to be more promising 
approach.
It appears that in the future the proper choice of the 
stategy and tactics coined to satisfy the specific demands of 
enzymatic synthesis would be of crucial importance for success­
ful development of the method. In particular, specially design­
ed protecting groups should open additional possibilities for 
application of proteinases in peptide synthesis.
In this paper we discuss the experience in the enzymatic 
peptide synthesis gained recently in our laboratory by L.A . 
Lyublinskaya, E.N. Lysogorskaya, T.L. Voyushina, E.S. Oksenoit,
I.Yu. Filippova and S.E. Boitsova. Our efforts were mainly con­
centrated on the synthesis of the peptides that might be used 
as chromogenic substrates for proteinase assay.
In the first series of our experiments we applied thermo- 
lysin or related metalloproteinase from B.subtilis to catalyse 
the synthesis of N-protected tripeptide p-nitroanilides (Lyub­
linskaya et al., 1982) (Table 1). The choice of these enzymes 
was dictated by their specificity that demands the place in 
the resulting peptide to be occupied by a hydrophobic amino 
acid. The favourable equilibrium shift was provided by the 
precipitation of a rather hydrophobic product from the reac­
tion mixture that contained substantial concentration of di- 
methylformamide.
As a rule, the yields approached the quantitative ones, few 
deviations are to be explained by inevitable losses during the 
isolation of the peptides. It appears that in all cases the 
^equilibrium was attained. Rapid formation of the precipitate 
indicates very high velocity of peptide synthesis. Duration of 
the synthesis dictated by technical considerations substantial­
ly overcomes the time necessary for reaction completion.
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Table 1
The synthesis of p-nitroanilides of tripeptides catalysed with 
thermolysin (TL) and B.subtilis metalloproteinase (BS)
Components Conditions Yield
Z-Ala-Ala-OH + H-Leu-NH-C,H.N0„ 6 4 2 TL 3 min, 25° 94 %
Z-Ala-Ala-OH + H-Leu-NH-C-H.N0_ „ T 6 4 2 TL, 20 min, 37° 93 %D ,L
Boc-Ala-Ala-OH + H-Leu-NH-C,H.NO- 6 4 2 TL, 2 h, 37° 76 %
Boc-Ala-Ala-OCH3 + H-Leu-NH-C.H.NO^ 6 4 2 TL, 4 h, 3 7C 67 %
Z-Gly-Gly-OH + H-Leu-NH-C-H-N0- 6 4 2 TL, 17 h, 37° 84 %
Z-Ala-Ala-OH + H-Phe-NH-C,H.N0n 6 4 2 TL, 30 min, 25° 88 %
Z-Ala-Ala-OH + H-Leu-NH-C^H„NO- 6 4 2 BS, 5 min, 25° 85 %
Boc-Ala-Ala-OH + H-Leu-NH-C,H NO. D, L 6 4 2 BS , 15 min, 25° 84 %
It is important,, that D,L- H-Leu-NH-CgH NC>2 might be used 
instead of L-isomer without noticeable drop in the yield, com­
mercial crude preparations of p-nitroanilides also give satis­
factory results. Even more interesting appears the successful 
synthesis of the tripeptide from leucine p-nitroanilide and 
benzylocycarbonyl-alanyl-alanine methyl ester. This reaction 
cannot be considered as a simple reversal of hydrolysis, we 
did not find any example of peptide bond alcoholysis catalysed 
by thermolysin. So far as no noticeable saponification of the 
peptide methyl ester was observed, it appears that the ester 
participates in the enzymatic reaction. This result might be 
useful for elucidation of the catalytic mechanism of metallo- 
proteinases. Voyushina and Lyublinskaya have shown that the 
combined use of thermolysin for peptide bond formation and oi 
subtilisin for subsequent removal of p-nitroanilide moiety from 
the C-terminus allowed step-wise elongation of the peptide chain. 
This approach is illustrated by the following examples:
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Obviously, in these syntheses p-nitroaniline acted as a 
rather convenient C-protecting group, although its application 
was handicapped by cumbersome preparation of amino acid p-nit- 
roanilides.
Peptide p-nitroanilides synthesised by this route are 
regularly used in our laboratory for assay of various bacterial 
serine proteinases - subtilisins, thiol-dependent serine pro- 
teinases, intracellular serine proteinases of bacteria etc.
All these enzymes were assayed by the measurement of p-nitro­
aniline amount set free after hydrolysis. Comparison of their 
efficiency as the substrates have revealed rather strong in­
fluence of the residue P^  and the participation of at least 
two preceding residues - P2 and P^ in the binding of the sub­
strates by the enzyme.
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1. Z-Gly-Ala-OH + H-Leu-NH-CgH^ ^ | r m o ^ i n _ _  ^
„ T „„ ,, „ subtilisinZ-Gly-Ala-Leu-NH-C6H4N02 yield 87 % *
Z-Gly-Ala-Leu-OH + H-Phe-NH-C6H4NC>2  yield°71^S%^—
Z-Gly-Ala-Leu-Phe-NH-C6H4N02
2. Z-Gly-Ala-OH + H-Phe-NH-C^NO., - ^ 1 ^ 3 1- & r
Z-Gly-Ala-Phe-NH-C6H4N02 ..>
Z-Gly-Ala-Phe-OH + H-Leu-NH-C^NO., yield°72-'9~2' %"
3. Z-Gly-Gly-OH ♦ H-Phe-NH-CgH^ -
Z-Gly-Giy-Phe-NH-C6H4N02 - *
Z-Gly-Gly-Phe-OH + H-Leu-NH-C6H4N02 g ” %-* 
Z-Gly-Gly-Phe-Leu-NH-C6H4N02
These substrates are poorly soluble in water that makes 
it necessary to add an organic solvent - dimethylformamide or 
dimethylsulfoxide to the assay mixture. Organic solvents, 
especially, dimethylformamide may act as concurrent inhibitors 
that induced us to look for less hydrophobic peptides. It turn­
ed out that the introduction of pyroglutamic acid residue as 
an amino protecting group allowed to improve the solubility of 
p-nitroanilides in water. Thus, Pyr-Ala-Ala-Leu-NH-CgH^NO^ has 
been found to be an excellent substrate for subtilisins and 
especially for serine enzymes from halophilic bacterium Halo- 
bacterium halobium and from Streptomyces rutgersensis. Both 
these enzymes show no activity against Z-Ala-Ala-Leu-p-nitro- 
anilide apparently being heavily inhibited by dimethylformamide.
The same principle of substrate hydrophilisation via in­
troduction of pyroglutamic acid residue was successfully applied 
for the synthesis of the substrates suitable for papain and 
other cysteine proteinases. To this end E.N. Lysogorskaya and 
her colleagues in our laboratory at Moscow State University 
pursued the following scheme. Pyr-Phe-OCH^ was prepared by 
H-Phe-OCH^ acylation with pyroglutamic acid pentafluorphenyl 
ester. The product separation from the residual pyroglutamic 
acid might be rather cumbersome, but for the enzymatic syn­
thesis this procedure is quite superfluous so far as pyro­
glutamic acid would not participate in the further condensa­
tion with leucine p-nitroanilide catalysed by Chymotrypsin:
Pyr-Phe-OCH + H-Leu-NH-C,H.N0o Chymotrypsin (_3 6 4 2  yield 79 %
Pyr-Phe-Leu-NH-C,H.NO-D 4 z
This p-nitroanilide was found to be convenient chromogenic 
substrate for papain that is to be explained by the presence of 
hydrophobic residue - that of phenylalanine in P^ position. The
hydrolysis of leucine - p-nitroaniline bond proceeds optimally_ 3at pH 6 in the presence of 3x10 M dithiothreitol and 10 % of 
dimethylsulfoxide, was found equal to 0.34 mM, kcat=0.13 s ^. 
Comparable data were obtained for the substrate hydrolysis by 
ficin and bromelain. From the practical point of view it is
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important that the specific activities measured against this 
substrate were found to be equal to 330 mol/A2 g0-min for papain, 
330 - for ficin, 43 - for bromelain, whereas the specific ac­
tivity of the same papain preparation measured against commonly 
used p-nitroanilide of benzoyl-D,L-arginine corresponded to 
only 4 units.
Following the same approach, Filippova, Lysogorskaya and 
others synthesized the substrate for assay of pepsin and other 
aspartyl proteinases. The synthesis was accomplished as follows. 
Benzyloxycarbonyl-alany1-alanine was condensated with phenyl­
alanine methyl ester in the presence of dicyclohexylcarbodi- 
imide (or, eventually, by thermolysin-catalysed reaction).
After deprotection with HBr/CH^COOH the tripeptide methyl ester 
was acylated by pyroglutamyl acid pentafluorphenyl ester, the 
crude product was coupled with leucine p-nitroanilide using 
Chymotrypsin as the catalyst, that gave Pyr-Ala-Ala-Phe-Leu-NH- 
CgH^NC^ with the yield of 71 %. On this stage the selectivity 
of the enzymatic reaction was once more used to make unnecessary 
rather complicated purification of Pyr-Ala-Ala-Phe-OCH^.
Swine pepsin was found to split phenylalany1-leucine bond 
in this substrate. This reaction might be followed by amino 
group quantitation with trinitrobenzenesulfonate or by p-nitro- 
aniline liberation from leucine p-nitroanilide with leucine- 
aminopeptidase.
The substrate is optimally hydrolysed by pepsin at pH 3,
by aspergillopepsin - at pH 4.0. K was found to be equal to
-1 ”0.55 mM and k = 18.5 s for its hydrolysis by pepsin,CSX __ ^
Km = 0.66 mM and kcat = 0.33 s - by aspergillopepsin. Shorter 
peptides, e.g., Pyr-Phe-Leu-NH-CgH^NC^, were optimally hydro­
lysed by swine pepsin at pH 4.0. It is to be noted that the 
increase in the substrate length by addition of Ala-Ala se­
quence before Phe-Leu moiety left K„ values practically un­
changed, whereas kcat was improved by the factor of 1300.
Pyroglutamic acid residue has been successfully used as 
a hydrophilic N-protecting group in design of specific sub­
strates for other proteinases. Thus, Pyr-Phe-OH was suggested 
by Tarasova as a convenient substrate for carboxypeptidase A, 
Pyr-Phe-NH-CgH^NC>2 was used as a chromogenic substrate for 
Chymotrypsin.
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DISCUSSION
VI T A L E :
Since many components for peptide synthesis are not 
readily soluble in water, what sort of solvents and 
what concentration do you use?
STEPANOV:
Indeed, the reaction mixtures practically always 
contained a rather high concentration of dimethyl- 
formamide - up to 50%. We may accept it as a rule, 
that the solvent would not hamper the enzyme stabi­
lity to the extent that would diminish its synthetic 
activity.
GRÁF :
In your stepwise synthesis of tetrapeptide Gly-Gly- 
Leu-Phe you were consequently using thermolysin.
My question is: could subtilisin also catalyze the 
final step of the synthesis?
STE P A N O V :
Yes, we have observed that subtilisin may catalize 
the synthesis of the peptide bond specifically in 
the case of tetrapeptide p-nitroanilides con­
taining rather bulky residues /Leu or Phe/ at P^ 
position. But these are only qualitative observations 
that should be further examined.
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REGULATION OF FIBRINOLYSIS
CHRISTENSEN, U. and IPSÉN, H.-H.+
Chemical Laboratory IV, University of Copenhagen 
Copenhagen, Denmark
Plasmin (EC 3.4.21.7) is the serine proteinase that con­
verts fibrin into soluble products in the last step of physiol­
ogical fibrinolysis. Antifibrinolytic amino acids, various com­
pounds analogous to lysine, are well known effectors of the 
fibrinolytic system (Muramatu et al., 1965) and are known to 
bind the so-called lysine binding sites (LBS) confined to the 
heavy chain, that is the non-proteinase part of plasmin(ogen) 
and thus influence various interactions of the components of • 
the fibrinolytic system (Ambrus et al., 1968; Thorsen and 
Astrup, 1 969; Landmann, 1973; Thorsen and Miillertz, 1974;
Richli and Otawsky, 1975; Christensen and Clemmensen, 1977,
1978; Christensen, 1978). The presence of two to three classes 
of LBS of the plasminogens has been demonstrated (Markus et al., 
1978a,b), and much focus has been placed on one of these, the 
high affinity or strong LBS (Wiman and Collen, 1978), whereas 
the possible importance of the other classes of LBS's have 
received little attention. Realizing that the ligand specific­
ity of the weak(er) LBS's is probably different from, but shows 
some resemblance to that of the strong LBS, as is indeed in­
dicated by their different affinities for antifibrinolytic 
amino acids, l-carboxyl-5-amino compounds (Markus et al.,
1978a,b), prompted us to study the interaction of Glu-, Lys-, 
and miniplasminogen with AH-Sepharose a potential affinity 
adsorbent for these proteins, because of its content of 6-ami- 
no-hexyl side chains.
+Present address: The Protein Laboratory, Univeristy of 
Copenhagen, Denmark.
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MATERIALS and METHODS
The following materials were obtained from the indicated 
commercial sources: a-N-acetyl-L-lysine methyl ester (ALME; 
Sigma), a-N-benzoyl-arginine ethyl ester (BAEE; Sigma), 6-ami- 
no-hexanoic acid (6-AHA; Fluka), D-Val-Leu-Lys-pNA (S-2251 
Kabi), human serum albumin (HSA; Behringwerke), urokinase (UK; 
Leo) .
Human Glu- and Lys-plasminogen were purified using affinity 
chromatography on lysine-substituted Sepharose 4B (Deutsch and 
Mertz,1970) as described by Castellino and Powell (1981). Mini­
plasminogen was prepared as described by Sottrup-Jensen et al. 
(1977).
Interactions of the plasminogens with 6-amino-hexyl ligands
The frontal, quantitative affinity chromatography (FQAC) 
method described by Kasai and Ishii (1978) for the determina­
tion of dissociation constants of protein-ligand complexes was 
used. Affinity chromatography of Glu-, Lys- and miniplasminogen 
were performed using AH-Sepharose 4B as affinity adsorbent and 
6-AHA and ALME as competing ligands. A solution of the plasmino­
gen in question (approx. 100 ml 0.5 pM), where appropriate also 
containing competing ligand, was continually added to a column 
(0.9x10 cm, flow rate 5 ml/h) of AH-Sepharose suitably diluted 
with Sepharose 4B to obtain an elution volume of the plasmino­
gen in the absence of competing ligand, not exceeding approx.
10 times the elution volume of non-adsorbed proteins (HSA). 
Experimental conditions: 0.1 M phosphate buffer, also contain­
ing 0.2 M NaCl to avoid ion exchange effects, pH 7.6, 25°C.
The elution pattern was determined by measuring the amount of 
plasminogen present in each 0.25 ml-fraction collected using 
an S-2251 assay after addition of UK and 6-AHA to a final con­
centration of 25 mM. None of the plasminogens were adsorbed to 
pure Sepharose 4B, here they all showed an elution volume 
equal to the bed volume.
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Conversion of Glu- and Lys-plasminogen to plasmin
Kinetic experiments on UK catalysed conversion of the 
plasminogens were performed and analysed as described earlier 
(Christensen and Müllertz, 1977; Christensen, 1977), but in 
some series of experiments a lysine substrate (S—2251) and not 
an arginine substrate (BAEE) for plasmin was used.
The reactions were also investigated using a two step 
assay method where plasminogen is incubated with UK in the 
absence of a plasmin substrate, and then an aliquot is added 
to a substrate solution and the plasmin formed is determined 
from the measured initial rate.
RESULTS
Interactions of the plasminogens with 6-amino-hexyl-ligands
Glu-plasminogen is a one chain protein, Glu-l-Asn-790, 
plasmin cleaves the Lys-76-Lys-77 bond rather easily so that 
Lys-plasminogen (Lys-77-Asn-790) is formed. Cleavage catalysed 
by elastase results in various fragments, one of which is mini­
plasminogen (Val-442-Asn-790). The serine proteinase part of 
plasmin is Val-561-Asn-790 (Sottrup-Jensen et al., 1977).
Glu-, Lys- and miniplasminogen all strongly interact with 
AH-Sepharose. The dissociation constants of the AH-ligand-plas- 
minogen complexes obtained from FQAC experiments are shown in 
Table 1. ALME was found to strongly effect these interactions 
in a simple competitive manner. The K^-values obtained are 
shown in Table 1. Also 6-AHA effects the plasminogen-AH-Shepha- 
rose interactions, but less strongly than ALME. With 6-AHA two 
effects could be distinguished on the Glu-plasminogen-AH-ligand 
interaction, whereas those of Lys- and miniplasminogen both 
were inhibited in a simple competitive manner (Table 1).
Lys- and miniplasminogen interact with AH-Sepharose 
equally well and their interactions are inhibited in the same 
way by ALME as well as by 6-AHA. As seen from Table 1 Lys- and 
miniplasminogen both interact with the column by weak LBS that 
binds 6-AHA with K. approx. 0.3 mM, not found (free) in Glu- 
plasminogen (Markus et al., 1978a,b). It is further seen that
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Table 1
Dissociation constants of various plasminogen-ligand 
complexes determined by FQAC on AH-Sepharose
Kd (pM) K± (pM) Ki (pM)
AH-Sheparose ALME 6-AHA
Glu-plasminogen 95 240(1* 1 0 (2)
5600(1)
Lys-plasminogen 10 25 (1 ) 295 <1)
Miniplasminogen 10 26 (1 * 290 (1 )
1. Competitive inhibition of the plasminogen-AH-Shepha- 
rose interaction.
2. Noncompetitive inhibition of the Glu-plasminogen-AH- 
Sepharose interaction.
lysyl-compounds are bound more than 10 times more strongly.
That site apparently, in contrast to the strong LBS, prefer 
lysine compounds not carrying a free carboxylate function, and 
therefore may interact with lysine side chains of proteins.
Native fibrin does not possess any C-terminal lysine- 
residues, which fulfil the structural requirements of the strong 
LBS and in our opinion are the only likely candidates present 
physiologically for ligands to bind the strong LBS, but fibrin 
does carry many lysyl-side chains. Miniplasminogen, but not 
various fragments of plasminogen from the N-terminal residues 
7 7 - 4 4 1 that possess strong LBS, binds rather well to fibrin 
(Thorsen et al., 1981; Suenson and Thorsen, 1981). Interactions 
between native fibrin and the plasminogens by a weak LBS, which 
is actually a lysyl-site located in the miniplasminogen part 
of the molecules, is strongly indicated.
Blocking of the strong LBS of Lys-plasminogen by 6-AHA 
(Ki=35 pM; Markus et al., 1978a) has no effect on its AH-Sepha- 
rose interaction. This is not so with Glu-plasminogen, as seen 
from the difference between the effects of 6-AHA and ALME.
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Gl u - p l a s m i n o g e n
A B C
Gl u  - p l a s m i n o g e n  + l y s y  1 - l i g a n d  (a )
A B C
Gl u  - p l a s m i n o g e n  + 6 - A HA ( ■ )
C
Fig. 1: The various forms of Glu-plasminogen. Dissociation 
constants are given in Table 1.
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The ratios of the Glu- and Lys-plasminogen apparent binding 
constants (Table 1) for ALME and AH-Sepharose are exactly the 
same (9.5), but for 6-AHA it is 20.
A model that fits these results and is compatible with 
other known features of the plasminogens is presented in Fig. 1. 
We propose that Glu-plasminogen exists in three forms. In the 
absence of external ligands the equilibrium state between these 
forms results in the presence of 89.5 % A-form, 5 % B-form and 
5.5 % C-form, where the A-form has an internally occupied lysyl- 
site and the internal bond is between a lysyl-side chain located 
in the Glu-l-Lys-76 part and the lysyl-site in the miniplasmino­
gen part of the molecule. The B-form has no such internal bond 
and the C-form has another (weak) internal bond affecting the 
interaction of 6-AHA with the strong LBS, most probably indi­
rectly by binding of the Glu-l-Lys-76 part of the molecule to 
a neighbouring weak LBS probably lysyl-site.
In the presence of a lysyl-ligand and equilibrium state 
between 5 forms: the A-form, two B- and C-forms (with and 
without bound lysyl-ligand) is established. In the presence of 
6-AHA a different 5-form-equilibrium state between the C-form 
and two A- and B-forms (with and without occupied strong LBS) 
results at low concentrations of 6-AHA, but at high concentra­
tions of 6-AHA a 7-form-equi]ibrium state adding the B- and 
C-forms with occupied lysyl-site is obtained, thus giving rise 
to the two effects observed with 6-AHA.
Apparent K^-values of Glu-plasminogen-fibrin and Lys-plas- 
minogen-fibrin complexes (Suenson and Thorsen, 1981) are of 
the same order of magnitude as those found here of the AH- 
Sepharose complexes and also approx. 10 times greater for Glu- 
plasminogen than for Lys-plasminogen. Supporting the suggestion 
that the (native) fibrin-plasminogen interaction mainly is 
mediated by a lysyl-site. The result reported by Markus et al. 
(1978a,b) that Glu-plasminogen binds the second 6-AHA molecule 
approx. 20 times more weakly than Lys-plasminogen 1(^=0.26 mM 
does, is also compatible with our model.
The presence or absence of the Glu-l-Lys-76 fragment 
makes the molecular differences between Glu-and Lys-plasmino­
gen. Lerch et al. (1980) studied the isolated CHBr-fragment Glu-
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l-Met-57 and found that it interacted with the isolated so- 
called kringle 1 part (K1) residues 77-approx. 160 of plasmi­
nogen, but not by the strong LBS, which is located there (Wimar 
and Wallen, 1977). It should be noted that the fragment Glu-1- 
Lys-76 that results from plasmin cleavage does contain a C-ter- 
minal lysine residue and therefore may interact with the strong 
LBS, whereas the Glu-l-Lys-76 part of Glu-plasminogen and the 
CNBr-fragment do not. An important feature of the C-form of 
Glu-plasminogen is its inhibition of the interaction of 6-AHA 
with the strong LBS, no such inhibition was observed by Lerch 
et al. (1980) using the CNBr-fragment, but that fragment is 
not a part of the polypeptide chain and has a loose C-terminal 
end.
The dissociation constants of the internal bonds of the 
A- and C-forms of Glu-plasminogen found are A=B, K=0.66 (di­
mensionless) and C=B, K=0.9. Thus the A-form is 15 times strong­
er bound than the C-form.
Conversion of Glu- and Lys-plasminogen to plasmin
The results on the kinetics of UK catalysed conversion of 
the plasminogens to plasmin obtained by Wohl et al. (1978, 1980) 
and those obtained by us previously (Christensen and Müllertz, 
1977; Christensen, 1977) are markedly different. The only major 
experimental difference between these studies is the kind of 
substrate used to detect the plasmin formed in the course of 
the reactions. Wohl et al. uses a lysyl- and we use an arginyl- 
substrate.
The realization, that the presence or absence of a lysyl- 
ligand possibly interacting with a weak LBS of the plasminogens 
may be of great importance for the activation process and may 
lead to completely different kinetic parameters, led us to re­
investigate the processes.
The results are presented in Table 2. It is seen that the
presence of a lysyl-substrate leads to K (Michaelis constants)m
for both Glu- and Lys-plasminogen activation remarkably low 
compared to the K^-values obtained using an arginyl-substrate. 
The values obtained here are similar to those reported by Wohl
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Table 2
Kinetic parameters of UK-catalysed conversion of Glu- and 
Lys-plasminogen to plasmin
One step assay (1) Two (2 )step assay
K k k (3) K k k (3)m c ,app c m c, app c
(PM) (s'1 23) (s' 1 ) (UM) (s' 1 ) (s'1)
Glu-plasminogen
BAEE >40 0.3 3 >40 0.3 3
S-2251 6 3 3 S40 3 3
Lys-plasminogen
BAEE 32 3 - 30 3 -
S-2251 5 3 - 31 3 -
1. Activation and pläsmin assay in the presence of BAEE or 
S-2251.
2. No plasmin substrate present during activation.
3. k corrected for Glu-plasmin/Lys-plasmin activity dif­
ferences .
et al. (1980). The apparent catalytic constant of the processes, 
kc, is unchanged with Lys-plasminogen, but increases approx. 10 
times with Glu-plasminogen as the UK-substrate when determined 
in the presence of lysyl-ligands.
Binding of a lysyl-ligand to Glu-plasminogen changes the 
equilibrium state from one where mainly A-form to one where 
mainly B- and C-forms are present, and that explains nicely 
the different K -values obtained in the presence and absence 
of lysyl-ligands, if it is assumed that UK is able to bind 
only the B- and C-forms.
The kc~values have to do only with the rate of the steps 
of the catalytic process following the binding of the sub­
strate to the enzyme and should not obviously change because 
more of the substrate is in a form that binds the enzyme. This 
was further investigated using a two step assay method where
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plasminogen and UK were first incubated in the absence of lysyl- 
ligands and then the plasmin formed was determined by two 
initial rate assays one using BAEE and the other using S-2251 
as substrates.
With Lys-plasminogen as the UK-substrate the kinetic para­
meters obtained were those expected in the absence of a lysyl- 
ligand (Table 2), and no difference was seen between the results 
of the BAEE- and S-2251-plasmin-assays. In contrast to this the 
Glu-plasminogen data were markedly different.
According to the BAEE (arginyl-substrate) assay the samples 
contained much less plasmin than according to the S-2251 (lysyl- 
substrate) assay; that is when the amount was calculated using 
the well-known kinetic parameters of Lys-plasmin for these sub­
strates, a fact that can be explained only by assuming a dif­
ference in the kinetic properties of Glu-and Lys-plasmin. The 
different apparent catalytic constants of UK-catalysed conver­
sion of Glu-plasminogen in the presence and absence of lysyl- 
ligands, obtained in the one step assay, disappears when a 
change of the activity of Glu-plasmin is taken into account.
And that change is explained, if it is assumed that only 
approx. 10 % of Glu-plasmin is in an active form in the absence 
of lysyl-ligands. So that Glu-plasmin similar to Glu-plasmino­
gen exists in several forms one of which is blocked and has no 
catalytic activity (A-form).
No difference in catalytic activity was found between Glu- 
and Lys-plasmin by Wohl et al. (1977) and that is in accordance 
with our suggestion, since they used a lysyl-substrate. We have 
previously found a positive effect of antifibrinolytic amino 
acids on the kc~value of plasmin catalysed hydrolysis of BAEE 
(Christensen, 1978) that was attributed to LBS-interaction of 
plasmin in general, in fact those results may be better ex­
plained by assuming the presence of some Glu-plasmin and the 
conversion of that to active form.
Not only Glu-plasminogen, but also Lys-plasminogen becomes 
a better UK-substrate in the presence of lysyl-ligands accord­
ing to our results (Table 2). We therefore assume that binding 
of a lysyl-ligand to the weak LBS, in general is important to 
obtain an efficient activation of the plasminogens, so that the
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B- and C-forms of Glu-plasminogen with bound external ligands 
are even better UK-substrates than the B- and C-forms them­
selves.
Glu-plasminogen Glu - plasmin Lys - plasmin
A G ä -
fi ÍI
B
Í1 II
Fig. 2: Model of UK-catalysed conversion of Glu-plasminogen
A model that illustrates the conversion of Glu-plasmino­
gen to plasmin is presented in Fig. 2. Only the B- and C-forms 
of Glu-plasminogen interact with UK and in the first place, 
only the B- and C-forms of Glu-plasmin are formed. In the 
presence of an external lysyl-ligand the ligand is bound to 
the lysyl-site and the enzyme is kept active and in its ab­
sence the enzyme converts to the inactive A-form. Active Glu- 
plasmin (at least in the C-form) is protected from ct-2-anti- 
plasmin, whereas autocatalytic cleavage to form Lys-plasmin 
apparently facilitates that interaction (Christensen, unpubl.).
The main physiological inhibitor of plasmin, a-2-anti- 
plasmin interacts specifically with the K1+2 + 3 part of plasmino­
gen (Wiman, 1 980) . The strong LBS is unoccupied in final 
plasmin-a-2-antiplasmin complexes and a-2-antiplasmin contains 
no C-terminal lysine residue and that agrees with our result 
that a weak LBS is involved (Christensen and Clemmensen, 1977, 
1978), but according to Wiman and Collen (1978) a-2-antiplasmin 
interacts at a strong LBS.
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DISCUSSION
The serine proteinases constitute an important group of 
enzymes that acts as catalysts in a variety of physiological 
processes. There are many indications that these enzymes each 
possesses a catalytic site similar to that of other serine 
proteinases and that they all probably employ a common mecha­
nism to catalyse the hydrolysis of their substrates. It seems 
reasonable therefore if sites other than the catalytic site 
are responsible for individual enzyme specificities.
Plasmin has a specific and selective physiological func­
tion, i.e. the degradation of fibrin deposits in the blood 
vessels. It shows catalytic characteristics similar to those 
of trypsin to low-molecular weight substrates, but the two en­
zymes are distinctly different in their reaction with fibrin 
and the inhibitors of the fibrinolytic system. The physiological 
function of plasmin presumably is controlled by sites other 
than the active site, the so-called LBS's, and according to the 
results presented here, a weak LBS, which is actually a lysyl- 
site that interacts with (specific) lysine side chains of pro­
teins, is of crucial importance in the regulation of fibrino­
lysis.
Below we present a hypothesis on the regulation of fibrino­
lysis that explains the efficient and specific hydrolysis of 
fibrin catalysed by plasmin.
1. In normal plasma only Glu-plasminogen and no Lys- or 
miniplasminogen is present. Glu-plasminogen exists mainly in 
the A-form which is not converted to plasmin by activator-en­
zymes .
2. In the presence of fibrin (native), where the concentra­
tion of specific lysyl-ligands is high, Glu-plasminogen binds 
and fibrin-bound Glu-plasminogen exists only in an activatable 
form.
3. Activator catalysed conversion of bound Glu-plasminogen 
results in Glu-plasmin bound to fibrin at the lysyl-site. In­
ternal Glu-plasmin-Kl (weak LBS) interaction protects it from 
a-2-antiplasmin.
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4. The lysyl-site interaction brings a (number of) partic­
ular fibrin peptide bonds in close contact with the catalytic 
site of plasmin, so that cleavages occur only at specific 
points of the fibrin molecule. During fibrinolysis a number of 
C-terminal lysine residues are formed, since plasmin preferen­
tially cleaves Lys-X bonds of fibrin and other proteins. Plas­
min uses these in getting from one cleavage point to another
by alternating LBS- and lysyl-site interactions and is not 
released until the fibrin network is dissolved.
5. Termination of fibrinolysis involves several mechanisms 
that protect the organism from damaging cleavages catalysed by 
plasmin. Binding of internal lysyl-ligand to a weak LBS in the 
miniplasmin part of the molecule converts most of the free Glu- 
plasmin to the inactive A-form, the interaction with a-2-anti- 
plasmin is no longer inhibited by internal Glu-plasmin-Kl 
interaction, and autocatalytic cleavage of the primary Glu- 
plasmin-a-2-antiplasmin complex to a similar Lys-plasmin com­
plex further facilitates the final formation of a-2-antiplasmin 
plasmin complex, that irreversibly inhibit plasmin. Further, 
since lysyl-site interactions apparently are stronger than 
active site interactions of plasmin, the binding of proteins 
may preferentially occur at the lysyl-site and reduce plasmin 
catalysed protein cleavage greatly, because only a limited 
part of the protein, perhaps containing no Lys-X or Arg-X bonds 
is accessible to the active site. The main features of this 
hypothesis are shown in Fig. 3.
interactions at a strong LBS are indicated by the classical 
effect of low concentrations of 6-AHA on fibrinolysis. The 
fragments of plasminogen have two strong LBS's (Kl and K4 
sites). Only that of Kl is open in free Glu- and Lys-plasmino- 
gen (Vali and Patthy, 1982). The conformational change involved 
when external lysy1-ligands bind Glu-plasmin(ogen) may,however, 
open the K4 site and ligands binding at that site may stabilize 
the active conformation of Glu-plasmin, as well as lysyl-site 
interactions.
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Fig. 3: Model of fibrinolysis
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DISCUSSION
PATTHY:
From your data presented here it apx^ears that there is 
little difference between the kinetic parameters of the 
activation of Glu-plasminogen and Lys-plasminogen by uro­
kinase. How do you reconcile your results with those of 
Peltz et al. (1982) who found about 10-fold difference in 
the values for the activation of Glu- and Lys-plasmi­
nogen?
CHRISTENSEN:
The kinetic data, you refer to, were obtained in the ab­
sence of lysine and Lysyl-compounds. Plasmin was assayed 
by titration using an arginine-analogous compound in a 
two step-assay. The results are not very different from 
ours obtained under similar conditions.
STEPANOV:
Do you have any direct evidence concerning the flexibility 
of kringle structures in plasminogen and its activation 
products?
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CHRISTENSEN:
There are well-known conformational differences Detween 
Glu- and Lys-plasminogen, and in the presence of high con­
centrations at 6-amino-hexanoic acid some changes of con­
formation occur in both proteins, more markedly in Glu- 
than in Lys-plasminogen.
GRÁF:
Do I understand well your suggestion that C-terminal 
lysines are important in the structure of fibrin for in­
teraction with plasminogen? Do these lysines provide a 
sort of binding site for the first interaction?
CHRISTENSEN:
C-terminal lysine residues are initially not present. We 
think, that such residues formed during fibrinolysis may 
play a role, but not in the initiation of fibrinolysis. 
We propose initial plasminogen-fibrin interaction at a 
lysyl-site by binding a lysyl-residue.
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INTRODUCTION
Plasmin, a trypsin-like serine protease, is primarily responsible for the 
removal of fibrin deposits from the walls of blood vessels. Although the 
enzyme has a broad sequence-specificity, intravascularly it shows a re­
markable selectivity for fibrin. The fibrin-specificity of plasmin is due 
to regulatory mechanisms which ensure that plasmin formation takes place 
predominantly when and where fibrin formation occurs (Wiman and Collen, 
1978). Recent studies have revealed that fibrin greatly facilitates the 
conversion of plasminogen to plasmin by tissue-type plasminogen activator 
since both plasminogen and plasminogen activator are adsorbed to fibrin 
to form a cyclic ternary complex and activation of plasminogen occurs 
within this complex (Hoylaerts et al ., 1982_). The plasmin formed remains 
bound to fibrin polymer, degrades fibrin into soluble fragments thus re­
moving the fibrin deposit. Plasmin released from the clot is rapidly in­
activated by the fast-acting plasmin inhibitor, a^-antiplasmin, therefore 
other plasma proteins are normally not attacked by plasmin.
The specific interaction of plasminogen and plasmin with fibrin, the 
rapid binding of plasmin by a^-antiplasmin thus play important roles in 
the regulation of fibrinolysis. The structures essential for these inter­
actions are located in the amino-terminal non-protease part of plasminogen 
(Wiman et al., 1979; Thorsen et al ., 1981). The multiplicity of binding 
functions associated with this segment is reflected in its structure since 
in this part of the molecule five closely homologous tb re e-disul phi de­
bridge structures, kringles, are present which carry the binding sites for 
fibrin, a -antiplasmin and low molecular weight compounds (Sottrup-Jensen 
et al., 1978).
GENERAL CHARACTERISTICS OP KRINGLE STRUCTURES
Kringles are present in several trypsin-type proteases of blood plasma. 
Thus the non-protease part of human plasminogen contains five kringles 
(Sottrup-Jensen et al., 1978), human and bovine prothrombin have two 
kringles (Magnusson et al., 1975; Wal z et a]., 1977), human high mol­
ecular weight urokinase contains one kringle (Günzler et a]., 1982) and 
human tissue-type plasminogen activator possesses two kringles (Pennica 
et al., 1983). The kringles of the different proteases show a high degree 
of sequence homology, they appear to be more closely related than the 
protease parts (Young et.al., 1978).
Several studies have demonstrated that the kringles are independent 
structural domains. Limited proteolysis of prothrombin and piasmjnogen is 
known to yield fragments corresponding to kringles, indicating that
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kringles are independent structural units (Magnusson et al., 1975; 
Sottrup-Jensen et al., 1978). Comparison of the circular dichroism spectra 
of prothrombin and its constituent fragments obtained by limited proteo­
lysis showed that dissection of the molecule causes little alteration in 
the structure of the kringles, suggesting that these regions exist as 
independent structural domains (Bloom and Mann, 1979)- Differential scanning 
calorimetry studies on plasminogen, prothrombin and proteolytic fragments 
thereof also showed that the kringles are independent structural domains 
(Ploplis et al ., 1981; Castellino et al ., 1981 ). Immunochemical studies 
using antibodies raised against piasminogen have shown that antigenic 
structures are conserved in isolated kringles thus providing further 
evidence for the view that kringles exist as independent domains in the 
native molecule (Ploplis et al., 1982).
The kringles appear to correspond to functional domains since 
kringles isolated by 1imited proteolysis of plasminogen and prothrombin 
retain their original binding functions. Isolated kringle 1 and kringle 4 
fragments of plasminogen bind co-aminocarboxy] ic acids (Sottrup-Jensen et 
a]., 1978; Lerch et al., 198o), kringle 5 fragment of plasminogen binds 
to benzamidine-Sepharose (Váradi and Patthy, 1981). Kringle 1 fragment of 
plasminogen also preserves its ability to bind to fibrin (lerch et al ., 
198o). Fragment 2 of prothrombin, which corresponds to one of the pro­
thrombin kringles, has an intact binding site for factor V (Esmon and 
Jackson, 1974).
In view of these findings it is likely that kringles are structural­
ly and functionally independent domains specialized to bind different 
proteins or ligands. In the case of prothrombin and plasminogen the 
kringles determine binding specificities which endow these proteases with 
some of the properties required for their highly specialized function. 
Although nothing is known at present about the exact function of the 
kringles of urokinase and tissue-type plasminogen activator, the homology 
with the prothrombin- and plasminogen-kringles suggests that they may be 
essential for binding functions important for the regulation of plasmino­
gen activation.
KBINGLE 4 DOMAIN OP HUMAN PLASMINOGEN
Considering the importance of kringles in the function of several highly 
specialized proteases it is of interest to define the structural and 
functional properties of these "miniproteins". In our studies we chose 
kringle 4 of plasminogen as a model since this kringle fragment can be 
prepared in high yield, it carries an intact co-aminocarboxylic acid bind­
ing site whose functional integrity can be readily tested by affinity 
chromatography on lysine-Sepharose.
The co-aminocarboxylic acid binding site of kringle 4 
Kringle 4 is known to bind various co-aminocarboxylic acids with high 
affinity (Lerch et al., 198o), the optimum distance between the amino 
and carboxyl groups of the ligand is o.68 nm (Violand et al ., 1978;
Winn et a]., 198o). Since both the positive and negative charges of the 
ligand are essential for ligand binding (Winn et al., 198o) it is prob­
able that complementary charges present in the binding site are involved 
in electrostatic binding of the ligand. Variation of substituents of 
co-aminocarboxylic acids also revealed that a polar group on the carbon 
a to the carboxyl retards binding, substitution of this polar group with 
an apolar substituent increases affinity (Winn et al., 198o). Therefore 
it may be assumed that a hydrophobic interaction between the ligand and 
the binding site is also important for binding of co-aminocarboxylic 
acids.
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Chemical modification studies have been carried out in order to 
identify residues essential for ligand binding by kringle 4. Modification 
of kringle 4 with 1,2-cyclohexanedione was found to lead to loss of 
lysine-Sepharose affinity and the abolition of ligand binding was shown 
to be due to modification of Arg-7o (JTrexler et al., 1982). Arg-7o is 
essential for ligand binding since it is responsible for the electro­
static binding of the carboxyl group of co-aminocarboxylic acids. The 
possibility that modification of Arg-7o caused loss of lysine-Sepharose 
affinity indirectly, through a modification-induced conformational change, 
is unlikely since nmr studies showed that reaction of Arg-7o did not 
cause a detectable conformational change of the kringle (Trexler et al., 
1983)- The direct involvement of Arg-7o in ligand binding is further 
supported by our observation that ligand protects Arg-7o against reaction 
with 1,2-cyclohexanedione since it renders the residue inaccessible to 
the reagent.
Modification of kringle 4 with 1-ethyl-3-(.3-dimethylaminopropyl)- 
carbodiimide also led to abolition of affinity for lysine-Sepharose, re­
action of Asp-56 of kringle 4 being responsible for loss of affinity 
(^Trexler et al ., 1982). The importance of Asp-56 for ligand binding is 
probably due to its involvement in electrostatic binding of the amino 
group of the ligand.
Reaction of Trp-71 of kringle 4 with dimethyl (^-hydroxy-S-nitrobenz- 
yl )sulfonium bromide (^Hochschwender and Laursen, 1981 b) or with hydrogen 
peroxide-dioxane (JTrexler et a]., 1983) destroys lysine-Sepharose affin­
ity. The Trp-71 residue is essential for ligand binding probably because 
it interacts with the hydrocarbon chain moiety of w-aminocarboxy]ic acids. 
Polar substitution of the a-carbon of ligands possibly weakens binding 
since it interferes with the interaction between the hydrocarbon moiety 
of the ligand and the indole side-chain of Trp-71.
The presently available informations thus suggest that Arg-7o, Asp-56 
and Trp-71 of kringle 4 are directly involved in ligand binding. It is 
noteworthy that these residues are clustered in the inner loop of 
kringle 4.
The solution structure of kringle 4
The solution structure of kringle 4 is studied by chemical modification 
and by nmr spectroscopy of native and chemically modified kringle 4 
species in collaboration with the Inorganic Chemistry laboratory of 
Oxford. Comparison of the nmr spectra of native and chemically modified 
kringle 4 species permitted the assignment of resonances to specific 
residues m  the kringle 4 sequence. Nuclear Overhauser experiments 
defined several residue-residue interactions in the kringle 4 structure, 
permitting the definition of an outline structure of kringle 4 (^ Trex] er 
et al., 1983). The most noteworthy feature of the kringle-fold is that 
Leu-45 interacts with the sequentially distant Trp-25 and Trp-61 
residues. Since these residues are conserved in all kringles sequenced 
so far it seems probable that this structural feature is common to all 
kringl es.
Folding autonomy of kringle 4
The structural and functional independence of kringles raised the possi­
bility that the kringles may be autonomous folding domains. To test this 
assumption we have carried out experiments with kringle 4 fragment to 
decide whether this isolated kringle is capable of refolding to its native 
structure following reductive cleavage of its disulphide bridges (JTrexler 
and Patthy, 1983). Treatment of kringle 4 with reducing agents in the 
presence of 6 M guanidinium chloride led to loss of lysine-Sepharose
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affinity, hut when the reduced-denatured kringle was incubated aerobical­
ly in the absence of reducing and denaturing agents, the lysine-Sepharose 
affinity was regained concomitant with the restoration of its disulphide 
bonds. Refolding and recovery of lysine-Sepharose affinity was significant 
ly faster when refolding was performed in buffers containing oxidized and 
reduced glutathione.
During refolding aliquots of the refolding mixture were withdrawn 
for alkylation with iodoacetic acid and the S-carboxymethylated folding 
intermediates were analyzed by isoelectric focusing. Chromatography of 
alkylated, refolding mixtures on lysine-Sepharose revealed that not only 
the fully refolded kringle 4 was capable of binding to lysine-Sepharose; 
a folding intermediate possessing only two disulphide bridges was also 
bound to the affinant. Structural analysis of this functionally active 
two-disulphide-bridge folding intermediate showed that it has two of the 
three native disulphide bonds but lacks the disulphide bond connecting 
Cys-1 and Cys-79. The ability of this two-disulphide-bridge folding 
intermediate to bind to lysine-Sepharose indicates that the third 
disulphide bridge is not essential for the maintenance of the functional­
ly active ’architecture of kringle 4.
In summary, kringle 4 of human plasminogen is capable of assuming 
the native, biologically active conformation after denaturation and 
reductive cleavage of its disulphide bonds, indicating that this fragment 
harbours an intact folding unit. The kringle 4 domain thus corresponds 
to an independent structural, functional and folding domain.
Although the different kringles of prothrombin, plasminogen, uro­
kinase and tissue-type plasminogen activator diverged to bind different 
proteins or low molecular weight ligands they retained the same triple­
loop architecture. If the amino acid sequences of kringles with different 
binding functions are compared, the residues essential for the autonomous 
folding should be found unchanged in all or most of the kringles, whereas 
the residues involved in the specialized binding functions may vary from 
kringle to kringle. Comparison of the sequences of the kringles of human 
plasminogen, human prothrombin, human high molecular weight urokinase and 
human tissue-type plasminogen activator reveals that in addition to the 
six cysteines conserved in all kringles, the conserved residues are 
clustered around Cys-5o, Cys-62 and Cys-74 (Trbxler and Pattby, 1983).
Of special interest is that leu-45, Trp-25 and Trp-61, which were shown 
by nmr studies to interact in the kringle-fold, are conserved in all 
kringles. This observation provides further support to the view that the 
residues conserved in all kringles are essential for the folding autonomy 
of these domains.
The residues involved in the varied binding functions of kringles 
are probably found in sequence areas where the different kringles show 
variability. Such regions are present in the right outer loop (residues 
26-44) and in the left and right arms of the inner loop (Trexler and 
Patthy, 1983). It is noteworthy that Asp-56, Arg-7o and Trp-71, residues 
essential for ligand binding by kringle 4, are located in these variable 
regions.
The function of the kringle 1 and kringle 4 domains of plasminogen 
Kringle 1 and kringle 4 of plasminogen are similar to each other in that 
both kringles bind co-aminocarboxylic acids, the ligand-specificity of the 
two kringles is apparently identical (Winn et al., 198o). Despite this 
similarity the binding sites of kringle 1 and kringle 4 probably have 
different function.
In the case of kringle 1 the binding site appears to be essential 
for fibrin affinity as the interaction of this kringle with fibrin is 
abolished by co-ami nocarboxyl ic acids (Lerch et al., 198o). The fibrin
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molecule possesses two types of plasminogen binding sites (Váradi and 
Pattby, 1983,) and the kringle 1 domain appears to be essential for bind­
ing of plasminogen to both sites since the plasminogen-fibrin complex is 
disrupted by co-ami nocarboxyl ic acids at concentrations that saturate 
only the site present on kringle 1 (Thorsen et al., 1981). In contrast 
with kringle 1, kringle 4 has practically no affinity for fibrin (Thorsen 
et al., 3981) suggesting that it has a function different' from that of 
the first kringle.
Several lines of evidence indicate that the kringle 4 domain and its 
co-aminocarboxylic acid binding site are buried in Glu-plasminogen. We 
have shown previously that the kringle 4 domain of Glu-plasminogen is un­
able to mediate binding to lysine-Sepharose since intramolecular inter­
actions render it inaccessible to external ligands (Vali and Patthy, 1982). 
Studies with antibodies raised against isolated kringle 4 also revealed 
that the antibodies bind twenty times more weakly to Glu-pl asminogen than 
to kringle 4 fragment, confirming that the kringle 4 domain is practically 
inaccessible in Glu-plasminogen (Hochschwender and Laursen, 1981 a). In 
Glu-pl asminogen the co-aminocarboxylic acid binding site of kringle 4 is 
involved in interactions that shield it even from small ligands, therefore 
in Glu-plasminogen it has only very weak affinity for ligands (Markus et 
al., 1979). Abolition of these interactions with co-aminocarboxylic acids 
causes the transition of Glu-plasminogen from a closed to a loose con­
formational state (Markus et al., 1979) suggesting that the co-aminocar­
boxylic acid binding site of the kringle 4 domain is essential for main­
taining the closed conformation of Glu-plasminogen. Since the two con­
formational states of plasminogen differ markedly in their activability 
by plasminogen activators (Markus et al., 1979; Peltz et al. 1982) the 
co-aminocarboxylic acid binding site controlling the conformation of 
plasminogen has an important role in the regulation of fibrinolysis.
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DISCUSSION
GRÁF :
The autonomous folding of kringle 4 could be further 
confirmed by an experiment in which the oxidation of 
reduced kringle 4 would be studied in the presence 
of other entities of plasminogen like the large 
fragment containing kringles 1-3. I wonder whether 
the oxidation rate /folding/ of kringle 4 was affect 
ed by other portions of the plasminogen molecule.
PATTHY:
We have not yet performed such experiments.
CHRISTENSEN :
Did you use the X-ray crystallographic results 
reported recently on one of the prothrombin-kringles 
when your model of kringle 4 was constructed?
PATTHY:
From the low resolution model of prothrombin 
fragment only the gross dimensions of the kringle- 
fold are known, but details cannot yet be deduced 
from these data. For this reason we did not use 
the X-ray crystallographic data in the construction 
of our kringle 4 model.
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The fundamental problem in the kinetic investigation of 
the enzymes which can hydrolyze several bonds of high-molec­
ular-weight substrates is that the size and the structure of 
the substrate and, thus, the availability of the bond to be 
split next are changing continuously as a result of each 
attack by the hydrolytic enzyme. Therefore, a basic demand 
of kinetic analysis, that every catalytic step has to take 
place exactly under the same conditions, is poorly satisfied 
in these cases. For example, in the pioneering studies on 
proteolytic enzymes /Northrop et al., 1948/ various proteins, 
denatured hemoglobin, casein, etc. were evidently assayed as 
substrates. The heterogeneity of the substrate in an assay 
mixture, however, prevents the exact determination of the 
kinetic parameters and the time-velocity function does usually 
not result in a straight line. Therefore, only apparent 
kinetic constants can be calculated from the data obtained 
on high-molecular-weight substrates. To avoid this, low- 
molecular-weight substrates, esters, amides, etc. of amino 
acid derivatives were introduced for the kinetic studies of 
proteolytic enzymes /Schwert et al., 1948/. These compounds
Abbreviations: B o c : -t-butoxycarbonyl; B z : -benzoyl;
pNA: -p-nitroanilide; Sue: -succinyl;
Tos : -tosyl; Z: -benzyloxycarbonyl.
This work was supported by the Hungarian Ministry of 
Health and by the Hungarian Academy of Sciences.
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contain only one scissile bond and the product of enzyme 
action does not get involved again with the enzyme after 
hydrolysis. Nevertheless, the low-molecular-weight synthetic 
substrates meet certain requirements of kinetic investigations, 
however, their affinity to enzymes is usually rather poor, it 
is somewhere in the milimolar range.
A satisfactory compromise was found in the last decade 
by the introduction of chromogenic peptide substrates of 
various lengths /Blombäck et al., 1967; Svedsen et a l . , 1972/ 
containing a chromogenic or fluorogenic group at the C-terminus 
of the peptide. The labeling group is usually bound to the 
peptide by an amide or ester bond. The properties of the syn­
thetic substrates are similar to those of natural substrates 
in many respects and surpass the characteristics of amino 
acid derivatives in the following:
1. They contain only one bond to be split.
2. Their affinity is superior to substrates that contain a 
single amino acid and their K value may approach the micro­
molar range. Thus, their affinity to enzymes is greater by 
orders of magnitude than that of the single amino acid deriv- 
a t ives.
3. By applying peptide substrates more information can be 
obtained than with compounds containing a single amino acid.
To the primary-specificity site we can add residues differing 
in size, polarity, charge and other properties at P^, P-j 
positions /notation of Schechter and Berger, 1967; Table 1/.
The investigation of these substrates may reflect the proper­
ties of the Sg, S j , etc. substrate-binding sites of protein- 
ases. The data obtained with substrates of various amino acid 
sequences may permit us to draw conclusions about the size, 
polarity or hydrophobicity of the binding site, or about the 
presence or absence of charged side chains in the binding area.
4. The convenience of measurements with chromogenic or fluoro­
genic substrates, the spectrophotometric recording of the 
changes in absorption, allowed the widespread application of 
chromogenic and fluorogenic peptide substrates for practical 
purposes in clinical and other laboratories /see for a 
review Huseby and Smith, 1980/.
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It seems to be evident that both the affinity of the 
enzyme to the substrate and the velocity of the cleavage of 
a sensitive bond may strongly depend on the size and composi­
tion of the rest of the peptide part joined to the primary- 
specificity residues of the substrate. If so, what should the 
composition of a substrate expected to work satisfactorily 
with a proteinase be like?
The are at least three different ways for finding an 
answer to this question: 1, imitation of the structure of 
the native substrate around the scissile bond, 2. synthesis 
of peptides of different composition by trial and error, and
3. application of a systematic method, if any, which enables 
us to predict the properties of good substrates. The first 
reasoning, which looks very logical at first sight, is based 
on the assumption that the structure of a good substrate 
should be similar to that of the sequence around the scissile 
bond of the natural substrate. This suggestion can be easily 
accepted as far as the structural requirements of enzymes i-n 
the blood-clotting system are concerned. However, in the case 
of less selective proteinases it may bring about difriculties.
The members of the blood-clotting cascade are fastidious 
enzymes. It was demonstrated, for example, that the last 
enzyme of the cascade system, thrombin, which was investi­
gated most extensively, can split only very few bonds. The 
substrates available commercially for the determination of 
thrombin activity /Blombäck et al., 1977; for reviews see 
Oackson and Nemerson, 1981; Lottenberg et al., 1981; Elődi, 
1983/ have slightly different sequences in the vicinity of 
the primary-specificity side chain, arginin /Table 2/, 
compared to those found in the natural substrates. In addi­
tion, they may contain non-natural residues, e.g. pipecolate, 
at P2 position, or D-derivatives of amino acids at position
appear to be at least as favourable as the side chain of 
natural amino acids.
The second method of finding good sequences is trial 
and error /Claeson et al., 1977; Claeson and Aurell, 1981; 
Ondetti and Cushman, 1981/, It is easy to admit that the 
selection of proper substrates by trial and error may be a 
time-consuming task, since, in principle, each substrate
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Table 1
Amino acid sequences adjacent to bonds cleaved by thrombin 
/cf. Blombäck et al., 1977/
Substrate P^ Pg Pj
HUMAN
Fibrinogen /Ac*/ .Gly.Val.Arg. Gly.
.Gly.Pro.Arg. Val.
/Bfi / .Ser.Ala.Arg. Gly.
Factor XIII .Val,P ro.Arg . Gly.
Factor VII .Gly.Val.Arg. He.
Prothrombin .Thr.Pro.Arg . Ser.
.Thr.Ala.Arg. Th r.
.Asn.P ro.Arg. Thr.
Antithrombin III .Ala.Gly.Arg. Ser.
Ac tin .Ala . P ro . Arg . Ala.
.Arg .Pro .Arg. His .
.Asn.Pro.Lys. Ala .
subsite may be occupied by one of the twenty natural amino 
acids. For good many reasons, only a limited number of amino 
acid residues was applied for the synthesis of peptide sub­
strates and inhibitors containing peptidyl parts of various 
lengths /Bajusz et al., 1975; Kettner and Shaw, 1981/.
When we started our work on substrate design we were 
looking for some kind of a solid basis that may ensure a 
simpler and safer way for finding out the best composition 
of a substrate built up from a given set of amino acids.
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Table 2
Kinetic parameters of the hydrolysis of peptidyl-p- nitroanilide
substrates by human th rombin
/ c f . Lottenberg et al . , 1981/
Substrate
Km ^ca t k /l< ca r m
/ W /s " 1/ /^ jM~ s- /
N-protected peptides
Tos-Gly-Pro-Arg- 4.2 130 31.0
/Ch romozym-TH/
2-DPhe-P ro-Arg- 20.0 32 1.6
2- Arg-Pro-Arg- 32.0 85 2.7
Unprotected peptides
H-DPhe-P ro-Arg- 91.0 82 9.0
H-DVal-Pip-Arg- 120.0 68 5.9
H-DPhe-Pip-Arg- 1.5 90 60.0
/S-2238/
H-DIle-P ro-Arg- 3.0 120 40.0
/S-2288/
H-DVal-Pro-Arg- 14.0 63 4.3
/S-2234/
There are some simple and common mathematical methods in 
use in pharmacological research that are successfully applied 
for designing drugs. It seemed to be promising to test these 
methods, since we were aware of the fact that the data ob­
tained by enzyme-kinetic measurements are based on more 
precise and reliable techniques than those applied in pharma­
cological investigations, therefore, it was hopeful to expect 
better quantitative correlations, as well. These methods are 
based on the linear free-energy relationship of the macro­
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molecule-ligand interaction /for a review see Martin, 1981/.
Our original assumption was that a similar interaction may 
occur in the formation of the enzyme-substrate complex, too 
/Grieco et al., 1977/. Thus, we selected a simple method de­
scribing the quantitative structure-activity relationship 
/OSAR/ suggested by Free and Wilson /1967/.
At the beginning of our work on substrate design we 
expected that the mathematical treatment of the data by 
regression analysis would provide reasonable answer to the 
following :
1. Can a quantitative correlation between the substrate 
sequence and the kinetic parameters be expected?
2. Can we find a general standard, if there is any, for this 
correlation?
3. Is it possible to demonstrate an interaction or connection 
between the role of P^ primary-specificity site and the 
residues of the secondary , P^ , etc, sites? Are the primary 
and secondary sites equivalent in importance in the enzyme- 
substrate interaction?
4. Is it worthwile to substitute the trial and error method 
by an exact one based on calculations?
To answer these questions we measured the kinetic para­
meters of eight proteolytic enzymes with substrate series 
composed of free and N-protected tripeptidyl-p-nitroanilides
and l< , the Michaelis constant, k , the catalytic constant, m C9 l
and k V K  were derived from the measured values /Pozsgay 
et al., 1977; 1979; 1981; 1981a; Cs-Szabó et al., 1980; 1980a; 
Marossy et al., 1980/. Then, these data were treated by 
regression analysis and the contribution of each side chain 
to the kinetic parameters was deduced. Since these contributions 
calculated by the OSAR method are additive, the values found 
by calculation permit us to predict the kinetic parameters 
of any kind of a substrate sequence composed from the 
investigated set of amino acids. Moreover, those residues 
that have the greatest contribution will form the best 
substrate, and the composition of an optimal substrate can 
be predicted.
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Table 3
Contribution of tripeptidyl-p-nitroanilide substrates 
to the kinetic parameters of the human granulocyte 
elastase /15 substrates/
/Marossy et a l , , 1980/
Contribution
Subsite Substituent 1/K m
mM_1
kca t
-1s
kcat/Km 
M - 1 s'1
P4 Boc 57.02 0.388 72 137.3
Bz 7.98 0.146
• •
4
«•*«*»
337.4
Z 4.49 0.178 6 226.5
Sue - 26.37 -0.534 - 33 128.3
P3 DPhe 33.40 0,218 31 419.6
Arg - 10.56 -0.686 4 599.8
Gly - 15.03 -0.059 - 13 818.1
Asp - 21.96 -0.673 - 27 949.0
Ala - 24.39 0.624 - 34 629.3
P2 Ala 16.16 -0,093 44 033.0
P ro 11.66 0.129 38 738.3
Val - 6.30 0.183 5 986.5
Nie -109.37 -1.135 -432 507.7
P 1 Nie 110.09 1.315 401 645.9
Val 37.34 -0.0001 Í 3 883.Í
Ala - 2.72 0.091 - 14 831.0
Leu - 6.73 -0.035 - 37 172.0
Arg - 70.77 -0.866 - 95 869.4
Overall //j/ 24.32 0.387 20 517.6
Co rrela t ion 0.8996 0.9365 0.,9163
coefficient /r/
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The mathematical treatment of the kinetic data provided 
us with three kinds of results. First, the predicted best 
susbstrate was a member of the assayed series, as was found 
with thrombin /Pozsgay et al,, 1981/. Secondly, the sequence 
obtained by calculation was characteristic of a compound 
insoluble in aqueous media /Pozsgay, 1979/. Thirdly, when a 
new sequence was obtained, that seemed easy to handle, it was 
synthesized and assayed kinetically. The predicted and experi­
mentally measured kinetic parameters showed good agreement 
/Gáspár et al., 1981/. In most of the cases the correlation 
coefficients of these values were over or near 0.9.
Let us take some examples that may illustrate the versa­
tility of the OSAR-treatment of kinetic data. As the first 
example, we shall take elastases isolated from porcine pancreas 
and human granulocytes. They are similar in their substrate 
requirements, both can cleave peptide bonds at the aliphatic 
side chains. A slight difference between the two elastases 
is that the pancreatic enzyme prefers smaller side chains, 
like Ala, whereas, the granulocyte enzyme works faster when 
a bulkier side chain, like Leu, Val or Nie, forms the scissile 
bond.
It is worth to compare the values of contribution calcu­
lated from kinetic measurements. It can be seen in Table 3 
that the best residues are not equally good in every respect. 
For example, DPhe at P^ position has the greatest contribution
to the l< value for both elastases. In contrast, it attenuates m
the substrate when its contribution to k . is taken intoca t
account. Both enzymes prefer Pro or Ala at P^ for a good l<m .
From the above data it was concluded that the aldehyde 
derivatives /Bajusz et al., 1975/ of compounds of the general 
formula
...DPhe.P ro/Ala/..X.H
may be reasonably good competitive inhibitors for elastases.
A small set of such aldehydes was synthesized and assayed 
with Boc-Ala-pNP as substrate, and the l<i inhibitory constants 
were calculated. At P^ the good inhibitor contained valine
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Table 4
K, inhibitory constants of peptide aldehyd es measured
with elastases
/Substrate Boc-Ala-pNP; in 50 mM Tris HC1, pH 8.0; at 37°C/
K inhibitory constant /uM/
Compound human bovine
g ranulocyte pancreatic
Suc-DPhe-Pro-Ala.H 620 900
Nle.H 380 2 1 0
Val.H 40 1 3 0 0
Suc-Pro-DPhe-Pro-Nle.H 65 850
Val.H 38 520
Val.H 3* -
substrate: human lung elastin
for the granulocyte enzyme, whereas, alanine seemed to be
more effective for pancreatic elastase /Table 4/. The l<i
inhibitory constants of these compounds were in the 10“4 to 
-510 molar range. When, however, human elastin was used as 
substrate, the effect of Suc-Pro-OPhe-Pro-Val.H inhibitor 
was improved, and the value decreased near to micromole.
The lengthening of Suc-DPhe-Pro-Val.H by a Pro residue 
at the N-terminus did not increase the inhibitory capacity 
of the compound when assayed with low-molecular-weight 
synthetic substrates. In contrast to the findings of Atlas 
/1974/ and MacRae et al. /1980/, the extension of peptide 
substrates and inhibitors for elastase definitely improves 
their catalytic productivity.
Another enzyme that became a point of interest recently 
is plasmin. A new line of research aims at some other aspects 
then the classical studies of enzyme-substrate or enzyme- 
inhibitor interactions, which encouraged us to reinvestigate 
our earlier data on plasmin /Cs-Szabó et al., 1980/.
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It was suggested by Chakravarty et al. /1983; 1983a/ that 
peptides containing Lys residues at the C-terminus could be 
successfully employed in cancer therapy. They had bound 
drugs to be directed to the site of cancerous poliferation to 
the carboxylic group of the C-terminal lysine of a peptide, 
and thus a prodrug was formed. This, due to the relatively 
high plasmin activity around the proliferating cells, is 
expected to decompose and, consequently, the drug will exert 
its effect on the very site of malignant proliferation and 
hit practically the cancerous cells only. It is reasonable to 
suppose that the composition of the peptide part of the pro­
drug will not be indifferent in respect to its efficacy.
A few years ago /Cs-Szabó et al., 1980/ we carried out 
investigations to find "optimal" substrates for plasmin. These 
studies resulted a DIle-Phe-Lys-pNA sequence as a promising 
compound. Substrates having Z - , Bz-, Boc- or other protective 
groups appeared to be less favourable than their unprotected 
derivatives. The blemish of these studies was that all inves­
tigated compounds contained D-amino acids at position.
Recently we repeated these experiments with a different 
and larger series of substrates containing both L and D 
derivatives of the same amino acids at position Dlle-Phe- 
Lys-pNA, the best member of the previous series was also 
included in the new substrate set, and the kinetic parameters 
were determined /Table 5/. Recent investigations revealed 
further remarkable features concerning both the reliability of 
regression analysis in predicting the kinetic parameters of 
peptide substrates and the plasmin-substrate interaction. 
First, again DIle-Phe-Lys appeared to be the best in respect 
of l/l<m and kcat/l<m /Table 6/, although, at P^ the contribu­
tion of DPro to 1/K and that of DVal to k ,/K seemed to 
be greater than the contribution of Dlle to the same kinetic 
parameters, Secondly, the calculated contribution of pGlu 
to k at P, was much greater than that of other ten sideC31 o
chains, whereas, its contribution to l< seemed to be ratherm
poor. In spite of this, we may list pGlu-Phe-Lys-pNA in the 
group of reasonably good substrates. Substrates No 16-18 in
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Table 5
Kinetic parameters of plasmin determined with 
unprotected tripeptidyl-p-nitroanilides
Number
Substrate subsites
P P P 3 2 *1
1/K m
mM- ^
kca t
-1s
kcat/Km 
M _ 1  s - 1
1 Dlle Phe Lys 33.8 3.13 106 0 0 0
2 DP ro Phe Lys 28,0 2.16 60 370
3 DVal Phe Lys 2 0 . 0 4.93 98 520
4 DGln Phe Lys 19.2 1.72 33 100
5 DAla Phe Lys 16.0 2.05 32 870
6 DVal Leu Lys 9.7 7.95 77 180
7 DGlu Phe Lys 8 . 0 3.18 25 500
8 H e Phe Lys 7.5 2.89 21 770
9 Dlle Leu Lys 6.5 2.65 17 230
1 0 Pro Phe Lys 5.5 1.87 10 290
1 1 pGlu Phe Lys 5.0 15.92 79 620
1 2 Ala Phe Lys 5.0 4.90 24 500
13 pGlu Leu Lys 3.0 7.96 23 910
14 Val Leu Lys 2.5 1.38 3 450
15 lie Leu Lys 1 .0 3.43 3 430
16 DLeu Met Lys 1 0 . 0 2.76 27 600
17 DSe r Ty r Lys 5.5 3.10 17 260
18 Gly Ty r Lys 5.0 2.85 14 230
Table 5 did not meet the requirements of regression analysis, 
therefore they were omitted from the calculation of contri­
butions listed in Table 6 .
Without exception, the D derivatives in the series of
substrates appeared to be superior to L ones /cf. Bajusz,
1979/. For example, the l< values of the D derivatives turnedm
out to be three to six times higher /Table 7/.
According to our experience, plasmin seems to be somewhat
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Table 6
Cont ribution to
Subsite Residue 1/K ' m ^cat k ,/l< ca t' m
- 1 - 1 - 1  - 1mM s M s
P3 DP ro 12.78 -2.65 3 840
Dlle 10.69 -1.31 28 1 0 0
DVal 5.39 2.23 54 340
DGln 3.98 -3.09 -23 430
DAla 0.78 -2.76 -23 660
Val - 1 . 2 0 -2 . 2 1 - 7 040
H e -5.21 -1.04 -20 900
pGlu -5.46 7.73 18 260
DGlu -7.22 -1.63 -31 030
P ro -9.72 -2.94 -46 240
Ala - 1 0 . 2 2 0.08 -32 030
P 2
Phe 3.84 4.06 15 350
Leu -7.68 -0.81 -30 690
Ove rail /TV 11.38 4.41 41 180
exceptional among the proteolytic enzymes assayed with chromo- 
genic peptide substrates, since the l< values found with these 
substrates appeared to be fairly insensitive to the composition 
of the substrates, in particular to the residue. It can be 
supposed that the P^-S^ interaction in the enzyme-substrate 
complex-formation is of limited importance in the case of 
plasmin.
In conclusion, we believe that regression analysis is a 
powerful tool for the study of protein-ligand interactions 
/Grieco et al., 1977; Martin, 1981; Gáspár et al., 1981/ and
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Contribution of subsites to the kinetic parameters 
/plasmin, calculated from a 15-member substrate series/
for the prediction of the sequence of peptides that will 
function well with their protein counterparts, This assumption 
is valid, probably not only for enzyme-substrate and enzyme- 
inhibitor interactions, but in other cases, as well, where a 
protein-peptide interaction may occur.
Table 7
The effect of D and L configuration on the l/K 
values of plasmin
m
Subsites l/K Ratiom
mM“1 1/KD 1/I<L' m m
Dlle Phe Lys /l/ 33.8
Lile /&/ 7.5
□ Pro Phe Lys /2 / 28.0
LP ro /10/ 5.5
DAla Phe Lys /5/ 16.0
LAla /12/ 5.0
DVal Leu Lys /6/ 9.7
LVal /14/ 2.5
Dlle Leu Lys /9/ CD • CJl
Lile /15/ 1.0
Definite quantitative correlations could be demonstrated 
between the properties of amino acid side chains and their 
contribution to the kinetic parameters with all proteinases 
investigated in our laboratory /Gáspár et a l . , 1981/. Our 
prime hypothesis was convincingly supported by correlation 
coefficients calculated by comparing the predicted and measured 
kinetic values, by synthesizing and assaying the predicted
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sequences as well as by preparing and testing inhibitors the 
structure of which was selected according to predicted values. 
These results may permit us the assumption that the analysis 
of quantitative structure-activity relationship can be suc­
cessfully extended not only to the investigations of proteolytic 
enzymes but also to various other biological phenomena where 
a protein-peptide ligand may play a role.
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DISCUSSION
KO V A C H : ^
How good is the correlation of the strueture-reactivity 
relationship for k t/l<m , which is the true kinetic 
parameter and is reflective on transition state stabi­
lization? Is the correlation better, as might be ex­
pected, for K , which may bespeak of intermediate sta­
bilization?
ELŐDI :
The correlation coefficients of predicted and measured 
data obtained by the comparison of calculated and 
experimentally determined kinetic values we re satis­
factory. In 22 out of 28 investigated series the values 
were over 0.95 and were less than 0.9 only in two cases.
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As a matter of fact, I do not know what kind of corre­
lation could be expected for l< . Anyway, in the majority 
of cases the best fit for expected and measured values 
was found for K _ .
S TEPANOV:
I am very much impressed by your success in the predic­
tion of kinetic constants. The question that immediately 
appears concerns the principles underlying such an 
approach. Is it based on the assumption that the inter­
action S^-P^, S^-P^ etc. are independent ones? If so, 
how do you evaluate the limits of this assumption?
ELODI :
Very probably, the interaction between the subsites of 
the binding sites and those of the substrate are not 
a sum of independent phenomena. They are rather influ­
enced by some kind of cooperative phenomena hard to 
express by mathematical terms. Nevertheless, the additive 
character of regression analysis provided values which 
can be applied for practical purposes to design "optimal" 
structures. We believe that this kind of analysis may 
supply useful information in investigating substrate 
specificity of other proteolytic enzymes, too.
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SUMMARY
A survey is given on the principles of the control of 
intracellular proteolysis in rat liver. Compartmentation, 
specificity of proteinases and inhibitors, and the activity 
of these enzymes are described as possible factors of control.
In particular, this survey deals with changes in the mole­
cular properties of substrate proteins as an important prin­
ciple of the regulation of intracellular proteolysis.
INTROPUCTION
It is important that a cell, when faced with a change in 
the environment, should be able to alter its enzyme composition 
in order to adapt oneself efficiently. Such adaptation occurs 
by the synthesis of enzymes appropriate to the new environment 
as well as by the removal of those proteins that are no longer 
needed. This degradation of proteins should be selective to be 
optimal. Thus, controls during adaptation are directed towards 
the activation or inhibition of the breakdown of individual 
proteins rather than towards the process of degradation as a 
whole (Bohley, 1968, 1974, 1979; Ballard, 1977).
The effect of this adaptation is that one group of pro­
teins (enzymes) is replaced by another more appropriate group 
without any change in the total amount of proteins.
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There is an enormous range of turnover rates of different 
proteins, i.e., half-lives from minutes to weeks in rat liver, 
which is the best investigated organ in this field. Goldberg 
and St. John (1976) showed that rat liver enzymes with very 
high turnover rates are sited at important metabolic control 
points, and they suggested that proteins with particularly 
long half-lives are relatively unimportant in metabolic control.
Enzymes which do not catalyze rate-limiting processes do 
not need to be changed in activity, and therefore have very 
slow turnover rates.
We propose to distinguish three main populations of pro­
teins with respect to turnover rates in rat liver:
1. / very-fast-turnover proteins with half-lives of less 
than one hour, i.e., mainly proteinogen processings and ab­
normal proteins.
2. / fast-turnover proteins with half-lives of 1-24 hours,
i.e., mainly enzymes which are important for metabolic control 
points, and
3. / slow-turnover proteins with half-lives of more than 
24 hours without important changes in mass or activity.
Which molecular mechanisms are responsible for such 
extremely different turnover rates? How is the selectivity of 
intracellular proteolysis regulated? What are the primary 
reactions of intracellular protein catabolism? We will attempt 
to answer these questions, in the following paragraphs de­
scribing the principles of the regulation of intracellular pro­
teolysis.
Compartmentation
It was shown by labéling experiments that probably all 
proteins of the liver turn over, but at variable rates. Many 
proteins of the outer mitochondrial membrane turn over more 
rapidly than the proteins of the matrix and particularly those 
of the inner membrane, a relatively stable organelle. A com­
parison of the turnover rates of short- and long-lived pro­
teins in vivo and all proteins in vitro is shown in Table 1.
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Table 1
Degradation of protiens ln subcellular fractions of rat liver
in vivo and in vitro
In vivo In vitro
6-24 h 24-12CI h
Homogenate 2,3 % 0,9 % 1,6 %
Nuclei 8,7 % 0,6 % 1,3 %
Mitochondria 2,4 % 0,4 % 2,1 %
Lysosomes 17,5 % 0,4 % 5,9 %
Microsomes 3,8 % 1,0 % 1,2 %
Plasma membranes 2,6 % 1,8 % 1,9 %
Cytosol proteins 5,6 % 0,6 % 0,5 %
(in vivo; decay of 1^0 between 6-24 h (Miehe, 1974), decay of 
14c between 24-120 h (Arias et al., 1969), in vitro: autopro­
teolysis at pH 6.8 in 0.2 % Triton X-100. All values in K=% 
of protein degraded per hour (Bohley, 1966, 1968), see also 
Waterlow et al., 1978; Schön and Bohley, 1977)
The half-life of short-lived proteins is shortest in ly- 
sosomes, nuclei and cytosol. The very short half-life or pro­
teins found in lysosomes, between 6 and 24 hours, represents 
mainly the degradation of autophagocytosed, short-lived sub­
strate proteins from other organelles, particularly from 
cytosol. The values of autoproteolysis in vitro show that the 
proteolytic capacity of cytosol is very low to explain the 
high turnover rate observed in this compartment in vivo. There­
fore, we have to postulate an intracellular cooperation in vivo 
in which cytosol proteins are substrates of protein-degrading 
systems in other organelles, especially in lysosomes (Bohley 
et al., 1969, 1971, 1974, 1979).
On the other hand, all true lysosomal enzymes hitherto 
investigated have been found to be long-lived. It can there­
fore be supposed that lysosomes contain short-lived proteins 
(their substrates) and long-lived proteins (their enzymes). 
Resident membrane proteins seem to be sterically protected 
against proteolysis. On the other hand, the cytoplasmic sur-
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face of lysosomes is susceptible to hydrolytic attack by 
Kupffer cell lysosomes. Henell et al. (1983) demonstrated that 
lysosomal membranes are degraded if their outer surface is ex­
posed to lysosomal enzymes and that proteins are degraded 
faster than lipids.
In any case, the compartmentation results in a high con­
centration of substrates and enzymes but also of effectors as 
protons and thiols in the lysosomes which constitute more than 
10 % of the total cell volume in Kupffer cells but less than 1 % 
of the total cell volume in parenchymal cells of rat liver.
More than 60 % of total proteolysis occurs in lysosomes, and 
the other degradative compartments, especially for the very 
short-lived proteins, are mainly unknown as yet.
Specificity of proteinases
A few proteinases with extremely high substrate specific­
ity are known to be able to select substrates for degradation 
without any additional control mechanisms (renin, angiotensinase, 
etc., see Holzer and Heinrich, 1980).
This, however, cannot be the only type of regulation of 
proteolysis. Namely, for each protein individually degraded, 
an individual proteinase is required. Furthermore, a regulatory 
mechanism is needed for all these proteinases.
In general, the specificity of proteolytic enzymes alone 
is insufficient to explain the selectivity of intracellular 
proteolysis and its control.
Nearly all intracellular proteinases preferentially split 
peptide bonds between hydrophobic amino acids (Ala-Leu, Leu-Tyr, 
Tyr-Leu, Leu-Val, Phe-Phe,...). On the other hand, a variety 
of proteolytic enzymes with very different specificities de­
grade preferentially short-lived proteins. This means that the 
short-lived proteins are more susceptible to attacks by any of 
these proteinases.
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Specificity of proteinase inhibitors
Hirado et al. (1981) isolated a proteinase inhibitor from 
the cytosol of rat liver cells (molecular mass 12 400, IP 5.04) 
which is very effective against cathepsin B and cathepsin H, 
it is less effective against cathepsin L and is ineffective 
against cathepsin A and cathepsin D. Such an inhibitor seems 
to function mainly as a safeguard against proteolytic damage 
which might arise from leaky or broken vacuoles. There are, 
however, some hints that in yeast the inhibitors, besides the 
safeguard function, may also serve as a control element regu­
lating proteinase activity (Holzer and Heinrich, 1980). Speiser 
and Etlinger (1983) found an inhibitor in rabbit reticulocytes 
that can be repressed by ATP in the presence of ubiquitin.
During reticulocyte maturation, the inhibitor and protease 
remain, but the ubiquitin-containing fraction is less effective 
in repressing the inhibitor. Etlinger's results (Speiser and 
Etlinger, 1983) do argue against an obligatory role for 
ubiquitin-conjugates in proteolysis.
In rat liver there exists a relatively high amount of 
calpastatin, an inhibitor against the Ca2+-dependent cysteine 
proteinases calpain I and calpain II (Murachi, 1983). In 
general, the role of a cytosol proteinase (Hershko and Ciechan- 
over, 1982) is not' important in the overall degradation of rat 
liver proteins, as will be shown in the next paragraph.
A c t i v i t y  o f  p r o t e i n a s e s  a n d  i n h i b i t o r s
The most active proteinase in rat liver parenchymal cells 
is cathepsin L, which degrades proteins as myosin, actin, cal­
modulin, hemoglobin, histones, collagen, insulin, glucagon, 
azocasein and especially cytosol proteins at least 10 times more 
rapidly than cathepsin B and cathepsin H do even at pH 6 
(Bohley et al., 1979). The role of cathepsin T (Gohda and Pitot,
1980) in comparison with these enzymes, however, was unknown 
as yet. The molecular weight of cathepsin T is 35 000 and 
therefore, we compared the activities of lysosomal supernatants 
(60-fold enriched) after fractionation on Sephadex G-75 under 
different conditions to estimate the share of cathepsin T in
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overall proteolytic activity. As is shown in Figure 1, the 
activity of proteinases of a molecular weight of 35 000 is less 
than 5% in comparison with the activity of proteinases of a mole­
cular weight between 20 and 30 000 (mainly cathepsin L).
It is shown in Table 1 that even under conditions specially 
selected for cathepsin T according to Gohda and Pitot (pH 6.5; 
glycerol; dithiothreitol and azocasein) the activity of cathep­
sin T is very low (less than 8 %) in comparison with the activ­
ity of cathepsin L.
Summarizing, the share of different proteinases in the 
degradation of cytosol proteins at pH 6 and pH 5 is compiled 
in Table 2, which shows that cathepsin L has indeed the maximum 
share and thatcathepsin T and all cytosolic proteinases to­
gether have only a very small share in the overall proteolysis. 
They may, however, have an important function in degrading 
special proteins (as cathepsin T for tyrosine aminotransferase).
Table 2
Share of different proteinases in vitro in the degradation
of cytosol proteins
pH 6 pH 5
Cathepsin B < 20 % < 10 %
Cathepsin D < 1 0 % < 20 %
Cathepsin H < 1 0 % < 5 %
Cathepsin L > 40 % > 50 %
Cathepsin T < 10 % < 5 %
Cytosol proteinases
(Calpains ATP-ubiquitin- 
dependent proteinases)
< 10 % < 5 %
It is necessary to obtain further information about other, 
as yet unknown, proteinases and their contribution in cytosolic 
proteolysis.
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L y so so m al s u p e r n a t a n t  (6 0  fold e n r ic h e d )
4 5 0 0 0  3 5 0 0 0  2 5 0 0 0  15000 weight
Fig. 1: Sephadex G-75 chromatography of 60-fold 
concentrated lysosomal supernatant at 
various pH values. Fractions were char­
acterized according to their proteolytic 
activity with azocasein as substrate.
The elution of catepsins is indicated 
by capital letters on the abscissa.
T: tyrosine amino transferase.
Lysosomal sup ern a tan t (6 0  fold en rich ed  )% degradation
of cy tosol proteins 0.1% TRITON X-100
'a t  pH 6.7 0.1% TRITON X-100
> 9 0 0 0 0  45000 3 5 0 0 0  2 5 0 0 0  m olecular weight
Fig. 2: Fractionation of 60-fold enriched 
lysosomal supernatant on Sephadex 
G-75 at pH 6.7 in the presence of
0.1 % Triton X-100. The degradation 
of the cathepsins and T (tyrosine 
amino transferase) is expressed as 
percentage.
It is unclear as yet, whether the very small- overall pro­
teolytic activity in cytosol is due to the high inhibitor ac­
tivities or to low proteinase activities. In any case, many 
cytosolic proteins need another degradative compartment in vivo. 
This is evident from a comparison of the turnover rates of 
cytosol proteins in vivo (0.6-5.6 % per hour) and in vitro 
(<0.5 % per hour), as was shown in Table 1.
Saus et al. (1982) demonstrated the limited scope of the 
ATP-ubiquitin-proteinase system and assumed therefore a highly 
specialized function. Mortimore and Ward (1981) found that even 
at pH 7 less than 5 % of total proteolysis of rat liver occurs 
in the cytosol and more than 95 % in the particulate fractions, 
especially in lysosomes.
On the other hand, the proteinase activity in rat liver 
lysosomes (even the cathepsin-L-activity alone!) at pH 6 is 
much higher than it is needed for the in vivo turnover rates 
of cytosol proteins.
We conclude that except for some special proteins, the main 
part of cytosolic proteins require another environment for their 
overall degradation.
Neither the specificity of lysosomal enzymes is high enough 
nor their activity is limited enough to explain ,the selectivity 
of intracellular proteolysis and its regulation.
Changes in molecular properties of substrate proteins
P r e s u m a b l y ,  t h e  p r i m a r y  r e a c t i o n s  o f  i n t r a c e l l u l a r  p r o t e o ­
l y s i s  a r e  t h e  m o s t  i m p o r t a n t  o n e s  f o r  i t s  r e g u l a t i o n .
Although in some special cases a first enzymatic attack by 
proteinases or thiol-proteindisulphide-oxidoreductases may 
occur (followed by conformational changes of the substrate 
proteins), we think that the main part of cytosol proteins 
first undergoes some conformational changes, afterwards is 
transferred to the degradative environment and finally is de­
graded by the enzymes.
It was first presumed that the size and charge of substrate 
proteins are important for their degradation rates. However, 
in 1981 it became evident from data published by Susan Russell
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e t  a l .  a n d  A nn  S t .  J o h n  e t  a l . t h a t  t h e  s i z e  a n d  c h a r g e  o f  s u b ­
s t r a t e  p r o t e i n s  a r e  n o t  c o r r e l a t e d  w e l l  e n o u g h  w i t h  t u r n o v e r  
r a t e s  t o  e x p l a i n  t h e  s e l e c t i v i t y  o f  p r o t e o l y s i s  b y  t h e s e  p r o ­
p e r t i e s  .
More important are some other properties of the substrate 
proteins, such as wrongly placed amino acids (Goldberg, 1 976; 
Ballard, 1977), glycosylation (Goldstone and Koenig, 1974; 
Kalish et al., 1979), phosphorylation (Ekman et al., 1978) or, 
finally, the quantity of hydrophobic areas on the surface of 
the substrate proteins (Bohley et al., 1968, 1977, 1979, 1981).
S i n c e  t h e  m o s t  d e g r a d a t i v e  e n z y m e s  o f  t h e  c e l l s  a r e  s e ­
p a r a t e d  f r o m  t h e  s u b s t r a t e  p r o t e i n s  b y  m e m b r a n e s ,  i t  s e e m e d  
r e a s o n a b l e  t o  t h i n k  t h a t  t h e  r a t e  o f  p r o t e o l y s i s  i s  c o n t r o l l e d  
b y  t h e  r a t e  o f  t r a n s f e r  o f  s u b s t r a t e  p r o t e i n s  a c r o s s  t h e  mem­
b r a n e s .  C l e a r l y ,  p r o t e i n s  w i t h  h y d r o p h o b i c  s u r f a c e  a r e a s  m ay  
b e  e x p e c t e d  t o  a s s o c i a t e  w i t h  m e m b r a n e s ,  a n d  t h u s  h a v e  t h e  
b e s t  c h a n c e  o f  b e i n g  t r a n s f e r r e d  a c r o s s  t h e m .
Experimental evidence supports this idea. It has been 
found that short-lived proteins have a special affinity for 
liver fat, organic phases, hydrophobic surfaces such as sili-- 
conized glass beads, phenyl sepharose and octyl sepharose 
(Bohley et al., 1977; Bohley and Riemann, 1977) and for lyso­
somal and other membranes (Dean, 1975).
If, indeed, hydrophobicity of a protein tends to cause 
it to be turned over rapidly, this property should be corre­
lated with other physical properties that are also conducive 
to a rapid turnover. A positive correlation has indeed been 
found between hydrophobicity and glycosylation (Hieke, 1 983), 
but not between hydrophobicity and low isoelectric point for 
the substrate proteins from rat liver cytosol. Further inves­
tigations on this topic are in progress.
It can be seen that control of protein turnover mediated 
by surface hydrophobicity could account for many of the ob­
served characteristics of the process. As a rule, in native 
proteins the majority of hydrophobic amino acid sidechains are 
buried in a hydrophilic environment.
Reversible changes which increase the rate of turnover of 
a protein, and can be expected to increase the hydrophobicity
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of its surface, include the following:
a. ) dissociation of the protein from an organelle,
b. ) dissociation of stabilizing ligands - substrates, cofactors,
etc. ,
c. ) dissociation of monomers from an oligomeric protein.
Further irreversible processes likely to have the same 
effect include:
a. ) the incorporation of amino acid analogs (e.g., canavanine
for arginine),
b. ) sequence errors in biosynthesis,
c. ) denaturation at interfaces (membranes, other proteins,
aggregates) and
d. ) limited proteolysis.
In extreme cases, the modified proteins may aggregate be­
fore being degraded, as has been shown for both bacterial and 
rat liver cytosol proteins (Bohley et al., 1974; Goldberg, 1974).
In summary of this view, we see that the increase in sur­
face hydrophobic areas could be a common factor in the accel­
erated degradation of many kinds of proteins, not only because 
it facilitates entry into the degradative compartment, but also 
because the cellular proteinases tend to act most rapidly on 
peptide bonds between hydrophobic residues.
We have concentrated our work on surface hydrophobicity, 
mainly because this property of substrate proteins can be 
changed and therefore allows regulation of protein degradation.
For instance, in the absence of stabilizing ligands (such 
as substrates or, for example, cofactors), superfluous sub­
strate proteins (for example, enzymes without substrates) 
might be degraded preferentially. There are some hundred dif­
ferent proteins in rat liver cytosol, and in the strictest 
sense we would need a hundred-pathway-model to describe their 
degradation. We can hope, however, that many of these path­
ways are similar.
In order to understand the molecular properties which may 
be important for the control of proteolysis in many of these 
pathways, we have investigated surface hydrophobicity of cyto­
sol proteins from rat after a 4-day period of a protein-free
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diet or after a 20-day period of a protein-rich diet.
Such nutritional changes involve firstly changes in the 
microenvironment of substrate proteins (changes in the con­
centration of substrates and other stabilizing ligands) and 
secondly, may produce changes in the composition of cytosol 
proteins. If surface hydrophobicity is really associated with 
an increased rate of degradation, the preferential degradation 
of short-lived proteins in the livers of protein-deprived rats 
with deficient resynthesis should be followed by a decrease of 
hydrophobic proteins in rat liver cytosol.
Indeed, the affinity of cytosol proteins from protein- 
deprived rats to hydrophobic surfaces is significantly decreased 
in comparison with the two other groups (Bohley et al., 1981).
To test the influence of small molecules as possible 
stabilizing ligands (substrates, etc.) we investigated the 
effect of ultrafiltration and washing on the affinity to hydro- 
phobic surfaces. After ultrafiltration and washing (which re­
sults in the removal of stabilizing ligands) we found that 
cytosol proteins bound more strongly to both hydrophobic sur­
faces. Furthermore, addition of the ultrafiltrates diminished 
the binding of cytosol proteins. We have not so far identified 
the molecules responsible for this protecting effect (protect­
ing here means: a decrease in the binding to hydrophobic sur­
faces) .
In rats kept on a protein-rich diet these low molecular 
weight protecting substances most probably are the substrates, 
cofactors and free amino acids.
Furthermore, cytosol proteins of young rats bind better 
to phenylsepharose than those of old rats, as was shown by 
B. Wiederanders (1978).
The degradative compartments can be: intracellular mem­
branes especially for short-lived proteins, and lysosomes main­
ly for long-lived proteins (leupeptin-treatment in vivo results 
in a prolonged apparent half-life of the slowly turning over 
proteins in rat liver, as we found by a triple labeling tech­
nique using ^C— and ^H-arginine and ^N-lysine).
Surprisingly, we have not any detailed knowledge of the 
intracellular place for the degradation of short-lived proteins.
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Most probably, microsomal membranes may be responsible for 
this process (Ballard, 1977).
Quite clearly, the investigation of the crude mixture of 
perhaps a hundred cytosol proteins can only give a faint in­
sight into the mechanisms which must next be studied with iso­
lated, well defined substrate proteins.
On the other hand, the use of fresh cytosol is the best 
way to preserve most of the substrate proteins in their natural 
environment in the presence of- other proteins and stabilizing 
ligands in as native a state as possible.
Transfer to other organelles (mainly microsomal membranes and 
lysosomes) is not the only process to be facilitated by increased 
surface hydrophobicity. There is, furthermore, an increased sus­
ceptibility to proteinases which attack mainly in the neighbour­
hood of hydrophobic amino acids as for instance cathepsin L.
We still do not know whether such enzymes are also located 
on the cytosolic face of the lysosomal membrane and in such a 
manner can initiate proteolysis by splitting only one or a few 
peptide bonds. This might be followed by an increase in sur­
face hydrophobicity of the nicked substrate protein molecule, 
which afterwards facilitates its transfer to an organelle more 
active in degradation.
Summarizing, we wanted to show you that changes in the 
metabolic state really are followed by changes in surface hyd­
rophobicity of substrate proteins and therefore can be impor­
tant for the control of intracellular proteolysis.
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DISCUSSION
GLAUMANN:
T h e  c e l l  a d a p t s  i t s e l f  t o  e n v i r o n m e n t a l  c h a n g e s ;  m a n y  
r e g u l a t o r y  e n z y m e s  i n c r e a s e .  T h i s  i s  n o t  t h e  c a s e  f o r  
l y s o s o m a l  e n z y m e s ,  i s  i t ?  I f  n o t ,  w h y ?
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BOHLEY:
The activity of lysosomal proteinases is much higher than 
it is necessary for the turnover rates of proteins found 
in vivo.
VITALE:
It is known that diabetes is accompanied by some protein 
glycosylation which is considered to be a cause for some 
late effects of the disease. How does this fit to the 
existing hypothesis; are there any enzymatic studies on 
their degradation?
BOHLEY:
We did not study this question. There is, however, a paper 
from Fred Dice showing that in diabetic state the behav­
ior of cytosol proteins is completely changed. Glycosyla­
tion causes a more rapid turnover and might be in part 
responsible for such changes.
ELŐDI:
As far as your classification i.e., short-, medium- and 
long-living group is concerned, what would you suggest 
for the definition of intracellular stability of proteins?
BOHLEY:
This is only an operational classification. To find a de­
finition - that is what we have to find out in the future.
ELŐDI:
When enzymes are considered, their activity may be re­
garded as a sign of stability and/or destruction. What 
method would you suggest for characterizing the intra­
cellular protein stability?
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B O H L E Y :
Slow-turnover proteins are more stable against proteolytic 
enzymes hitherto investigated.
Hydrophobicity on the surface of substrate proteins 
always tends to cause a more rapid turnover in vivo and 
this means a limited stability.
Therefore, hydrophobic chromatography is a good tool to 
isolate the less stable proteins from cytosol.
SOHÁR:
How can you explain the higher cathepsin B activity in the 
homogenate during autolysis?
BOHLEY:
We did not investigate this problem.
TURK:
The increased proteolytic activity of cathepsin B results 
in the cleavage of cathepsin B and cytosolic protein in­
hibitor complex.
BOHLEY:
Whether an inhibitor-proteinase complex is split also in 
vivo remains to be clarified.
GLAUMANN:
Since we know there are several endogenous proteolytic 
inhibitors present in the cytosol, can we really estimate 
the role of cytosolic enzymes in overall proteolysis, by 
simply incubating the cytosol without first removing the 
inhibitors?
BOHLEY:
Yes, we can. Since the in vivo-conditions in cytosol 
include proteinase-inhibitor-complexes (safeguard func­
tion of inhibitors) it would be wrong, in my opinion, to 
separate the inhibitors for the estimation of overall 
proteolysis,and for the comparison with proteolysis in vivo.
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INTRODUCTION
Aspartic proteinases presumably act synergistically 
with cysteine proteinases and exopeptidases in intracellular 
protein degradation. This essential living process takes 
place in rat liver mainly in the lysosomes /Bohley, 1968;
Dean and Barrett, 1976; Goldberg and St. Oohn, 1976;
Holtzmann, 1976; Holzer and Heinrich, 1980/. In the last 
years especially the lysosomal cysteine proteinase, cathepsin L 
/EC 3.4.22.15/ and the lysosomal aspartic proteinase, cathepsin 
D /EC 3.4.23.5/ have been shown to play an important role in 
int racellular proteolysis in the rat. liver /Huisman et al., 
1974; Dean, 1975; Wiederanders et al., 1976; Kirschke et al., 
1977/.
About 60-70% of the total cell number of the rat liver 
consists of parenchymal cells /hepatocytes/ and about 
30-40% is occupied by nonparenchymal cells, i.e. Kupffer 
cells, endothelial cells and fat-storing cells /Wisse, 1977; 
van Berkel, 1979; Knook et al., 1982/. In the last decade 
numerous authors have determined the activity of cathepsin D 
with hemoglobin substrate at pH 3-4, and they measured a
Abbreviations: Z-Phe-Phe-CHN2 : benzyloxycarbonyl-phenyl-
alanyl-phenylalanyl-diazomethane; SPA: specific 
proteolytic activity.
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significantly higher activity in nonparenchyma1 cells than in 
the parenchymal cells /Arborgh et al., 1974; van Berkel et al., 
1975; Mun'the-Kaas et al., 1976; Knook, 1977/.
However, nothing is known of the occurrence and distribu­
tion of cathepsin L activity in the individual cell types.
Thus, we have developed two methods that can be applied to 
different substrates at different pH values and allow a spe­
cific determination of cysteine proteinase activity /mainly 
cathepsin L/ and of aspartic proteinase activity /mainly 
cathepsin D/. Since specific substrates for both proteinases 
are still lacking, we have used specific inhibitors: the 
synthetic inhibitor Z-Phe-Phe-CHN^ /Leary and Shaw, 1977;
Green and Shaw, 1981/ which inhibits specifically isolated 
rat liver cathepsin L /Kirschke and Shaw, 1981/, and the 
microbial inhibitor pepstatin which inhibits cathepsin D 
/Knight and Barrett, 1976/. Details concerning some essential 
presuppositions for the development of the tests were published 
/Riemann et al., 1982/.
Applying a method using urea-denatured azocasein as sub­
strate we investigated several organs of carp, frog, pigeon 
and rat. The kidneys of carp, frog and rat were found to have 
a particularly high Z-Phe-CHN2 ~inhibited activity, therefore 
they are very promising sources for the isolation of cathepsin 
L /Riemann et al., 1982/.
Some authors reported on the involvement of lysosomal 
proteinases in tumor-genesis /Grabske et al., 1979; Oshima 
et al., 1979; Geyer et al., 1980; Mort et al., 1980; Recklies 
et al., 1982/. Thus, we have investigated human tumors of 
different tissues, Ehrlich-ascites-tumor cells from mice and 
L-cells with regard to the occurrence of pepstatin- and Z-Phe- 
Phe-CHNg-inhibited activities.
MATERIALS AND METHODS
1. Isolation of various rat liver cells
Parenchymal cells, Kupffer cells and endothelial cells 
were isolated according to van Bezooijen et al. /1974/ and
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Knook and Sleyster /1976/. Besides parenchymal cells were 
isolated according to the method of Seglen /1976/. The prepa­
ration of the whole liver homogenate was described by Riemann 
et al, /1982/.
2. Preparation of tumors, Ehrlich-ascites tumor cells and L- 
cells
The preparation of human tumors was performed as de­
scribed by Riemann et al. /1982/. Isolation of Ehrlich-ascites 
tumor cells was carried out 8 days after inoculation into mice 
/Agnes-Bluhm/. Under ether narcosis the abdomen was opened, 
the tumor cells were removed and centrifuged at 5 000 g. The 
sedimented cells were homogenized with an equal volume of 
Triton X-100, 0.1% /v/v/. L-cells, transformed fibroblasts 
were cultivated for 5 days at 37°C in Eagle's MEM containing 
10% calf serum. After harvesting, the cells were washed twice 
in 150 mmol/1 NaCl solution, centrifuged and homogenized with 
the equal volume of Triton X-100, 0.1% /v/v/.
3. Preparation of substrates
Azocasein was prepared according to Langner et al. /1973/. 
3 14H- and C-labeled cytosol proteins were obtained by the 
method of Bohley et al. /1971/.
4. Assay of proteolytic activities
The two methods used were published in detail /Riemann 
et al., 1982/. The final concentration of Z-Phe-Phe-CHN^ in 
the assay mixtures was 5 pmol/1 and that of pepstatin was
0.5 /jmol/1.
5. Calculation of the results
The results are expressed as specific proteolytic activity 
/SPA/. For method I, which used urea-denatured azocasein at
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pH 5.0 as substrate, SPA is defined as follows:
SPA _ %  degradation of azocasein 
mg protein x 1 h
/The degradation of azocasein in the test tubes never exceeded 
10% per hour of incubation./
For method II, which used double-labelled cytosol proteins 
at pH 3.0 as substrate, SPA is defined as follows:
s p a  - %  degradation of cytosol proteins 
mg protein x 1 h
/The degradation of double-labelled cytosol proteins in the 
assay tubes was always below 1% during incubation for 1 h./
6. Protein determination
The amount of cellular protein was determined by the 
modified LOWRY procedure, according to Langner et al. /1971/, 
using human serum albumin as standard.
RESULTS AND DISCUSSION
Figures 1 and 2 show the results obtained with the iso­
lated rat liver cells. Both methods yielded striking results.
In Kupffer cells the specific proteolytic activity /control 
value/ was about 10 to 30 times higher than in parenchymal 
cells. Compared to the endothelial cells the proteolytic 
activity was 2 to 3 times higher in Kupffer cells. This may 
be due to the fact that Kupffer cells contain more lysosomes 
than the other liver cells. As reported by Blouin et al.
/1977/, lysosomal structures contribute to the cell volume 
of parenchymal cells with 0.8%, to that of endothelial cells 
with 7% and to that of Kupffer cells even with 14%.
These results were confirmed by other authors, i.e.
Kupffer cells have higher cathepsin D activity than endo­
thelial and parenchymal cells. In the presence of 0.5 yumol/1 
pepstatin we have found an inhibition of 80 to 100% with
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SPA
'2 20
" 2 f 0
LH (a) PC (a) LH(b) PC(b) KC EC EC
n=20 n=2 n=1 n = 5 n=5 n=4 n=1
Fig. 1. Specific proteolytic activity of isolated rat liver 
cells as determined by method I /see methods/.
n = number of cell preparations. Each value is the 
mean ÍSD of at least 8 determinations.
LH = whole liver homogenate /a/ prepared in Halle
/b/ prepared in Rijswijk
PC = parenchymal liver cells /a/ prepared in Halle
/b/ prepared in Rijswijk
KC = Kupffer cells
EC = endothelial liver cells
f I SPA of the control value /without inhibitor/
[SJ SPA after inhibition with 5 ^mol/l Z-Phe-Phe-CHN 
L* I SPA after inhibition with 0.5 pmol/1 pepstatin 
SPA after inhibition with the mixture of both 
inhibitors at the given concentrations.
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SPA
ll
\2 50
LH PC KC KC KC EC EC
n = 7 n - 5 n = 1 n = 1 n = 2 n = 4 n = 3
Fig. 2. Specific proteolytic activity of isolated rat liver 
cells as determined by method II /see Methods/
Each value is the mean ^SD of at least 12 determi­
nations. For symbols see Fig. 1.
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Kupffer cells, 60 to 70% with endothelial cells and 50 to 55% 
with parenchymal cells, respectively.
Ansorge et al. /1979/ have obtained similar results by 
immunological determination. They found that the amount of 
cathepsin D in the endothelial cells is three times higher 
and in the Kupffer cells even 15 times higher than in paren­
chymal cells. The share of the aspartic proteinase cathepsin E, 
which is assumed to play a minor role compared to cathepsin D 
in the pepstatin-inhibited activity, still has to be ex­
plained .
We measured 2 to 10% inhibition in Kupffer cells with 5 
/jmol/1 Z-Phe-Phe-CHN^, 10 to 30% inhibition in endothelial 
cells, and about 40% inhibition in parenchymal cells. This 
result is a first hint that cathepsin L is more concentrated 
in the parenchymal cells.
Recently, it has been shown that Z-Phe-Phe-CHN2 at con­
centrations of 0.1 mmol/1 and 1 mmol/1 inhibits the lysosomal 
protein degradation in isolated viable rat hepatocytes to 60 
and 70%, respectively /Grinde, 1983/. This finding confirms 
our result and emphasizes the importance of cysteine protein- 
ases probably cathepsin L, in hepatocytic protein degradation.
However, the previously discovered lysosomal cysteine 
proteinase, cathepsin T, /Gohda and Pitot, 1981/ cannot be 
excluded as being inhibited also by Z-Phe-Phe-CHN2 . The same 
may be true for the calcium-dependent cysteine proteinases 
isolated from the cytosol of rat liver cells /Kishimoto et 
al., 1981/. A possibly disturbing influence of the cysteine 
proteinases cathepsin B and cathepsin H is almost completely 
excluded, as was described recently /Riemann et al., 1982/.
In the presence of a mixture combining the two inhibitors 
at the given concentration a relatively high activity which 
was not inhibited remained only in the endothelial cells. It 
seems to be very likely that in these cells not only the 
cysteine and aspartic proteinases participate in the total 
cellular protein breakdown under these conditions.
Moreover, endogenous cysteine proteinase inhibitors 
/Kominami et al., 1981; Hirado et al., 1981; Anastasi et al.,
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SPA
3 toe ach rectum pancreas kidney bile-duct liver liver bone-narrow
Zk r. or cal CA normal CA normal CA normal CA normal aetastm- normal aetastm» normal
tissue tissue tissue tissue tissue ses tissue scs tissue
Fig. 3. Specific proteolytic activity of different human carcinomas and normal tissues 
as determined by method II
n = 1 throughout. CA = carcinoma.
Each value is the mean í SD of at least 6  determinations.
For symbols see Fig. 1.
1983/ and aspartic proteinase inhibitor/s/ /Turk et al., 1981/ 
should be considered to possibly influence the described 
results .
Several authors /van Berkel, 1979; Brouwer et al., 1981/ 
suppose a close relation between the high amount of cathepsin 
D in Kupffer cells and their high activity in heterophagic 
processes. Whether or not there is any connection between the 
relatively high cathepsin L content and autophagic processes 
in parenchymal cells should be investigated.
L - c e l l s  E h r l i c h - a s c i i e s
tumor c e l l s
Fig. 4. Specific proteolytic activity of L-cells and of
Ehrlich-ascites tumor cells method II
Each value is the mean - SD of 12 determinations.
For symbols see Fig. 1.
The results concerning the tumors are summarized in 
Figure 3. In all tumor homogena*tes Z-Phe-Phe-CHN^- as well as 
pepstatin-inhibited activity could be identified. Contrary to 
some reports /Grabske et al., 1979; Geyer et al., 1980/ we 
found a higher specific proteolytic activity in comparison to 
the normal tissues only in two cases /pancreas carcinoma and 
liver metastases. In normal tissues, except L-cells and 
Ehrlich-ascites tumor cells /see Fig. 4/, as well as in tumorous
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tissues we always measured markedly higher inhibition by pep- 
statin than by Z-Phe-Phe-CHN^. Compared to the normal tissues 
only carcinomas of the bile-duct, the kidney and the pancreas 
showed stronger inhibition by pepstatin. Whether this more 
pronounced inhibition was due to contaminating macrophages 
could not yet be clarified.
The results are encouraging and ask for further experiments 
whereby isolated tumor cells should be incubated with pepstatin- 
loaded liposomes to provide more information about the role 
of cathepsin D in tumor-genesis and its share in tumor prote­
olysis.
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ENDOPEPTIDASE-24.il, A MEMBRANE ENZYME WITH DIVERSE ROLES IN MANY TISSUES
KENNY, A .J .
Department of Biochemistry, University of Leeds 
Leeds, UK
BACKGROUND
The purpose of this report is to review some of our 
recent work on this endopeptidase. The first evidence for the 
presence of a membrane bound enzyme in kidney that was capable 
of hydrolysing [125lJ insulin B chain was obtained about 15 
years ago (Wong-Leung and Kenny, 1968). Subsequent work showed 
it to be localized in the brush border membrane (George and 
Kenny, 1973). It was characterized in detail after purifica­
tion from rabbit kidney (Kerr and Kenny, 1974a,b) and was shown 
to be a Zn-metallo endopeptidase that cleaved insulin B chain 
at bonds -X-Y, provided Y was a hydrophobic amino acid residue. 
In both these respects it resembled the microbial metallo- 
endopeptidases typified by thermolysin. Phosphoramidon, a 
potent inhibitor of thermolysin, also inhibited the kidney en­
zyme (K^=2 nM, Kenny, 1977). The EC name, kidney brush border 
neutral proteinase, 3.4.24.11, was appropriate at that date, 
but subsequent work has shown that the enzyme has a much wider 
distribution, being present not only in the brush border of 
the intestine (Danielsen et al., 1980) but also in membranes 
of other tissues (Kenny and Fulcher, 1983). We have therefore 
proposed the name "endopeptidase-24.11" in order to embrace 
the wider role of this enzyme (Matsas et al., 1 983a) .
In rabbit and pig, it is the only endopeptidase in the 
renal microvillar membrane. The other peptidases in this mem­
brane are exopeptidases that exhibit a wide range of specific­
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ities (Table 1). It seems likely that an initial attack by the 
endopeptidase may be the essential step in the hydrolysis of 
some peptides, e.g. those with blocked termini, before the 
exopeptidases can be effective.
Table 1
Peptidases so far identified in pig kidney microvilli
Enzyme Active site Specificity Specificinhibitors
Endopeptidase-24.11 
(EC 3.4.24.11) Zn2 +
-O-O-i-O-
(hydrophobic)
Phosphoramidon
Thiorphan
Aminopeptidase N Zn2 + »io-o-o-
(many)
Aminopeptidase A Ca2 + o-o-o-
(Glu/Asp)
Aminopeptidase P ? 0-I-0-0-
(Pro)
Proline carboxypeptidase ? -o-o-*io
(Pro)
Dipeptidylpeptidase IV Serine
i
0-I-0-0-
(Pro)
Dip-F
Peptidyldipeptidase Zn2 + i—0-0-*-*
(nonspecific)
Captopril
y-Glutamyl transferase ? #±o-o-o-
(y-Glu)
Topology of endopeptidase-24.11 in pig kidney microvilli
The rabbit enzyme had been successfully released from the 
membrane by toluene-trypsin treatment (Kerr and Kenny, 1974a) 
and the purified product was a monomer of 93 000 with
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hydrophylic properties. In contrast to most other microvillar 
hydrolases, the endopeptidase cannot be released by treatment 
of the membrane with papain or trypsin (Kenny, 1977) a feature 
possibly suggesting a different type of association with the 
membrane from the well-studied "stalk proteins" (for review 
see Kenny and Maroux, 1982). We therefore sought to study the 
detergent-solubilised form of endopeptidase-24.11 purified 
from pig kidneys (Fulcher and Kenny, 1983). The purification 
was achieved by an immuno-adsorbent step employing a poly­
clonal antibody raised in rabbits. This form was dimeric and, 
being amphipathic, bound a micelle of Triton X-100. It was 
successfully reconstituted into liposomes and electron micro­
graphs established that it, too, is a stalked protein. Mor­
phometry of the micrographs revealed that it possessed an 
unusually short stalk (2 nm) (Kenny et al., 1983). Aminopep- 
tidase N (EC 3.4.11.2), an enzyme that is readily released 
from the membrane by papain, has a 5 nm stalk (Hussain et al.,
1981). We have therefore suggested that the inability of papain 
to release endopeptidase-24.11 relates to the limited space 
between the mass of the protein and the membrane surface, which 
is clearly insufficient to accommodate proteinases of the 
size of papain with a minimum diameter of 3.7 nm.
A monoclonal antibody to endopeptidase-24.11
Although the purified enzyme was not highly antigenic 
when injected into rabbits, a monoclonal antibody to it was 
obtained at an early stage in a programme in which Balb/c 
mice were immunized with pig kidney microvilli. This antibody, 
GK7C2 (Gee et al., 1983), has been valuable for purifying the 
enzyme in batches of 1 mg or more, by immunoadsorbent chromato­
graphy, the elution step being achieved by bicarbonate buffer 
at pH 10.6. Immunofluorescence with GK7C2 has also shown that 
the enzyme is located predominately in the brush borders of 
the proximal tubule of the kidney and of mucosal cells of the 
intestine including those lining the crypts. However, weak 
fluorescence was also demonstrated over the glomeruli and in 
basolateral membranes of the enterocytes, an observation that
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indicates that the antigen is probably not unique to microvilli. 
Other regions of the nephron - distal tubules and collecting 
ducts - appeared to lack the antigen.
Endopeptidase-24.11 in pig tissues
The availability of a specific inhibitor, phosphoramidon, 
provided the opportunity to search for this type of endopep- 
tidase in other tissues.
Table 2
Endopeptidase activity in pig tissues
The fractions were assayed with 6 yM insulin B chain as
substrate in the presence and absence of 1 yM-phosphoramidon.
Activity Inhibition
Tissue Membranefraction
-1 -1(pmol-min mg 
of protein)
by
phosphoramidon
(%)
Spleen microsomal 76 38
Aortic
endothelium microsomal 54 50
Lung microsomal 1 6 75
Myocardium microsomal 31 34
Skeletal muscle microsomal 20 7
Liver microsomal 40 0
Brain caudate 
nucleus synaptic 30 50
Brain cerebral 
cortex synaptic 25 5
Intestine microvilli 1700 1 00
Kidney microvilli 8000 1 00
Table 2 shows the activities, using L^^l] insulin B chain 
as substrate, in membrane fractions prepared from several 
sources. For spleen, aortic endothelium, lung, myocardium and 
skeletal muscle, a crude microsomal pellet was prepared. For 
brain, the results are for synaptic membranes and for kidney 
and intestine, microvilli were prepared. It is clear that the
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activities of microvilli are about two orders of magnitude 
higher than those for any other membrane and that the micro- 
villar activity is wholly inhibited by phosphoramidon. In other 
membranes, the proportion of the activity sensitive to phos­
phoramidon varied from 7-75 %, the highest being in lung. In 
brain, the activity in synaptic membranes was non-uniform. In 
the caudate nucleus, 50 % of the activity was phosphoramidon- 
sensitive, but in cerebral cortex only 5 % could be attributed 
to endopeptidase-24.11. When the phosphoramidon-sensitive activ­
ity in lung, heart and spleen was titrated with the polyclonal 
antibody raised to the kidney enzyme, inhibition was observed. 
This supports the view that endopeptidase-24.11 rather than an 
unrelated protein was present in these tissues (Kenny and Ful­
cher , 1 983).
Endopeptidase-24.11 and the hydrolysis of neuropeptides
Much attention has been given in the literature to the 
inactivation of [Leu] and [Met] enkephalins:
Tyr-Gly-Gly-Phe-Leu
Tyr-Gly-Gly-Phe-Met
The main points of hydrolysis by membrane preparations of 
1 2  3 4brain are the Tyr -Gly and the Gly -Phe bonds. The first is 
attributable to a membrane aminopeptidase sensitive to inhibi­
tion by puromycin (Vogel and Altstein, 1 979; Barclay and Phil­
lips, 1980; Hersh, 1981). The second has attracted greater in­
terest and has been variously attributed to peptidy1-dipeptid­
ase A (EC 3.4.15.1) (Swerts et al., 1979a; Benuck and Marks,
1979).However, the lack of inhibition by captopril (Swerts et 
al., 1979b) made this view untenable. It was then suggested 
that "enkephalinase" was another peptidyldipeptidase for which 
a specific inhibitor, thiorphan N-(DL-2-benzyl-3-mercaptopro- 
pionyl)glycine, had been designed (Roques et al., 1980). This 
reagent not only inhibited enkephalin hydrolysis in vitro, but 
was able to protect [Met]enkephalin released from brain slices 
(Patey et al., 1981). However, the hydrolysis of the -Gly-Phe- 
bond is also consistent with an endopeptidase attack as suggest­
ed by Blumberg et al. (1981) and is the predictable site of 
hydrolysis by endopeptidase-24.11.
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When we compared thiorphan with phosphoramidon as an in­
hibitor of the hydrolysis of insulin B chain or [Leujenkephalin 
by the purified kidney enzyme, the two inhibitors were indis­
tinguishable, giving values in the range 10-13 dM. Partial
inhibition by both was also observed for enkephalin hydrolysis 
by brain synaptic membranes (Fulcher et al., 1982). A compar­
ison of the structures of the two inhibitors (Fig. 1) shows 
that both are substituted dipeptides with an anionic group 
(-PO of -S ) adjacent to the P^' residue which has a hydro- 
phobic side chain.
S-CH,CHCONH—CH,CO,-
Fig. 1:
Chemical structures of (a) 
thiorphan and (b) phos­
phoramidon
We have also compared the hydrolysis of another neuropep­
tide, substance P, by the purified kidney enzyme and synaptic 
membranes prepared from caudate nuclei (Matsas et al., 1983a). 
This peptide has the sequence:
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met NH^ 
and thus contains several possible sites for endopeptidase-24.11 
attack. The peptides produced by the kidney enzyme and synaptic 
membranes were found to be identical when resolved by hplc and 
were all derived from hydrolysis at three bonds:
-Gln®-Phe^-, -Phe^-Phe®- and -Gly^-Leu”' 
the last being slightly more favoured than the other two. The
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hydrolysis of the substrate was fully inhibited 'by phosphor- 
amidon in both, preparations. Moreover, the hydrolysis of Tyr- 
DAla-Gly-Phe-Leu (which is attacked by synaptic membranes only 
at the -Gly-Phe- bond) could be titrated by phosphoramidon and 
gave an IC..Q value of 8 nM. The polyclonal antibody also gave 
identical inhibition curves for the hydrolysis of substance P 
and the enkephalin analogue by detergent solubilized membranes 
from kidney and caudate nuclei.
On the basis of these experiments we have argued that 
endopeptidase-24.11 probably has a general role in the hydro­
lysis of neuropeptides at the surface of synaptic membranes and 
that there iß no need to postulate the existence of a series of 
peptide-specific peptidases each recognizing only one type of 
neuropeptide.
Purification of brain endopeptidase-24,11 by monoclonal
antibody GK7C2
The close similarity of the kidney and the brain caudate 
endopeptidase activities, as revealed by inhibitors, bond 
specificity and titration by a polyclonal antiserum, has now 
been confirmed by the isolation of the enzyme from caudate 
nuclei (Relton et al., 1983). The very low abundance of the 
enzyme in caudate membranes required a rapid and specific 
method for its isolation. An immunoadsorbent column containing 
monoclonal antibody GK7C2 achieved essentially a single step 
purification. The overall purification factor was 24 000. The 
product (118 yg from 130 g of striatum obtained from 25 brains) 
was homogeneous on SDS-PAGE and had an apparent subunit M of 
87 000. This is lower than that tor pig kidney (89 000) and 
for pig intestine (94 000) (Fulcher et al., 1983) and it 
appears to be explained by the lower content of carbohydrate. 
Brain contains 12.9 %, kidney 15.0 % and intestine 18.3 % 
carbohydrate. All three have similar amino acid compositions 
and all show identity by Ouchterlony immuno diffusion (Fig. 2).
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Fig. 2:
Ouchterlony
immunodiffusion
Ab, polyclonal antibody in 
centre well; peripheral 
wells contain purified 
endopeptidase-24.11 from:
B, brain; K, kidney; X, in­
testine. Precipitate stain­
ed for protein.
Hydrolysis of synthetic and natural peptides by endo- 
peptidase-24.11
Although the primary attack can be predicted from the 
specificity originally defined with insulin B chain (Kerr and 
Kenny, 1974), it is becoming increasingly clear that the ef­
ficiency of hydrolysis may be greatly influenced by residues 
in positions somewhat remote from those adjacent to the bond 
hydrolysed. This was clear from some careful studies by Or- 
lowski and Wilk (1981) on a partially pure preparation of endo­
peptidase-24 .11 from bovine pituitaries in which a marked in­
fluence of residues at P2, and P4 on hydrolysis rates was 
demonstrated. Similar conclusions were obtained with the pu­
rified rabbit kidney enzyme (Almenoff and Orlowski, 1983).
In regard to natural peptides, our own work (Matsas et 
al., 1983b) has shown a very considerable range in Kcat/Km 
values for their hydrolysis by purified pig kidney endopep­
tidase-24 . 1 1 . Some are shown in Table 3. Substance P and the 
deamidated form were the best substrates. Enkephalins were 
also hydrolysed well, but the efficiency was lowered when 
amidated, though not when the peptide was extended by one or 
two residues, nuteinising hormone releasing hormone (LHRH) was
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Table 3
Relative K ^/K values for the hydrolysis of some 
neuropeptides and analogues by kidney endopeptidase-24.11
Peptide
K . /K cat m
(relative to Substance P)
%
Substance P 1 00
Substance P (deamidated) 115
[Leu] enkephalin 15
[Leu]enkephalinamide 0.5
[DAla^,Leu^] enkephalin 21
[DAla ,Leu"[j enkephalinamide 0.6
[DAla^,Met^]enkephalinamide 5
[Leu^,Arg®]enkephalin 1 4
[Leu~* ,Arg6 ,Phe^ j enkephalin 54
Neurotensin 5
LHRH 0.3
a very poor substrate. These preliminary studies suggest that 
the role of endopeptidase-24.11 in inactivating biologically 
active peptides, at cell surfaces in the central nervous 
system and elsewhere, may be more selective than had been ori­
ginally thought.
CONCLUSIONS
We have now purified endopeptidase-24.11 from kidney, 
intestine and brain. Apart from some differences in post- 
translational processing, the three preparations have similar 
properties. One practical gain from this information is that 
the purified kidney enzyme can be confidently regarded as a 
valid model for investigating properties of the brain enzyme 
and, since it is 100-fold more abundant in kidney than caudate 
nuclei, the advantages of working with the former are obvious.
141
The various roles of the endopeptidase in its different loca­
tions are to some extent a matter for speculation. In kidney 
microvilli, the enzyme accounts for 4 % of the membrane pro­
tein, comparable to dipeptidyl peptidase IV and exceeded in 
amount only by aminopeptidase N and the principal core protein, 
actin. Yet its role and that of the other hydrolases in this 
membrane remain to be clarified experimentally. It seems un­
likely that the endopeptidase can initiate the hydrolysis of 
any native proteins that are filtered by the glomerulus. Its 
natural substrates are probably peptide hormones exhibiting 
minimal secondary and tertiary structure. Unlike the isolated 
chains of insulin and glucagon, insulin itself resisted attack 
(Kerr and Kenny, 1974a). However, since the potential sub­
strates in the glomerular filtrate are essentially excluded 
from exerting a biological action on sites other than those 
bathed by the fluid in the lumen of the nephron, we may assume 
that the existence of this intensive battery of peptidases, 
located in the first segment of the nephron, must relate to a 
need to ensure that one or more peptide does not cause an un- 
physiological effect lower in the nephron. But the identity 
of the potentially hazardous peptides is at present unclear.
On the other hand, the presence of the endopeptidase and its 
attendant exopeptidases in the intestinal microvillar membrane 
can be explained with more confidence. It is clear that many 
peptides generated by the action of gastric and pancreatic 
proteinases may well require the attack of the membrane pep­
tidases, including endopeptidase-2.4.11 , before absorption can 
take place. However, the precise role of endopeptidase-24.11 
in this context remains to be experimentally determined. In 
synaptic membrane of at least some regions of the brain, we 
may be nearer to understanding the role of this enzyme. If we 
can assume that its topology in these membranes is like that 
in microvilli (i.e. at the extracellular surface facing out­
wards) , it is ideally placed to terminate the signals generated 
by neuropeptides at synapses. Since its specificity is broad, 
it is likely that a wide spectrum of neuropeptides may be so 
inactivated, but it is clear that other peptidases also play 
major roles in respect of different regions of the central
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nervous system and in respect of neuropeptides that are vulner­
able to attack by other means, e.g. that by aminopeptidase on 
enkephalins. The precise role of endopeptidase-24.11 in the 
membranes of other cell types in hydrolysing peptides at cell 
surfaces is at present an unexplored field.
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DISCUSSION
KÖPITAR:
I am interested in the pH dependent stability of endopep- 
tidase 24.11. How long does this enzyme retain its (total) 
enzyme activity at pH 10.6, at 37°C and at room tempera­
ture?
KENNY:
When we first used the immunoadsorbent column we neutral­
ised each fraction as it was collected. But this does not 
seem to be necessary - later we bulked the fractions and 
then dialysed against pH 7.4 buffer, at 4°C and we know 
that this process takes several hours before the pH falls 
significantly. So the stability of the endopeptidase to 
pH 10-6 is high.
VITALE:
What are K^ values for captopril and other angiotensin - 
converting enzyme inhibitors for your enzyme?
KENNY:
Captopril does not inhibit endopeptidase - 24.11, even 
at 1 mM concentration.
GRÁF:
I have not seen ß-endorphin among the endopeptidase sub­
strates shown in your last slide. Has ß-endorphin been 
tested? I wonder if ß-endorphin is a similarly good sub­
strate of Endopeptidase 24.11 as enkephalin (the N-ter- 
minal fragment of ß-endorphin) is.
KENNY:
No, it has not been tested, we are beginning to look at 
it. We don't yet know exactly the rules of the game, we 
don't quite know how to describe which substrate is going 
to be good or bad, and I think we need to look at lot 
more.
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SOME PROPERTIES OF LYSOSOMAL CYSTEINE PROTEINASES AND 
THEIR COMPLEXES WITH ANTIBODIES
KIRSCHKE, H ., BOHLEY, P., FITTKAU, S. and 
WIEDERANDERS, B.
Institute of Physiological Chemistry, Martin-Luther 
University
H a l l e - W i t t e n b e r g , GDR
SUMMARY
Cathepsin L (M 29,000) can be cleaved in two chains of 
Mr 24,000 and about 5,000 as it has already been described for 
cathepsins B and H.
Labelling of the active center cysteine by Z-Phe-Phe- 
- ^ CHIS^  and by the fluorescent labelled Dans-Ala-Ala-Phe-CI^Cl 
shows that the active site thiol of cathepsins L and H is 
located in the heavy chain (M^ 23 - 24,000). This finding is 
in contrast to the location of the active site thiol of 
cathepsin B which has been found in the light chain.
Enzyme activity of cathepsin I was retained in the heavy 
chain after removing the light chain.
Cathepsins H and L have been found to precipitate with 
their antibody at a pH as low as 6.0, where the enzymes are 
enzymatically active. Cathepsin B has only shown precipitation 
after alkaline denaturation.
A n t i g e n - a n t i b o d y - c o m p l e x e s  o f  c a t h e p s i n s  H a n d  L e x h i b ­
i t e d  e n z y m e  a c t i v i t y  a g a i n s t  l o w  m o l e c u l a r  w e i g h t  s u b s t r a t e s .
A h i g h  m o l e c u l a r  w e i g h t  p r e c u r s o r  p r o t e i n  o f  c a t h e p s i n  B 
a n d  H c o u l d  n o t  b e  d e t e c t e d  i n  l y s o s o m a l  e x t r a c t s ,  w h e r e a s  s u c h  
a n  a c t i v e  p r o e n z y m e  o f  c a t h e p s i n  D i s  p r e s e n t  i n  l y s o s o m a l  
e x t r a c t s .
A b b r e v i a t i o n s :  D a n s :  d a n s y l -
Z : b e n z y l o x y c a r b o n y l -
147
INTRODUCTION
In search of proenzymes of lysosomal cysteine proteinases
35we use the following technique: after incorporation of S- 
labelled methionine of the cells in culture the enzymes and 
their precursors were specifically bound to their respective 
antibody. The molecular weight of the bound antigens was 
examined after SDS-gel electrophoresis. The interpretation of 
the results of these and the related experiments using specific 
radio-labelled inhibitors (Docherty et al., 1983) needs know­
ledge of the dissociation behaviour of the cysteine proteinases 
on SDS-gels both under reducing and non-reducing conditions.
The determination of the active site in the separated chains 
would be of equal importance. On the other hand, we are also 
lacking detailed knowledge of the reactions of lysosomal cys­
teine proteinases with their antibodies.
In the present paper we describe properties of cathepsins 
B, H and L concerning their dissociation behaviour on SDS-gel 
electrophoresis and location of the active site cysteine in the 
separated chains. In the second part some results are given 
of experiments with cathepsins B, H and L and their antibody.
Separation of héavy and light chains of cathepsins B, H
and L and location of the active site
Cathepsin B from pig liver (Takahashi et al., 1979, 1980) 
and beef spleen (Pohl et al., 1982) has been studied in detail 
with respect to the noncovalently bound chains. According to 
the authors the cleavage of cathepsin B (Mr 28 - 29,000) 
after reduction resulted a heavy chain (Mr 22 -25,000) and a 
light chain (M^ 5 - 6,000). The latter forms the N-terminus of 
the native molecule (M^  28 - 29,000). The active site thiol of 
cathepsin B was located in the light chain.
In contrast to cathepsin B the light chain (Mr ca. 6,000) 
of cathepsin H from rat liver originated from the C-terminus 
of the aggregated molecule (M^ ca. 28,000) (Takio et al., 1982). 
Molecular weight of ca. 22,000 for the heavy chain was deter-
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mined by the same authors. The location of the active site 
thiol of cathepsin H remained undecided.
We could show that cathepsin L also consists of two chains. 
The separation on SDS-gel electrophoresis of the chains of 
cathepsins B, H and L is shown in Fig. 1 .
1 2 3 4 5 6 7 8 9
Fig. 1: SDS-polyacrylamide gel electrophoresis of 
cathepsin L and B and H
The samples were run on 15 % polyacrylamide gel slab, 
1, 4, 7; protein standards: bovine serum albumin 
(68,000), egg white albumin (45,000), carbonic an- 
hydrase (29,000), soybean trypsin inhibitor (21,000), 
myoglobin (17,800), insulin B chain (3,495), indicated 
by arrow. 2: cathepsin L after reduction with 2-mer- 
captoethanol; 3: cathepsin L without reduction;
5: cathepsin B after reduction; 6: cathepsin B without 
reduction; 8: cathepsin H after reduction; 9: cathep­
sin H without reduction
Cathepsin L has a molecular weight of ca. 29,000, the 
heavy chain of 24,000 and the light chain of about 5,000. The 
chains of cathepsin L can be separated completely by SDS-gel 
electrophoresis already under mild reducing conditions (0.1 %
2-mercaptoethanol). With cathepsin H, however, under these con­
ditions and even after reduction with 1 % 2-mercaptoethanol a 
part of the intact molecule remained undissociated on the gel
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(Fig. 1). We determined the same molecular weight of about 
5,000 for the light chains of cathepsin L and H, whereas the 
light chain of cathepsin B has a slightly lower molecular 
weight of about 4,000.
The molecular weights have been determined by SDS-gel 
electrophoresis using 15 % polyacrylamide gels (2,6 % cross 
linked). The low molecular weights could be only roughly calcu­
lated by this method.
It was of interest to know whether the active site cysteine 
of cathepsin L was located also in the light chain as has been 
described for cathepsin B (Takahashi, et al., 1980; Pohl et al.,
1982). In contrast to the results with cathepsin B, however, 
we detected the active site thiol in the heavy chain of cathep­
sin L by the following methods.
1. / Cathepsin L reacts irreversibly and fast with Z-Phe- 
Phe-CHN2 (Kirschke and Shaw, 1981). This reagent can be used 
to titrate the active site of cathepsin L. The inactivation of 
cysteine proteinases by diazomethyl ketones was shown to result 
from the alkylation of the essential SH-group (Leary et al., 
1977).
1 4After reaction of cathepsin L with C-labelled Z-Phe-Phe- 
-CHN2 the chains were separated by SDS-gel electrophoresis. The 
gel was stained for protein and afterwards sliced in sections 
which were solubilized for measuring radioactivity. Radioactiv­
ity was detected only in the gel slices of the heavy chain. It 
was shown by autoradiography of the dried gel that the labelled 
inhibitor had reacted only with the heavy chain. A non-reduced 
sample of enzyme-inhibitor-complex exhibited the radioactivity
in the intact molecule with M 29,000.
r  142. / There was no reaction of cathepsin L with C-labelled 
Z-Phe-Phe-CHN2 after the enzyme had reacted with a different 
inhibitor as iodoacetic acid or E-64. This results is a piece 
of evidence that the labelled inhibitor reacted with the active 
site thiol of the enzyme.
3. / Z-Ala-Ala-Phe-CH2C1 is an irreversible and fast react­
ing inhibitor of cathepsins B, H and L (unpublished results).
For the experiments described here we used the inhibitor after 
substitution of the N-terminal protective group (Z-) by dansyl- 
residue.
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After reaction of the enzymes with Dans-Ala-Ala-Phe-C^Cl 
and separation of the chains by SDS-gel electrophoresis, a 
bright fluorescence was detectable of the heavy chains of 
cathepsins L and H and of the light chain of cathepsin B. This 
experiment shows clearly that the inhibitor Dans-Ala-Ala-Phe- 
C^Cl reacts with an amino acid in the active center, otherwise 
the heavy chain of cathepsin B would have been marked, as well. 
Studies of the reaction of chloromethyl ketones with papain 
have shown an alkylation of the active center thiol group 
(Glazer and Smith, 1971).
4./ The heavy chain (M 24,000) of cathepsin L retained 
the enzyme activity after removing the light chain. The chains 
of cathepsin L have been separated after reduction by gel 
electrophoresis at pH 3.7 with cetylpyridinium chloride. A gel 
strip was stained for protein and a duplicate gel strip was 
sliced in sections. The enzyme activity was determined in the 
extracts of the gel slices with Z-Phe-Arg-methyl coumaryl amide 
as substrate. Only the gel slices of the heavy chain exhibited 
catalytic activity.
Reaction of cysteine proteinases with their antibody
The formation of insoluble antigen-antibody-complexes of 
cathepsin B from rat is in a special way pH dependent. Already 
at pH values between 6 or 7, where the enzyme exhibits enzyme 
activity, cathepsin B does not precipitate with its antibody. 
This has been described in detail for cathepsin B from rabbit 
and human (Graf, 1981). Cathepsins H and L precipitate with 
their antibody at pH 8-9, as well as at pH 6-6.5. The antigen- 
antibody-complexes of cathepsin H and L precipitated at pH 6 
retained the enzyme activity against low molecular weight 
substrates.
In the search of proenzymes of lysosomal cysteine pro­
teinases, first we tried to detect such precursors in the ly­
sosomal extract. A lysosomal extract from rat liver was run 
on Sephadex G-75. The fractions were tested by fused rocket 
immunoelectrophoresis. We were unable to detect antigens of 
molecular weight higher than 30,000 either for cathepsin H or
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for cathepsin B. On the other hand, we could show that an
antibody against cathepsin D (aspartic proteinase) precipitated
with an antigen of Mr about 100,000.
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DISCUSSION
TURK:
In your presentation you mentioned the molecular weight 
of the precursor of cathepsin D to be about 100 000 dal- 
tons. In my opinion this value is too high. Reports of 
e.g. Hasilik, Neufeld, Blotel and our own results show 
that the Mr of cathepsin D precursor is about 50 000 dal- 
tons.
KIRSCHKE:
The molecular weight of the precursor of cathepsin D which 
has been detected outside the lysosomes is 53 000. We 
found a compound with a molecular weight of about 100 000 
in the lysosomes which reacted with an antibody against 
cathepsin D. Further experiments will show whether this 
is an aggregate of cathepsin D with other proteins and if 
this compound exhibits enzymatic activity.
STEPANOV:
Would you tell me something about the inhibitory effect 
of diazomethanes?
KIRSCHKE:
Leary and Shaw showed that diazomethanes react specifical­
ly with cysteine proteinases by alkylation of the active 
site SH-group. They do not react with low molecular weight 
SH-compounds and do not inhibit serine proteinases. As­
partic proteinases react only in the presence of Cu^+ ions 
with diazomethanes.
BARRETT:
Although the largest precursor of cathepsin D detected so 
far is only 50 000 molecular weight, I think that still 
larger precursors might exist, as indicated by your results.
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INTRODUCTION
T issu e  c y s te in e  p ro te in a se s  a r e  re sp o n s ib le  fo r  the d eg rad a tio n  of in tr a c e llu ­
l a r  p ro te in s  un d er both n o rm a l and p a tho log ica l c o n d itio n s . This fa c t is  su p ­
p o r te d  by s e v e ra l  o b se rv a tio n s  whi ch  su g g est th e ir  ro le  in  the p ro c e s s e s  of 
ho rm one  m etab o lism  g en e ra tin g  th e ir  ac tiv e  p ep tid e s  fro m  p r e c u r s o r s  (Quin 
and Ju d ah , 1978; Sm ith and V anF rank , 1975), in  the m e tab o lism  of op ia te  
p ep tid es  (S uhar e t  a l . ,  1 981), the in ac tiv a tio n  of so m e enzym es involved in 
g ly co ly s is  (O tto , 1971; N a k a i e t a l . ,  1 9 8 3 ) ,co llag en  d eg rad a tio n  (Eeckhout 
and V a e s , 1977) and d eg rad a tio n  of m y o fib rila r  p ro te in s  (M a tsu k a ra  e t a l . ,  
1 981). F u r th e rm o re , c y s te in e  p ro te in a se s  a r e  a lso  involved in the pathology 
of c a n c e r  ( M o r t e t a l . ,  1980; G r a f e t  a l . ,  1981; G ira ld i e t a l . ,  1982).
R ecent s tu d ie s  have shown th a t the a c tiv it ie s  of ly so so m a l cy s te in e  p ro te in a ­
s e s  m ay be re g u la te d  by th e ir  endogenous p ro te in  in h ib ito rs , w hich a r e  lo c a ­
ted  in  the cy to so l (K o p ita r e t  a l . , 1978; Lenney e t  a l . , 1979; H irado  e t  a l . , 
1981; J ä r vinen and R inne, 1982; B r z i n e t a l . ,  1982; K om inam i e t  a l . ,  1982; 
K op ita r e t a l . ,  1983). The m ech an ism s by w hich th e se  in h ib ito rs  re g u la te  
the a c tiv it ie s  of the co rre sp o n d in g  enzym es a r e  not y e t d efined .
A lthough ly so so m a l c y s te in e  p ro te in a se s  and th e ir  endogenous p ro te in  in h ib i­
to r s  iso la te d  fro m  v a rio u s  s o u rc e s  have m any c a ta ly tic  p ro p e r t ie s  in  com m on, 
th e re  a r e  n u m ero u s d isc re p a n c ie s  in  th e ir  o th e r  c h a r a c te r i s t ic s .  In th is  p a ­
p e r  the p u r if ic a tio n , p ro p e r t ie s  and s t ru c tu ra l  da ta  of ca th ep sin s  B, H and L 
fro m  bovine sp leen  as  w ell a s  the p r im a ry  s t ru c tu re  and so m e c h a ra c te r is t ic s  
of cy to so lic  p ro te in  in h ib ito r from  hum an leu co cy tes  Stefin  and the egg w hite 
in h ib ito r  c y s ta t in , a r e  p re s e n te d .
EXPERIMENTAL PROCEDURES 
M a te r ia ls
F re sh  bovine sp le e n s  w e re  u sed  fo r the iso la tio n  of c y s te in e  p ro te in a s e s .  A 
cy to so lic  p ro te in  in h ib ito r , s te f in , w as iso la te d  from  f re s h  hum an b lood . The 
egg w hite inhibitor; c y s ta tin , w as iso la te d  from  f re s h  ch icken  e g g s . All ch e ­
m ic a ls  u sed  in  the  e x p e rim e n ts  w ere  of re a g e n t g ra d e .
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M ethods
P ro teo ly tic  a c tiv it ie s  of papain  and c a th ep sin  B on b e n zo y l-D L -A rg -2 -n ap h ty l- 
am ide  (BANA) s u b s tra te  and ca th ep sin  H on L -leu cy l-2 -n ap h th y lam id e  (L eu- 
NA) s u b s tra te  w e re  d e te rm in e d  acco rd in g  to  B a rre tt  (1 9 7 2 ). C a th ep sin  L a c ­
tiv ity  w as d e te rm in e d  acco rd ing  to  the Anson m ethod (1939) using haem oglo­
bin  a s  s u b s tra te  in  the  p re s e n c e  of 10 M of the in h ib ito r p e p s ta tin . Stefin 
in h ib ito ry  ac tiv ity  w as d e te rm in e d  un d er the cond itions d e sc r ib e d  fo r  p ro te i­
n ase  a s s a y . A known am ount of in h ib ito r w as p re in cu b a ted  w ith the  enzym e fo r  
5 m in a t room  te m p e ra tu re  b e fo re  adding the  s u b s tr a te .  C y sta tin  in h ib ito ry  
ac tiv ity  w as d e te rm in e d  w ith papain  using  BANA as  s u b s tra te  (B a r re t t ,  1972). 
One in h ib ito ry  un it of Stefin  and c y s ta tin  w as defined as  the am ount of the  in ­
h ib ito r  w hich co m p le te ly  in h ib its  1 pg of p ap a in . P ro te in  was d e te rm in e d  by 
th e  m ethod of Lowry (1 9 5 1 ).
M olecu la r w eight w as d e te rm in e d  by gel ch ro m ato g rap h y  acco rd in g  to  W hita­
k e r  (1963) and by SDS p o ly ac ry lam id e  gel e le c tro p h o re s is  (PAGE) accord ing  
to  L aem li (1 9 7 0 ). A naly tical gel e lec tro fo cu s in g  w as c a r r ie d  out on 1 mm 
th ick  5% p o ly ac ry lam id e  p la te s  w ith c a r r i e r  am pholines (pH 4 -8 ) and gels 
w e re  s ta in ed  fo r  p ro te in  w ith C o o m assie  b r i l l ia n t  b lu e . Am ino ac id  a n a ly s is , 
and sequence  a n a ly s is  by au tom ated  so lid -p h a se  Edman d eg rad a tio n  w ere  d e ­
te rm in e d  (M ach le id t e t a l . ,  1983, in  p r e s s ) .
The p u rif ic a tio n  p ro c e d u re  of ca th ep sin  B, H and L is  b ased  on the m ethod fo r 
the  iso la tio n  of bovine lym ph node c a th ep sin  B and H (Z v o n ar e t  a l . , 1979) and 
the  m odified  m ethod fo r  the  iso la tio n  of ca th ep sin  B, H and S (L ocnikar e t  a l . . 
1981). The p u rif ic a tio n  s te p s  include ac id  e x tra c tio n , acetone fra c tio n a tio n , 
am m onium  su lpha te  p re c ip ita tio n , gel f i l tra tio n  ch ro m ato g rap h y  on Sephadex 
G -5 0 , cov a len t ch ro m ato g rap h y  on th io l-S e p h a ro se  4B, C M -ce llu lo se  c h ro m a ­
tog raphy  and as the la s t  s te p  fo r  ca th ep sin  B fa s t  p ro te in  liqu id  c h ro m a to g ra ­
phy (FPLC) from  P h a rm a c ia , U p p sa la . The d e ta ils  of th is  new p u rif ic a tio n  p ro ­
c e d u re  w ill be p u b lished  e ls e w h e re . The hum an leucocy te  in h ib ito r , s te f in , 
w as iso la te d  from  leucocy te  cy toso l using  affin ity  ch ro m ato g rap h y  on c a rb o x y - 
m eth y la ted  p apa in -S epharose  4B and DEAE-Sephacel ch ro m ato g rap h y  (B rzin  e t 
a l . ,  1983, in  p r e s s ) .  The egg w hite in h ib ito r , c y s ta tin , w as iso la te d  from  egg 
w hite a f te r  a lk a lin e  and h ea t t r e a tm e n t, gel f i l tra tio n  ch ro m ato g rap h y  on 
Sephadex G -50 and DEAE-Sephacel ch ro m ato g rap h y  (T urk e t  a l . , 1983a, in 
p r e s s ) .
RESULTS AND DISCUSSION 
P ro p e r tie s  of c a th ep s in s  B, H and L
As we re p o r te d  e a r l i e r  (L ocn ikar e t  a l . , 1981) ca th ep sin s  B, H and L ( fo rm e r  
c a th ep sin  S) w e re  re so lv e d  by ion exchange ch ro m ato g rap h y  on C M -ce llu lo se . 
The p u rity  of a ll th re e  c a th e p s in s  (F ig . 1) w as analyzed  by SDS-PAGE under 
den a tu rin g  ( i . e .  SDS) and non -d en a tu rin g  co n d itio n s . W hereas ca th ep sin  H and 
L con ta in  only one p ro te in  band w ith M r of abou t 28 000 and 24 000 d a lto n s , 
r e s p e c tiv e ly , c a th ep sin  B c o n s is ts  of two m a jo r po lypeptide ch a in s  of M r of 
about 30 000 daltons and 25 000 daltons (heavy ch a in ) and m in o r ( lig h t cha in ) 
of M r of about 5 000 d a ltons ( only w eakly v is ib le ) .  It was su g g ested  r e c e n t ly ,
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F ig . 1. SDS-PAGE : from  le ft to  r ig h t : s ta n d a rd  p r o te in s , 
ca th ep sin  B, ca th ep sin  L, ca th ep sin  H.
F ig . 2 . I s o e le c tr ic  focusing : s ta n d a rd , c a th ep sin  H , c a ­
th ep sin  L, two fo rm s  of c a th ep sin  B (fro m  le ft to  
r i g h t ) .
th a t lim ite d  p ro te o ly tic  c leav ag e  m ight o ccu r to  fo rm  the heavy and ligh t 
chain  of ca th ep sin  B (K atunum a e t  a l . , 1981).
I s o e le c tr ic  focusing of a ll th re e  p u rif ie d  ca th ep sin s  show ed th a t fo r ca th ep sin  
B p i va lu es  a r e  betw een  4 .7  and 5 .5 ,  fo r  ca th ep sin  H , betw een 7 .0  and 7 .3  
and  fo r  ca th e p s in  L betw een  6 .3  and 6 .8  (F ig . 2) . The p i va lu es  fo r bovine 
sp leen  c a th ep sin  B and H have been  found to  be s im ila r  to r a t  and hum an 
e n z y m e s , w h e reas  the pi va lu es  fo r  ca th ep sin  L a re  s lig h tly  h ig h e r (B a rre tt  
and K irsc h k e , 1981).
C a th ep sin  B w as a lso  p u rif ie d  by the fa s t  p ro te in  liqu id  ch ro m ato g rap h y  m e­
th od . The enzym e w as e lu ted  in  two p ro teo ly tic  a lly  ac tiv e  p e a k s , w ithout 
co n tam ina tion  w ith in ac tiv e  p ro te in s  (F ig . 3 ) .  I t i s  p o ss ib le  th a t th e se  two 
p eak s a r e  m u ltip le  fo rm s , w hich d iffe r  s lig h tly  in  th e ir  is o e le c tr ic  p o in ts .
R ecently we o b se rv ed  th a t c a th ep sin  S , iso la te d  in  o u r la b o ra to ry  (T urnsek  e t 
a l . , 1975; L ocnikar e t  a l . , 1981) c o rre sp o n d s  to  ca th ep sin  L on the b a s is  of 
the s u b s tra te  sp e c if ic ity , using  hexapep tide L eu -T rp -M et-A rg -P h e -A la  as su b ­
s t r a te  (Turk e t  a l . , 1983b, in  p r e s s ) .  The c leav ag e  of M e t-Arg bond can  be 
co m p ared  w ith s im ila r  r e s u l ts  ob tained  fo r  r a t  l iv e r  ca th ep sin  L (K atunum a 
e t a l . , 1 9 81). Some o th e r p ro p e r t ie s  of iso la te d  bovine sp leen  ca th ep sin  L a re  
g e n e ra lly  in  good a g re e m e n t w ith p u b lish ed  d a ta  (rev iew ed  by B a rre tt  and 
K irsc h k e , 1981). Sm all d iffe re n c es  m ay be d u e to  sp e c ie s  and tis s u e  v a r ia ­
tions .
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P a r tia l p r im a ry  s t ru c tu re  of ca th ep sin s  B and L
Our p u rif ic a tio n  p ro c e d u re  enab led  us to  p re p a re  enzym e sa m p le s  in  h igher 
am ounts to  c a r r y  out the f i r s t  s t ru c tu ra l  s tu d ie s . In Table 1 the a m in o - te rm i­
nal seq u en ces of ca th ep sin  B and L a re  p re se n te d  and co m p ared  w ith th o se  of 
papain  (D ren th  e t  a l . , 1971) and r a t  l iv e r  ca th ep sin  B (K atunum a e t a l . , 1981).
VOLUME ( ml)
F ig . 3 . FPLC of c a th ep sin  B on Mono S co lum n: 2 .7  mg of ca th ep ­
s in  B was ap p lied ; s ta r tin g  b u ffe r: 20 mM N a -a c e ta te  in 
the p re s e n c e  of 1 mM EDTA, pH 5 .0 ;  e lu tion  buff e r :  0 -0 .3  
M NaCl in  the  s ta r tin g  b u ffe r ; e lu tion  volum e 25 m l , s e ­
p a ra tio n  tim e  25 m in ; -------  p ro te in , BANA a c tiv ity ,
------ NaCl g ra d ie n t.
H igh d eg ree  of hom ology betw een bovine sp leen  c a th ep sin  B and r a t  l iv e r  c a ­
th ep sin  B is  e v id e n t. I t is  a lso  ev iden t th a t the am ino  te rm in a l p a r t  of c a th ep ­
s in  L is  m o re  hom ologous to  papain  than  to  ca th ep sin  B w hich can  be seen  from  
a s h o r t  loop ( re s id u e s  7 -10 ) w hich is  m issin g  in  papain  and c a th ep sin  L. C y s- 
29 w as found to  be in  the  ac tiv e  s ite  of ca th ep sin  B and L, using ac tiv e  s ite  
ra d io la b e llin g . The co m p le te  hom ology of am ino ac id  r e s id u e s  26-32 (ca th ep ­
s in  B n u m b erin g ) in  a ll four enzym es in d ica te s  th a t the s t ru c tu re  of the c y s te ­
ine p a r t  of the  ac tiv e  s i te  m ight be the  s a m e . In ad d itio n , a highly hom ologous 
re g io n  in  ca th ep sin  B and papain  w as found around  C ys-69  from  re s id u e s  6 8 -73 , 
ap p aren tly  a s  a consequence  of the  com m on d isu lph ide  b rid g e  C ys-26  -  C y s -6 9 . 
An add itional d isu lph ide  bond betw een C y s-1 4  and C ys-43  w as found in  ca th ep ­
s in  B, w hich does not e x is t  in papain  and ca th ep sin  L. F u r th e rm o re , our p r e l i ­
m in a ry  sequence  s tu d ie s  of ca th ep sin  H fu r th e r  su g g est a com m on evo lu tionary  
o rig in  of the  fam ily  of c y s te in e  p ro te in a se s  (in  p re p a ra tio n  fo r p u b lic a tio n ) .
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10 20 30
a ) L P E S F D A R E Q W P N C P T 1 K E I R D Q G s C G S C W
b) L P E S F D A R E Q W S N C P T I A Q I R D Q G s c G S C W
c) L P D s V D - - -  -  W R E K G G V T P V K Y Q G A c G S C+W
d) I P E Y V D - - - - w R Q K G A V T P V K N Q G s c G S C+W
40 47 50
a ) A F G A V E A I S D R I C I H S -  N V N V E V S A E D M L T
b) A F G A V E A M S D R I c I H T -  N V N V E V s A E D L L T
c ) A F S A V V L A Q -
d) A F S A V V T 1 E G I I K I R T G N L N - Q Y s E Q E L L D
60 70 80
a) C C G G E C G D G C N G G F P S G A W N F W T V -
b) C C G I Q C G D G C N G G Y P s G A X N F -
c )
d) C D - - R R S Y G C N G G Y P w S A L Q L V A Q -
+ in d ic a te s  ac tiv e s i te  Cys
Table 1. A m ino -te rm in a l seq u en ces of a )  bovine sp leen  ca th ep sin  B,
b) r a t  sp leen  ca th ep sin  B (K atunum a e t  a l . , 1981),
c ) bovine sp le e n  ca th ep sin  L , d ) papain  (D ren th  e t  a l . ,
1971).
The am ino ac id  sequence  of c a th ep sin  B lig h t chain  ( re s id u e s  1-47) is  in  a g re e ­
m ent w ith re c e n tly  p u b lished  r e s u l ts  (Pohl e t  a l . ,  1 982). In co n c lu s io n , the 
e lu c id a tio n  of the  co m p le te  s t ru c tu re  of ly so so m al cy s te in e  p ro te in a s e s  w ill 
co n tr ib u te  to w ard s fu r th e r  understand ing  of the  m echan ism  of th e ir  a c tio n .
P ro p e r tie s  and s t ru c tu re  of c y s te in e  p ro te in a se  in h ib ito rs
W hereas egg w hite c y s ta tin  has been  p re v io u s ly  iso la te d  (F ossum  and W hitaker, 
1968; Sen and W hitaker, 1973; K eilova and T o m asek , 1974) and v e ry  re c e n tly  
re in v e s tig a te d  (A n a s ta s i e t  a l . ,  1 9 83), m am m alian  cy to so lic  p ro te in  in h ib i­
to r s  of c y s te in e  p ro te in a se s  w ere  d isc o v e re d  and c h a ra c te r iz e d  only re c e n tly  
( s e e  re fe re n c e s  in  In tro d u c tio n ) . Due to  m any s im ila r  p ro p e r t ie s  it  w as a s s u ­
m ed th a t egg w hite c y s ta tin  and cy to so lic  p ro te in  in h ib ito rs  a r e  m e m b e rs  of a 
hom ologous fa m ily . T h e re fo re  our s tu d ie s  w e re  o r ie n te d  in  th is  d ire c tio n . 
In troducing  the new iso la tio n  p ro c e d u re  fo r  egg w hite c y s ta tin  and the hum an 
leu co cy te  in h ib ito r  Stefin we iso la te d  both in h ib ito rs  in  the e le c tro p h o re tic a lly  
p u re  fo rm s  (T urk e t  a l . ,  1983a, in  p r e s s ;  B rzin  e t  a l . , 1983, in  p r e s s ) .
Som e of the  p ro p e r t ie s  of c y s ta tin  and Stefin  a r e  p re se n te d  in  Table 2 . It can  
be se e n  th a t both in h ib ito rs  have so m e com m on p ro p e r t ie s ,  e . g .  te m p e ra tu re  
and pH s ta b il i ty . In ad d itio n , egg w hite c y s ta tin  and m am m alian  cy to so lic  in ­
h ib ito rs  fo rm  co m p lex es w ith in ac tiv e  p ap a in . This fa c t w as su c c e ss fu lly  in ­
tro d u ced  in to  the p u rif ic a tio n  p ro c e d u re  by the  u se  of the  in ac tiv e  papain  as a 
ligand  fo r the  affin ity  c h ro m a to g rap h y  s te p  (A n a s ta s i e t  a l .  , 1983; Jä rv in e n  
and Rinne, 1982; B rzin e t a l . ,  1983, in  p r e s s ) .
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C ysta tin Stefin
Iso la tio n  p ro c e d u re s ta n d a rd  m ethods 
affin ity  ch ro m ato g rap h y
affin ity  ch ro m ato g rap h y
U sual a s sa y w ith papain w ith papain
pH s ta b ility pH 3-12 pH 4-12
T em p era tu re  s ta b ility 20 m in  a t 80 °C 20 m in a t 80 °C
M ultip le fo rm s s e v e r a l ,  m ain  a t p i 5 .6  
and 6 .5
pi 4 .7
M olecu la r weight fo rm  I about 13 100 
fo rm  II 12 181
11 006
Inhib ition
Ki
ca th ep sin  B ,H ,L , 
papain  
-11about 10 on 
papain
c a th ep sin  B ,H ,L , 
papain
-7  -1110 -  10 on
d iffe re n t enzym es
Table 2 . P ro p e r tie s  of egg w hite c y s ta tin  and hum an leucocy te  
in h ib ito r  Stefin
10 20 30
a) S E D R S R L L G A P V P V D E N D E G L 3 R A L Q F A M  A
b) G A P V P V D E N D E G L G R A L Q F A M  A
c) M I P G G L S E A K P A T P E I Q E I V D K V K P Q L E E K
40 50 60
b) E Y N R A S N D K Y S S R V V R V I S A K R a L V S G I K Y
c) T N E T Y G K L E A V Q Y K T Q V V A G T N Y Y I K V R A G
70 80 90
b) I L Q V E I G R T T c P K s S G D L Q S C E F H D E P E M  A
c) D N K Y M H L K V F K S L p G a N E D L V L T G Y a V D K N
100 110
b) K Y T T C T F V V Y s I P W L N Q I K L L E S K C Q
c) K D D E L T G F
Table 3 . A m ino-acid  se q u en ceo f a )c y s ta t in  fo rm  I ( p a r t i a l ) ,  b ) c y s -  
ta tin  fo rm  II , c )  S tefin .
T h e re fo re  ou r fu r th e r  s tu d ie s  w e re  o r ie n te d  to w ard s the d e te rm in a tio n  of the 
am ino  ac id  seq u en ce  of egg w hite c y s ta tin  and the hum an leu co cy te  inh ib ito r 
S te fin . Am ino ac id  seq u en ces  w e re  d e te rm in e d  by au tom ated  so lid -p h ase  
Edman d eg rad a tio n  and the  r e s u l ts  a r e  p re se n te d  in  Table 3 . (T urk  e t  a l . , 
1983a, in  p r e s s ;  M achleid t e t  a l . ,  1983, in  p r e s s ) .
The hum an leu co cy te  in h ib ito r s te fin  does not con ta in  tryp tophane  and only 
one a rg in in e  and h is tid in e . An outstanding  fe a tu re  is  lack  of cy s te in e  which
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th is  in h ib ito r has in  com m on w ith th e rm o s ta b le  y e a s t p ro te in a se  B in h ib ito r 
(M a ie r  e t  a l . ,  1979) and eg lin  c (S e e m ü lle r  e t  a l . ,  1981).
Two m a jo r fo rm s  of egg w hite in h ib ito r c y s ta tin  w ith p i v a lu es  6 .5 (fo rm  I) and 
5 .6  (fo rm  II) w ere  iso la te d  and fo rm  II w as sequenced  c o m p le te ly . Form  II 
c o n s is ts  of 108 am ino ac id  re s id u e s  and a hom ogenous a m in o -ac id  seq u en ce , 
s ta r tin g  w ith G ly -A la -P ro  was o b ta in ed . When fo rm  I w as sequenced  two d iffe­
r e n t  seq u en ces w ere  ob tained  and one of them  w as id en tica l w ith th a t of fo rm  
II . The second  sequence  tu rn e d  out to  be an elongation  of the s h o r t  fo rm  w ith 
8 re s id u e s  s ta r tin g  w ith S e r-G lu -A sp . A s in g le  N - te rm in a l seq u en ce  S er-G lx - 
A sx w as re p o r te d  re c e n tly  fo r  two fo rm s  of c y s ta tin  w ith the sam e  p i va lu es  
co m p ared  to  our r e s u l ts  (A n a s ta s i e t a l . ,  1983). Two d iffe re n t is o e le c tr ic  
p o in ts , nam ely  pi 6 .5  and 5 .6  w e re  ex p la ined  by sm a ll d iffe re n c es  in  the  p a t­
te rn  of try p tic  d ig e s t.  It m u st be a ssu m ed  th a t ou r long fo rm  re p re s e n ts  the 
m o re  co m p le te  sequence  of in h ib ito r , w h e reas  the s h o r t  fo rm  v e ry  lik e ly  o r i ­
g inated  fro m  th e  c leav ag e  of a pep tide  bond . As is  ev iden t fro m  our r e s u l t s ,  
we sequenced  only the s h o r t  fo rm  co m p le te ly , w h e reas  the  lo n g er fo rm  was 
sequenced  only p a r t ia l ly .  C y sta tin  con ta in s 4 cy s te in e  r e s id u e s ,  w hich fo rm  
p re su m ab ly  two d isu lph ide  b r id g e s , as a lre a d y  p ro p o sed  (A n a s ta s i e t a l . ,
1983). In th is  r e s p e c t  c y s ta tin  d iffe rs  from  Stefin w hich co n ta in s  no c y s te in e  
a t a l l .  A lso  both  seq u en ces of c y s ta tin  and s te fin  a re  d if fe re n t. T h e re fo re  we 
can  a ssu m e  th a t egg w hite c y s ta tin  and the  hum an leucocy te  in h ib ito r s te fin  
belong to  two d iffe re n t fa m ilie s  of cy s te in e  p ro te in a se  in h ib ito rs .T h is  is  add i­
tio n a lly  su p p o rted  by the  co m p le te ly  d iffe re n t c i r c u la r  d ic h ro ism  s p e c tra  of 
both in h ib ito rs  ( Turk e t  a l . ,  1 9 8 3 ,in  p r e s s ) .
Both in h ib ito rs  a re  pow erfu l in h ib ito rs  of ly so so m al c y s te in e  p ro te in a se s  and 
p ap a in . S ince s te fin  does not con ta in  c y s te in e  and c y s ta tin  does not con ta in  a 
f re e  th io l g roup  i t  m ay be concluded  th a t n e ith e r  in h ib ito r is  involved in  a 
th io l-d isu lp h id e  exchange m e ch an ism . F u rth e r  in v es tig a tio n s  in  th is  d ire c tio n  
in  o rd e r  to  u n d e rs tan d  the m echan ism  of ac tion  of the  cy s te in e  p ro te in a se s  
w hich a re  re g u la te d  by th e se  p ro te in  in h ib ito rs  a r e  n eed ed .
ACKNOWLEDGEMENT. The in v es tig a tio n s  w ere  su p p o rted  by the r e s e a r c h  
g ra n t fro m  the R esea rch  C ouncil of S loven ia , L jub ljana , Y ugoslav ia  and by 
the  D eu tsche  F o rsch u n g sg em e in sch a ft, S o n d e rfo rsch u n g sb e re ich  0207, 
M ünchen, BRD.
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DISCUSSION
WIEDERANDERS:
With respect to your first slide, I would like to ask you 
about the differences in the properties of lysosomal and 
cytosolic insulin-glucagon proteinases.
T U R K :
This is described in the literature. It is hard for me 
to recall it at the moment.
WIEDERANDERS:
Did you look for the presence of cathepsin T in bovine 
spleen?
TURK:
No , we d i d n 't .
P A T T H Y :
Have you performed experiments to find out whether the 
inhibitors form covalent complexes with the proteases?
TURK :
Yes, and the results clearly indicated that there is no 
covalent bond between the enzymes and protein inhibitors.
164
P A T T H Y :
What were the conditions of eluting the inhibitors from 
the affinity column?
TURK:
For example in the case of purified papain it was nicely 
eluted from egg-white affinity column with urea at higher 
pH. In the case of cysteine proteinases, cathepsin B, H 
and L we had some troubles because when the pH was higher 
than 7.0 they were unstable. But with papain we have got 
vehy nice elution using eluents of higher pH than 7.0 + 
urea. These are unpublished results.
GRÁF:
How did you determine the l<i constants for your inhibitor?
TURK:
K^ was determined by the method of Green and Work.
GRÁF :
By which method was the sequence work done?
TURK:
Sequence was determined by automatic solid-phase 
sequanator using Edmann degradation. Details will be 
published soon in Hoppe Seyler's Z. Physiol. Chem.
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CHARACTERIZATION OF HUMAN ALANINE AM I NOPEPTIDASES 
HÜTTER, H.J.
Institute of Clinical Biochemistry, Martin Luther 
University
Halle-Wittenberg, GDR
Exopeptidases are peptide hydrolases whose assault upon 
a peptide bond is limited to one of the two terminus of the 
peptide chain.
The N-terminal exopeptidases require a free oC-amino 
group and are denominated aminopeptidases, if they split off 
free amino acids. They can be classified according to their 
subcellular localization, e.g. membrane bound, lysosomal or 
cytosolic.
The alanine aminopeptidase / A A P , EC 3.4.11.2/ is the 
best known example of a particulate N-terminal exopeptidase 
and has been isolated and characterized from various sources 
by Pfleiderer and Celliers /1963/, F.3. Behai et al. /1966/,
Abb revia tions :
AAP: alanine-aminopeptidase
NANA: N-acetyl-neuraminic acid
D I F P : diisopropyl fluorophosphate
PMSF : phenyl-methylene-sulfonylfluoride
NEM: N-ethylmaleimide
pCMB: p-chloromercuribenzoate
DTNB : dithio-bis-nitrobenzoic acid
NBS : N-bromosuccinimide
DTT: dithiothreitol
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H. Hanson et al. /1967/, N. Rehfeld et al. / 1 9 6 7 / , H.D. Hütter 
et al. /1 9 7 2 / , S. Maroux et al. /1973/, Garner and Behal 
/1974/, Y.3. Kao et al. /1973/.
The enzyme is localized in the brush border region of the 
proximal convoluted tubules of the kidney, in the brush border 
region of the small intestinal mucosa and was found in the 
globular knobs of plasma membrane fractions of the liver cells.
At least, in human liver, kidney, pancreas, small intes­
tine and placenta, different electrophoretic variants have 
been detected. They are usually found in the microsomal frac­
tion by subcellular fractionation. The A A P s , isolated from 
human liver, kidney, pancreas and placenta have a molecular 
mass of 230 000, the enzyme of the jejunum one of 295 000 and 
that from the ileum 310 000.
Sepharose chromatography in the presence of 8 M urea and
0.1 M mercaptoethanol provided evidence for subunits of 
30-35 000 molecular weight. Thus,six subunits would presumably 
make up the molecular weight of the native enzyme.
The molecular weight of the liver-AAP was calculated by 
Little and Behai /1976/ using sedimentation and gel filtration 
data as 234 000, In the presence of 6 M guanidine and 0.1 M 
mercaptoethanol agarose chromatography provided evidence for 
subunits of 38 000 molecular weight. In an other communication 
a subunit molecular weight of 120 000 was reported by Garner 
and Behai /1974/. According to Feracci and Maroux /1980/ the 
completely denaturated enzyme after detergent solubilization 
from the small intestine of the rabbit corresponds to a molec­
ular weight of 130 000 and exists in native form as a monomer.
According to Böhme et al. /1976/ the different electro­
phoretic mobility of the alanine aminopeptidases, isolated 
from human liver, kidney and pancreas is due to a different 
net charge as demonstrated by different isoelectric points.
The results of the carbohydrate analysis point to NANA as the 
main factor causing these differences in electrophoretic mo­
bility. The NANA content varies from 96 mol for the liver AAP 
to 16 mol for the kidney- and zero for the pancreas-enzyme 
/Table 1/.
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\Table 1
Carbohydrate content of alanine aminopeptidases from human 
liver, kidney and pancreas in percent with regard 
to protein /Böhme et al,, 1976/
Ca rbohyd rate Liver AAP Kidney AAP Pancreas AAP
Glucose 1 18 18
Galactose 2 2 3
Fucose 0 5 3
Amino sugars 9 9 9
N-Acetylneuraminic acid 11 2 0
The isoelectric point of jejunum- and ileum-AAP corre­
sponds partly to that of the pancreas enzyme. This means, the 
high molecular weight of the small intestinal AAP could be the 
cause for the lowest electrophoretic mobility found till now 
/Table 2/.
Table 2
Molecular weight, R e v a l u e  and isoelectric point 
of human alanine aminopeptidases
AAP isolated 
from human
Molecula r 
weight
R .-values 
on 7.5% 
polyac rylamide 
gels
Isoelect ric 
points 
pH
Mol NANA/mol 
enzyme
live r 230 000 0.39 3.62 96
kidney 230 000 0.31 4.35/4.70 16
pane reas 230 000 0.25 4.70/4.44 0
j ej unum 310 000 0.20 4.45 n . e .
ileum 295 000 0.20 4.45 n.e.
placenta 220 000 0.35 4.25 n.e.
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Metal ion chelators are usual inhibitors for AAP. EDTA 
and o-phenanthroline affect a significant reduction in enzyme 
activity. Dialyzing the enzymes against 1 mM EDTA, the activi­
ties can be restored by the addition Co^+ only. Other ions 
tested, failed to bring about any restauration of activity 
/Fig. 1/.
Fig. 1. Effect of metal ions and EDTA on human alanine 
aminopeptidases. Effector concentrations: 5 mM
liver-AAP, kidney-AAP, pane reas-AAP,
jejunum-AAP, ileum-AAP
The high affinity of the enzymes towards metal ions as 
well as to chelating substances could be demonstrated by 
estimation of the inhibition constants for Ni , Hg and 
EDTA, evaluated in the range of 10~5 to 10~7 M /Table 3/.
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Table 3
Inhibitory and affinity constan ts of various effectors
AAP from 
live r , 
kidney, 
pane reas
K.X
/mol/1/ lxm /metal/ 
/mol/1/
Co2+ 2.5 x 10~4
Ni2 + 1 x 10"5
u 2 +h9 9 x 10“7
EDTA 1 x IO'7
Dithiothreitol 4 x 10-3
Using L-alanine-2-naphtnylamide as substrate, the 
Michaelis constants of the enzymes investigated were not
effected during the activation process.
2+Co activated the cleavage of all other substrates con­
tained L-alanine at N-terminal position, such as L-alanyl- 
amide, L-alanyl-L-alanine, L-alanyl-glycine, L-alanyl-L-leu- 
cine and L-alanyl-glycyl-glycine. On the other side, the 
turnover of the L-alanyl-p-nitroanilide was nearly completely 
inhibited by Co2+ ions /Table 4/.
The hydrolysis of substrates containing L-leucine 
in N-terminal position is not influenced by Co2 + and is by 
Mn 2+ rather inhibited. This could be found using L-leucyl-2- 
naphthylamide , L-leucyl-p-nitroanilide, L-leucyl-amide, 
L-leucyl-glycine and L-leucyl-glycyl-glycine. These results 
suggest that the enzyme molecule might consist of two cata­
lytic units, or the active center may possess two indistin­
guishable metal binding sites.
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Table 4
Influence of cobalt ions on the turnover 
of different substrates using kidney-AAP 
enzyme
Subs t ra te Effector /I mM/
Activity
/U/l/
Relative activity
/%/
L-Ala-NA _ 780 100
" Co2 + 1435 184
L-Ala-NH_ 645 1002
Co2+ 1185 184
L-Ala-L-Ala 560 100
" Co2 + 572 102
L-Ala-Gly - 378 100
ii Co2 + 542 144
L-Ala-L-Leu _ 197 100
" Co2 + 405 200
L-Ala-Gly-Gly - 2020 100
" Co 2 + 2429 118
L-Ala-p-N — 20.3 100
"
+CMOO 1.95 10.4
A broad range of substrate specificity is characteristic 
of the alanine aminopeptidase.
In the case of the aminoacyl-2-naphthylamide substrates 
with nonpolar aminoacyl residues are preferred. The enzyme 
has very low activity with acidic /e.g. aspartyl-/ and basic 
/e.g, lysyl-/ 2-naphthylamides. In addition, D-aminoacyl-2- 
naphthylamides are not hydrolyzed. Generally, a free cA-amino
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group is required for enzymatic activity and substrates 
having no aryl-group, e.g. dipeptides and tripeptides are 
split quite well, too.
Using the relation of V/I<m as a constant of effective­
ness of the substrate turnover, alanyl-2-naphthylamide is the 
substrate split most effectively /Table 5/,
Table 5
Michaelis constants of kidney-AAP determined with various
arylamides and peptides
Substrate l<m
/mM/
V
/U/l/
V/K 7 m
L-Ala-2-NA 0.25 7 520 30 080
L-Phe-2-NA 0.66 5 500 8 333
L-Leu-2-NA 0.20 855 4 275
Gly-2-NA 0.67 565 843
L-His-2-NA 1.25 48 38.4
L-Leu-p-N 0.72 196 272
L-Leu-NH2 57.0 5 263 92.3
L-Leu-NH.NHg 0 0
L-Leu-Gly-Gly 9.1 6 849 753
Gly-L-Leu 11.0 735 67
Gly-Gly 333.0 8 333 25
The physiological role of the alanine aminopeptidases 
seems to be still unknown. On the other side, peptide sub­
strates like e.g. oxytocin and vasopressin, are split readily 
by the enzyme, isolated from human kidney, as demonstrated by 
Barth et al, /1969/. The enzyme was able to hydrolyze angio- 
tensin-II-amide as found by H.J. Hütter et al. /1970/. In 
view of these results, besides the aminopeptidase A, which 
hydrolyzes angiotensin and other peptides containing aspartic 
or glutamic acid as amino terminal, the particle bound alanine
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aminopeptidase may also be considered as possible factor of 
angiotensin and angiotensinamide regulation in the kidney.
The alanine aminopeptidases were not influenced by re­
agents specific for the serine residue at the active site. 
In the same way, we failed to detect histidine in the active 
centre, as indicated by the absence of photooxydation effect 
in the presence of methylene blue.
Preincubation of the enzymes with SH-blocking reagents 
e.g. p C M B , NEM, DTNB, 3AM inhibited the activity in nearly 
identical relations. Prexncubation with mercaptoethanol or 
DTT in 10 mM concentration inhibited the enzyme markedly.
Table 6
Influence of active site specific reagents on AAP
Relative activity
/%/
E f fecto r Concent ra tion 
/M/
1 ive r 
AAP
kidney
AAP
pancreas
AAP
DIFP 0.1 100 100 100
PMSF 0.001 100 100 100
NEM 0.001 78 76 72
pCMB 0.005 61 73 63
DTNB 0.005 50 57 51
NBS 0.001 0 0 0
DTT 0.010 24 9 31
As seen in Table 6, NBS inhibited the enzymes completely 
in 0.001 M concentration.
The titration of bound tryptophane in proteins by NBS 
can give some clue for the presence of reactive and unreactive 
tryptophanes. Treating tryptophanes according to Green and 
Witkop /1964/, different values were found in the untreated 
proteins as well as in the enzymes denaturated with urea 
/Table 7/.
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Table 7
Oxydation of tryptophane residues of the alanine 
aminopeptidases by 1 ,uM NBS
mol tryptophane/mol enzyme
AAP 
f rom pH 7.0 pH 4.0
8 M 
urea
Calcula ted 
according to 
Behai et al. 
1974, 1978
kidney 40 40 36 32
live r 18 18 59 62
pancreas 15 17 60 -
According to these results, in the case of liver and 
pancreas AAP the primarily unreactive tryptophanes are buried 
by the tertiary structure indicating that both enzymes could 
be of a more compact structure. These results correspond 
quite well to the values published by Starnes and Behai 
/ 1 9 7 4 / , and Y.3. Kao et al. /1978/.
On the other hand, the results lead to the assumption 
that the decrease of activity following tryptophane oxydation 
is caused partly by conformational changes of the protein 
molecule as by some contribution of some tryptophane residues 
to the enzyme activity of AAP /Table 7, Fig. 2/.
Membrane bound enzymes are generally defined as enzymes 
appearing in a membranous fraction, when a homogenate is 
subjected to a subcellular fractionation.
The enzymes can be displaced from the membranes by the 
effect of detergents and proteolytic enzymes. But only in the 
detergent form the native primary structure is preserved. The 
proteinase form lacks the site of the molecule originally 
associated with the lipids of the membrane.
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Fig. 2. Effect of tryptophane oxydation by 1 mM NBS on the 
activity of kidney AAP
Such membrane bound enzymes are not so well character­
ized as soluble enzymes, due to the difficulties in the iso­
lation procedure. Sometimes, during the last years they were 
reconstituted with other well defined components in lamellar 
or vesicular model systems, to reproduce the physiological 
surrounding for the catalytic activity. This interaction 
between the enzyme and the remainder of the cell membrane may 
affect the enzyme activity and may influence some kinetic 
characteristics /Table 8/.
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Table 8
Comparison of the substrate specificity of the protease and 
detergent-forms of alanine aminopeptidases isolated from 
human kidney and rabbit small intestine
Subs t ra te
Rela tive activity, %
Human kidney Rabbit small intestine
protease
form
de te rgens 
form
protease 
f o rm
detergens 
f o rm
L-Ala-NA 100.0 100.0 100.0 100.0
Gly-L-Leu 10.7 72.4 39.9 272.9
" + Ca2+/Zn2+ 10.5 68.8 55.4 289.7
Gly-Gly 30.4 153.4 57.8 67.9
" + Co2+ 31.2 147.4 58.2 60.5
Gly-L-P ro 0 1.2 0.9 49.1
" + Mn2+ 0 5.6 9.3 65 .0
L-Pro-Gly 2.4 6.2 5.8 68.9
" + Mn2+ 2.6 10.1 6.8 54.2
L-Leu-NH 43.8 327.2 246.3 450.0
" + Mn2+ 32.5 185.9 121.0 450.0
L-Leu-Gly-Gly — 222.0 847.0
" + M n 2+ - - 122.0 736.0
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DISCUSSION
KE N N Y :
Alanine aminopeptidase in other species, e.g. rabbit 
or pig, has a large subunit /130-160 l<Da/ but the 
protease forms clips yielding apparent "subunits". 
Your data showing an oligomeric structure comprising 
smaller subunits is very unexpected. Have you de­
termined zinc in your preparations? Other data 
/e.g. by Wacker/ have shown 2 Zn/dimeric molecule 
/~300 kDa/ indicating one active site per subunit.
In regard to your experiments with metal ions after 
EDTA treatment, the reactivation with Zn^+ may have 
a sharp optimum concentration with higher concen­
trations being strongly inhibitory.
HOTTER:
Results obtained by SDS electrophoresis show M r 
30 000-35 000 for the subunits, but higher M r of 
140 000 was also detected. Up to now, we cannot 
say that the enzyme exists only as a dimer, as it 
was reported by Maroux et al. in the case of rabbit 
and pig enzyme.
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STEPANOV:
What was the relationship between the concentration 
of Co2+-ion or the other ions and your substrates?
If you have really high concentration of Co com­
pared to the concentration of substrate, practically 
a part of the substrate could be converted into 
Co-complexes.
HOTTER :
The Co2+-concentration was in every case 5 mM in 
the test tube and the substrate concentration was 
0.75 mM. In comparison to the substrate concen­
tration there exists a metal ion excess.
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DIFFERENT EXOGENOUS AND ENDOGENOUS CONDITIONS 
AFFECTING THE ACTIVITY OF PROTEINASES IN 
SKELETAL MUSCLES
SOHÁR, I .  a n d  GUBA, F .
D e p a r t m e n t  o f  B i o c h e m i s t r y ,  U n i v e r s i t y  M e d i c a l  S c h o o l  
S z e g e d ,  H u n g a r y
Faster protein degradation and enhanced activity of pro- 
teinases can be observed in the different kinds of skeletal 
muscle damaged by changes in exogenous and/or endogenous con­
ditions. Higher proteinase activities can be measured not only 
in the atrophied muscle but also in hypertrophied muscle. The 
enhanced proteinase activity may originate a.) from faster 
proteinase synthesis, or b.) as a result of an activation 
process. Very often these causes play a role together in the 
faster process of protein degradation. It is known that a high­
er proteinase activity is only one of the factors operating in 
muscle damage. The skeletal muscles are very sensitive tissues 
compared to others, e.g. liver, kidneys, heart, in spite of 
their lower proteinase activities. Therefore, muscle tissues 
proved to be a good media for the study of several influences 
on proteinase activity. According to Szent-Györgyi (1981) 
"muscle is the most wonderful material of study for anybody who 
wants to penetrate into the deeper secrets of life".
Recently some of the factors which play a role in the 
elevated proteinase activities in skeletal muscles were studied 
in our laboratory, e.g. mechanical activity, hormone levels, 
redox state, energy level, proteinase inhibitor content, nut­
ritional changes, energy level, alien proteins.
The results of hormonal changes and reduced redox state 
were summerized this year (Sohár et al., 1983). It was found 
that dexamethasone, a synthetic glucocorticoid, caused higher 
lysosomal and calcium-activated proteinase activities in the
181
fast-glycolytic type semimembranosus muscle, but there were no 
changes in the proteolytic enzyme activity of the slow oxi­
dative type soleus muscle (Sohár, 1982). The soleus muscle be­
came hormone-sensitive when the rats were kept under reduced 
air pressure. Under these conditions the lysosomal proteinase 
activity in soleus muscle upon dexamethasone-treatment was 
higher than that measured with the animals kept under reduced 
air pressure and without hormone administration. This result 
showed us that redox condition may play a role in the elevated 
lysosomal proteinase activity in glucocorticoid-treated ani­
mals .
The role of testosteron in the protein synthesis of 
skeletal muscle has been known for long. Its role in protein 
degradation is not unambiguous. Four weeks after castration 
higher lysosomal proteinase activity was measured in the andro­
gen-dependent levator ani muscle. The increased activity could 
be inhibited by testosteron or progesteron. The Levadosin ad­
ministration could inhibit only the higher azocaseinolytic 
activity (Levadosin is an ATP-containing substance, produced 
by Boehringer, Mannheim). The influence of redox state on 
hormonal effect on proteolytic enzyme activity showed that 
ox-idative capacity may play a role in the higher proteinase 
activity. Hypoxia of rat skeletal muscles was produced by 
ligature of the abdominal aorta. The activity of cathepsin D,
L and chymotrvpsin-like proteinase of soleus and semimembra- 
nous muscles was measured after surgery. The cathepsin-L-like 
activity increased markedly on the fourth day, and the changes 
in cathepsin D activity were similar, but the activity of C h y ­
motrypsin increased only slightly in the soleus muscle. The 
alterations were more expressed in the slow-oxidative type 
muscle.
Physical activity. The effect of decreased movement can 
be examined under immobilization by plaster cast (right hind 
leg) fixation in full extension. In this position the soleus 
muscle is in a shortened state. If the angle of fixation is 
decreased, the muscle length increases. In the case of the 
rabbit the normal angle is 20-30°, further bending of the 
leg stretches the soleus. In a previous experiment elevated
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lysosomal proteinase activity was measured in the immobilized 
soleus muscle fixed in a shortened state. The extralysosomal 
proteinase activities did not change. A reduced redox potential, 
ATP and insulin content, and an increased number of glucocor­
ticoid receptors were measured in this muscle. Direct connec­
tion between the high proteinase activity and these results 
require further studies. There was a correlation between the 
angle of fixation and the lysosomal proteinase activity. At 
normal position we could not measure higher activity during a 
two-month period of immobilization. In this case the cytosolic 
enzyme proteins were degraded faster than the total muscle. An 
enzyme protein specific for a certain muscle (that is, its 
activity is relatively high compared to that in other muscles) 
is damaged faster than the other proteins. After four weeks of 
immobilization a new protein distribution appeared. Disconti­
nuing the cast fixation, proteinase activity increased further 
for a week, degrading the synthesized proteins characteristic 
of an other type of muscle, for these proteins were alien to 
the original muscle (Sohár et al., 1981).
These experiments raised tne question: What happens to the 
muscle in overstreched position? We collected protein turnover 
data measuring the influence of stretch on protein degradation. 
Most of them originated from in vivo experiments. The results 
are summarized in Table 1.
Table 1
The influence of stretch on protein degradation in 
skeletal muscles
Author Stretch Protein degradation
Goldberg 1969 increase decrease
Vandenburgh 1980 increase decrease
Millward 1980 increase increase
Etlinger 1980 increase increase
decrease increase
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Increased physical activity can be studied by different 
kinds of exercises. Table 2 shows some resvilts published re­
cently. Most of the exercises examined.endurance training. We 
used high jumping as a dynamic force velocity training to study 
the changes in proteolytic activity during this type of train­
ing. The results demonstrated that proteinase activity began 
to increase when the load, i.e. number of jumping and the 
weight put on the rats's backs was too much for their muscles. 
They could carry out the task consuming the energy originating 
from muscle tissue, and the type of training with this load 
became equal with an endurance training (Sohár et al., 1982).
Table 2
Effect of exercise on protein catabolism
Author Species Training Measurement
Shott 1979 rat running no alteration in free 
cath. D activity
Salminen 1 980 mouse running acid proteinase acivityt
Dohm 1980 rat swimming alkaline proteinase ac­
tivity , CANP no changes 
in. free cath. D activity!
Dahlmann 1981 rat swimming alkaline proteinase 
activity !
Rennie 1981 man treadro Lie 3-Me-His excretion+
Dohm 1982 man running
3-Me-His excretion !man weight-lifting
rat running
Kasparek 1982 rat running lysosome sizet
Sohár 1982 rat high-jump Lng proteinase activity!
The combination of stretch and training is when the 
animals, rats in our experiments, are kept in a small cage 
which prevents them from moving. The muscles are in a stretch­
ed position and in the first peiiod the rats try to escape 
from the cage. We call this the active stretch model. In the 
present paper the results of the experiments are discussed.
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After examining passive and active stretch we measured 
the effect of permanent contraction on proteinase activity. A 
widely used weed killer, 2,4-dichlorphenoxyacetate (2,4-D) 
disturbs the functioning of skeletal muscles. The most striking 
effect of 2,4-D is the development of muscular rigidity. The 
activities of cathepsin D, cathepsin L-like and 5 mM calcium- 
activated neutral proteinases (CANP) were measured in the so- 
leus and semimembranosus muscles of rats injected with 2,4-D 
in a period of two and three weeks (Sohár et al., 1981).
The energy requirement of protein degradation is an inten­
sively investigated topic nowadays. Influence of ATP on protein 
metabolism in mammalian tissues are shown in Table 3. In skel­
etal muscle ATP plays a special role during the contraction and
Table 3
Effect of ATP on protein metabolism
Author Observation
DeMartino 1 979 ATP-dependent proteinase in the liver
Dell'Antone 1 979 ATP-driven proton pump in the lysosoim
Decker 1 980 cathepsin D activity increases in 
hypoxia
Morgan 1980 inhibition of proteolysis in hypoxia
Taegtmeyer 1980 ATP increases and decreases proteo­
lysis
Seglen 1 981 protein degradation is inhibited: ATP 
content increases or decreases
Etlinger 1981 ATP-dependent proteinase in skeletal 
muscle
relaxation. When its function is suspended, the ATP content 
decreases during the first four weeks. We could not measure 
directly the activity of ATP-dependent proteinase in muscle 
homogenate (this enzyme was identified in reticulocytes and 
rat liver). Rabbits were treated (Nagy et al., 1981) with 
2,4-dinitro-sec-butyl-phenol, an uncoupler used as herbicide, 
for 3 weeks, and proteinase activity was measured in various
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organs and in skeletal muscles. Lechner et al. (1970) publish­
ed that the increase in the concentration of uncoupler can 
reduce the level of creatine phosphate, ATP and pyruvate in 
isolated atria.
The nutritional changes have no obvious or immediate 
effect on the protein metabolism in muscle, but on closer exa­
mination the effects of feeding and starvation can be observed 
in the skeletal muscle, too. During starvation, higher lyso­
somal proteinase activity can be measured in both types of 
skeletal muscles on the fourth or fifth day after the beginning 
of the experiment. The extralysosomal proteinase activity in­
creases only slightly, similar to that in the immobilized 
skeletal muscle. The proteolytic activity returns to the normal 
level on the seventh or eigth day (Odobasic, 1981). Feeding and 
starvation change the hormonal concentration, first of all in- 
suline and glucocorticoid levels. Insulin can inhibit protein 
degradation. Glucose and amino acids can diminish the proteo­
lytic activity, too. In the present study the effect of the 
long-term protein-free diet on proteolytic enzyme activity in 
muscle is shown. The effect of inhibitor concentration during 
fasting was described by Noguchi (1974). The concentration of 
alkaline proteinase inhibitor decreased during starvation and 
the increased alkaline proteinase activity can be explained 
by this lower inhibitor level. Data about other proteinase 
inhibitors in skeletal muscles were also published (Table 4).
Table 4
Endogenous inhibitors of proteinases in skeletal muscle
Reference Proteinase inhibited
Noguchi 1974 alkaline proteinase
Katunuma 1977 group-specific proteinase
Bird 1977 cathepsin B
Goll 1978 calcium-activated neutral proteinase
Lenney 1 979 cathepsin B and H
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The investigation of inhibitor capacity on cathepsin B and 
serine proteinase in immobilized and dexamethasone-treated 
muscle will be presented.
MATERIALS AND METHODS
Male CFY rats weighing 230 g and New-Zealand rabbits 
weighing 2300 g were used in groups of 10 animals each. The 
animals were kept under normal laboratory conditions (23°C,
12 hours light cycle). The food and water uptake was ad libi­
tum.
Limitation of moving: each rat was kept in a small cage 
prevented from moving. The control group was kept in normal 
laboratory boxes.
Treatment with 2,4-D: 2,4-dichlorphenoxyacetate (Chemical 
Work, Fűzfő, Hungary), 100 mg per kg body weight, was adminis­
tered intraperitoneally to rats for 2 or 3 weeks.
Uncoupler effect: rabbits were treated with dinitro-sec- 
butyl-phenol (DNSB),(Chemical Work, Fűzfő, Hungary) in an oral 
dose or 10 mg/kg/day for 3 weeks.
Protein-free diet: rats were kept on a protein-free diet 
for 10 days, 3, 6 and 9 weeks, respectively. Instead of pro­
tein the diet contained in terms of calory an equivalent 
amount of fat as the food given to the control animals.
Inhibitory experiments: a.) The right hind leg of rabbits 
was fixed in plaster cast in full extension. After two weeks of 
immobilization the soleus muscle was used for measurements, 
b.) The rabbits received intramuscular injections of dexametha- 
sone (Oradexon®, Organon) 2 mg/kg every second day, for a three- 
week period.
Samples for enzyme and inhibitor measurements: After 
the animals had been bled, the soleus muscle, containing mainly 
slow-twitch oxidative fibres, and the semimembranosus muscle, 
containing mainly fast-twitch glycolytic fibres, were excised 
and cleaned of connective and fat tissues and homogenized in 
an Ultra-Turrax homogenizer (Janke Kunkel). 1.) To measure 
total enzyme activity, the muscles were homogenized in
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10 volumes of 1 % KCl and 0.1 % Triton X-100 solution. 2.) For 
measurements of inhibitor the muscles were homogenized in 
3 volumes of 25 mM Tris-HCl buffer, pH 7.5, containing 1 mM 
EDTA-Na2 - 3.) To assay "free" activity of cathepsin D, the 
muscle was homogenized with 1 % KC1. 4.) The "bound" cathepsin 
activity was determined in the precipitate No. 3 homogenate 
obtained after centrifugation at 2000 g, for 20 min, and the 
pellet was homogenized in 0.1 % Triton X-100 solution and 
centrifuged again. Activity of cathepsin D was determined in 
the clear supernatant as described by Barrett (1972). Cathep­
sin L activity was measured by incubating the muscle samples 
at 40°C for 120 min in 1.0 ml 50 mM potassium phosphate, pH 
6.0, containing 0.5 % azocasein and 5 mM 2-mercaptoethanol. 
Azocaseinase activity was measured with azocasein, pH 6.0, in 
the presence of 2-mercaptoethanol. The control contained 10 ® M 
Z-Phe-Phe-CH-N^ and 10 6 M pepstatin. CANP activity was assay­
ed with azocasein substrate at pH 7.5, in the presence of 5 mM 
CaC^ and 5 mM 2-mercaptoethanol as activators. Chymotrypsin- 
like activity was measured with acety1-Tyr-p-nitroanilide (1 mM) 
as substrate at pH 8.0).
To measure the inhibitory capacity the supernatants were 
incubated with purified cathepsin B (Barrett, 1973) and tryp­
sin (Sigma) for 10 min. Residual cathepsin B and trypsin activ­
ities were determined with benzoyl-D,L-Arg-p-nitroanalide at 
pH 6.0 and pH 7.5, respectively. Protein content was determined 
according to Goa (1953). Alanine aminopeptidase was assayed as 
described by Farr et al. (1968) using Co^+ ions (1 mM) for 
activation.
RESULTS
Specific enzyme activities are usually given in percentage 
compared to the control. The normal enzyme activities are de­
monstrated in Table 5.
The activity of cathepsin D was measured in the soleus 
muscle of rats kept in small cages. It can be seen in Fig. 1 
that the "free" activity increase fell mainly in the first
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period of the experiment. The increase in the "bound" and in 
the total activities is not evident till the end of the second 
week.
Table 5
Specific enzyme activities in muscles of rabbits. 
Mean values ± SD for 10 animals
Enzyme Semimembranousmuscle
Soleus
muscle Unit
Cathepsin D 6.45 ±0.68 10.20+0.83 nkatg(protein)
Azocaseinolytic 5.02+0.41 7.90+0.52 mg(azocasein)activity sec x g(protein)
CANP 1.09+0.09 0.90+0.08 mg (azocasein)sec x g(protein)
Chymotrypsin-like 
(Cathepsin G-like j 1.76±0.8 1.68± 0.13
nkat
g(protein)
Fig. 1: Effect of active stretch on the activity of cathep- 
sin D in the soleus muscle of rats. The values are 
percentages taking the controls as 100 percent.
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The effect of 2,4-dich'lorphenoxyacetate on proteinase 
activities in the semimembrano us muscle of rats can be seen 
in Fig. 2. The activity of cathepsin D increased only in the 
second week. The cathepsin L-like activity increased signifi­
cantly in the second week of the experiment and it further in­
creased in the third week. The calcium-activated neutral pro­
teinase activity was elevated in the second week, but it re­
turned to the normal level in the third week. In the soleus 
muscle only moderate or negligible changes in proteinase activ­
ity could be observed.
Fig. 2: Proteinase activities in the semimembranous muscle 
of rats treated with 2,4-dichlorphenoxyacetate.
0 - normal value, 2 - two weeks'treatment, 3 - three 
weeks' treatment, x - p<0.05
The activity of proteinases increased in the semimembra- 
nous muscle of rabbits treated with an uncoupler (Fig. 3). 
Cathepsin D showed the highest activity. The activities of
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Fig. 3: Changes in the proteinase activities of skeletal 
muscles after 2,4-dinitro-sec-butyl-phenol admi­
nistration. 1 - soleus muscle, 2 - semimembranous 
muscle + - p<Q.05, ++ - p<0.01; CANP - calcium 
activated neutral proteinase.
the two extralysosomal enzymes increased less than the lyso­
somal enzyme activity. The proteinase activity in soleus 
muscle did not change significantly compared to the control.
During a long-term protein-free feeding both the lysosomal 
proteinase activity and the calcium-activated neutral pro­
teinase activity increased in the soleus muscle. The alanine 
aminopeptidase and cathepsin G-like (chymotrypsin-like) ac­
tivities slightly decreased. The cathepsin L-like activity 
was highest in the sixth week and the calcium-activated neut­
ral proteinase activity was highest at the end of the experi­
ment (Fig. 4)
Table 6 shows the effect of inhibitors. The inhibitor 
binding capacity of serine proteinases is higher in the immo­
bilized soleus and in the steroid-treated semimembrancus 
muscles. The cathepsin B inhibitor level increased slightly
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in the immobilized muscles and in the steroid-treated soleus 
muscle.
•  C a t h e p s i n  0 
O -.1- l
0 - II - G
+ CANP
L Alanine aminopeptidase
d a y s
Fig. 4: Proteolytic activities in the soleus muscle of rats 
kept on long-term protein-free diet. The values are 
percentages of the control value.
Table 6
Changes in inhibitor binding capacities after immobilization 
and dexamethason treatment
Muscle
Trypsin inhibitor Cathepsin B inhibitor
Control
%
Immobilized
%
Control
%
Immobilized
%
Soleus
Gastrocnemius
100± 8.5 
100+ 7.6
142 ±12.1 
109.6± 9.2
100± 5.6 
100± 9.1
1 2 2 .6 1 6 . 2
119.318.3
Control
%
Steroid-
-treated
%
Control
%
Steroid-
-treated
%
Soleus
Semimembranous
100±10.6 
10 0±11.4
104.6111.2 
125 ±10.3
100110.1 
100111.5
118.119.8
1 1 0 .1 1 8 . 8
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DISCUSSION
The increased proteolytic activity in skeletal muscles 
was studied in the present paper and the first question con­
cerned the influence of stretch and immobilization. Till 1980 
the general view had been that protein degradation increased 
with the decreased stretch and protein degradation decreased 
when the muscle was in a lenghtened position. Etlinger and 
Millward (1980) reported that the alteration of the normal 
length or sarcomer caused faster protein degradation. The 
effect of exercise assisted these effects. Vihko and Salminen 
(1980) observed higher cathepsin D activity in the muscle of 
running mice. They explained that the muscle in the running 
mouse is similar to the ischemic muscle. In our experiment the 
free part of cathepsin D activity increased in the first step. 
Dohm et al. (1980) found similar results in swimming rats.
The stretched state promotes the degradation (or permeability) 
of the cell membrane. On the other hand, this increase in the 
proportion of free lysosomal proteinase activity resembles the 
alteration found by Decke and Wildenthal (1980) in ischemic 
heart where the lysosomal enzymes leak out from the lysosomes 
into the cytoplasm. Thus, leakage could play a role in the in­
creased degradation during exercise. In the second step there 
is immobilization indeed and the proteinases activated earlier 
could activate the newly synthesized proteinases. Protein 
synthesis decreased during "shortened state" immobilization and 
the activated proteinases could not find new proteinases. The 
hypothetical process of activation in immobilized muscle is 
shown in Fig. 5. The experimental model of myotonia showed the 
same results as the proteinase activities increased in this 
muscle, too. However, the question remains the same: which is 
the first step in the activation process. The acidification, 
reduced redox potential, decreased insulin concentration, in­
creased glucocorticoid content, etc., each can also cause 
higher proteinase activity in the skeletal muscle. In the 
immobilized or 2,4-dichlorphenoxy-acetate-treated muscle these 
causes are acting simultaneously. This is the problem with the
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Fig. 5: Hypothetical processes during immobilization in shortened state.
uncoupler-treated animals, too, because the effect of uncoupler 
was shown in the isolated atria, but the uncoupler may cause 
local reduction in pH (by H+/Ca^+ exchange) and thereby pro­
mote lysosomal breakdown (Duncan et al., 1980). In this case 
we can examine only simultaneous phenomena. The decrease in 
ATP concentration in the immobilized muscle is not an evidence 
for the role in proteinase activation. The various results are 
shown in Table 3.
During immobilization there is a reduced fuel supply in 
the muscles. Among other materials the protein supply also 
decreases. The protein-free diet could cause, beside the high­
er lysosomal proteinase activity, higher calcium-activated 
neutral proteinase, too. We may say that this factor also 
could play a role in proteinase activation in the immobilized 
skeletal muscle.
Many authors (see Table 4) found that endogenous protein­
ase inhibitors in the skeletal muscles play a role in the 
inactivation of proteinases, and their leakage allows the pro­
teinase to act freely in the cell. We measured a total pro- 
reinase capacity with cathepsin B and trypsin.. In both cases 
a lot of compounds can inhibit the same proteinase. During 
protein degradation amino acids and small peptides are pro­
duced in the muscle. For example, leucine was shown to be an 
inhibitor of protein degradation. In our experiments the pro­
tein-inhibitor capacities did not decrease. In immobilized 
muscles a higher level of trypsin inhibitor was measured, and 
this could explain why the serine proteinase activity did not 
increase in these muscles. In future specific proteinase in­
hibitors such as those reported by Lenney (1979) are to be 
determined, and they might be found to play a physiological 
role in proteinase activation in the skeletal muscle.
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DISCUSSION
W IE D E R A N D E R S :
Is there anything known about the effect of hypoxic con­
ditions on proteinases in other organs than muscle?
S0HÁR:
During starvation the lactate/piruvate ratio increases in 
the liver and it is known that in this case the protein 
degradation is faster in the liver. There are other papers 
on the changes of proteolytic activity in blood (enzymes 
of coagulation, leucocytic proteinases), when the animals 
are kept under hypoxic conditions. In our experiments 
skeletal muscle was studied, since these muscles have a 
similar function but their oxidative metabolism (red fiber 
content) differ from each other. Results on heart muscle 
are described in details in our paper.
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The proteinases of the papain superfamily are of physiological, 
medical and nutritional importance, and in all of these connections it 
is necessary to know what controls exist over their activity in the 
human body. Four distinct human proteins have now been found to provide 
potent inhibition of these enzymes in the blood, tissues and cells. In 
this article we propose to start by commenting on some of the exciting 
results recently published by others on the membership of the papain 
superfamily of enzymes. We shall then briefly review knowledge of the 
protein inhibitors of these enzymes, with emphasis on work from our own 
laboratory, under three headings: alpha^M, alpha-cysteine proteinase 
inhibitor, and the cystatin-like inhibitors.
THE PAPAIN SUPERFAMILY
Dayhoff ejt al_. (1983) has defined a "superfamily" of proteins as a 
group for which statistical analysis of the amino acid sequences shows a 
less than one in a million probability of evolutionary relationship with 
other proteins. The best known of the cysteine proteinases (EC 3-4.22, 
previously called "thiol" proteinases) is papain, and the majority of 
the known cysteine proteinases fall into the superfamily of proteins 
homologous with papain. Sequence data shows that these include 
chymopapain, papaya peptidase, ficin, bromelain, the asclepains, 
actinidin, cathepsin B and cathepsin H (Fig. 1). Other evidence 
establishes beyond reasonable doubt that the superfamily also includes 
cathepsin L and calotropin. Thus, the molecular and enzymic properties 
of cathepsin L are very similar to those of the other lysosomal cysteine 
proteinases and papain (Barrett & Kirschke, 1981), and the tertiary 
structure of calotropin, from the madar plant Calotropus gigantea, 
determined by X-ray diffraction (Heinemann et ál"., 1982) shows the 
positions of the main-chain alpha-carbon atoms and of some residues that 
have been identified at the catalytic site so as to leave no doubt that 
this enzyme has essentially the same structure and catalytic mechanism 
as papain.
On the basis of sequence and other data, it seems probable that 
there are at least four other superfamilies of cysteine proteinases 
represented by the streptococcal cysteine proteinase(Tai et al., 1976), 
clostripain (Gilles ejt al., 1983), the calpain3 (Murachi, 1983), and the 
processing proteinase of poliomyelitis virus (Koránt, in the present 
volume). If this is so, the cysteine proteinases are a great deal more 
diverse than the serine proteinase:'.
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1 2 3 4 5 6 7 8 9
Papain I P E _ Y V D ¥ R Q
Cathepsin B (rat) L P E S F - D A R E
Cathepsin B (beef) L P E S F - D A R E
Cathepsin H (rat) Y P S s - M D ¥ R K
Cathepsin S/L(beef)L P D s - V D ¥ R E
Papaya Peptidase A L P E N - V D ¥ R K
Papaya Peptidase B L P E s - V D ¥ R A
Chymopapain B Y P E s - I D W R A
Asclepain A L P N s - I D ¥ R Q
Asclepain B L P N - F V D ¥ R -
Actinidin L P - s Y V D W R S
Ficin
Bromelain V P Q s - I D ¥ R D
Conserved P D R
1 * 2
0 1 2 3 4 5 6 7 8 9 0 1 2 3 4
K _ G A V T P _ V K N _ _ _ Q G S C G S
- Q ¥ S N C P T I A Q I R D Q G S C G S
- Q ¥ P N C P T I K E I R D Q G s c G S
K - G N V V S P V K N - - - Q G A c G s
K - G G V T P - V K Y - - - Q G A c G s
K - G A V T P - V R . . .
K - G A V T P - V K . . .
K - G A V T P - V K,,R V P D - - S - G E
K N - V V F P - I K N - - - Q G G . . .
K N G V V F P - I R N - - - Q G Q . . .
A - G A V V D - I K S - - - Q G E c G G
. . . p - I R Q - - - Q G Q c G S
Y - G A V T - S V K N - - - Q N P c G A
Q C G
5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2
Papain C W A F s A V V T I E G I I K I R T G N L N Q - Y s _ E Q E
Cathepsin B (rat) C ¥ A F G A V E A M S D R I C I H T - N/V N V E V s A E - D
Cathepsin B (beef) C ¥ A F G A V E A I S D R I C I H S - N . . .
Cathepsin H (rat) C ¥ T F S T T G A L E S A V A I A S G K M M T - L - A E Q Q
Cathepsin S/L(beef)G ¥ A F S A V V L A Q . . .
Chymopapain B C ¥ . . .
Actinidin C ¥ A F S A I A T V E G I N K I T s G S L I S - L s - E Q E
Ficin C V . . .
Bromelain C ¥ G F A A X A T V E S V A S I Y K G I L Q p - L s - 0 Q Q
Conserved C ¥
(Continued)
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6 7
3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8
Papain L T, D C D R - _ R s Y G c N G G Y P V s A L Q L V A Q -  - Y
Cathepsin B (rat) L L T C C G I Q C G D G C N G G Y P s G A G N F w T R K L V
Cathepsin H (rat) L V D C A Q N F N N H nVJ C Q G G L D s Q A F E Y I - - - L Y
Actinidin L I D C G R T Q N rp R G n D G G Y I T D G F Q F I - - I N
Bromelain V D D C A K • • •
Conserved C G C G G
8 9
9 0 1 2 3 4 5  6 7 8 9  0 1 2 3
Papain --G I H Y R N T -------- P Y Y E ----------- - G V Q R
Cathepsin B (rat) S G G V - Y - N S H I G C L P Y T I P P C E H H V N G S R P
Cathepsin H (rat) N K G I M G E B S  ------- Y P Y - I  ---------------  G K N G
Actinidin B G G I -----N T ------ B E N Y T A Q B - ---------- G B ----
Conserved G Y G
10
4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9
Papain Y C R S R _ E K G P --------------- Y A A ------- - K T D G
Cathepsin B (rat) P C T G E G B T P K C N K M C E A G Y S T S Y K E B K H Y Q
Cathepsin H (rat) Q C K F N P E K ------------- V A F V K N V V N I - T L -
Actinidin - C D V A L Q D Q K --------------- Y V T ------- I D T
Conserved C
1 1 12 15
0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6
Papain V R Q V Q p Y N Q G _ A L L Y S I A _ N Q P V s V V L - Q A
Cathepsin B (rat) Y T s Y s V S E S E K E I M A E X Y K N G P V E G A F - T V
Cathepsin H (rat) N D E A A M V E A V A L Y N P V S F A F - E V
Actinidin Y E N V - p Y N N E W A L Q T A V T - Y Q P V s V A L - D A
Bromelain . K A R V p R N N E - S S M Y A V S - K Q P I T V A V V s A
Conserved P
14 15 *16
7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2
Papain A G K D F Q L Y R G G I F V G P _ C G N _ - - K V B H A V A
Cathepsin B (rat) F - S D F L T Y K S G V V K H E A - G B V - - M G G H A I R
Cathepsin H (rat) T - E D F M M Y K S G V Y S S N S n H K T P D K V N H A V L
Actinidin A G B A F K Q Y A S G I F T G P - C G T A -  -  - V D H A I V
Bromelain A - - jf F(Z,-L,,Y)K S G V G D G Y - C K D - ---K L N H A V T
Conserved F Y G H A
(Continued)
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17 * * 18
3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8
Papain A V G Y G P - N - _ _ Y I L I K N S W G T G ¥ G E N G Y I R
Cathepsin B (rat) I L G W G I E N G V P Y W L V A N S W N V D ¥ G D N G F F K
Cathepsin H (rat) A V G Y E - Q/N G L L Y w I V K N S W G S N W G N N G Y F L
Actinidin I V G Y G T E G G V D Y ¥ I V K N S ¥ T T T ¥ G E E G Y M R
Bromelain A I G Y N K • • • • K A R W G E A G Y I R
Conserved G N s ¥ ¥ G
19 20 21
9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2
Papain I K R G T G N S Y G V C G L Y T S S F Y P V K _ N
Cathepsin B (rat) I L R G E N H - - - - p G I E S E I V A G I p R T Q
Cathepsin H (rat) I E R G K N M - - - - C G L A A C A S Y p I ■P Q V
Actinidin I L R N V G G A - G T C G I A T M P S Y p V K Y N N
Bromelain M A R D V S S S S G I C G I A I D P L Y P m E G
Conserved E C G
Fig. 1. Comparison of amino acid sequences of cysteine proteinases of the 
papain superfamily. The data are taken from the original publications cited 
below, and the sequences are numbered to cor' opond to that of papain. Cys-25 
and the other residues thought to be intime ely involved in catalytic 
activity (Lowe, 1976) are marked with asterisks. Lots indicate that a 
sequence continues. Oblique strokes show the points of limited proteolysis in 
cathepsins B and H. References: papain (Bayhoff, 1972), cathepsin B (rat) and 
cathepsin H (rat) (Takio et al., 1983), cathepsin B (beef) (Pohl et al.,
1982), cathepsin L/S (beef)- ~CÍTurk et al. , 1983), papaya peptidases A and B 
(Lynn & Yaguchi, 1979), chymopapain B~T?rocklehurst et al., 1981; Lynn & 
Yaguchi, 1979), asclepains A and B (Lynn et al., 19807, actinidin (Takio et 
al., 1983), ficin (Friedensohn & Liener, 1972; Brocklehurst et al., 1981) and 
bromelain (Goto et al., 1976; Goto & Murachi, 1980).
In general terms, one can say that the proteinases of the papain 
superfamily are proteins of about 25,000 molecular weight containing one 
essential thiol group (and sometimes, as in chymopapain, a non-essential 
one) as well as several disulphide bonds. Bromelain and the cathepsins are 
glycoproteins, whereas most of the other plant enzymes are not. There have 
been recent reviews of the properties of papain, chymopapain and papaya 
peptidase (Brocklehurst _e^t al., 1981), bromelain (Cooreman et al., 1976), 
the cathepsins (Barrett & Kirschke, 1981) and the mechanism of action of the 
cysteine proteinases in general (Lowe, 1976; Dolgar & Halasz, 1982).
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In fig. 1 we bring together all of the seauence data we are aware 
of for the enzymes homologous with papain. The sequences of papain, 
actinidin, and cathepsins B and H from rat liver are complete, and that 
of bromelain is over 80$ complete, but the others are shorter N-terminal 
or active site sequences. In order to make the best matches, gaps have 
been inserted into some of the sequences, and these are not necessarily 
where they were indicated by the original authors cited in the legend, 
but where they appear most reasonable to us in view of all of the data 
available.
We have considered the sequence data of Fig. 1 in conjunction with 
a molecular model of papain constructed according to the coordinates 
determined by Dreath et al. (1968). Parts of the polypeptide chain that 
lie away from the active site cleft in the folded proteins show numerous 
differences in sequence, but there is a good deal of conservation of 
residues in the active site cleft. In this part of the molecules there 
are substitutions that have prompted us to speculate about the reasons 
for some of the differences in substrate and inhibitor specificity 
between the enzymes. These inevitably depend upon the assumption that 
all of the enzymes fold in very much the same way as papain, and this 
may not always be true.
With reference to the catalytic mechanism, it is notable that Asp- 
158 which was proposed by Angelides & Fink (1979) to play a significant 
role in activity of papain is replaced by glycine in cathepsin B, and is 
perhaps therefore not vitally important. Rat cathepsins B and H have 
sites of limited proteolysis towards the N- and C-terminals, 
respectively (Takio _et al., 1983), and rat liver cathepsin L also is 
cleaved towards the C-terminus (Kirschke in the present volume). Since 
conserved residues, some of which are known to be important in the 
catalytic mechanism, tend to be clustered near both ends of the 
molecules, it would be surprising if any of the separated "heavy chains" 
were active.
The S2 subsite of papain (in the nomenclature of Scnechter & Berger 
1968) is the dominant site in the specificity of the enzyme for low 
molecular weight substrates. The position of this site, which binds 
hydrophobic residues and consists of a fairly deep pocket binding the P., 
side chain of the substrate, has been identified by Drenth et al.
(1976)- The beta-carbon of the side chain is in contact with the 
residues Pro-68 and Ala-160. Val-1 33 and Val-157 form the end of the 
pocket. In cathepsin B, Val-133 is replaced by glycine and Val-157 
probably by methionine (there is insufficient correspondence in this 
region to be absolutely certain). The replacement of valine by glycine 
may well create a gap at the end of the pocket. In the papain model the 
side-chain of Ser-205 is very close to the end of this pocket, whereas 
in cathepsin B, it is substituted by glutamic acid. Clearly, this 
substitution could explain why cathepsin B binds both X-Phe-Arg- and X- 
Arg-Arg- substrates well (Barrett & Kirschke, 1981). Unlike the 
subsite of trypsin, the end of the S2 pocket of cathepsin B would be at 
the surface of the molecule, and hence it would not be essential that a 
basic residue be placed in this site, but it could be favourably 
accommodated with no severe size restriction. Rather more 
speculatively, the high activity of cathepsin B towards triple basic
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substrates (e.g. X-Lys-Lys-Arg- substrates: MacGregor et al., 1979) 
could be explained by the fact that Tyr-61 of papain is replaced by 
aspartic acid. Drenth (1976) identifies Tyr-61 as a hydrophobic binding 
site for the side chain in papain.
In their paper on the sequence of cathepsins B and H, Takio _et al. 
(1983) reasonably suggest that the change of Ala-162 to arginine in 
cathepsin B could explain the ability of cathepsin B to act as a 
peptidyl dipeptidase. The Pg' binding site of papain has not been 
identified, but it would certainly approach residue 162 which is within 
the active-site cleft. The side chain of Ala-162 in papain, however, is 
turned in towards the hydrophobic core of the protein.
Cathepsin H shows a substitution of Tyr-61 by histidine, which 
might give the enzyme a P-^  specificity towards acidic residues. The 
most notable feature of cathepsin H, however, is that it shows strong 
aminopeptidase activity. Gln-135 of papain is close to the P^  peptide - 
NH of the substrate. In cathepsin H the equivalent residue seems to be 
glutamic acid, which could account for the specificity by binding the 
positively charged free amino terminus. Once again, however, the 
specificity would not be obligatory, as this residue is on the surface 
of the molecule.
Table 1 summarizes the extent of difference between the sequences, 
on the basis of which we have constructed the phylogenetic tree - Fig.
2. The numbers of PAM's between the enzymes indicate that papain and 
actinidin are the most closely related, cathepsin H is more distant from 
these plant enzymes, and cathepsin B is remote from the plant enzymes 
and from cathepsin H.
Table 1. Numbers of differences between pairs of sequences. The
comparisons were made on the basis of the alignments in Fig. 1, 100$ 
non-identity corresponding to 266 differences (the complete length of 
the alignment). The numbers of accepted point mutations (PAM's) were 
obtained from the numbers of differences by use of the table supplied by 
Dayhoff (1978).
Sequences compared Non-identical Difference (%) PAM's
Papain Cathepsin B 190 71 166
Papain Cathepsin H 160 60 112
Papain Actinidin 126 47 70
Cathepsin B Cathepsin H 189 71 166
Cathepsin B Actinidin 185 70 159
Cathepsin H Actinidin 159 60 112
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Cathensin B Papain Actinidin Cathepsin H
Fig. 2. Simple phylogenetic tree based on the differences in sequence 
between papain, actinidin and cathepsins B and H.
INHIBITORS
Many of the papain-type cysteine proteinases impinge upon human 
physiology and pathology. Thus, papain is used in the tenderizing of 
meat, and in other aspects of food processing. Bromelain has been used 
pharmaceutically (Cooreman et al., 1976), and chymopapain is an 
important agent for the treatment of herniated intervertebral discs. 
Several human parasites and pathogens contain cysteine proteinases that 
probably belong to the papain group: these include species of Leishmania 
(Coombs, 1982) and Schistosoma (Dresden et_ al., 1982). Cathepsins B, H 
and L are responsible for most of the proteolytic activity of lysosomes, 
which means that they mediate a significant proportion of intracellular 
protein degradation, and also are implicated by strong circumstantial 
evidence in the extracellular destruction of connective tissue matrices. 
For these reasons, it is important to understand the mechanisms that 
exist for regulation of the activity of proteinases of the papain 
superfamily in the human body.
a l p h a2-m a c r o g l o b u l i n
Alphag-macroglobulin (alphapM) was the first protein clearly 
characterized as an inhibitor of cathepsin B and related cysteine 
proteinases. An inhibitor of cathepsin B in human serum was found to 
inhibit the action of the enzyme on high molecular weight protein 
substrates more than that on small synthetic substrates. The inhibitor 
was purified and identified as alpha2M (Starkey & Barrett, 1973).
Working in an attempt to explain the curious effect of substrate 
molecular weight on the inhibition of cathepsin B and other proteinases 
by alphag-macroglobulin, we hit upon the "trap hypothesis" for the 
action of this protein (Barrett & Starkey, 1973; Starkey & Barrett, 
1977). This idea has been modified in detail over the years, but we 
would now express it as follows. The alphapM molecule, a 725,000
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molecular weight tetramer of identical subunits comorises two half­
molecules, each independently capable of binding one proteinase 
molecule. The interaction is initiated by the active proteinase 
cleaving the sensitive "bait region" of one of the subunits (Fig. 3)•
For this reason, catalytically inactive forms of the proteinases do not 
interact, and in this respect alpha2M differs sharply from all of the 
tight-binding protein inhibitors described below. Cleavage of the bait 
region in one subunit causes a rapid conformational change in it and its 
partner in the half-molecule, such as physically to trap the enzyme 
molecule within the macroglobulin. Large molecules, whether substrates, 
inhibitors or antibodies are then shut out, and the enzyme molecule is 
unable to react with them. The complexes have the distinctive 
characteristic of being active against low molecular weight substrates, 
however. The conformational change in the first half-molecule is 
transmitted to the second, which may "close" without trapping an enzyme 
molecule, but under favourable conditions a binding ratio of 2:1 is 
achieved. The very high rate of reaction of papain with alphag- 
macroglobulin is conducive to this (Howell et al., 1983).
-Glu-Gly-Leu-Arg-Val-Gly-Phe-Tyr-Glu-Ser-Asp-Val
690 f 700 
-Met-Gly-Arg-Gly-His-Ala-Arg-Leu-Val-His-Val-Glu-
Fig. 3- The "bait region" of alpha2M, showing the 
points susceptible to cleavage by papain.
Papain readily cleaves the native protein at any of 
these points, triggering the conformational change 
which traps the enzyme molecule (Mortensen et al., 
1981; Sottrup-Jensen _et a]^., 1983)-
Some of the molecules of papain and other proteinases that have 
become trapped by the alpha^M molecule also become covalently linked to 
the macroglobulin molecule (Salvesen & Barrett, 1980, 1981). The 
physiological significance of this is uncertain, but what almost 
certainly is of physiological significance is the very rapid clearance 
of alphajM-proteinase complexes from the circulation by the action of a 
macrophage cell-surface receptor specific for the special conformation 
of alpha2M after it has complexed proteinase molecules (Starkey & 
Barrett, 1977). The concentration of alpha2M in the plasma is about 3-4 
micromolar, and this could inhibit up to 6.8 micromolar proteinase. The 
very high molecular weight of alpha2M prevents it from escaping from the 
circulation except as a result of greatly increased vascular 
permeability at sites of inflammation.
Proteinases of the papain superfamily that are known to be trapped 
by alpha2M include papain, ficin, bromelain, Schistosoma cathepsin B- 
like proteinase and cathepsins B, H and L. As yet, there is no reason 
to think that any proteinase of this group will be found not to be 
trapped by alpha2M.
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ALPHA-CYSTEINE PROTEINASE INHIBITOR
Alpha-cysteine proteinase inhibitor (alpha-CPl) of human plasma was 
first described by Sasaki et al. (1977), and further work by Ryley 
(1979) and Sasaki's group ^Sasaki et al., 1981; Taniguchi et al., 1981) 
showed that the protein occurs in relatively low and high molecular 
weight forms in plasma, with alpl^- and alpha^- electrophoretic 
mobilities, respectively. Järvinen (1979) described the purification of 
two inhibitors of cysteine proteinases from human skin by use of 
affinity chromatography on a form of immobilized papain; the higher 
molecular weight form of these was almost certainly alpha-CPI derived 
from the blood.
In our work (Gounari3 et al., 1983) alpha-CPI has been purified by 
a two-stage method: affinity chromatography on (S-carboxymethyl-papain)- 
Sepharose, and high resolution anion-exchange chromatography. The 
protein was obtained as a low molecular weight form (molecular weight 
about 64,000) and a high molecular weight form (molecular weight about 
95,000). An antiserum was raised against alpha-CPI, and "rocket" 
immuno-assays showed the mean concentration in sera from 19 individuals 
to be 35-9mg/dl. Both forms of alpha-CPI were confirmed to be 
sialoglycoproteins by the decrease of electrophoretic mobility following 
treatment with neuraminidase. alpha-CPI was shown immunologically to be 
distinct from antithrombin III ard alpha^-antichymotrypsin, two serine 
proteinase inhibitors from plasma with somewhat similar molecular weight 
values. Neither these proteins nor haptoglobin showed any affinity for 
the (Cm-papain)-Sepharose column, but curiously kallikrein (or 
prokallikrein) wa3 efficiently bound from plasma. alpha-CPI also was 
immunologically distinct from the two intracellular low molecular weight 
cysteine proteinase inhibitors from human liver.
Complexes of alpha-CPI with papain and S-carboxymethyl-p.’ >ain were 
detectable in immunoelectrophoresis and in pore-limit gel electro­
phoresis, but dissociated to free enzyme and intact inhibitor in SDS 
polyacrylamide gel electrophoresis. The stoichiometry of binding of 
papain was close to 1:1 for both low and high molecular weight forms. 
alpha-CPI was found to be a tight-binding inhibitor of papain and human 
cathepsins H and L (see Table 2). By contrast, inhibition of cathepsin 
B was much weaker, and dipeptidyl peptidase I also was weakly inhibited.
Digestion of alpha-CPI with bromelain gave rise to an inhibitory 
fragment of molecular weight about 20,000, which was isolated. The 
properties of this fragment, and the nature of the high molecular weight 
form(s) of alpha-CPI are under further investigation.
CYSTATIN AND SIMILAR INHIBITORS
Cystatin. The protein from chicken egg-white that inhibits 
cysteine proteinases, and has been named "cystatin", was purified and 
characterized by Anastasi et al. (1983). The purification was by 
ovomucin precipitation, affinity chromatography on (S-carboxymethyl- 
papain)-Sepharose, and chromatofocusing. The final purification step 
separated two major forms of the protein (pi 6.5 and 5-6), with total
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recovery of about 20# from the egg-white. By use of affinity 
chromatography and immunodiffusion it was shown that the inhibitor is 
also present at low concentrations in the serum of male and female 
chickens. Tryptic peptide maps of the separated forms 1 and 2 of egg 
white cystatin were similar except in one peptide, and each form had the 
N-terminal sequence Ser-Glx-Asx. The two forms showed complete 
immunological identity, and neither contained carbohydrate.
Enzyme
Papain
Cathepsin B 
(human)
Cathepsin H 
(h,uman)
Cathepsin L 
(human)
Dipeptidyl 
peptidase I 
(bovine)
Liver CPI-A 
1.9 x 10_1 1
8.2 x 10-9
3.1 x 10'10 
1 .3 x 10~9
3.3 x 10-8
Liver CPI-B
1.2 x 10-10
7.3 x 10-8 
5.8 x 10-10
2.3 x 10-10
2.3 x 10-10
Lbitor
Cystatin
<5.0 x 10-12
1 .7 x 10-9
6.4 x 10'11
1.9 x 10-11
2.0 x 10-10
alpha-CPI 
3.4 x 10_11 
3-5 x 10 '7 
1.1 x 10-9 
3.7 x 10_11
1.3 x 10“7
Table 2. values for CPI-A and CPI-B from human liver, egg white 
cystatin and human plasma alpha-CPI. CPI-A was the "5.2" form, and the 
CPI-B the '*8.1 11 form (Green et al., 1983)- Egg white cystatin was mixed 
forms 1 and 2 (Anastasi _et al., 1983; M. J. H. Nicklin, unpublished 
results). alpha-CPI was the low molecular weight form (Gounaris et al.,
1983).
values for the inhibition of papain, cathepsins B, H and L, and 
dipeptidyl peptidase Í by cystatin in comparison to the other protein 
inhibitors are given in Table 2. Some other cysteine proteinases, and 
several non-cysteine proteinases were found not to be significantly 
inhibited by cystatin. Cystatin complexes with active cysteine 
proteinases and with the inactive derivatives formed by treatment of 
papain with iodoacetate, E- 6 4  [L-trans-epoxysuccinyl-leucyl-amido(4- 
guanidino)butane] and Z-Phe-Ala-CHN2 were demonstrated by isoelectric 
focusing and cation exchange chromatography. The complexes dissociated 
in SDS gel electrophoresis (with or without reduction) with no sign of 
fragmentation of the inhibitor. Cystatin was found not to contain a 
free thiol group, and there was no indication that disulphide exchange 
plays any part in the mechanism of inhibition.
The complete amino acid sequence of cystatin was established by 
Schwabe et al. (1983). As is shown in Pig. 4, cystatin is composed of 
116 amino acid residues, and the molecular weight can be calculated as
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13,143- No significant similarity to any other known seauence has been 
detected, and cystatin probably represents a new superfamily. The four 
cysteine residues form two disulphide bonds. The results of computer 
analysis of the sequence and circular dichroic spectrometry indicate 
that the secondary structure includes relatively little alpha-helix 
(about 20%) and that the remainder is mainly beta-structure (Fig. 4).
5 10 15
H-Ser-Glu-Asp-Arg-Ser-Arg-Leu-Leu-Gly-Ala-Pro-Val-Pro-Val-Asp-
20 25 30
-Glu-Asn-Asp-Glu-Gly-Leu-Gln-Arg-Ala-Leu-Gln-Phe-Ala-Met-Ala-
35 40 45
-Glu-Tyr-Asn-Arg-Ala-Ser-Asn-Asp-Lys-Tyr-Ser-Ser-Arg-Val-Val-
50 55 60
-Arg-Val-Ile-Ser-Ala-Lys-Arg-Gln-Leu-Val-Ser-Gly-Ile-Lys-Tyr-
65 70 75
-Ile-Leu-Gln-Val-Glu-Ile-Gly-Arg-Thr-Thr-Cys-Pro-Lys-Ser-Ser-
80 85 90
-Gly-Asp-Leu-Gln-Ser-Cys-Glu-Phe-His-Asp-Glu-Pro-Glu-Met-Ala-
95 100 105
-Lys-Tyr-Thr-Thr-Cys-Thr-Phe-Val-Val-Tyr-Ser-Ile-Pro-Trp-Leu-
110 115
-Asn-Gln-Ile-Lys-Leu-Leu-Glu-Ser-Lys-Cys-Gln-OH
Fig. 4- Amino acid sequence of egg white cystatin. The sequence of 
chicken egg white cystatin form 1 as determined largely by automatic 
sequencing methods (Schwabe _o^t al. , 1983).
Recent work on the interaction of cystatin with cysteine 
proteinases and dipeptidyl peptidase I (M. J. H. Nicklin and A. J. 
Barrett, unpublished results) has shown that cystatin is a tight-binding 
but reversible inhibitor of these enzymes, that binds to the catalytic 
site competitively with substrate, so as to mask the chemical reactivity 
of the active site thiol and to quench the fluorescence of a nearby 
tryptophan residue (Trp-177) in papain. Contrary to what has been 
thought, the inhibitory site lor dipeptidyl peptidase I is very close 
to, or identical with, that for the proteinases, so that they compete. 
Work is in progress to identify the "active site" region in the sequence 
of cystatin.
Human liver cellular cysteine proteinase inhibitors. There have 
now been many reports of low molecular weight (12,000-15,000) proteins 
that inhibit cysteine proteinases being found in tissues and cells from 
man and other species (reviewed by Green et_ al. , 1983).
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In the work of Green et al. (1983) cysteine proteinase inhibitor 
(CPI) forms from human liver have been purified from the tissue 
homogenate by alkaline denaturation of complexing cysteine proteinases, 
acetone fractionation, affinity chromatography on (S-carboxymethyl- 
papain)-Sepharose and chromatofocusing. The multiple forms of CPI were 
shown immunologically to be forms of two proteins, referred to as CPI-A 
(comprising the forms of relatively acidic pi) and CPI-B (comprising the 
more basic forms). CPI-A and CPI-B are similar in their molecular 
weight of about 12,400, considerable stability to pH 2, pK 11 and 80°C, 
and tight-binding inhibition of papain, several related cysteine 
proteinases and dipeptidyl peptidase I. In all these respects they also 
resemble cystatin. values were estimated for papain, human 
cathepsins B, H and L, and dipeptidyl peptidase I (Table 1). The 
affinity of CPI-A for cathepsin B was approximately 10-fold greater than 
that of CPI-B, whereas CBI-B showed approximately 100-fold stronger 
inhibition of dipeptidyl peptidase I. For all four enzymes, the liver 
inhibitors were less tight binding than cystatin. On the basis of 
antigenicity and pi, CPI-A seems to correspond to the epithelial 
inhibitor described previously, and CPI-B to the inhibitor from other 
cell types (Järvinen & Rinne, 1982).
Residue number
10 20 5 0  6 0  70 8 0  9 0
a)
b)
c)
d)
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I
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Key: w  a-helix; ß-sheet; /J-turn; —  random coil.
Fig. 5- Computer prediction of secondary structure from the sequence of 
cystatin. The algorithms used to make the four predictions were those 
of (a) Burgess et al_., (b) Chou & Fasman, (o) Nagano, and (d) Robson & 
Suzuki. Line ("ej shows those parts of the structure for which three of 
the four predictions agree. (See Schwabe et al., 1983, for full 
details.)
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CONCLUSIONS
The clear knowledge that is now emerging about the evolutionary 
relationship and close structural similarities of the lysosomal cysteine 
proteinases to some well known plant enzymes is providing a valuable 
basis for an understanding of their distinctive reactivities with 
substrates and inhibitors.
Until recently, the protein inhibitors of cysteine proteinases have 
been almost unstudied, in contrast to the decades of detailed investi­
gation that have been devoted to the serine proteinase inhibitors. This 
imbalance is now being adjusted, and already we seem to be able to 
identify the inhibitors that are likely to restrict the activities of 
cysteine proteinases in the body. In the blood, alphajM is likely to be 
particularly important, rapidly trapping the enzymes to form complexes 
that are efficiently cleared from the circulation. No doubt alpha-CPI 
is also active in the plasma, but being slightly smaller than albumin it 
is able to escape into the urine and almost certainly into extravascular 
tissue fluids. Cysteine proteinases secreted by tissue cells are likely 
to encounter alpha-CPI before the other inhibitors. Inside human cells 
there are two low molecular weight inhibitors with properties remi­
niscent of those of cystatin. Probably these serve to mop up minor 
leakages of lysosomal cysteine proteinases which would otherwise be most 
destructive in the cell. They may also provide defence against some 
intracellular parasites, and some larger ones, but we have yet to learn 
the full significance of the existence of two proteins of this type with 
different cellular distributions.
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INTRODUCTION
Studies from several laboratories report that leucocyte 
cells contain many types of proteinases (Havemann and Janoff, 
1978; Barrett, 1977). These enzymes are known to be potent 
mediators of inflammatory response (Weissmann et al., 1978; 
Rossi and Patriarca, 1982). Regulation of their proteolytic 
activity is cellularly and extracellularly controlled by 
various inhibitors of proteinases (Kopitar et al., 1981, 1982b; 
Fritz et al., 1974). Recent investigations shoved that leuco­
cytes contain inhibitors of elastases, cathepsin G, plasmino­
gen activator - urokinase type, and cysteine proteinases 
(Kopitar et al., 1981; 1982a, b).
The present communication describes the biochemical and 
biological properties of endogenous proteinase inhibitors iso­
lated from peripheral pig and human leucocytes.
Abbreviations: Bz-Arg-Nap: benzoyl-arginine-p-nitroanilide 
DTT: dithiothreitol
GSSG: glutathion, oxydized 
NEM: N-ethylmaleimid 
pNA: -p-nitroanilide
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Inhibitor of elastase and cathepsin G
A protein inhibitor of elastase and cathepsin G, designated 
1-2, was purified to apparent homogeneity from the cytosol of 
pig peripheral blood (Kopitar and Lebez, 1975). Its molecular 
weight is about 40 000 , its isoelectric point is 5.6-5.7. It 
is stable in buffer solutions in the pH region between pH 
3.0-8.0, but is not resistant to heat. This inhibitor diminish­
ed the hydrolysis of haemoglobin, fibrinogen and elastin by 
pig elastase, as well as of human elastase (the experiment was 
performed by M. Jochum, Münich) with Succ-Ala-Ala-Val-pNA sub­
strate. The determined according to Green and Work (1953) 
for pig elastase (Hb pH 7.5) was 7 nM.Cathepsin G is also in­
hibited with the 1-2 protein inhibitor, whereas cysteine pro- 
teinases, Chymotrypsin, trypsin and urokinase are not. It was 
found that it could be inactivated by cathepsin D, by hydro­
lysis of the inhibitory molecule (Kopitar et al., 1980; 1982a).
A similar endogenous elastase inhibitor of 36 kDa was isolated 
from horse peripheral leucocytes by Dubin (1977), and from 
bovine pulmonary macrophages by Valentine et al. ('981).
Inhibitor of plasminogen activator - urokinase type
Two inhibitors of urokinase were isolated from the cytosol 
and the extract of the nuclei of peripheral pig leucocytes 
(Kopitar, 1981). Only the inhibitor of higher molecular weight 
was isolated in the homogenous form, as a single polypeptide 
chain with a molecular weight of 68 000, designated 1-3.
The latter one has an isoelectric point from 4.4 to 4.5 
and it is stable in buffer solutions between pH 3.0-8.0, and 
belongs to the so called fast reacting inhibitors.
The inhibitor was effective only with plasminogen activa­
tors of urokinase type, but not with tissue plasminogen acti­
vator (test made in the laboratory of Prof. Rifkin, New York).
It does not inhibit plasmin, trypsin, Chymotrypsin or intra­
cellular proteinases of serine and cysteine type.
In some of our recent studies we have already reported 
that the inhibitor of plasminogen activator can also be in­
activated by hydrolysis with cathepsin D (Kopitar et al., 1980; 
Drobnic Kosorok et al., 1981) .
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Recently a similar inhibitor acting against urokinase was 
also found in rabbit endothelial cells (Loskutoff and Edgington,
1981), human placenta (Kawano et al., 1970) and in human cor- 
nified cells (Hibino et al., 1981).
Inhibitor of cysteine proteinases
During the last five years, the inhibitors studied most 
intensively were those for cysteine proteinases. In our pre­
vious publications the isolation and characterization of a pro­
teinase inhibitor of cysteine proteinases, designated 1-1A and 
B or sericystatin A and B from pig leucocytes were described. 
This inhibitor occurs in the cell in various molecular forms 
(Kopitar et al., 1978, 1981, 1982a, b).
Table 1
Properties of pig leucocyte sericystatin A and B
Characteristics A B
Molecular weight 1 3 000 1 1 000
Pi 4.6 - 5.6 5.8 - 7.0
Location in nuclear fraction + +
Cytosol + -
IC (mol/1) of the complex of the inhibitor with:
Papain „94 x 10 1 .2 X 10"9
Cathepsin B n.d. 7.0 X 10-8
Cathepsin H n.d. 5.0 X 10-8
Cathepsin G 1. 0 x 1  0-5 no inhibition
n.d.: not determined
Table 1 shows the main characteristics of these two iso­
inhibitors isolated from pig leucocytes. In Fig. 1 their homo­
geneity, as well as their isoelectric points determined by gel 
isoelectric focusing are seen. As shown by Table 1 and Fig. 1, 
the samples differ not only in isoelectric point but also in
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their inhibitory activity towards the target enzymes.
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Fig. 1:
Isoelectric focusing of 
sericystatin A and B. 
Sericystatin A (1), pro­
teins eluted in third pro­
tein peak from CM-cellu- 
lose, containing sericys­
tatin B (2) , sericystatin 
B (3), standards (4)
(Ip 3.0-10.4).
As it was reported recently (Babnik et al., 1983) these 
isoinhibitors differ also in their antigenic structure. As 
shown in Fig. 2 intracellular inhibitors belong to specific 
types and they are unrelated proteins.
Inhibitors of cysteine proteinases are characterized by 
their high thermostability (Järvinen et al., 1978; Kopitar et 
al., 1978; Lenney et al., 1979). More detailed studies showed 
that their stability is time- and temperature-dependent. Pig 
inhibitor of cysteine proteinases, types A and B, were stable 
in buffer solution at pH 7.5, -20°C for a longer time; up to 
1 year the specific inhibitory activity decreases by less 
than 10 %. Similar stability was observed when these inhibitors 
were incubated at 37°C up to 3 h (0.25 nmol in 0.25 ml of
0.03 M phosphate buffer, pH 6.5). Further, they were rather 
stable at room temperature (20-24°C); during 24 h incubation 
their activity was diminished only by about 10 %, but after
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5 days of incubation the inhibitory activity was completely 
lost.
Fig. 2:
Double immunodiffusion of 
inhibitor 1-1 A , 1-2 and 1-3 
against antiinhibitor (1-2 
and 1-3) antiserum. Antiin­
hibitor antibodies (10 yl) 
were placed in the middle 
well and all three inhibi­
tors (10 yl) were put into 
the separate outer wells as 
indicated (published in 
Mol. Immunol. 1983, Babnik 
et al.).
Complexes of cysteine proteinase - inhibitor were stable 
in sodium phosphate buffer, pH 6.5, up to 1 h at 37°C. Under 
these conditions there was no evidence for reappearance of en­
zyme activity. As it was observed (Kopitar et al., 1981) the 
effect of these endogenous inhibitors on cysteine proteinases 
is reversible. However, the nature of the bond formed between 
the enzyme and the inhibitor is still obscure. The cysteine 
proteinases can be displaced from the complex by disulphide 
containing agents, such as oxydized glutathione and cystine 
with subseguential reactivation of the enzyme activity. The 
rate of reactivation depends on time, temperature and disulphide 
concentration.
Activation of the inhibitor of cysteine proteinases
. As shown in Fig. 3, the activity of the inhibitor was in­
creased by 15-20 % by incubating 0.15 nmol inhibitor in 0.25 ml 
of 0.03 M sodium phosphate buffer, pH 6.5, containing 100 nmol 
DTT at 37°C for 20 min (curve a). In the absence of DTT 30 min
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incubation was required to achieve 20 % enhancement. As both 
curves show, activation at 37°C is faster in the presence of 
DTT.
Fig. 3:
Effect of temperature 
and DTT on sericystatin A
activity, a: -- with DTT;
b: --- without DTT.
Fig. 4:
Inhibition of bovine 
cathepsin B (0.15 nmol) 
by adding various quan­
tities of pig sericys­
tatin B (10-100 pi i.e. 
0.3-3 nmol). Full line 
represents unactivated- 
- control inhibitory 
tests. Enzyme was pre­
incubated with inhibitor 
used in different con­
centrations, in buffer 
solution, at room tempera­
ture for 5 min. Dotted 
line represents DTT ac­
tivated inhibitor sample 
(100 nmol for 20 min).
Titration of bovine spleen cathepsin B with activated and 
non-activated pig sericystatin B (Fig. 4) shows a significant 
increase in inhibition of activated inhibitor, thus inhibitor 
activated by DTT was more potent. The value was calculated
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according to Green and Work (1953) and in the case of cathepsin
_  7 _ o
B it decreases from 5.5x10 M to 7.0x10 M. A control experi­
ment with cathepsin B was performed in the presence of same 
amount of DTT for 5 min incubation at room temperature (20-24°C). 
During the complex formation only the enzyme was in contact 
with DTT. There was no decrease in enzyme activity. The titra­
tion experiments (Table 1) show that this inhibitor strongly
inhibits cysteine proteinases, the K. of the complex being 
— 9 — 810 M to 10 M, whereas it appeared to be much weaker against 
cathepsin G (Ki 10  ^M). This inhibitor does not affect trypsin, 
Chymotrypsin, elastase, urokinase and collagenase (the experi­
ment was performed by D. Wooley, Manchester).
Inactivation of the inhibitor of cysteine proteinases
The effect of GSSG in increasing doses on the inhibitory 
activity of pig inhibitor type A was studied at two different 
times and temperatures. Fig. 5 shows the effect of 3-75 nmol 
GSSG on the activity of 0.5 nmol inhibitor. As it can be seen 
the inactivation of the inhibitor is reversible, time- and tem­
perature-dependent. At higher concentrations of GSSG, the in­
activated inhibitor was reactivated. Papain was also incubated 
with the same amount of GSSG for 10 min at 22°C and the enzyme 
was in contact with GSSG only for this period (during the ac­
tivity assay). As shown in curve d, under these conditions GSSG
did not inactivate papain.
Fig. 5:
Effect of GSSG on the ac­
tivity of pig sericystatin
A. 0.5 nmol of inhibitor 
could inhibit 0.35 nmol of 
papain to produce 85 % in­
hibition. a) 15 min at 
room temperature, b) 1 h 
at 37°C, c) 3 h at 37°C. 
After incubation the tubes 
were cooled and papain 
(0.35 nmol) was added. 
After 5 min papain activity 
was assayed on Bz-Arg-Nap 
substrate.
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The results of inactivation with GSSG presented in Fig. 5 
have been confirmed by simultaneously performed gel electropho­
retic studies . The enzyme and inhibitor were shown to be com- 
plexed, but adding GSSG to the inhibitor prior to cathepsin 
B, the complex formation was prevented (Fig. 6).
Fig. 6:
PAGE demonstrating the inter­
action between cathepsin B: 
sericystatin B and GSSG.
1) Sericystatin B (40 yg);
2) cathepsin B (8 yg); 3) com­
plex of cathepsin B and inhi­
bitor; 4) inactivation of in­
hibitor by prior preincubation 
with GSSG resulted in preven­
tion of complex formation.
Preliminary analyses of the amino acid composition re­
vealed 2 Cys and 2 Met residues in pig sericystatins (A and B).
The free -SH group content of pig inhibitor type A and B 
was determined. In the case of type A at a protein concentra-
— fition of 0.7x10 M, the sulfhydryl group concentration was 
determined as 0.15x10  ^M. In the case of type B, however, 
the titration result indicated approximately 0.1 mol SH/mol 
of inhibitor. Alkylation of the free SH groups of the inhibitor 
with iodacetamide did not affect inhibitory activity, only by 
about 15-20 %. A similar effect was obtained with the sulf­
hydryl reagent N-ethylmaleimide (NEM). Our experiments in vitro 
on the treatment of the inhibitor with NEM disagree with the 
recent finding of Morgan et al. (1981), who showed that NEM can 
inactivate cytosolic inhibitor of cysteine proteinases of NIL
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and PyNIL hamster fibroblasts when these cells are incubated 
in a culture medium containing NEM. These results indicate that 
this inhibitor is present in cells (cytoplasm) in an active 
SK form, and that its formation is regulated by enzymes coupled 
to the redox potential of the glutathione cycle.
The results of the present paper contribute to our recent 
study on the inhibitory mechanism of inhibitor types A and B, 
and the inactivation effect of GSSG on these inhibitors (Kopi- 
tar et al., 1981). The inactivation of the inhibitor by GSSG 
could be reversed with the subsequent regeneration of inhibitory 
activity, and the effect of GSSG on inhibitor is concentration­
time- and temperature dependent. The equilibrium between inac­
tivated - activated states could be ascribed to the ratio oxi­
dized (GSSG) and the reduced form (-GSH) of glutathione. The 
activation experiments with DTT contribute to the redox poten­
tial dependent regulatory mechanism of inhibitory activity 
(Fig. 2 and 3).
Effect of the inhibitor in systems in vivo and in vitro
Pig leucocyte inhibitor type 1-1A was investigated for 
V-79-379A cell proliferation ability in vitro. It was found 
that the inhibitor at doses of 10-80 yg per ml cell culture 
medium showed a profound cytocydal effect on the colony form­
ing ability of these cells (Kopitar et al., 1981).
The regressive effect of pig leucocyte inhibitors type 
1-2 and 1-1A and B has already been reported (Giraldi et al., 
1977; Kopitar et al., 1982a). It was found that leucocytes in­
hibitors significantly diminished the growth of the primary 
tumour in mice bearing Lewis lung carcinoma. The number of 
lungmetastases found at sacrifice was also markedly reduced 
to about 64 %. A similar regressive effect on metastases forma­
tion was also obtained when animals were treated with spleen 
intracellular inhibitors (Giraldi et al., 1980).
Since lysosomal cathepsin B converts proinsulin to in­
sulin (Ansorge et al., 1977; Bansal et al., 1980), the effect 
of pig sericystatin A was tested on an insulin dependent tu­
mour - murine myeloid leukemia (Pavelic et al., 1983). The
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experiments showed that inhibitor administered intraperitoneally 
to mice bearing myeloid leukemia diminished insulin in blood 
and prolonged their mean survival time . Simultaneous applica­
tion of insulin could abolish these effects.
Studies on the inhibitory ability of cytosol obtained from 
leucocytes of synovial fluid of patients with rheumatoid 
arthritis against neutral proteinase and trypsin showed very 
pronounced differences (Rozman et al., 1983). In three samples 
(patients) no inhibitory activity was found against neutral pro- 
teinases and only a slight effect was observed on trypsin. In 
four samples a low (0-20 %) inhibitory activity was found 
against neutral proteinases and trypsin. The other ten speci­
mens showed rather evident inhibitory activity on the tested en­
zymes. The absence of proteinase inhibitory activity in some 
samples was explained by the formation of inhibitor - protein­
ase complexes, because the inhibitory activity generated after 
the activation. An interesting finding is that in the absence 
of cytoplasmic inhibitory activity the negative latex test 
rheumatoid factor was more frequent and the cartilage and bone 
of the affected joint was preserved.
What is the role of these cellular proteinase inhibitors, 
which are located in cytoplasm and nuclei? The presented results 
indicate that these inhibitors have an important protective 
function against inappropriate proteolysis.
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GRÁF:
Why d o  y o u  t h i n k  t h a t  t h e  i n  v i t r o  i n h i b i t o r y  e f f e c t  o f  
y o u r  l e u k o c y t e  i n h i b i t o r  o n  l y s o s o m a l  c a t h e p s i n  B a n d  t h e  
d e c r e a s e  o f  i n s u l i n  l e v e l  i n  b l o o d  o f  m i c e  a r e  r e l a t e d  
p h e n o m e n a ?  I s  i t  p o s s i b l e  t h a t  t h e  i n h i b i t o r  d i r e c t l y  
a f f e c t s  i n s u l i n  r e l e a s e  b y  a n  u n k n o w n  m e c h a n i s m  i n s t e a d  
o f  i n h i b i t i n g  t h e  i n t r a c e l l u l a r  p r o c e s s i n g  o f  p r o i n s u l i n  
t o  i n s u l i n ,  i n  w h i c h  p h e n o m e n o n  t h e  s e c r e t o r y  g r a n u l e s  
r a t h e r  t h a n  l y s o s o m a l  p r o t e i n a s e s  a r e  i n v o l v e d ?
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KOPITAR:
It is known that cathepsin B and some other cysteine pro- 
teinases convert proinsulin to insulin (Bansal et al., 
1980). In our paper (Pavelic et al., Eur. J. Cancer Clin. 
Oncol., J_9, 123. 1983) we reported that sericystatin A 
reduces the supranormal blood levels of insulin detectable 
by insulin-specific radioimmunoassay in mice (with murine 
myeloid leukemia). It was concluded that sericystatin A 
reduces tumor proliferation indirectly i.e., by reducing 
the circulating insulin level.
HALÁSZ:
What kind of papain did you use in your experiments? Was 
it purified or not?
KOPITAR:
In our experiments we used 2x crystallized papain (type III. 
and IV) from Sigma.
CHRISTENSEN:
Can the sericystatin A be a substrate for cathepsin G? Is 
it possible that the inhibition is caused competitively 
by the degradation products of sericystatin A?
KOPITAR:
Theoretically this possibility may exist. In these 
experiments we used 10 min preincubation time, at 25°C, 
for the complex formation of cathepsin G and the inhibitor 
sericystatin A. The residual cathepsin G activity was 
assayed with a specific substrate (Succ-Ala-Ala-Pro-Phe- 
-pNA) for 5 min. The difference in the activity (AA/min) 
was constant.
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INTERACTION OF HORSE LEUCOCYTE PROTEINASES WITH SOME NEUTRAL INHIBITORS FROM BLOOD PLASMA AND LEECHES
DUBIN, A., POTEMPA, J. and KOJ , A.
Institute of Molecular Biology, Jagiellonian University 
Kraków, Poland
ABSTRACT
The granules from horse blood leucocytes contain three 
serine proteinases: 1, 2A and 2B. Unlike proteinases 2, native 
proteinase 1 occurs in a form consisting of two proteins: ca­
talytic and regulatory. It is known that the action of neutral 
proteinases from blood leucocytes is responsible for acute in­
flammatory states e.g. acute arthritis or lung emphysema. For 
this reason the interaction of these enzymes with alpha-1-anti- 
proteinases from horse and rabbit blood and the inhibitor from 
leeches, called eglin, was investigated. The stoichiometry of 
inhibition and interaction rate of the enzymes and dissociation 
constant of the complexes were determined, attention being paid 
to accurate determination of the amount of active enzymes in 
the preparations by titration of their active centre with ^H- 
-di-isopropylphosphofluoridate. From the obtained results it 
was concluded that the alpha-1-proteinases inhibitor from 
rabbit blood is more efficient than the one from horse blood, 
and that eglin is a fairly effective inhibitor of horse leuco­
cyte proteinases: this finding may have potential therapeutical 
application during treatment of horse emphysematous diseases.
INTRODUCTION
Resent studies indicate that azurophil granules from horse 
polymorphonuclear leucocytes contain three groups of proteinases
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elastase-like (EC 3.4.21.11), Chymotrypsin-like (cathepsin C,
EC 3.4.21.20) and collagenase-like (EC 3.4.24.7) (Starkey, 1977). 
A comparison of the neutral proteinases from polymorphonuclear 
leucocytes of several experimental animal species was given by 
Ashe and Zimmerman (1982). In distinction to human (Starkey, 
1977), bovine (Marossy, 1980) and pig (Kopitar and Lebez, 1975) 
polymorphonuclear leucocytes, horse granules contain only 
elastase-like neutral proteinases (Dubin et al., 1976). Three 
different serine proteinases are responsible for hydrolysing 
casein, N-benzyloxycarbonyl-L-alanine 4-niteophenyl ester (Z- 
-Ala-ONp), acetyl-tri-alanine methyl ester (Ac-Ala-Ala-Ala-OMe) 
(Koj et al., 1976), and N-butyloxycarbonyl-L-alanine 4-nitro- 
phenyl ester (Boc-Ala-ONp) (unpublished results). These serine 
proteinases, designated 1, 2A and 2B, possess isoelectric points 
5.3; 8.8 and over 10, respectively (Dubin et al., 1976) and 
relative molecular mass M 49 000 (Potempa, 1982a), 24 500 and 
20 500, respectively (Dubin et al., 1976). Native proteinase 1 
occurs in the leucocyte granule extract in a form consisting 
of two proteins, one of which is catalytically active (M 
30 000, pi 8.2 and 9.15) and the other acidic protein has no 
proteolytic activity (M 20 000, pi 4.5) (Potempa, 1982b). The 
complex can be completely dissociated on Cibacron-Blue-Sepha- 
rose or by sodium dodecyl sulphate during electrophoresis even 
in the absence of a reducing agent. It is known that the 
neutral proteinases of granulocytes are involved in the degra­
dation of connective tissue components in inflammatory diseases 
(Jannof, 1975; Baggioloni et al., 1979; Zimmerman, 1979). Pro­
teinase inhibitors might therefore be valuable therapeutical 
tools in the treatment of this condition (Baugh and Schnebli, 
1980; Janoff and Dearing, 1980). Hence, it was decided to in­
vestigate the interaction of horse leucocyte proteinases with 
some neutral inhibitors from blood plasma and leeches.
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MATERIALS AND METHODS
Enzymes
Crystalline bovine trypsin and alpha-chymotrypsin were 
from Koch-Light (Colnbrook, England), while neutral proteinases 
from horse leucocytes were purified from granule extract: 
proteinase 1 by the method of Potempa (1982b) and proteinases 
2A and 2B by the method of Dubin et al. (1976). The amounts of 
active enzymes were independently determined by titration with 
p-nitrophenyl guanidinobenzoate (for trypsin according to Chase 
and Shaw, 1970), with p-nitrophenyl acetate (for Chymotrypsin, 
according to Kézdy and Kaiser, 1970), or by using tritiated di- 
isopropylphosphofluoridate (Dip-F) (6.5 Ci/mmol , Radiochemical 
Centre, Amersham, Bucks, UK) for neutral proteinases in the 
following procedure, using trypsin and Chymotrypsin as stand­
ards: tritiated Dip-F was diluted with fresh 8 mM carrier 
Dip-F in dry propylene glycol to obtain approximately 5 pCi 
in 15 pi. The tested enzymes (2 to 8 nmole) were diluted with
0.05 M Tris-HCl pH 8.8 to 0.4 ml in plastic tubes (Eppendorf 
type) of a microcentrifuge and immediately 15 pi ^H-Dip-F solu­
tion was added with vigorous shaking. Shaking was continued 
for 30 min and then 50 pi of bovine serum albumin solution 
(10 mg/ml 0.05 M Tris-HCl, pH 8.8) was pipetted, followed 10 
min later by 0.5 ml 10 % trichloroacetic acid. The precipitate 
was centrifuged, dissolved in 0.2 ml 0.1 N NaOH, reprecipitated 
with 1 ml 10 % trichloroacetic acid, washed 2 times in 1 ml 
5 % trichloroacetic acid, and finally dissolved in 0.1 ml 
Protosol (New England Nuclear, Boston, MA USA). The tube con­
tents were transferred quantitatively to a scintillation vial, 
made up to 10 ml with the Bray scintillation cocktail, and 
radioactivity was determined in a Packard spectrometer. The 
values of radioactivity found in samples containing known 
amounts of trypsin or Chymotrypsin were used as standards for 
calculation of the concentration of active leucocyte protein­
ases run in a parallel assay. In the described conditions a 
linear relationship was found between incorporated radioactiv­
ity and the amount of serine proteinases ranging between 2 and
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8 nanomoles. At lower concentrations of the enzymes the 
accuracy was not satisfactory.
Inhibitors
Rabbit alpha-1-proteinase inhibitor (alpha-1-PI) was 
purified as the F and S forms by the procedure described else­
where (Koj et al., 1978), and horse alpha-1-proteinase inhibi­
tor by the method of Kurdowska et al., 1982). Eglin C, the in­
hibitor from leeches, was obtained by the procedure of Seemül­
ler et al., (1 977) .
Assay of enzymatic activity
The activity of trypsin was determined at pH 8.0 with 
p-toluene-sulphonyl-L-arginine methyl ester (Tos-Arg-OMe, Koch- 
Light, Colnbrook, England) (Hummel, 1959), Chymotrypsin at 
pH 6.5 with N-benzyloxycarbonyl-L-tyrosine-p-nitrophenyl ester 
/CBZ-Tyr-ONp, Sigma Chemical Co., St.Louis, MO, USA) (Aubry 
and Bieth, 1977), and leucocyte proteinases at pH 6.5 with 
N-tert-butyloxycarbonyl-L-alanine-p-nitrophenyl ester (BOC- 
-Ala-ONp, Fluka AG, Buchs, Switzerland) (Visser and Blout, 
1972) .
The stoichiometry of the reaction between the tested pro­
teinases and inhibitors as well as the dissociation constants 
(K^ ) were determined either by the method of Green and Work 
(1953) or of Bieth (1980), depending on the shape of the reac­
tion curves, and the association rate constants (k ) accord-on
ing to Bieth (1980).
In some experiments inhibition of leucocyte proteinases 
by eglin was tested with protein substrates - azocasein (pre­
pared according to Hazen et al., 1965) and bovine fibrinogen 
(Miles Lab., Elkhart, USA) - using the following procedure:
0.1-0.2 nmol of enzyme was incubated for 5 min at 25°C with 
variable amounts of eglin in 0.3 ml 0.1 M sodium phosphate 
pH 7.4. Then 0.3 ml of the protein substrate in the same buf­
fer was added to the final substrate concentration of 1.5 % 
(w/v). After 60 min at 37°C the reaction was stopped by addi­
tion of 0.3 ml 12 % (w/v) trichloroacetic acid and the mixture
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was centrifuged. The A 360 (for azocasein) or A28Q (for fibrino­
gen) of the acid soluble reaction products were determined.
RESULTS AND DISCUSSION
The final preparation of horse plasma alpha-1-proteinase 
inhibitor (alpha-1-PI) purified by the method of Kurdowska et 
al., (1982) always showed a considerable degree of heterogene­
ity during electrophoresis on polyacrylamide gel at pH 8.3, 
while it gave a single precipitin arc on immunoelectrophoresis 
in agarose. This is an agreement with a recent report of 
Laegreid et al. (1982). As shown by Juneja et al. (1979) by 
two-dimensional electrophoretic analysis the horse serum con­
tains two groups of alpha-1-globulin (designated PI1 and PI2) 
proteinase inhibitors. Preliminary studies indicated that PI1 
and PI2 proteins differ from each ether in relative molecular 
mass and in proteinase inhibiting spectra. The PI1 fractions 
showed a strong inhibition for both trypsin and Chymotrypsin 
while the PI2 fractions had an equally strong inhibition for 
trypsin but showed a much weaker one for Chymotrypsin. A 
similar phenomenon was found by Kobayashi and Nagasawa (1974) 
for proteinase inhibitors from guinea pig serum. It was very 
difficult to purify these two inhibitors on a preparative 
scale, but by using the method of Kurdowska et al. (1982) it 
was sometimes possible to separate the PI2 proteinase inhibitor fron 
PI1. As shown in Fig. 1, the PI2 fraction effectively inhibited 
trypsin (approximately 1:1 molar ratio of the inhibitor to en­
zyme) and the proteinase-inhibitor complex was rather stable 
(dissociation constant Ki=17 nM). On the other hand, this 
fraction inhibited only about ten per cent of the esterolytic 
activity of Chymotrypsin, even with a five-fold molar excess 
of the inhibitor, and no inhibition was observed either in the 
case of pancreatic elastase or three horse leucocyte neutral 
proteinases. In most cases, however, the tested alpha-1-PI 
isolated from horse plasma was a mixture of PI1 and PI2 
(Table 1). The reaction of this preparation with trypsin was 
prompt, the stoichiometry in most experiments being close to 
a 1:1 molar ratio and the complex enzyme inhibitor fairly
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Fig. 1: Inactivation of bovine trypsin (circles) and 
Chymotrypsin (triangles and squares) by horse 
alpha-1-proteinase inhibitor: PI1 + PI2 (full 
symbols) or PI2 (open symbols).
stable (K.=11 nM). In t h e  c a s e  of C h y m o t r y p s i n  the e n z y m e  a lso1 5reacted quickly with the inhibitor (rate constant k =1.45x10 _ 1 _ 1M s  ) but the molar ratio could not be determined at all, 
and even with a five-fold molar excess of alpha-1-PI the pro­
teinase retained approximately 30 per cent of its initial 
activity (Fig. 1). A somewhat similar picture was observed 
with three elastase-like proteinases from horse leucocytes but 
the reaction was much slower. A high dissociation constant 
(Table 1) of the proteinase-inhibitor complex cannot alone 
explain the peculiar stoichiometry of the reaction between 
alpha-1-PI and Chymotrypsin, but it represents an additional 
factor responsible for the low inhibitory capacity of horse 
alpha-1-PI against both Chymotrypsin and leucocyte proteinases. 
Hence, in horse blood alpha-1-PI are probably not involved in 
the inactivation of Chymotrypsin and leucocyte proteinases in 
vivo.
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Table 1
Comparison of Inhibitory constants (K^) and reaction rates (k ) of serine
proteinases and inhibitors
Enzyme
Alpha- 1-PI horse Alpha-1I-PI rabbit Eglin C
K . l
(nM)
k-on
io5m~ V 1
k.l
(nM)
Form F
^on
l o W 1
Form
k.1
(nM) 10
S
^on5M-1 -1 M S
k.1
(nM)
k-on
105M-1s-1
Trypsin 11.0 1 . 33 0.81 5.05 2.69 0.21 n.d. n.d.
Chymotrypsin 190.0 1 .45 0.22 14.50 1.02 11.60 0.23 30-90
Proteinase 1 145.0 0.07 1 . 02 39.30 1.14 0.27 0.63 12.8
Proteinase 2A 172.0 n.d. 0.68 >100.00 1.93 0.53 0.47 9.5
Proteinase 2B 262.0 n.d. 0.38 >100.00 3.82 58.60 25.50 8.9
n.d.: not determined
In rabbit blood alpha-1-PI occurs in two principal immuno- 
logically identical forms, designated according to their elec­
trophoretic mobility as F (fast) and S (slow) (Koj et al., 
1978). As is shown in Fig. 2 and Table 1, these two forms of 
rabbit alpha-1-PI have differential reactivity with various 
proteinases. The F form reacted much faster with trypsin or 
horse leucocyte proteinases 1 and 2A than the S form, whereas
Fig. 2: Inactivation of bovine chymotrypsin by rabbit 
alpha-1-PI F (circles) or S (triangles) with 
CBZ-Tyr-ONp as substrate
with chymotrypsin or proteinase 2B the values of the inactiva­
tion rates were faintly similar for the two forms. When these 
differences in reaction rates were taken into account during 
determination of the stoichiometry of enzyme inactivation by 
alpha-1-PI-F and S, the curves extrapolated to approximately 
1:1 molar ratio of the inhibitor to the enzyme, with the ex­
ception of the chymotrypsin and alpha-1-PI-S interaction. In 
this case an approximately three-fold molar excess of alpha- 
-1-PI-S was required for almost total inhibition of enzymatic
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activity (Fig. 2). Such a mixture of a three-fold excess of 
alpha-1-PI-S and Chymotrypsin was totally inactive against 
trypsin, this indicating that all the inhibitor reacted with 
chymotrpysin to form a stable complex or inactivated inhibitor. 
On this basis, the supposition that the native alpha-1-PI-S con­
tains only third of the binding sites for Chymotrypsin while 
being fully active with trypsin appears not to be justified.
In agreement with reports of other authors on human alpha-1- 
-PI (Beatty et al., 1980) it was found that also rabbit inhi­
bitor F reacted much faster with leucocyte proteinases than 
with trypsin or Chymotrypsin (Table 1). On the other hand, the 
S form showed much lower inactivation rate constants with 
trypsin and leucocyte proteinases 1 and 2A than with Chymo­
trypsin and proteinase 2B,. thus resembling chemically modified 
human alpha-1-PI (Beatty et al., 1980). All these findings 
indicate structural differences in the reactive centre of the 
two forms of rabbit alpha-1-PI, but the problem requires 
further studies. From the values given in Table 1 it was 
concluded that alpha-1-proteinase inhibitors from rabbit blood 
are more efficient than that from horse blood.
The low molecular mass inhibitor (Mr 6 000) isolated from 
leeches as described by Seemüller et al. (1977) was fairly ef­
fective inhibitor of horse leucocyte proteinases in vitro as 
is shown in Table 1. The interaction of proteinase 1 and 2A 
gave typical rectilinear curves (Fig. 3a and 3b) which were
not altered by changes in BOC-Ala-ONp concentrations within 
— 4the range 1-3x10 M. Hence, the value could be calculated
by the method of Green and Work (1953). At higher substrate
-4concentrations (e.g., 5x10 M) the curves became slightly 
concave although the method of Bieth (1980) could not be 
applied for calculation of . In the case of proteinase 2B 
the inactivation curve with eglin always yielded a concave
curve, even at the lowest tested BOC-Ala-ONp concentration 
-4(10 M, Fig. 3c). The apparent values calculated by the 
method of Bieth (1980) at 3 different substrate concentrations 
could be corrected for substrate-induced complex dissociation 
assuming a value for BOC-Ala-ONp equal to 0.24 mM. The
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3: Interaction of eglin with proteinase 1 (a), 2A (b) and 2B (c) with
BOC-Ala-ONp as substrate. Insert shows replot of the curve c accord­
ing to Bieth (1980) with the apparent K^)32.5 nM.
Fig.
corrected values for proteinase 2B ranged between 28.2 and 
22.9 nM with the mean value given in Table 1. Further experi­
ments indicated that the complex of proteinase 2B with eglin 
was also dissociated with one of the protein substrates-azo- 
casein (Fig. 4c). The inhibition of proteinase 2B by equimolar 
concentration of eglin was only slight. The other two protein- 
ases (1 and 2A) were fairly effectively inhibited by eglin 
with azocasein, although the curvature of the lower portion of 
the curves and extrapolated equivalence points suggest the 
occurrence of equilibrium between free and complexed enzymes 
(Fig. 4a and 4b). On the other hand, the results shown in 
Fig. 4 indicate that with fibrinogen as substrate all three 
proteinases are almost completely inhibited by eglin at nano­
molar concentrations. From the inactivation rate constants 
given in Table 1 it may be concluded that the reactions with 
both Chymotrypsin and neutral proteinases are very fast, inac­
tivation of proteinases being practically completed within 
less than 30 seconds. It remains to be explored whether eglin 
is also an effective inhibitor of horse leucocyte proteinases 
in vivo.
The action of neutral leucocyte proteinases on the lung 
elastin tissue is responsible for lung emphysema. Although the 
ethiopathology of such a condition is best documented for man, 
certain data suggest that the horse is also a sensitive species 
(Gerber cited after Von Feilenberg and Pellegrini, 1979).
Three very active elastase-like neutral proteinases from horse 
leucocyte (Dubin et al., 1976; Koj et al., 1976) can be rather 
inefficiently inhibited by homologous alpha-2-macroglobulin 
(von Feilenberg and Pellegrini, 1979) and by alpha-1-proteinase 
inhibitor (this study). Moreover, homologous antithrombin III 
is completely inactive against these enzymes but a prolonged 
exposure of inhibitor to leucocyte proteinases reduces the 
antitryptic activity of the inhibitor (Koj and Kurdowska,
1981). Exogenous proteinase inhibitors may therefore have 
some potential practical significance in the prevention and 
treatment of horse lung emphysema. On the other hand, the 
horse leucocyte cytosol contains very active inhibitor against
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4: Curves of inhibition of three leucocyte proteinases by eglin with 
azocasein (full circles) or fibrinogen (open circles) as substrates, 
a - proteinase 1; b - proteinase 2A; c - proteinase 2B.
Fig.
Chymotrypsin, pancreatic alastase, and horse leucocyte neutral 
proteinases (Dubin, 1977). Detailed kinetic studies of the 
interaction between this inhibitor and proteinases are now in 
progress.
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DISCUSSION
KORÁNT:
Which pathological conditions in horses do you propose 
to treat with your inhibitors?
DUBIN:
We suggest to use eglin to treat horse-lung emphysema.
/
248
Symposia Biologioa Hungarioa 25 {1984)
GRANULOCYTE ELASTASE MEDIATED FIBRINOLYSIS 
GRAMSE, M., GRÜN, A. and BECKMANN, I.
Department of Internal Medicine, University of Marburg 
Marburg, FRG
Neutral proteinases from neutrophil granulocytes are re­
leased at inflammatory sites by phagocytic stimuli (Baggiolini,
1982) and during clot formation (Plow, 1982) from the involved 
granulocytes. They are able to degrade a variety of substrates 
and may therefore play a role in pathological protein break 
down (Havemann and Janoff, 1978). Elastase, the most important 
granulocyte proteinase, is known to degrade beside fibrinogen 
and other clotting factors (Schmidt et al., 1974) and the 
coagulation inhibitors (Jochum et al., 1981) also the inhibitor 
of plasmin fibrinolysis, o^-plasmin inhibitor (Klingemann et 
al., 1981).
ci2-plasmin inhibitor is known to exist in three forms 
(Clemmensen et al., 1981), the plasminogen binding (69 kDa), 
the non-plaminogen binding still active (65 kDa) and the inac­
tive 58 kDa from, o^-plasmin inhibitor is inactivated by elas­
tase as measured by the inhibitory activity of c^-plasmin in­
hibitor against plasmin (Fig. 1).
The a^-plasmin inhibitor, used, consisted mainly of the 
69 kDa plasminogen binding inhibitor as shown in Fig. 2 by 
SDS-polyacrylamide gel-electrophoresis. During inactivation 
this band disappeared and a 65 kDa and a 58 kDa band became 
visible, representing the non-plasminogen binding active and
Abbreviations: BOC: t-butyloxycarbonyl- 
Nan: p-nitroanilide 
Np : nitrophenyl ester 
Pig: plasminogen
17* 249
later on (24 h) inactive inhibitor molecule and the inactive 
plasmin inhibitor with a lower molecular mass. While unchanged 
after 24 h incubation in buffer, no residual plasminogen bind­
ing <*2 plasmin inhibitor was visible in the 24 h digest with 
elastase.
Fig. 1: Elastase induced inactivation of a  ^ plasmin inhibitor. 
02 plasmin inhibitor activity was estimated by its 
capacity to inhibit plasmin action on the chromogenic 
substrate D-Val-Leu-Lys-Nan. Molar ratio elastase to 
02 plasmin inhibitor = 0 . 0 1
kDa V t
94 -
k—i* w «*§ t e sj ■m tm- * 1».
68 - * f  .■ * * 4  *
45 - 
31 -
21 -
14.3-
15 60 1440 1440
min incubation time
c- ' 1 _ Fig. 2:
SDS-polyacrylamide gel- 
electrophoresis of ot2 ~ 
plasmin inhibitor 
samples, incubated with 
buffer (0 ) or elastase 
(E) 15 or 1440 min. The 
* ■ 60 min incubation with
elastase was also ap­
plied to the gel fol­
lowing reduction (Er). 
The molecular mass of 
the marker proteins 
in kDa are indicated 
on the left.
6 0
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Following reduction the" 69 kDa band remained unchanged, the 
65 kDa band, however, disappeared. Judging by the staining in­
tensity, the 58 kDa band may exist of the unchanged inactive 
58 kDa molecular and of the reduced non-plasminogen binding a2 
plasmin inhibitor. Obviously elastase splits an intramolecular 
loop of <*2 plasmin inhibitor which leads to the loss of plas­
minogen binding capacity of the plasmin inhibitor.
The plasminogen binding and the non-binding a2 plasmin in­
hibitor forms can be demonstrated by two-dimensional immuno- 
electrophoresis, if separation in the first dimension is per­
formed in the presence of plasminogen (Fig. 3).
Fig. 3:
Two-dimensional Immuno­
electrophoresis of plas­
ma, incubated with buf­
fer (0) or elastase (E) 
to give residual c*2 
plasmin inhibitor 
activities as indicated 
on the right. Separation 
during the first dimen­
sion was performed 
without (left plates) 
or with 0.5 CTA U 
plasminogen/ml agarose 
(right plates) , anti-ct2 
plasmin inhibitor serum 
was used for precipita­
tion in the second di­
mension .
The appearance of two 
precipitation arcs only 
is due to the presence 
of plasminogen, as 
without plasminogen only 
one arc became visible.
w/o Pig 0.5 CTA U Plg/ml agarose
%  «-zPl
A .
® «-
<> «>100
Cl E 100
© ©
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Plasma was incubated with varying concentrations of 
elastase to give the residual plasmin inhibitor activities 
as indicated. The inhibition was separated with and without 
plasminogen in the first dimension and precipitated with anti-
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a-2 plasmin inhibitor serum in the second dimension. Only in 
the presence of plasminogen the two inhibitor forms are sepa­
rated: The plasminogen-binding form is retarded. The concentra­
tion of the faster migrating non-plasminogen binding form in­
creases with inactivation.
It may be concluded by the results, that elastase or a 
similar reacting proteinase induce the conversion which was 
hitherto described to occur spontaneously (Clemmensen et al., 
1981).
Inactivation of plasmin inhibitor in plasma required 
physiologically unexpected high elastase concentrations (Fig. 4)
Fig. 4: % Ű2 plasmin inhibitor activity (---) following 5 and
60 min incubation of human plasma with 0 to 630 yg 
elastase per ml. The elastase activity (nkat/ml) of 
identical samples was measured with the chromogenic 
substrate < Glu-Pro-Val-Nan (-- ).
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Following 5 rain incubation with 550 yg elastase per ml plasma 
plasmin inhibitor was totally inactivated, following one 
hour incubation still 500 yg elastase/ml plasma were required. 
Elastase below 100 yg/ml concentration did not inactivate a  ^
plasmin inhibitor even after prolonged incubation time (two 
days).
Elastase activity was simultaneously measured with the 
chromogenic substrate (<Glu-Pro-Val-Nan). The beginning of a^ 
plasmin inhibitor inactivation at 450 yg elastase/ml plasma 
corresponds with a steeper increase in elastase activity. The 
initial flat increase of elastase activity with growing con­
centrations represents the low residual activity of elastase, 
which is saturated by numerous protein substrates, among them 
<*2 macroglobulin, oi^ macroglobulin bound elastase is known to 
react with peptide substrates. In experiments with macro- 
globulin/elastase complexes and purified a2 plasmin inhibitor, 
however, no inactivation of the plasmin inhibitor was to ob­
serve .
Degradation of purified fibrinogen, leeding to split 
products with anti-clotting properties is well described 
(Gramse et al., 1981). If elastase induced fibrinogen degrada­
tion was performed in human plasma and measured by thrombin 
clotting time also an unphysiologically high concentration was 
required to make fibrinogen uncoagulable (Fig. 5). But, throm­
bin time was prolonged already in a concentration range, where 
mainly 02 macroglobulin bound elastase yielded the low residual 
activity against the chromogenic substrate. Moreover, thrombin 
time measurement is not a highly susceptible indicator for 
fibrinogen degradation, as the high molecular early X-like 
degradation product of fibrinogen yet can be coagulated by 
thrombin. It was therefore of interest to know, if «2 macro­
globulin bound elastase is able to split fibrinogen. This was 
tested using FITC-labelled fibrinogen as substrate (Fig. 6).
The release of trichloroacetic acid soluble peptides, 
which served as criterion for fibrinogen degradation by elas­
tase, was measured by fluorometer. Elastase was preincubated 
with increasing molar excess of macroglobulin before incuba­
tion with FITC-fibrinogen. For comparison, the activity of the
7.53
Fig. 5: Thrombin time of plasma, measured after 5 min in­
cubation with 0 to 500 yg elastase/ml. Measurement 
of elastase activity see Fig. 4.
Fig. 6: Esterase activity of granulocytic elastase against
Boc-Ala-Np and proteinase activity against FITC-fib- 
rinogen (%) in the presence of 0 to 5 mol ci2 macro­
globulin per mol elastase. For each test, 1.5 yg 
elastase had been preincubated for 30 min with dif­
ferent amounts of 0(2 macroglobulin.
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(*2 macroglobulin/elastase samples was measured using a chromo- 
genic substrate. Despite the proteinase activity against FITC- 
fibrinogen was much stronger inhibited by macroglobulin than 
the esterase activity against the dipeptide, it also reached a 
plateau of residual activity and was not fully inhibited. De­
spite some denaturation of fibrinogen by FITC-labelling one 
may therefore speculate, that a2 macroglobulin bound elastase 
is able to split fibrinogen.
Heparins which are widely used for anticoagulation, are 
also known to inhibit serin proteinases (van Haeringer, 1963). 
We therefore tested the influence of this anticoagulant on 
elastase, on its esterolytic and especially on its fibrinolytic 
properties. Elastase, a strongly cationic protein, cannot be 
demonstrated in two-dimensional immunoelectrophoresis because 
of its cathodic migration. But if heparin is present in the 
first dimension, the formed heparin/elastase complex migrates 
towards the anode and can be precipitated with anti-elastase 
serum in the second dimension (Fig. 7).
Fig. 7:
Two-dimensional immunoelectrophoresis 
of purified granulocyte elastase- 
upper plate: with 2 USP U heparin/ml 
agarose in the first dimension, pre­
cipitated with anti-elastase serum 
in the second one. The elastase for 
the upper plate had been preincubated 
with heparin.
lower plate: heparin was omitted.
The bond between elastase and heparin, however, is dis­
sociated when the complex migrates in electrophoresis without 
heparin.
To show the influence of heparin on complex formation of 
elastase with its plasma proteinase inhibitors - macroglo-
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bulin and proteinase inhibitor - two-dimensional immunoelec- 
trophoresis with plasma and elastase, plasma were carried out in 
the presence or absence of heparin. Neither macroglobulin 
alone nor its complex with elastase; neither active -protein­
ase inhibitor nor its proteolytic degraded, inactive form were 
modified in their electrophoretical behaviour by heparin. In 
contrast, the elastase/a^ proteinase inhibitor complex, without 
heparin migrating more slowly than proteinase inhibitor 
alone, is shifted towards the anode. This is demonstrated in 
two-dimensional Immunoelectrophoresis in Fig. 8 with anti-a^ 
proteinase inhibitor serum and anti-elastase serum, respectively.
Fig. 8:
Two-dimensional Immunoelectrophoresis 
of plasma preincubated with 150 yg 
elastase per ml.
The first dimension on plates c and d 
was performed in the presence of 2 USP U 
heparin/ml agarose. Anti-a-j proteinase 
inhibitor serum was used for precipita­
tion in the second dimension on plates 
a and c, anti-elastase serum on plates 
b and d.
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Nevertheless, the binding of heparin to elastase or its 
complex with proteinase inhibitor is not as strong as heparin
binding to antithrombin III. This was proven by gelfiltration
3experiments with protein/ H-heparin complexes. While the anti­
thrombin III/heparin complex was stable even in a strongly
3chaotropic buffer, elastase was separated from H-heparin by 
gel filtration under identical conditions.
The influence of heparin on the elastase activity was 
assayed with various substrates. While elastase activity against 
the chromogenic substrate (<Glu-Pro-Val-Nan) was not changed 
by heparin, elastase activity against the dipeptide Boc-Ala-Np 
was inhibited to about 60 % by 50 to 5x10  ^USP U/ml. Lower 
and higher heparin concentrations had no effect (Fig. 9).
Fig. 9: Activity of elastase or elastase/a-j proteinase 
inhibitor mixture (molar ratio 2:1) against 
Boc-Ala-Np in the presence of 500 to 5x10-6 USP U 
heparin per ml test volume.
The inactivation of elastase by proteinase inhibitor was 
not affected by heparin. Elastase/a. proteinase inhibitor mix­
tures in the molar ratio of 2 to 1 showed the same susceptibi­
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lity of the non-inhibited elastase like free elastase to he­
parin .
When FXTC-fibrinogen was used as a substrate for elastase, 
a strong enhancement of fibrinogen degradation by heparin was
— ftobserved (Fig. 10). Incubation in 5 to 5x10 USP U heparin/ml 
nearly doubled the amount of trichloroacetic acid-soluble split 
products of fibrinogen. Sti^l higher heparin concentrations 
abolished this effect. Incubation in 5 mmol/'l EGTA, a strong 
Ca++ chelator, yielded the same degree of fibrinogen splitting 
as low heparin concentrations. The behaviour of the elastase/a^ 
proteinase inhibitor mixtures again is in accordance with free 
elastase.
Rel. FI.U. 
150
EGTA 1
300
200
0ip 510 510 5-10 5 500
USP U Heparin /ml
Fig. 10: Degradation of FITC-fibrinogen by elastase in the 
the presence of 500 to 5x10"6 USP U heparin/ml or 
5 mmol/1 EGTA in the test volume. 1 yg elastase/mg 
FITC-fibrinogen was incubated for 60 min at 37°C. 
High molecular weight fragments were precipitated 
by trichlorocetic acid and the acid-soluble fibrino- 
peptides were measured by its fluorescence relative 
to a standard by an Eppendorf-Fluorimeter expressed 
in relative fluorescence units (Rel.FI.U.)
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The results show, that beside the direct fibrinogen degra­
dation by granulocytic elastase and its enhancement by heparin 
fibrinolysis may also be induced indirectly by c«2 plasmin in­
hibitor inactivation, which results in an increase in plasmin- 
mediated fibrinolysis. By our experiments in plasma the degra­
dation óf <*2 plasmin inhibitor in systemic fibrinolytic events 
seems unlikely as more than 450 pg elastase/ml plasma were re­
quired to inactivate the plasmin inhibitor. Fibrinogen degra­
dation by elastase, however, which already occurred at lower 
elastase concentrations and probably also by «2 macroglobulin- 
bound elastase may contribute to the bleeding tendencies ob­
served in patients with septicemia and leukemia (Egbring et 
al., 1977; Deswald et al., 1982).
Nevertheless, following elastase.release at inflammatory 
sites or during clot formation, fibrinolysis may be also in­
directly mediated by plasmin inhibitor inactivation. Within 
such a microenvironment, heparin - released from basophils or 
mast cells (Camussi et al., 1978) - may further enhance the 
elastase induced fibrinogen degradation in concentrations, up 
to now considered as to low for anticoagulation.
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DISCUSSION
JOCHUM:
Have you ever used pathological plasma in your experiments? 
Probably in this case a part of -proteinase inhibitor 
might be oxidized and the elastase could be able to de­
grade much earlier the c^-antiplasmin present in plasma.
GRAMSE:
That is true, but even the oxidized -proteinase inhibitor 
is very efficient with elastase.
JOCHUM:
Oh, no. That is not the case. Oxidized c^-proteinase in­
hibitor is not at all effective with leukocytic elastase. 
There are some data published by Dr. Travis from Athens, 
Georgia, and he has shown that the oxidized inhibitor re­
acts with the elastase by a factor of about 2000 times 
less than the non-oxidized protein.
GRAMSE:
I think that the factor was 10 000. But it depends on the 
substrate you use and Dr. Travis used elastin, which has 
much higher affinity for elastase than a^-plasmin inhibi­
tor. And the other important thing is that the affinity of 
the substrate for elastase is different.
JOCHUM:
That is true, but the results I have mentioned were ob­
tained with synthetic substrates, not with elastine.
GRAMSE:
For synthetic substrates it is true, but c^^plasmin in­
hibitor is not very highly susceptible, and it has not 
such high affinity for instance for synthetic substrates, 
as for example elastase to elastin or fibrinogen or some 
complement factors.
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ELŐDI:
Have you any evidence for the diphasic property of the 
binding plasrain inhibitor to elastase, since your Fig. 1 
reminds me very much of a simple inactivation curve of an 
enzyme? This phenomenon follows usually apparently first 
order kinetics. Have you ever tried to plot semilogarith- 
mically the time dependent data as a function of time?
GRAMSE:
It depends on the test system and our system measured not 
first order but second order reaction.
ELŐDI:
Have you tried a semi-logarithmic plot?
GRAMSE:
No, we didn't try to do so, bi^ t the authors who described 
this inactivation did so, and they made experiments also 
with ethylene amino caproic agid to show the difference 
between binding and inactivation. They could show the dif­
ference between the binding capacity of other two plasmin 
inhibitors.
ELŐDI:
Concerning the inhibitory effect of a2_macr0<jl0bulin one 
would expect an opposite situation i.e. the inhibitory 
effect to be less pronounced with low molecular weight 
substrate and stronger with a protein. Besides, is there 
any explanation for the fact that even at high inhibitor 
concentration the enzyme is only partially inhibited?
GRAMSE:
I have no correct idea, but I believe it must be dependent 
on the competition between a2-macroglobulin and fibrinogen 
as two protein substrates, and perhaps therefore the inac­
tivation occurs at a higher molar excess of other two 
macroglobulins than with low molecular weight substrates.
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BENZAMIDINE DERIVATIVES AS INHIBITORS OF SERINE PROTEINASES SPECIFIC INHIBITION OF TRYPSIN AND 
THROMBIN
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INTRODUCTION
Trypsin and trypsin-like serine proteinases cleave C-terminal 
bindings of basic amino acids, particularly those of arginine. 
Consequently, the first synthetic inhibitor of these enzymes, 
tosylagmatine (Lorand and Rule 1961), has been developed from 
the substrate tosylargininemethyl ester. Further basic struc­
tures of inhibitors are aromatic amines, guanidines and ami- 
dines (Table 1). Our group is engaged mainly in the develop­
ment of competitive reversible inhibitors of the benzamidine 
type. However, in most cases benzamidine derivatives and like­
wise inhibitors of other type are no specific inhibitors of
Table 1. Inhibition of thrombin and trypsin by basic compounds
K j , pmol / I
Thrombin Trypsin References
h 2 N - C H 2- Q 12300 300 M a r k w a r d t  e t  a l .  19 6 8
/ = \  
c - n h {  /)
H2N
9000 M a r k w a r d t  a n d  
W a l s m a n n  1 9 6 8
H N v  v = \
h 2n 7 2 2 0 35
M a r k w a r d t  e t  a l .  1 9 6 8
H N ' c - 0H 2n ' '-i
550 485 G e r a t z  e t  a l .  1 9 7 9
HN-.
n / t D 85 15 M a r k w a r d t  e t  a l .  1968
FIN.
h2n/C~OQ 7.7 29 G e r a t z  e t  a l .  19 7 9
H
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one of these enzymes due to the similarity of the active 
centres of the trypsin-like serine proteinases. They were 
found to possess inhibitory activity towards thrombin, factor 
Xa and other coagulation factors, kallikreins, Cl-esterase, 
plasmin, urokinase, acrosin and other enzymes of this type 
besides trypsin.
Particular attention was directed to the development of spe­
cific inhibitors of thrombin. Thrombin is one of the key 
enzymes of blood coagulation. It initiates the conversion of 
fibrinogen into fibrin, it activates coagulation factors 
(V, VIII) and the fibrin-stabilising factor XIII and it trig­
gers aggregation of blood platelets. Therefore, the inhibi­
tion of the enzyme thrombin represents an effective interfer­
ence in blood coagulation. Synthetic, low molecular weight 
inhibitors of thrombin have stimulated growing interest since 
such substances could find potential use as orally active 
anticoagulants with a rapid action (Markwardt 1980). In order 
to avoid interactions of thrombin.inhibitors with other serine 
proteinases of the blood in their in vivo use, particular 
attention was directed to the development of inhibitors with 
specific antithrombin activity. Comparison of the antitrypsin 
and antithrombin activity of various benzamidine derivatives 
demonstrates that synthetic inhibitors are capable of inhib­
iting relatively selectively one of the related enzymes.
DETERMINATION OF INHIBITORY ACTIVITY
All derivatives presented are competitive inhibitors. The in­
hibitory activity was determined from the influence of the 
compounds on the thrombin- or trypsin-catalysed hydrolysis of 
Ndt-benzoyl-D,L-arginine-p-nitroanilide at pH 8.0 and 25 °C 
(for details see Markwardt et al. 1973). When the K- values 
for inhibition of thrombin decreased below 2 .umol/I the com­
pounds were tight binding inhibitors and the more sensitive 
substrate H-D-Phe-Pip-Arg-pNA had to be used (Stürzebecher 
et al. 1983). In the case of trypsin, K ± values up to 0.2 
,umol/l can be determined with Na-benzoyl-D,L-arginine-p- 
riit roanilide as substrate. Data on the synthesis of the deriv­
atives and their inhibitor constants have been reported in 
previous papers (Stürzebecher et al. 1976, 1981a, b, 1982,
Walsmann et al. 1981).
BENZAMIDINE DERIVATIVES WITH NON-SPECIFIC INHIBITORY ACTIVITY
Studies of the inhibitory effect of benzamidine derivatives 
were started with the 3- and 4-substituted compounds listed 
in Fig. 1/Structure I (Markwardt et al. 1968, Walsmann et al. 
1975).
The inhibitory effect of some compounds is shown in Table 2.
In most cases, the affinity of these compounds was higher for 
trypsin than for thrombin, the l<i values differed by about 
factor 10, Substituents with electron-donating and hydrophobic 
properties caused an increase in the inhibitory effect of 
benzamidine. This could be demonstrated also by Hansch analy­
sis (Stürzebecher and Walsmann 1978, Labes and Hagen 1979),
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Structure I
Rm ,p Alkyl, Alkoxy, Aralkoxy, Halogen, NH 2
Structure II
(CH2 )n-CO-X
X = COOH, C00C 2 H5 , Alkyl, Aryl; n = 1, 2
Fig. l. Structure of benzamidine derivatives
From the structure-activity relationships the following bind­
ing sites can be postulated. First, the so-called specificity 
pocket to which the protonated side chain of arginine of the 
substrates is attracted is occupied by the benzamidine ring. 
Substituents with electron-donating properties influence the 
amidinophenyl moiety so that the affinity for the specificity 
pocket increases. Then, hydrophobic interactions with secon­
dary binding sites occur.
Comparatively potent inhibitors were found among the 4-amidino- 
phenyl compounds with ß-carbonyl function in the side chain
Table 2. Inhibition of thrombin and trypsin by benzamidine 
derivatives
HN^
H2N' pmol  / 1
R Thrombin Trypsin
n o 2 >1000 330
CO O H >1000 200
O C H 3 720 70
Cl 380 40
H 220 35
n h 2 80 12
O C g H ^7 (n) 24 6.0
c h 2 o a Q 58 9.0
c h 2 ° < 3 6 .6 2 6
4  /)
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(Fig. l/Structure II). The antithrombin and antitrypsin activ­
ities of some representative compounds are listed in Table 3. 
In comparison with the isosteric compounds it is shown that 
the cärbonyl function enhances the affinity of the inhibitors 
for the enzymes. In this group, no specific thrombin inhibi­
tors were found. However, the ratio of the l<^  values for in­
hibition of thrombin and trypsin is less than ten.
By quantitative structure-activity relationships detailed 
information was obtained about the mode of interaction be­
tween the carbonyl function and the enzyme. In order to des­
cribe the inhibitory effect, an electronic parameter of the 
inductive influence of the substituent X (Fig. l/Structure II) 
localised at the carbonyl function was necessary besides 
parameters of the electronic and hydrophobic properties of 
the whole side chain. Both terms describe the binding of the 
benzamidine ring in the specificity pocket and hydrophobic 
interactions as in compounds of Structure I (Stürzebecher et 
al. 1976). This additional electronic parameter represents 
the interaction of the carbonyl function with the enzyme.
That means, electron-accepting substituents that enhance the 
positive charge of the carbonyl function increase the inhib­
itory strength of the compound. Thus, the carbonyl function 
is believed to interact with a nucleophilic group of the 
enzyme, possibly with the active site serine alkoxide, by 
formation of a tetrahedral arrangement.
Table 3. Inhibition of thrombin and trypsin by benzamidine 
derivatives with a keto group
H N ^  / “ X 
h 2 n /C ^ R
R
Kj ■
Thrombin
pmol / 1
Trypsin
c h 2 -c h 2 -c h 3 320 38
c h 2 -c o -c h 3 6 8 40
c h 2 -c h 2-c o o h > 1 0 0 0 500
c h 2 -c o - c o o h 6.5 1.6
c h 2 " 0 58 9.0
C H 2 - C O h ^ ) 7.5 12
c h 2 -c o -c h 2 o c o -^~ 1.4 1 .2
Table 4. Inhibition of thrombin and trypsin by amides of
4-amidinophenylacetic acid
pmol  / 1
R Thrombin Trypsin
n h -c h 3 340 18
n h -c 3 h 7 89 16
NH-C 4 H 9 100
10
- a 28 43
0 44 25
20 62
BENZAMIDINE DERIVATIVES WITH SPECIFIC INHIBITORY ACTIVITY
A number of compounds with certain thrombin specificity were 
found with secondary amides of 4-amidinophenylacetic acid 
(Walsmann et al. 1981) (Table 4). The primary and secondary 
amides possess the same antitrypsin activity, the secondary 
amides, however, are more potent inhibitors of thrombin.
Since primary and secondary amide groups exert different in­
ductive effects (Hansch et al. 1973, 1977), the carbonyl 
function seems to play a role, particularly in the binding 
of these inhibitors to thrombin.
This finding prompted us to examine further amides of amidino- 
phenylalkylcarboxylic acids, particularly those whose side 
chain is branched via a sulfonamide group. The basic structure 
of the first type of inhibitors designed - the N<4~arylsulf on- 
ylated co-amidinophenyl-a-aminoalkylcarboxylic acids - is 
shown in Fig. 2/Structure I. Variation of the position of the 
amidino group and chain length (x) and modification of the 
Not- and the carboxyl substituent led to interesting structure- 
activity relationships which will be illustrated by some 
examples (Stürzebecher et al. 1981a, b, 1982).
An essential prerequisite for the specific inhibition of 
thrombin is a secondary amide structure, as shown in Table 5 
for several amides of Na-tosyl-(4-amidinophenyl)-alanine.
Only the cyclic amides possess high affinity for thrombin 
This is also true for cyclic amides of various chain length 
(Table 6 ). The number of methylene groups is of great impor­
tance for the inhibitory activity. Only derivatives of
4-amidinophenylalanine (x = 1) and 2-amino-5-(4-amidinophenyl) 
valeric acid (x = 3) are able to inhibit thrombin effectively.
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HV . NH2
Structure I
Structure I
Fig. 2. Basic structure of Na-arylsulfonylated (Structure I) 
and Na-arylsulfonylaminoacylated (Structure II) 
co:-amidinophenyl-a-aminoalkylcarboxylic acid amides. 
The formulae show the piperidides with tosyl as aryl- 
sulfonyl residue.
Table 5. Inhibition of thrombin and trypsin by amides of 
No-tosy1-4-amidinophenylalanine [A = C^NHjNHg]
a-^~^-ch2-ch-co-r, 
h _ s o 2NH-
Kj , umol /1
R 1
Thrombin Trypsin
n h - c 2 h 5 1 2 0 160
N H -C 4 H9 23 150
NH — C6 H1 3 60 48
NH “(^ ) 340 130
NH-O 1 0 0 31
e 5.9 58
0 2.3 64
/—v 
N O 5.4 80
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Table 6 . Inhibition of thrombin and trypsin by piperidides of 
Na.r-tosyl-( 4-amidinophenyl )-a--arninocarboxylic acids
A - 0 - ( C H 2) - C H - C O - ^
N H - S 0 2 - ( ^ C H 3
K j , pmol / I
X Thrombin Trypsin
0 61 550
1 2.3 64
2 80 37
3 0.36 7.0
Table 7. Inhibition of thrombin and trypsin by anilides of 
Na-tosyl-(4-amidinophenyl)-a-aminocarboxylic acids
A (C H 2 ),r C H -C O -N H
N H - S 0 2 c h 3
K j , jjmol / I
n Thrombin Trypsin
1 100 31
2 4 0  0.34
3 16 4.1
In contrast, the affinity for trypsin is enhanced with in­
creasing chain length. The corresponding primary amides show 
another specificity of inhibition. As shown in Table 7 for 
the anilides, the antithrombin activity is enhanced with in­
creasing chain length, however, it does not reach the inhibi­
tor strength of the cyclic amides. All compounds of this type 
inhibit trypsin more potently than thrombin. Primary amides 
of 2-amino-4-(4-amidinophenyl)-butyric acid (x = 2 ) exhibit
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Table 8 . Inhibition of thrombin and trypsin by amides of
Na-tosyl-(3-amidinophenyl)-alanine
CH2 — CH — C O — Rt 
A
NH —  S O 2—
Kj , pmol / 1
Rj_____________ Thrombin___________ Trypsin
a ~ C ^ ch2 - C H  — C'1
°-{J>
NH — S 0 2 — R 2
K j . p m o l  /1
r 2 Thrombin Trypsin
T o s 2.3 64
oc N as 2.8 11 0
B N a s 0.42 23
T o s  -  G ly 0.048 1.7
06 N a s  -  G ly 0.014 1.6
ß N as -  Gly 0.006 0.69
T o s  -  ßAla 0.17 13
T o s  - e A c p 13 49
Tos = tolylsulfonyl, aNas = a-naphthylsulfonyl, 
ßNas = ß-naphthylsulfonyl, EAcp = B-aminocaproyl
the most pronounced inhibitory effects specifically directed 
against trypsin.
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Table 9. Inhibition of thrombin and trypsin by piperidides of 
Na-substituted 4-amidinophenylalanine
All inhibitors presented are 4-amidinophenyl derivatives. As 
shown in Table 8 , also the isomeric 3-amidinophenyl compounds 
are potent thrombin inhibitors. The variation of the position 
of the amidino moiety, however, leads to one order of magnitude 
lower K. values for thrombin and trypsin. The affinity of the 
butyl amide is increased by more than one order of magnitude. 
Thus, primary and secondary amides of 3-amidinophenylalanine 
possess similar inhibitory potency.
The most striking increase in affinity of 4-amidinophenyl- 
alanine derivatives for thrombin was attained after variation 
of the Na-substituent (Table 9 ) .  Since the aromatic nucleus in 
P2 contributes only slightly to the binding of the inhibitors 
to the enzymes - replacement of the tosyl residue for a naph- 
thylsulfonyl residue had no effect - no further variation of 
the aromatic ring structure was carried out. Instead of this, 
an to-aminoalkylcarboxylic acid was interpositioned between 
the a-nitrogen of 4-amidinophenylalanine and the arylsulfonyl 
residue (Stürzebecher et al. 1 9 8 3 ) .  The secondary amides of 
these pseudo-peptides, especially the pyrrolidide and piperi- 
dide, with glycine as spacer are highly potent inhibitors of 
thrombin. The K . of the most potent compounds reach the nano­
molar range. Although these compounds exert more pronounced 
effects on trypsin than the corresponding Na-arylsulfonyl 
derivatives, the K. values for thrombin inhibition decrease 
more largely than those for inhibition of trypsin. In the 
case of the primary amides introduction of an aminoalkylcarb­
oxylic acid spacer has no influence on the inhibitory effect 
of the Na— arylsulfonylated compounds both of thrombin and 
t rypsin.
In contrast to glycine, ß-alanine and e-aminocaproic acid as 
spacer did not enhance significantly the inhibitory effect of 
the Na-arylsulfonylated 4-amidinophenylalanine amides.
DISCUSSION
The question arises which structural elements of the amidino- 
phenylamino acid derivatives account for the specific inhib­
itory activity and which interactions occur. As mentioned 
before, the extent and specificity of inhibition caused by 
these derivatives depend on the type of the amide component, 
the Na-substituent and the chain length. Obviously, the carbon 
amide structure plays an important role in the enzyme-inhibi­
tor interaction besides the benzamidine moiety. The carbon 
amide moiety of the inhibitor molecule might contribute to 
the interaction with the enzyme either by the hydrophobic part 
of the amine component or by the carbonyl group. Differences 
in hydrophobic interactions do not account for the specific 
affinity for both thrombin and trypsin, since the hydropho­
bic parameters of the various amines lie in the same order of 
magnitude. The electronic parameters of the amine groups, 
however, differ greatly. Secondary cyclic amine groups pos­
sess electron-accepting properties.primary amines are elec­
tron-donators (Hansch et al. 1973, 1977). That means, the 
carbonyl group of the two amide types is differently polar­
ized. In the cyclic amides the electron density of the car­
bonyl carbon is reduced. In the primary amides, however, the 
electron density of the carbonyl oxygen is enhanced. Thus,
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different interactions with the enzyme may occur. In the case 
of binding of secondary amides to thrombin an interaction 
between a nucleophilic enzyme moiety and the carbonyl carbon 
is believed. The nucleophile could be the Ser-195 alkoxide. In 
this case, a tetrahedral arrangement may occur without cova­
lent binding. Similar enzyme-inhibitor interactions have been 
postulated for benzamidines with keto structure (Stürzebecher 
et al. 1976).
Since the electron density is enhanced in the carbonyl oxygen, 
the primary amides are believed tp form preferentially hydro­
gen bonds. Such bridges could be formed with the amide nitro­
gens of Gly-193 and Ser-195 which form the so-called oxyanion 
hole. Interactions of this type have been demonstrated in the 
inhibition of trypsin by aprotinin (Bode 1979).
In the association reaction of inhibitors of the benzamidine 
type with thrombin or trypsin first the amidinophenyi moiety 
occupies the specificity pocket and next, secondary binding 
sites are involved. Topographical differences in the structure 
of the active sites of either enzyme might be the cause that 
the inhibitors with a carbonamide group are bound to thrombin 
preferentially via a nucleophilic mechanism, while they are 
bound to trypsin via an electrophilic mechanism. Optimum bind­
ing occurs when the carbonyl function is in a favourable posi­
tion. Thus, only secondary amides of co-amidinophenyi- a- 
aminoalkylcarboxylic acids with a certain length of the alkyl 
chain possess high and specific affinity for thrombin. In 
contrast, potent and specific inhibitors of trypsin were found 
among primary amides of 4-amidincphenyl- a-arninobutyric acid. 
In the case of Na.-a rylsulf onylglycyl derivatives of 4-amidino- 
phenylalanine, optimum binding of the Na-substituent seems to 
occur which is not achieved with the Na-arylsulfonyl deriva­
tives. There are many hints that hydrophobic side chains of 
amino acids bound to the a-nitrogen of arginine play an essen 
tial role in the binding of peptide substrates and inhibitors 
to thrombin (Blombäck et al. 1969, Bajusz et al. 1978). Never­
theless, it does not appear reasonable to assume that the 
considerable increase in inhibitory activity by two orders of 
magnitude caused by introduction of a glycine spacer is solely 
due to hydrophobic binding. We would rather say that the inter 
action between the inhibitor carbonamide moiety and the active 
site of the enzyme is promoted as a consequence of the ideal 
fixation of the Na-substituent on secondary binding sites. 
Summarising, Fig. 3 shows the enzyme binding sites occupied 
by a tight binding inhibitor.
The structure-activity relationships show some differences in 
the binding sites of thrombin and trypsin. Similar differences 
were observed also with other serine proteinases. Future devel 
opment of even more active inhibitors could lead to still more 
detailed knowledge of the topography of the active site of 
serine proteinases and could lead to the development of highly 
specific inhibitors.
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Fig. 3. Binding of Na-tosyl-glycyl-(4-arnidinophenyl)-alanine 
piperidide to the active centre
A = specificity pocket, B = catalytic mechanism, 
C*, C ' = secondary binding sites
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DISCUSSION
CJOCHUM:
You h a v e  shown a  t r e m e n d o u s  num ber  o f  go o d  t h r o m b i n  i n ­
h i b i t o r s .  Have y o u  e v e r  u s e d  o n e  i n  a n i m a l  m o d e ls  o r  
c l i n i c a l l y ?
STÜRZEBECHER:
S y n t h e t i c  low  m o l e c u l a r  w e i g h t  i n h i b i t o r s  o f  t h r o m b i n  a r e  
p o t e n t i a l  d r u g s  f o r  c o n t r o l l i n g  b l o o d  c o a g u l a t i o n .  I n  o u r  
l a b o r a t o r y  a l l  p o t e n t  i n h i b i t o r - c a n d i d a t e s  f o r  t h r o m b i n  
h a v e  b e e n  e x a m in e d  f o r  t h e i r  e f f e c t  on c o a g u l a t i o n  b o t h  i n  
v i t r o  and  i n  v i v o .  T hey  a r e  a b l e  t o  p r e v e n t  th r o m b u s  f o r ­
m a t i o n  i n  a n i m a l s .  Some com pounds  h a v e  a l r e a d y  b e e n  i n t r o ­
d u c e d  i n  p r e c l i n i c a l  s t u d i e s .
KORÁNT:
Have y o u  s e e n  a n y  c h a n g e s  i n  t h e  X - r a y  s t r u c t u r e  o f  t r y p s i n  
b o u n d  t o  b 'e n z a m id in e ?  S i n c e  t h e  com pounds b i n d  so  t i g h t l y ,  
t h e r e  m u s t  be  s e v e r a l  p o i n t s  o f  a t t a c h m e n t  b e tw e e n  t h e  
enzym e and  t h e  i n h i b i t o r .
STÜRZEBECHER:
Up t o  now, X - r a y  d a t a  h a v e  b e e n  o b t a i n e d  o n l y  f o r  t h e  
t r y p s i n - b e n z a m i d i n e - c o m p l e x  and  n o t  f o r  c o m p le x e s  fo rm e d  
b e tw e e n  t r y p s i n  a n d  o u r  new com pounds  o f  h i g h e r  a f f i n i t y .
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INTERACTION OF TRYPSIN-LIKE ENZYMES WITH 
SMALL INHIBITORS
BAJUSZ, S.
Institute for Drug Research 
Budapest, Hungary
PEPTIDE INHIBITORS OF TRYPSIN-LIKE ENZYMES
The structure of peptide inhibitors and substrates of 
highly specific trypsin-like enzymes can be derived from the 
sequence at the cleavage site of physiological protein sub­
strates. As the first example, peptide esters with anticoagu­
lant activity were derived from the thrombin sensitive region 
of fibrinogen by Blombäck et al. /1969//Table 1/. Each pep­
tide of this series contained Arg at the C-terminus and, the 
active members, like H-Phe-Val-Arg-OMe, Val as the penultimate 
residue which is identical with that residing at position P 0 
of the fibrinogen Ajk-chain. The N-terminal Phe was taken from 
position Pg of the native substrate.
The peptide esters thus obtained are actually thrombin 
substrates rather than inhibitors. However, as such they can 
compete with the native substrate for the enzyme, thereby 
delaying coagulation in the thrombin-fibrinogen system. To 
double the clotting time of fibrinogen the ester substrates 
have to be present in about a 40-fold molecular excess over 
the native substrate. In addition, the inhibitory action of 
peptide esters disappeares progressively in some 1 0  min as 
the hydrolysis of the ester bond proceeds since the free pep­
tides, which cannot combine with thrombin, are not inhibitory.
Abbreviations: -pNA: p-nitroanilide; - B o c : t-butyloxycarbonyl- 
-Bz-Arg-OEt: benzoyl-arginine-ethylester;
-Agm: agmatine
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Table 1.
Sequence at substrate cleavage site of trypsin-like enzymes 
and peptide inhibitors derived therefrom
Enzyme Physiologicalsubstrates
S e q u e n c e
p3 - p2 - pr i - p i
X
I n h i b i t o r s
Th rombin Fibrinogen 
A «-chain Gly-Val-Arg--Gly H-Phe-Val-Arg-OMe
P ro th rombin Ile-Pro-Arg--Se r H-D-Phe-Pro-Arg-Hxx
Factor XIII Val-Pro-Arg--Gly Boc-D-Phe-P ro-Arg-H
Plasmin Fib rin/ogen/ Asn-Phe-Lys--Se r 
Glu-T rp-Lys--Ala 
Gly-Ty r-Arg--Ala
Boc-Gln-Phe-Lys-H
Kallikrein Kininogen P ro-Phe-Arg--? H-D-Pro-Phe-Arg-Hxxx
H-D-Glp-Phe-Arg-H
x H-Phe-Val-Arg-OMe was prepared by Blombäck et al. /1969/, the others. Bajusz et al.
/ 1 9 7 5 , 1978, 1982/
y y y y U XXX XX
1 Chloromethyl ketone derivatives were prepared by Kettner and Shaw /1978 , 1979 /
To overcome these shortcomings, the terminal ester function 
has to be replaced by a non-hydrolyzable group, like the 
aldehyde, chloromethyl ketone or, perhaps, by a secondary amide 
group. Of these, the aldehyde function was chosen in our 
studies /Bajusz et al. , 1975/. The first representatives of 
peptide aldehyde inhibitors of serine proteases, mainly tri- 
and tetrapeptides, such as leupeptin and antipain, were nat­
ural products, isolated from culture filtrates of Streptomyces 
species by Umezawa and his colleagues /cf. Um e z a w a , 1972/.
Accordingly, in our work, the findings of Blombäck and 
Umezawa were combined. The C-terminal and the middle residues 
were taken from the physiological substrates, those found at 
positions and P^, respectively, while the N-terminal moieties 
were selected experimentally.
In the case of thrombin inhibitors Pro at middle position, 
corresponding to the sequence of native substrates prothrombin 
and factor XIII, proved to be more favourable than Val residing 
at P^ of the fibrinogen Aot-chain. Both Boc- and H-D-Phe-Pro- 
Arg-H showed high anticoagulant activity with an 1,-q valuex 
of 1.4 x 10 - 7  M.
In contrast to thrombin, which can only split two Arg-Gly 
bonds of fibrinogen, plasmin has much less specificity since it 
cleaves - at different rates - about 20 of the 362 Arg-X 
and Lys-X bonds of fibrin. Differences in the susceptibility 
of peptide bonds to plasmin may mainly be due to differences 
in accessibility, but some correlation can be observed be­
tween the hydrolysis rate of peptide bonds P-^-P£ anc' su^-
sites Pg and P-^ . Lys at P^ seems to be more susceptible than 
Arg since most of the bonds cleaved during 10-min digestion 
are Lys-X, and most of the fragments attacked by plasmin 
first contain an aromatic residue at P^. Three of such sequence 
portions are shown in Table 1. From these structural elements, 
Boc-Gln-Phe-Lys-H was developed as a rather good inhibitor of 
the plasmin-fibrin reaction with an 1 ,-q value of 1 . 1  x 1 0  M
^Molecular concentration required for doubling the reaction 
time.
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/Bajusz et a l , , 1981/. H-D-Pro-Phe~Arg-H also showed the 
expected inhibitory action on plasma kallikrein both in vitro 
and in. vivo. Namely, the esterolytic activity of the enzyme, 
measured with Bz-Arg-OEt, could completely be inhibited at a 
peptide concentration of about 1 x 10 M, and a dose of 5 mg/kg 
could completely block the paw-oedema-producing effect of 
kallikrein in the rat /Toinay, P., Banáky, I., unpublished 
results/.
Except Boc-D-Phe-Pro-Arg-H, the tripeptide aldehydes 
proved to be specific inhibitors. For instance, H-D-Phe-Pro- 
Arg-H, the highly potent inhibitor of the thrombin-fibrinogen 
reaction, has practically no effect on the plasmin degradation 
of fibrin gel and on the hydrolytic actions of kallikrein. Its 
Boc derivative, the other powerful thrombin inhibitor, neither 
has any effect on kallikrein but, additionally, it can inhibit 
fibrinolysis by plasmin as well as plasminogen activation by 
urokinase and the proteolytic action of trypsin. Thus one may 
take Boc-D-Phe-Pro-Arg-H as a "general inhibitor" of a group 
of trypsin-like enzymes - at least in systems involving pro­
tein substrates /Bajusz et al., 1978/,
The chloromethyl ketone analogue of the two tripeptide 
aldehydes, H-D-Pro-Phe-Arg-H and H-D-Phe.-Pro-Arg-H, have been 
prepared by Kettner and Shaw /1978; 1979/ and found to be 
highly active and specific irreversible inhibitors of kallik­
rein and thrombin, respectively.
BINDING OF INHIBITORS TO TRYPSIN-LIKE ENZYMES
Peptide aldehydes and peptidyl chloromethyl ketones
The findings presented above may indicate a certain 
distribution of specificity-determining sites of these enzymes 
/Fig. 1/.
Common specificity of trypsin-like enzymes is obviously 
determined by their Asp-189 residue /when using chymotrypsin 
numbering/ which can recognize and bind the basic side chain 
of Arg or Lys at position P^ of substrates and inhibitors.
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Catalytic siteSpecificity- 
determining sites
3rd 2nd 1st
0" OH
I !—■ A s p . ..Ser.His.Asp,
189 195 57 102
---------------- TRYPSIN-LIKE ENZYME —
Fig. 1. Specificity determining- and catalytic sites of 
trypsin-like enzymes. S^ and S^ denote subsites 
being responsible for binding residues P a n d  P , 
respectively, of substrates/inhibitors. Chymo­
trypsin numbering is used.
Thus, Asp-189 corresponds to the subsite residing at position 
of these type of enzymes. Subsite at which is to recog­
nize and bind the amino acid residue at P^ of substrates and 
inhibitors seems to be responsible for the individual speci­
ficity of enzymes. This specificity can be increased further 
with the assistance of subsites at positions S^, , etc.
There can be no doubt that peptide inhibitors and sub­
strates being flexible molecules bind to the enzymes accord­
ing to the "zipper" model /Burgen et al., 1975/ which term 
covers a kind of stepwise binding.
Schematic representation of the zipper model for binding 
of fibrinogen and inhibitors to thrombin is given in Fig. 2. 
The initial, "nucleation" complex can be formed by the ionic 
interaction discussed above. This is followed by a series of 
conformational rearrangements of the pertly bound substrates 
and inhibitors leading to binding of Val and Pro at P 2 of 
fibrinogen and the inhibitor, respectively, to the corre­
sponding subsite at S^, then the remaining segments at P^ 
positions combine with their appropriate subsites at posi­
tions. Finally, the CO group of the Arg residue at P^ reacts 
with the active OH group of thrombin. In the case of the
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,0
■ \OH
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= = /0~ °
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/
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1------------------------------------------------------------------------THROMBIN-1 1--------------------------------------------------------------------THROMBIN-1
/ ° H
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\
.OH
f--P-NH-CH-C--CH 2 -C1/
\
0
L
..... S 3 .S2 .A^p...S^r.His.
-THROMBIN-
«^i-^ p .. ,S<= r .His i
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Fig. 2. Interaction of thrombin with fibrinogen (a ) and in­
hibitors: H-D-Phe-Pro-Arg-H(j3) and H-D-Phe-Pro-Arg-CH„Cl(c) . 
G, P, V and f are one-letter symbols for G l y , Pro, Val and 
D - P h e , resp., r+ stands for the side chain of Arg.
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chloromethyl ketone, a second covalent bond can also be formed 
by which this inhibitor will be irreversibly fixed in the 
active center of thrombin.
The high anticlotting activity of these tripeptide inhib­
itors may indicate that the enzyme-inhibitor complex is formed 
readily even in the presence of the native substrate fibri­
nogen. It seems likely that the thrombin subsite at S„ shows 
higher affinity to Pro than Val at P 2 of fibrinogen. In addi­
tion, the N-terminal D - P h e , having an "unnaturally" oriented 
side chain, may bind to a subsite at an which is not in­
volved in complexing fibrinogen.
According to this model, if no favourable interactions 
between subsites at P and S positions, in particular between 
those at P^ and S^, can be formed, the "nucleation" complex, 
being stabilized by a single salt bridge only, will dissociate, 
and so no hydrolysis or inhibitior can occur.
Peptide inhibitors lacking terminal reactive groups
The primary importance of side chains in binding of pep­
tide inhibitors to thrombin could be demonstrated by the fact 
that H-D-Phe-Pro-Arg-H and H-D-Phe-Pro-Arg-CH^Cl were by 3-4 
orders of magnitude more inhibitory than H-Gly-Val-Arg-H and 
H-Gly-Val-Arg-CH^Cl, respectively. In this context we may 
also examine the significance of trie C-terminal reactive 
group when it is linked to a suitably assembled peptidyl 
portion. For this purpose we prepared /Bajusz et al., 1983/ 
H-D-Phe-Pro-Agm, an analogue of the two highly potent inhib­
itors, lacking only the -CHO and -COCH^Cl functions, respec­
tively, /Fig. 3/ and compared its anticlotting activity with 
that of the corresponding tripeptide aldehyde /Table 2/.
The high potency of H-D-Phe-Pro-Agm, about 1/4 of that 
showed by H-D-Phe-Pro-Arg-H, supports the view that peptide 
portions /and thereby the so-called secondary forces, i.e. 
ionic and hydrophobic bonds/ can be determinant in the forma­
tion of enzyme-inhibitor complexes. The aldehyde group, or 
rather the covalent bond formed by this group, could increase
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-NH-CH-C -NH-CH-C -NH-CH-H1 n h CH HI 2 V  SCH2C1 1 2 CH_ 1 ZCHq 1 2 CH0 1 2 CH_ i ZCHqi 2 CH0i 2 CH„ 1 ZNHi NHi NH1
AH2N NH2 AH2N NH2 AH2N nh
-Arg-H(A) -Arg-CH 2 Cl(B) -Agm(c)
Fig, 3. Structure of H-D-Phe-Pro-Arg-H /A/, its chloromethyl 
ketone analogue /B/ and the corresponding agmatine 
peptide /C/.
the stability of the complex, which, in this particular case, 
resulted in a four-five-fold enhancement of the anticlotting 
activity. A much higher effect of the aldehyde group could be 
observed when activities of the former tripeptides /and their 
Boc derivatives/ were compared in systems comprising peptide 
substrates, e.g. Z-Phe-Val-Arg-pNA. In these experiments the 
antitrypsin activities were also examined.
Table 2
Antithrombin activity of tripeptides with fibrinogen substrate
P e p t i d e I *50 K .l
H-D-Phe-P ro-Arg-H 
H-D-Phe-P ro-Agm
1.4xl0 “ 7 M 
6 ,6xl0 - 7  M
5xl0~ 8 M 
2xl0 - 7  M
xMolecular concentration required for doubling the clotting 
time of fibrinogen.
l<i values presented in Table 3 indicated that both 
thrombin and trypsin were inhibited 20-30 times more ef­
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fectively also by the free and the Boc tripeptide aldehydes 
than the corresponding Agm peptides. Moreover, inhibitory 
action of the Agm peptides on trypsin could only be observed 
after 10-min incubation. Accordingly, the three amino acid 
side chains of these inhibitors can play a more important 
role in binding of the highly specific thrombin than in that 
of the less specific trypsin - at least in the presence of 
the tripeptide substrate Z-Phe-Val-Arg-pNA,
Table 3
Antithrombin and antitrypsin activity of tripeptides 
with Z-Phe-Val-Arq-pNA substrate
P e p t i d e
K.l
Th rombin
//jM/
T rypsin
H-D-Phe-P ro-Arg-H 0.08 0.17
H-D-Phe-P ro-Agm 2 . 0 0 6 .0 0 *
Boc-D-Phe-P ro-Arg-H 0 . 2 0 0.08
Boc-D-Phe-P ro-Agm 4.60
Xooc\j
^Determined after 10-min incubation.
Since heparin has long been known to enhance the interac­
tion of thrombin with its physiological protein inhibitor 
antithrombin-III, and, according to a recent note /Griffith 
et a l , , 1979/, it can also increase the binding affinity of 
peptidyl arginine chloromethyl ketones, the question may 
arise whether thrombin inhibition by our tripeptides, in par­
ticular by the Agm peptides, can be catalyzed by heparin 
/Bajusz et al., 1982; 1983/.
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values for the four tripeptides /Table 4/ were deter­
mined at heparin/thrombin molecular ratios* of 0 . 1  and 1 or 
2, respectively, with fibrinogen and Z-Phe-Val-Arg-pNA, re­
spectively, as substrates.
No substantial effect of heparin could be observed. Acti­
vities of the two aldehydes were not influenced at all. Using 
the synthetic substrate, a slight effect could only be found 
at a heparin/thrombin ratio of 2 : 1  when heparin can be inhib­
itory in its own right, too. As the best result K^'s for the 
two Agm peptides in the thrombin-fibrinogen system were 
lowered by a factor of about 3 at a 1:1 molecular ratio of 
heparin to thrombin. In this case the existance of a thrombin- 
heparin-peptide inhibitor ternary complex cannot be excluded 
either. In any case, the antithrombin activity of the free 
Agm peptide is more similar to that of the free tripeptide 
aldehyde, and so H-D-Phe-Pro-Agm could show significant anti­
clotting activity in v i v o , too /Bajusz et al., 1982/.
Inhibitors with rigid conformation
According to some data, certain enzyme inhibitors having 
molecules with limited degrees of conformational freedom 
could be more effective than their flexible congeners. For 
instance, ornithine decarboxylase could be inhibited by
x
Calculation of the molecular activity of heparin was based 
on the findings of Rosenberg et al. /1978; 1979/ and Oordan 
et al. /1979/. Fractionation of commercial heparin resulted 
in polysaccharide chains with different activities and molec­
ular weights. Some of the highly potent fractions with molec­
ular weights of 6-7000 daltons had specific activities of 
350-363 USP U/mg. Another species with approximate molecular- 
weight of 2 0  0 0 0  daltons contained two binding sites for 
antithrombin-III and showed an activity of 738 USP U/mg.
Based on the big difference between the binding constants ob­
tained for the highly active and relatively inactive heparin, 
/i.e. Ixl0~7 M and lxlO - 4  M, respectively/ the effect of the 
less potent /4-12 USP U/mg/ and inactive components of com­
mercial heparin was neglected. Thus an average molecular 
weight of 8000 daltons and a specific activity of 362 USP U/mg 
might be calculated. Accordingly, 2.9 USP U of heparin may 
be taken as 1 nmole.
Table 4
Thrombin inhibition by tripeptides /H/Boc-D-P he-Pro-Aqm/Arq-H/ and 
the catalytic effect of heparin thereon / determined in the
-ft.absence /A/ and presence /B/ of heparin; substrate: fibrinogen 
and Z-Phe-Val-Arg-pNA/
P e p t i d e F i b
A
r i n o 
Ba
!<i values /pM/ 
g e n  Z-Phe- 
B b A
-Val-Arg-pNA 
B b Bc
H-D-Phe-P ro-Agm 0 . 2 0 . 1 0.07 2.65 2.65 1.25
H-D-Phe-Pro-Arg-H 0.05 0.05 0.05 0.08 0.08 0.08
Boc-D-Phe-P ro-Agm 1.75 1.75 0.60 4.6 4.6 2.4
Boc-D-Phe-P ro-Arg-H 0 . 1 0 . 1 0 . 1 0 . 2 0 . 2 0 . 2
Hepa rin/thrombin molecular ratios were 0.1a , l *3 and 2°, respectively. 
2.9 USP U of heparin and 113 NIH U of thrombin were taken as 1 nmole.
1 ,4-diaminobut-2-ene more efficiently than by the saturated 
analogue, 1 ,4-diaminobutane, and the unsaturated analogue of 
substrate ornithine, i.e. 3-dehydro-ornithine, could behave 
as inhibitor /Relyea and Rando, 1975/. Presumably, when the 
latter binds to the enzyme, and loses its carboxyl group, the 
unsaturated product, 1 ,4-diaminobut-2-ene, remained bound to 
the enzyme for a longer time than its saturated analogue. The 
double bond can stabilize the transform of the carbon chain, 
thereby giving a fixed orientation to both amino groups. By 
analogy, in our case, dehydro-agmatine might be profitable at 
the terminus of H-D-Phe-Pro. In this context it may be noted 
that highly potent reactants of trypsin-like enzymes, such as 
p-nitrophenyl-p-guanidinobenzoate /Chase and Shaw, 1957/, 
esters of p-guanidinophenylacetic acid and p-amidino-benzoic 
acid /Mares-Guia et al., 1967/, and substituted benzamidines 
/cf. Mares-Guia et al., 1977/ all have molecules with more 
or less rigid conformation. Prompted by these findings, we 
have prepared some dipeptide amides in which the above-men­
tioned rigid moieties were linked to the dipeptidyl portion 
H-D-Phe-Pro. These compounds together with their inhibitory 
action on the thrombin-fibrinogen reaction are given in Table 5 
/□uhász, A., Bajusz, S., Barabás, É. and B a g d y . D . ;  unpublished 
results/.
Contrary to all expectations, replacement of the Agm res­
idue by its unssturated analogue led to a less potent com­
pound. When compared at a higher level /indicated by values 
Igo/ a 3-fold decrease of activity could be observed.
The other dipeptide amides were practically inactive in 
spite of comprising the favourable dipeptidyl portion H-D-Phe- 
Pro and the p-guanidinophenyl /or benzyl/ moiety of the highly 
potent aromatic reactants.
This failure may be interpreted as follows. The esters 
of p-guanidinobenzoic acid and p-guanidinophenyl-acetic acid 
being rigid small molecules can react according to the 
"lock-and-key" model. In this one-step binding, when the 
guanidino group forms a salt bridge with Asp-189, the ester 
function is simultaneously delivered to the catalytic site to
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form an acyl-enzyme. In our compounds the p-guanidinophenyl 
moiety is carried by a bulky dipeptidyl portion being apt to 
binding to the enzyme rather than to be split off. In addition, 
unlike to the corresponc'ing Agm peptide rearrangement of the 
side chains and thereby accomodation of the dipeptide portion 
to subsites at positions and , could not take place 
because of the rigidity of the amide moiety.
Table 5
Antithrombin activity of H-D-Phe-Pro-Agm and analogues of
type -H—D-Phe—P-ro-NH-X—NH-Ő/
Usi with fibrinoqen substrate
Sceleton of amide portions Ix I*_n h -x -n h -c (nh )+ ^ ^
50 80
/N—^\1 —C-— ■ C--N*—C + 4x10-7M 1x10“5M
-Agm VN
k 1 0 1 o II 0 1 0 1 1 o
2
5x10"7M 3x10"6M
-dehydro-Agm 'N
»1x10_3M -
“N— ^ o ) “  C— N-Cn n »1x10-3M -
—N— C— (C3)--N-C + »1x10-3M -
-N--C--C— < g > --N-C ylxlO-3M -
^Molecular concentration required for prolonging the 
clotting time of fibrinogen by factors of 2 (i^q ) 
and 5 (Io0) - resp.
As it has been discussed above, inhibition of trypsin­
like enzymes by peptide aldehydes involves - besides ionic 
and hydrophobic bonds - the formation of tetrahedral semi-
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acetals /Westerik and Wolfenden, 1972/, p-Nitrophenyl p-gua- 
nidino-benzoate and related esters form acyl-enzymes which 
intermediates have been shown to deacylate unusually slowly, 
permitting their use as inhibitors /cf. Chase and Shaw, 1969/. 
H-D-Phe-Pro-Agm /Bajusz et al., 1983/ and derivatives of 
benzamidine /cf. Mares-Guia et al., 1977/ can combine with 
trypsin-like enzymes by ionic and hydrophobic bonds merely.
Acylamino acids
A further kind of complexes can be formed by acylamino 
acids, like arylsulfonyl arginine amides /Okamoto et al.,
1975/ and the corresponding p-amidinophenylalanine /Wagner et 
al., 1981; Stürzebecher, 1982/ or p-guanidinophenylalanine 
/Claeson et al., 1983/ derivatives synthesized as thrombin 
inhibitors. A detailed analysis of strueture-activity rela­
tionships among the Arg compounds /Okamoto et al., 1980; 
Kikumoto et al., 1980a, 1980b; Okamoto and Hijikata, 1981/ 
revealed the primary importance of an arylsulfonyl group as 
an N-substituent and an imino group, preferentially a cyclic 
imino acid residue, as the carboxamide portion. As it appears 
from the structure of the most potent compound of the Oapanese 
group, No. 805 in Fig. 4, the imino acid portion, 4-methyl- 
2-piperidinecarboxylic acid, has D configuration. Four orders 
of magnitude less potency was reported for the L isomer. 
Accordingly, apart from its side chain, this highly active 
inhibitor of thrombin has nothing in common with the native 
substrates of this enzyme. Namely, the arylsulfonyl group 
residing in place of an amino acid residue at P 2 is unusual 
both in size and chemical character, i.e. while the peptide 
bond /CONH/ is practically neutral, the sulfonamide /S0 2 NH/ 
is acidic. Moreover, like other trypsin-like enzymes, thrombin 
does not cleave peptide bonds involving a D-amino acid resi­
due, and particularly not those formed by an imino acid, i.e. 
dialkyl amine, like the Arg-Pro bond.
It can be supposed that inhibitors of unusual structure 
may bind to enzymes through unusual interactions. Binding 
sites for the arylsulfonyl and carboximide portions of
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H N NH„ 2 \ + /  2
CI
NH
H2C(
/ H2
Isomer of No.805
Antithrombin activity
'50 K.x
3.2xlO_8M 1.9x10“8M
1.5x10~4M 2.8x10~4M
Fig. 4. Structure and antithrombin activity of No. 805 and 
one of its isomers /Okamoto and Hijikata, 1981/.
No. 805 and its congeners, must be other than those for the 
corresponding amino acid residues at positions P^ and P£ of 
the native substrates. It is also an open question whether 
the active OH group of thrombin can react with the dialkyl- 
amido group of the inhibitor to form a sort of tetrahedral 
adduct.
In my opinion the high antithrombin activity of No. 805 
may just be due to the formation of such an adduct stabilizing 
the enzyme-inhibitor complex. In the case of its L-imino 
acid-containing analogue, however, the attack of the active OH 
group may not take place because of a steric hindrance caused 
by the carboxyl group of the L-imino acid portion. It is, of 
course, also possible that the COOH group of No. 805 can 
stabilize the enzyme-inhibitor complex by forming a salt 
bridge with an otherwise insignificant basic side chain of
thrombin but this or similar ionic bond cannot be formed 
between the L-imino acid portion and the enzyme.
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Pertaining to the structural requirements for the acyl 
and carboxamide portions of this type of inhibitors, Table 6  
presents the anticlotting activity of dansyl-L-arginyl-pirroli- 
dine of the series of Okamoto's group /Kikumoto et a l . f 1980a/ 
and some peptides prepared in our laboratory /Fauszt et a l . , 
1983/. Comparing the potencies of compounds A/B and B/C/D, 
respectively, two conclusions may be drawn. First, as an acyl 
moiety, dansyl is much more favourable than the dipeptidyl 
portion Ac-Thr-Pro - in spite of endowing Pro at P^. This 
finding in concert with those presented in Table 5 give evi­
dence that combination of molecular portions with different 
binding patterns may not be fruitful. Secondly, if there is 
a substituent at the position of the carboxamide portion,it 
must have the D configuration - as it has been found with the 
highly potent inhibitor No. 805 /Fig. 4/.
The peptides presented in Table 6 were the Arg analogues 
of hirudine fragment Gly-Thr-Pro-Lys-Pro, which portion to­
gether with the preceeding segment Val-Thr-Gly-Glu, is the 
putative inhibitor site of this highly active and selective 
thrombin inhibitor of the leech /Magnusson et al., 1976/. As 
shown in Table 7, the D-Pro-containing one of the two Lys- 
peptides /Fauszt, I., Bajusz, S., Barabás, É., Diószegi, M. 
and Bagdy, D .; unpublished results/ possessed the higher 
activity, and both were more inhibitory than the corresponding 
Arg analogue, in spite of the fact that thrombin preferentially 
cleaves Arg-X bonds, when X is an amino acid residue other 
than P r o .
In the molecule of hirudin, the Pro-G'ln bond in the seg­
ment Pro-Lys-Pro-Gln must unusually be distorted to make an 
interaction possible between the Lys-Pro bond and the active 
Oh of thrombin. Still, in my opinion formation of the thrombin- 
hirudin complex could be started by interactions between the 
clustered acidic residues of the C-terminal fragment of 
hirudin /Glu-Glu-Ile-Pro-Glu-Glu-Tyr [SO^-]-Leu-Gin/ and some 
of the five pairs of basic residues found in thrombin /i.e. 
Lys-Lys, Arg-Lys and Lys-Arg/ rather than by saltbridge for-
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Table 6
Antithrombin activity of dansyl-L-arqinyl-pirrolidine /A/ 
and relating Arq peptides /B-D/ with fibrinogen s u b s t rate
I n h i b i t o r Ix80
-S— Arg— N 
° A
Ac-Thr-Pro— Arg— N 
B
Ac-Thr-Pro— Arg
C
1 x 1 0 “ 6 M * *
(D-Pro)
4x10~4M 2.9x10"3M
9x10_4M 4.3x10“3M
COOH
Ac-Thr-Pro— Arg— N COOl(b-Pro)
o M -
16x10_4M 17.6x10“3M
x See Table 5. xxl<ikumoto et al. , 1980a.
mation between Asp-189 and the Lys residue of hirudin*.
Table 7
Antithrombin activity of hirudin peptide Ac-Thr-Pro-Lys-Pro-NH^ 
and analogues with fibrinogen substrate
P e p t i d e  I*0> mM I*q , mM
Ac-Thr-Pro-Lys-L-Pro-NH 2  0.78 /1.6/ 3.0 /17.6/
Ac-Thr-Pro-Lys-D-Pro-NH 2 0.62 /0.9/ 1.6 /4.3/
xDefined as in Table 5; values for the corresponding Arg 
peptides are given in parentheses.
With the findings and speculations concerning hirudin 
and its fragment-analogues I only wanted to exemplify that 
sometimes a peculiar enzyme-inhibitor interaction may be 
found in nature, too.
SUMMARY
According to the above, three main functional portions 
could be distinguished in the inhibitors of trypsin-like 
enzymes. The first one is a basic residue relating to the side 
chain of Arg or Lys, that forms a salt bridge, the first bond 
between the enzyme and the inhibitor. The second portion, 
usually comprising more than one grouping, endows the inhibi­
tor with an ability to be accomodated to the given enzyme 
much better than to any other of the same type, thereby in­
creasing specificity. The third portion, a reactive group, 
stabilizes the enzyme-inhibitor complex. Apart from the basic 
residue and the reactive group mentioned first and last, we 
hardly know anything about the structural requirements for
^Unsuitability of Lys at P^ could be demonstrated by comparing 
the Iq q  values of 4xl0 " 4  M and 7xl0 - 7  M obtained for Boc-D-Phe- 
Pro-Lys-H anc! Boc-D-Phe-Pro-Arg- H , respectively.
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the others comprised by the three main functional portions.
As a corollary, construction of an inhibitor is nothing else 
but effort to find the most favourable counter-sites of cer­
tain completely unknown subsites of given enzymes in order to 
obtain a highly stable enzyme-inhibitor complex. That is the 
very reason why peptide inhibitors should be preferred. It 
has been examplified that binding pattern of peptides to 
enzymes has much in common with enzyme-substrate interactions, 
and sequences around the cleavage sites of physiological sub­
strates are frequently known. With this knowledge, the two 
amino acid residues being favourable at positions ?2 and 
can easily be selected. Since a molecular size of a tripeptide 
or an acyl tripeptide is generally satisfactory, there is 
only one amino acid and possibly an acyl group left to be 
selected experimentally.
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DISCUSSION
STEPANOV:
You certainly mean geometric isomers, i.e. cis/trans 
isomers. In the case of dehydro-agmatine the trans­
form can only be obtained.
BAOUSZ:
I know neither about the dehydro derivative nor 
about the activity of the cis isomer of D-Phe-Pro- 
A A g m .
O O C H U M :
Have you ever used your inhibitors in animal or 
clinical experiments?
BAOUSZ :
Preclinical testing of D-Phe-Pro-Arg-H has already 
been carried out. This reversible inhibitor has 
favourable properties both in vivo and in vitro, 
e.g. it does not bind irreversibly to the protein 
components of blood /red cells or other components 
of large surfaces and good binding properties/.
I think this compound will soon find its way to 
clinical application.
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SUMMARY
The effects of various proteolytic inhibitors - and leu- 
peptin in particular - were tested in different experimental 
designs, namely in vivo, during liver perfusion and in vitro. 
Injection of leupeptin to rats caused a prompt increase in 
autophagic vacuoles by 0.5-1 hour. The proteolytic capacity 
of the isolated autophagic vacuoles was assessed as a function 
of treatment time. Generation of TCA-soluble radioactivity in 
isolated autophagic vacuoles from rats prelabelled with ^4 C-L- 
leucine for 16 hours before sacrifice displayed a minimum 
/50% inhibition/ 0.5-1 hour following leupeptin injection. 
Conversely, after longer leupeptin exposure times /up to 16 
hours/ the rate of proteolysis increased over the control 
value /catch up proteolysis/ with a maximum by 4 to 6  hours.
The effect of leupeptin on degradation of long and short 
lived proteins was studied also in the liver perfusion model.
Proteins were labelled for 30 minutes or 16 hours by an in vivo 
14injection of C-L-leucine. Leupeptin was injected into rats 
15 minutes before sacrifice and was also included in the per­
fusate. Leupeptin decreased the proteolytic rate assayed as 
release of TCA-soluble label to the perfusate by 30 and 50% 
for short and long labelling periods, respectively. The per-
Abbreviations: A V s : autophagic vacuoles; T C A : trichloroacetic 
a c i d ,
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fused livers were also subfractionated. The autophagic vacu­
oles were isolated and their proteolytic activity monitored.
In this system leupeptin was found to cause 70% /short lived 
proteins/^and 80% /long lived proteins/ inhibition of break­
down. Extrapolating the inhibition of lysosomal proteolysis 
to 1 0 0 % allows one to conclude that the nonlysosomal pathway/s/ 
would account for roughly 40% /long labelled/ and 55% /short 
labelled/ of total proteolytic activity in the perfused rat 
liver.
Isolated liver lysosomes from rats prelabelled for 30 
minutes and 16 hours as above were also incubated in the ab­
sence and presence of either propylamine, leupeptin or chloro- 
quine. The highest proteolytic rate was obtained following short 
labelling times /15 minutes and 2 hours/. Accordingly, we 
conclude that lysosomes are active in the degradation of both 
long and short lived proteins. Irrespective of labelling period 
and tested agent 100% inhibition was never recorded. As far 
as can be judged from experiments with isolated lysosomes the 
lysosomal inhibitors may thus not be used under the assumption 
that they cause a complete shut down of lysosomal proteolytic 
activity.
INTRODUCTION
The lysosomes have long been regarded as the only well 
documented and well characterized intracellular locus of 
protein degradation. On the basis of electron microscopic 
evidence it has generally been assumed that organelles such 
as e.g. mitochondria are degraded within lysosomes /Glaumann 
et al., 1981/, An important role for lysosomes in organelle 
degradation also appears likely since they contain all enzymes 
required to degrade proteins, lipids and carbohydrates 
/Barrett and Heath, 1977/. Experiments performed with bacteria 
/Goldberg and St. Cohn, 1976/ and cell free reticulocyte 
extracts /Etlinger and Goldberg, 1977/ show that abnormal 
proteins have a higher rate of turnover than normal protein. 
Moreover, studies on cultured cells /Knowles and Ballard,
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1976/ suggest a nonlysosomal pathway of degradation for ab­
normal and other short lived proteins. Recently, rat liver 
mitochondria have been shown to contain a proteolytic system 
that can hydrolyse proteins to constituent amino acids 
/Desautels and Goldberg, 1982/. The presence of one or several 
extra lysosomal pathways is appealing since the lysosomal 
sequestration mechanism is believed to be indiscriminate and 
is therefore difficult to reconcile with the finding that the 
half-lives of mitochondrial and cytosolic proteins differ 
considerably.
There are at least three different ways for endogenous 
proteins to gain access to the lysosomal apparatus, namely 
by means of autophagy, microautophagy and crinophagy /Marzella 
et al., 1981/. The process by which cells sequester and sub­
sequently degrade their organelles has been designated auto­
phagy. This mechanism operates in cells under normal conditions 
/De D u v e , 1969; Glaumann et al., 1981/. However, the number of 
morphologically detectable autophagic vacuoles /AVs/ is usually 
small during basal steady state. This fact may in part be a 
result of the rapid transition of newly formed autophagic 
vacuoles into more mature lysosomes /Mortimore and Schworer, 
1977; Pfeifer et al., 1978/. Another contributing factor could 
be, as suggested by Ballard /1977/, a relatively minor impor­
tance of the lysosomal pathway in basal proteolysis as compared 
to the extralysosomal pathway.
Autophagy appears to be especially activated in states 
of induced degradation such as starvation, cell injury and 
remodelling of organs. Its level may also be manipulated by 
the administration of hormones such as insulin /Pfeifer et al., 
1978/ and glucagon /Deter and De Duve, 1967; Schworer and 
Mortimore, 1979/; microtubular inhibitors such as vinblastine 
/Marzella and Glaumann, 1980a, b/ and amino acids /Grinde and 
Seglen, 1981; Schworer and Mortimore, 1979; Kovács et al., 
1981/. Gray et al. /1981/ administered chloroquine /a weak 
base and inhibitor of cathepsin B^/ and Furuno et al. /1982a/ 
leupeptin /an inhibitor of the lysosomal thiol proteases 
cathepsin B, H and L/ to rats. Both groups found an increase 
in the number of AVs in the liver tissue. It seems likely
301
that the marked increase in AVs is due to an impeded turnover 
of these organelles secondary to a drug inhibited intralyso- 
somal degradation.
Most of the evidence supporting the hypothesis of a dual 
pathway for proteolysis comes from experiments with inhibitors 
of lysosomal enzymes, showing that degradation of long-lived 
proteins is generally more sensitive to inhibition than 
degradation of short-lived proteins. The sensitive pathway 
has tentatively been equated with the lysosomally mediated 
proteolysis. The different proteolytic inhibitors are useful 
tools when trying to identify the different intracellular ways 
of degradation, although the interpretation of the results is 
not clearcut. For example, in the majority of instances the 
inhibition of lysosomal enzymes has not been complete and 
for many inhibitors of proteolysis nonspecific effects such 
as decreased protein synthesis may well influence the results.
The aim of the present study was to compare the effects 
of certain proteolytic inhibitors in different experimental 
designs. These included 1/ administration of the inhibitor 
to rats in vivo followed by measurements of proteolysis in 
isolated lysosomes and autophagic vacuoles; 2 / comparison of 
the effects of leupeptin on protein degradation in the perfused 
liver - as measured in the perfusate - with the effects of 
the inhibitor on lysosomes isolated from the same liver; and 
3/ evaluation of the effects of different lysosomal inhibitors 
following their addition to isolated lysosomes.
MATERIAL AND METHODS
Male Sprague-Dawley rats /150-200 g/ were used. They 
were maintained on standard laboratory chow and water ad 
libitum in an environmentally regulated room with automatic 
light control /dark between 6 p.m. and 6  a.m./.
Isolation of autophagic vacuoles and lysosomes
Leupeptin was dissolved in Ringer's solution /2 mg/ml/
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and injected int raperitoneally /2 mg/100 g body weight/. The 
procedure for isolating autophagic vacuoles was based on the 
method by Wattiaux et al. /1978/ with several modifications 
according to Marzella et al. /1982/. Lysosomes were isolated 
according to Wattiaux et al. /19Í78/. Purity was checked by 
ultrastructural analysis and measurement of marker enzymes 
/Marzella et a l , , 1982/.
Measurement of proteolysis
The animals were isotopically labelled with ^4 C-L-leucine 
at different time points before sacrifice, Lysosomes or auto­
phagic vacuoles from 1 gram of liver suspended in 1 ml of 
isotonic sucrose were incubated with appropriate additions 
and adjusted pH at 37°C in a gently shaking water-bath. TCA 
was added to stop the reaction. The test tubes were centrifuged 
/37 000 g for 15 minutes/ and the radioactivities in the super­
natants were measured. Generation of TCA-soluble radioactivity 
during incubation was linear with time and protein and used 
as a measurement of protein degradation after substraction of 
blank values incubated in ice water-bath.
Chemicals
^ C - L - l e u c i n e , specific activity 54 mCi/mmol, Code nr 
C F A , 273, was purchased from the Radiochemical Centre 
/Amersham, U.K./. Other chemicals were of highest available 
purity and purchased from Sigma Chemicals Co. /St. Louis,
Mo, U.S.A./.
Electron microscopy
Livers were perfusion-fixed with glutaraldehyde as de­
scribed before /Glaumann et al., 1975/. The subcellular frac­
tions /autophagic vacuoles or lysosomes/ were fixed overnight 
with glutaraldehyde and subsequently placed on the bottom of 
a 10 ml centrifuge tube and pelléted at 35 000 g for 6 C minutes.
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After an overnight rinse in 0.1 M cacodylate buffer /pH 7.4/ 
containing 0 . 1  M sucrose, the pellets were cut through the 
entire depth. The resulting strips were either embedded as 
such or cut in the transverse plane into two or three pieces.
Liver perfusion
Male rats /250-280 g/ were labelled with ^4 C-L-leucine 
0.5 or 16 hours before sacrifice. The animals were anaestetized 
and the bile canaliculi and portal vein rapidly cannulated.
The liver was removed and connected to the perfusion apparatus 
/Beije et al., 1979/. The perfusion medium consisted of a 
70 ml Krebs-Ringer bicarbonate buffer, containing 3% bovine 
albumin /Fraction V, Sigma/, 10 mM glucose and a suspension 
of fresh human red blood cells. The pH of the perfusate was 
adjusted to 7.2 and oxygenated with carbogen gas. During 
perfusion samples from the perfusate were taken for isotopical 
assay of protein degradation /TCA soluble radioactivity/.
After 1 hour the perfusion was stopped and the livers pro­
cessed for subcellular fractionation and measurement of pro­
teolysis in the A V s .
RESULTS
Effect of leupeptin in vivo
Electron microscopy. Rats were given leupeptin and the 
livers were analyzed from 3 0  minutes to 16 hours after injec­
tion. For each time point autophagic vacuoles were isolated 
and characterized /Henell and Glaumann, 1984/. Only a few 
points pertinent to this study are presented here. Hepatocytes 
of rats treated for 30 minutes displayed a modest increase in 
autophagic vacuoles containing mitochondria, peroxisomes and 
portions of endoplasmic reticulum as well as glycogen. The 
sequestered organelles were well preserved /Fig. 1A/. The 
corresponding isolated autophagic vacuolar fraction was pure 
and consisted mainly of secondary lysosomes and some auto-
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Fig. 1. Leupeptin treatment time thirty minutes.
A. Live r tissue. Nascent /arrows/ and more mature /double arrows/ autophagic vacuoles are seen.Most autophagic vacuoles contain particulate sequestered glycogen. X 14 500.
B. Fraction of autophagic vacuoles. Lysosomes /arrows/ are seen intermingled with autophagic vacuoles /double arrows/ containing material in early stages of degradation. X 13 200.
phagic vacuoles typically containing identifiable material 
/Fig. IB/.
After one and especially two hours of leupeptin treatment 
the liver displayed a conspicuous increase in autophagic 
vacuoles. The identity of the sequestered material could no 
longer be determined. The one exception was glycogen particles 
which appeared relatively resistant to degradation. The relative 
number of autophagic vacuoles vis-a-vis other types of lysosomes 
had increased as compared to the fraction from animals treated 
for 30 minutes.
By four hours the autophagic vacuoles had become even 
more enlarged /Fig. 2A/. The nature of sequestered organelles 
could only rarely be determined since the degradation was far 
advanced. The isolated autophagic vacuoles contained mostly 
amorphous material /Fig. 2B/ as an indication of progressive 
deg rada t ion.
Fig. 2. Leupeptin treatment time four hours.
A. Liver tissue. The autophagic vacuoles have become larger than by the earlier time points. The sequestered organelles have been degraded to fine-granular material. X 13 200.
B. Fraction of autophagic vacuoles. The isolated organelles contained amorphous material. Only occasionally could more well preserved sequestered organelles be observed. X 10 000.
Eight hours following the injection of leupeptin abundant 
large autophagic vacuoles were still present in the hepato- 
cytes. Particulate glycogen was detectable in some of the 
autophagic vacuoles, which is evidence that glycogen is only 
slowly degraded by lysosomes /Glaumann et al., 1979/.
By sixteen hours following the injection of leupeptin 
the ultrastructure of the hepatocytes was restored to normal. 
The huge autophagic vacuoles seen by eight hours had dis­
appeared. Possibly a small increase in residual bodies of 
ordinary size and form could be detected.
Marker enzymes. We have characterized the autophagic 
vacuolar fraction obtained after 30 minutes of leupeptin 
treatment by means of marker enzyme analysis /Henell and 
Glaumann, 1984/. Cathepsin D /chosen because it is unaffected 
by leupeptin/ was enriched approximately twenty-fold as com­
pared to the homogenate. As judged by negligible activities 
of marker enzymes for endoplasmic reticulum and mitochondria
contamination of the autophagic vacuolar fraction was small 
confirming the morphological results.
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Proteolysis in isolated autophagic vacuoles. Having as­
certained that the autophagic vacuolar fractions are pure with 
satisfactory enzyme latencies /not shown/ we assessed their 
proteolytic capacities. In Fig. 3 the rates of proteolysis in 
the autophagic vacuolar fractions are shown as a function of 
the time interval following the injection of leupeptin.
Maximal inhibition occurred after 30 minutes of treatment.
If the animals were subjected to longer leupeptin exposures 
/up to 16 hours/ before fractionation the rate of proteolysis 
increased with a peak occurring after 4-6 hours exceeding the 
control value by 50%, a phenomenon called "catch up" prote­
olysis /Amenta and Brocher, 1980/. Hereafter peoteolysis 
decreased reaching control values by 16 hours.
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Fig. 3. Proteolysis in the isolated autophagic vacuolarfraction as a function of leupeptin exposure time.
Rats were given an injection of C-L-leucine 16 hours before sacrifice. At the indicated time points following the injection of leupeptin /2 mg/100 g body weight/ the autophagic vacuoles were isolated. Prote­olysis is given both on a per cent basis /per cent of total activity in the fraction/ and as the gener­ation of TCA soluble DPM in the isolated vacuolar fraction from one gram of liver during incubation.
Liver perfusion
The effect of leupeptin on proteolysis was also studied 
by means of the rat liver perfusion technique. The perfusion 
model has proven extremely valuable for studies on protein 
breakdown, since indirect effects often inherent in in vivo 
studies can be avoided to a large extent /Mortimore and 
Schworer, 1977/.
PERFUSION TIME. HOURS
Fig. 4. Effect of leupeptin on the release of degradation 
products to the perfusate during liver perfusion.
14Proteins were labelled by an injection of C-L-
leucine 0.5 /---- / hours /for labelling of proteins
with short half-lives/ and 16 /..../ hours /for 
labelling of proteins with long half-lives/ before 
sacrifice. Leupeptin was injected 15 minutes before 
sacrifice and was also included in the perfusion 
medium. Aliquots were taken from the perfusion medium 
at indicated time points and analysed for acid soluble 
radioactivity.
We tried to evaluate whether or not there exists a 
correlation between total "net" proteolysis as measured in 
the perfusate on the one hand and in the isolated lysosomes 
on the other hand at two levels of protein breakdown, namely 
with and without the addition of leupeptin. This correlation 
was tested for both short time labelled /short-lived/ and long 
time labelled /long-lived/ proteins since it is generally 
believed that the regulation of the breakdown of these classes 
of proteins is different.
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To compare the effects of leupeptin on the degradation of 
long lived and short lived proteins we injected rats with 
■^C-L-leucine 30 minutes and 16 hours before sacrifice and 
removal of the livers for perfusion. Leupeptin /2 mg/100 g/ 
was injected to rats 15 minutes before sacrifice and was also 
included in the perfusion medium / 2  mg/100 ml/. The time course 
of release of TCA-soluble radioactivity to the perfusate is 
shown in Figure 4. As is seen the rate of protein breakdown 
is two to three times higher following short time prelabelling 
in comparison with long prelabelling with "^C-L-leucine. Leu­
peptin decreased the release of TCA-soluble radioactivity by 
55% as measured during the last 30 min of perfusion /period 
30-60 min/ following 16 hours of ^ C - L - l e u c i n e  prelabelling.
The corresponding value for short labelled proteins was 30% 
inhibition. The perfused livers were also used for the iso­
lation of autophagic vacuoles /Marzella et a l , , 1982/. Gener­
ation of TCA-soluble radioactivity from isolated autophagic 
vacuoles was linear during the in vitro incubation for 30 
minutes. Leupeptin treatment resulted in 80% inhibition of 
the degradation of both long and short labelled /-lived/ pro­
teins in isolated autophagic vacuoles /Fig. 5/.
Electron microscopy. Perfusion of liver for 1 hour with 
a medium lacking amino acid supplementation causes some increase 
in the number of autophagic vacuoles /Fig. 6 A / . The lysosomal 
fraction from such a liver contains autophagic vacuoles /Fig.
6 B/ in addition to the secondary lysosomes characterizing the 
corresponding fraction from the nonperfused liver. Leupeptin 
increases the number of autophagic vacuoles even more in 
liver /Fig. 7A/. Thp lysosomal fraction from corresponding 
animals consisted mainly of autophagic vacuoles /Fig. 7B/.
In summary our data from liver perfusion demonstrate 
that leupeptin decreased the breakdown of both long and short 
lived proteins. This inhibitory effect was monitored in the 
perfusate and also in the autophagic vacuolar fraction. These 
results indicate - in some contradiction to the general 
notion - that lysosomes are engaged in the degradation of all 
classes of proteins, be they short or long lived. The next
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/
series of experiments were devoted to a more thorough study 
of this question.
Fig. 5. Effect of leupeptin on proteolysis in autophagic 
vacuoles isolated from perfused liver.
14Rats were given an injection of C-L-leucine 0.5
/-----/  and 16 /..../ hours before sacrifice. When used
leupeptin was injected 15 minutes before sacrifice 
and also included in the perfusion medium. The liver 
was perfused and subsequently subfractionated 
/Marzella et al,, 1982/. After 15 minutes of incu­
bation the AVs were assayed for released radioactivity 
Degradation is given in per cent /per cent of total 
radioactivity in the fraction/.
Characterization of lysosomal proteolysis in vitro
Experiments were first performed to evaluate the effect 
of pH variation of the incubation medium on lysosomal protein 
degradation. As could be expected maximal proteolytic rate 
was seen in the acidic range at pH 4-5 /not shown/, since most 
of lysosomal enzymes have an acidic pH optimum.
Proteolytic rates after different labelling times in v i v o . 
As was discussed above ths general opinion is that lysosomes 
are preferentially engaged in the degradation of long lived 
proteins as opposed to proteins which turn over rapidly. To 
elucidate this specificity further, rats were prelabelled with 
■^C-L-leucine for different time-intervals ranging from 15 mi-
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Fig. 6 . Control liver. Perfusion time one hour.
A. Liver tissue. Perfusion causes some increase in 
the number of autophagic vacuoles /arrow/. The 
sequestered material consisted of mitochondria, 
glycogen and endoplasmic reticulum. X 15 000.
B. Fraction of autophagic vacuoles. Fraction consists 
of mainly secondary lysosomes /arrow/ but several 
nascent autophagic vacuoles /double arrows/ are 
also seen. X 13 200.
nutes to 16 hours, followed by subfractionation of the livers. 
Figure 3 summarizes the results from measurements of proteo­
lysis in isolated lysosomes. A higher rate /about two to 
three fold/ of proteolysis was noted at pH 5 in comparison 
with pH 7 irrespective of labelling time. The highest frac­
tional rates were obtained by shorter labelling times /15 mi­
nutes and 2 hours/.
Inhibition of p roteolysis. The effect of different inhib­
itors of proteolysis was also tested on isolated lysosomes 
from rats prelabelled with ^4 C-L-leucine for 15 minutes and 
for 16 hours. The lysosomes were incubated with the different 
inhibitors in increasing concentrations.
The following inhibitors were tested /Table 1/: Propyl- 
amine which impedes proteolysis by increasing the lysosomal 
pH /Seglen and Gordon, 1980/; leupeptin inhibiting lysosomal 
cathepsins B, H and L /Barrett and Heath, 1977/; chloroquine 
which impairs the action of proteinases by elevating intra-
21 Elődi 311
Fig. 7. Leupeptin treatment. Perfusion time one hour.
Leupeptin was injected into the rat /15 min before
sacrifice/ and also included in the perfusion medium.
A . Liver tissue. Leupeptin causes a conspicuous 
increase in autophagic vacuoles /arrow/. Many of 
these contain glycogen particles /double arrows/ 
as evidence that cytosol is also taken up and 
degraded within lysosomes. X 9 500.
B. Fraction of autophagic vacuoles. This fraction 
consists of autophagic vacuoles in early stages
of maturation as is evident from their identifiable 
contents. X 10 000.
lysosomal pH as well as by inhibiting cathepsin B-^  /Wibo et 
ali, 1974/. As to propylamine no more than maximally 36 and 
69% inhibition was obtained for long and short labelled pro­
teins, respectively, even at high concentration /100 mM/. 
Leupeptin impeded proteolysis in lysosomes by 50% for both 
classes of proteins. Chloroquine was the most effective in­
hibitor tested. It resulted in 65 and 80% decrease of the 
degradation of slowly and rapidly turning over proteins, 
respectively. Neither addition of Triton nor sonication of 
the lysosomal suspension increased the inhibition of any 
agent.
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Fig. 8 . Correlation between degradation rate in isolated 
lysosomes and labelling times in vivo.
The rats were prelabelled with ^C- L - l e u c i n e  at 
different time points before sacrifice. Lysosomes 
were prepared as described in Material and Methods 
and were incubated for 30 minutes at pH 5 and 7. 
TCA-soluble activity was measured after centrifugation 
at 37 000 g for 15 minutes. Blanks were run at +4°C. 
Degradation is expressed as TCA soluble DPM divided 
by total DPM in the same fraction.
DISCUSSION
As is apparent from the present study leupeptin 
increases the occurrence of autophagic vacuoles in rat liver 
considerably. This is due to the retarded degradation of 
sequestered organelles and thus prolonged lifespan of the 
autophagic vacuoles. The lower degradation rate of the seques­
tered organelles is in turn due to the inhibition of cathepsins 
B, H and L caused by leupeptin. The increase in number of 
autophagic vacuoles following leupeptin administration seems 
to be a good approach for their subsequent isolation into a 
pure fraction as is evident from the marker enzyme and electron 
microscopic analyses /Furuno et al., 1982b; Henell and Glaumann, 
1984/. This iponclusion is valid also for the perfused liver.
During Inasai proteolytic conditions obtained when cells 
are grown in, incubated in, or when an organ is perfused with 
a fully supplemented medium, autophagic vacuoles are compara-
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Table 1
Effect of different inhib itors on proteolysis 
in isolated lysosomes
Inhibitor Short labelling time Long labelling time
deg radation
0/7o
inhibition
%
deg rada t ion
0/7o
inhibition
0/7o
None 8 . 0 - 4.5 -
Propylamine
50 mM
3.0 63 3.0 33
P ropylamine 
100 mM
2.5 69 2.9 36
Leupeptin 
2 0  pg
4.8 40 3.0 33
Leupeptin
1 0 0  jjg
3.6 55 2.5 45
Leupeptin 
2 0 0  ^g
3.5 56 2 . 2 52
Ohio roquine 
25 mM
0 .8 78 1.75 62
Chloroquine 
100 mM
0 . 6 81 1.55 6 6
Rats were prelabelled with C-L-leucine for 15 minutes /short 
labelling time/ or 16 hours /long labelling time/ before sac­
rifice. Lysosomes /Wattiaux et al,, 1978/ from 1 g of liver 
suspended in isotonic sucrose were incubated with the inhibitor 
at pH 5.0 for 15 minutes at 37°C. The reaction was stopped by 
adding an equal amount of cold 24% TCA. Radioactivity was 
measured in the supernatant after centrifuging the suspension 
37 000 x g for 10 minutes. Blanks were run at 4°C. Mean of 
four experiments.
tively few. Experiments along these lines indicate that the 
lysosomal pathway of protein degradation is of less importance 
during basal conditions. However, it should be taken into 
consideration that the half-life of the autophagic vacuoles 
is short or approximately 8-9 minutes /Pfeifer et al., 1978/. 
This means that a substantial portion of cytoplasm can be 
taken up and degraded by the lysosomal apparatus in spite of 
the foct that this organelle only constitutes a small frac-
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tional volume of the cell. Our experiments with leupeptin 
illustrate this. As soon as the transition of AVs into secon­
dary lysosomes is blocked a dramatic increase in AVs occurs.
This phenomenon is seen within one hour following leupeptin 
treatment. Accordingly, leupeptin treatment illuminates the 
importance of AVs in organelle degradation and unveils these 
organelles, which at least during basal conditions easily 
escape detection in the electron microscope.
We found no specificity as to the sequestration or the 
degradation of various organelles in autophagic vacuoles in 
accordance with earlier results from heterophagocytosis of 
cell organelles demonstrating that lysosomes have the ability 
to digest all types of biological membranes including lysosomes 
/Glaumann et al., 1975; Henell et al., 1983/. The only exception 
was glycogen, which was degraded comparatively slowly inside 
lysosomes.
The perfusion model has the advantage that total liver 
proteolysis can be estimated by monitoring the release of 
degradation products to the perfusate; such measurements are 
difficult to perform in vivo. Recent development in subcellular 
fractionation techniques has made possible the isolation of 
pure lysosomes /Wattiaux et al., 1978/ and autophagic vacuoles 
/Marzella et al., 1982/. Accordingly, by first perfusing a 
liver and then subfractionating the same liver it is possible 
to estimate the lysosomal contribution to total endogenous 
protein breakdown.
The present results clearly demonstrate that leupeptin 
inhibits protein breakdown both in vivo and in the perfused 
liver. As to the in vivo model, maximal inhibition of prote­
olysis in isolated autophagic vacuoles occurred after 30 mi­
nutes of treatment. At later intervals /4-6 hours/ the prote­
olytic rate increased now exceeding the initial basal rate. 
Amenta and coworkers /1980/ have designated this phenomenon 
"catch up” proteolysis, apparently a result of the elimination 
of the leupeptin block. By setting up an isotopic labelling 
protocol in which rats were given ^C-L-leucine and sacrificed 
at 30 minutes and 16 hours later it was possible to label
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preferentially short lived /30 minutes incorporation time/ and 
long lived proteins /16 hours of incorporation/. As to the 
degradation of these two classes of proteins, leupeptin inhib­
its the release of degradation products to the perfusate from 
short- and long labelled proteins by 30% and 50%, respectively.
Regarding the cellular site of this inhibition, we tried 
to disaggregate total protein breakdown by dissecting out one 
of its components, namely the lysosomes, in an effort to lo­
calize the effect of leupeptin more precisely. By this approach 
it was possible to demonstrate that leupeptin inhibits lyso- 
somally mediated protein breakdown by approximately 70% /short 
lived proteins/ and 80% /long lived proteins/. /Corresponding 
values for the degree of inhibition of the release of degra­
dation products to the perfusate were 30 and 50% for short 
and long lived proteins, respectively./ Extrapolating the 
leupeptin mediated inhibition of lysosomal proteolysis to 
1 0 0 % would allow one to conclude that the nonlysosomal 
pathway would account for roughly 40% /long lived/ and 55% 
/short lived/ of the total proteolytic activity in the perfused 
live r .
To characterize further the lysosomal route of degradation, 
we tested some additional lysosomal inhibitors often used as 
tools in assessing the relative importance of lysosomes in 
protein breakdown /Table 1/. The compounds were added in vitro 
to lysosomes isolated from ^4 C-L-leucine labelled rats. 
Chloroquine was the most effective inhibitor, followed by leu­
peptin and propylamine. However, none of the agents produced 
total inhibition. The lack of 100% inhibition was not due to 
insufficient intralysosomal concentration of the inhibitor 
since rupture of the lysosomal membrane did not enhance the 
effect of the inhibitors /not shown/. The extent of inhibition 
was highest for short lived proteins. This finding is contra­
dictory to the general notion that the turnover of short lived 
proteins is less affected by lysosomotropic agents than long 
lived proteins. However, this discrepancy might be more appar­
ent than real, since when using inhibitors in intact cells one 
is studying not only the degradative phase but also the supply
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of protein substrates, i.e. the input of proteins into lyso- 
somes. With isolated lysosomes only the degradative phase is 
monitored. Accordingly, comparison between earlier results on 
intact cells with the present data on isolated lysosomes is 
not necessarily valid.
As was discussed above, the general notion is that amino 
acid analogue containing and other short lived proteins are 
degraded by a nonlysosomal ATP-dependent cytosolic process. 
However, our results from measurements of degradation in 
isolated lysosomes, demonstrate that already following 15 mi­
nutes and 2  hours of isotopic labelling time, proteolytic 
activity was recorded in lysosomes. Moreover, the fractional 
proteolytic rate was in fact somewhat higher for the short 
labelling time intervals than for the 16 hour interval. 
Accordingly, we conclude that lysosomes are active in the 
degradation of all types of proteins, irrespective of their 
half lives.
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DISCUSSION
BA3USZ:
Leupeptin seems to be a rather weak inhibitor of 
Cathepsin B. Don't you think of testing a better one?
GLAUMANN:
Yes, we have tried various inhibitors. You can combine 
them, too, and get better and higher inhibition. One of 
the main point of this lecture is that if you use these 
inhibitors and you use them as a weapon to distinguish 
between two types of the lysosomal pathway of degradation 
and non-lysosomal pathway of degradation, this is not a 
good tool, because they don't inhibit completely.
BA3USZ:
I see, thank you. But if you want to try a better one,
I'd suggest you such a tripeptide aldehyde, namely 
Boc-DPhe-P ro-Arg-H,
BOHLEY:
The values of residual activity you found in lysosomes 
after inhibition with leupeptin a re exactly in agreement 
with ours. What kind of proteinases might be responsible 
for this residual activity in your opinion?
GLAUMANN:
In the case of leupeptin, several proteinases such as 
aminopeptidases, cathepsin D are not affected by the 
inhibitor. As far as lysosomotropic bases are concerned, 
the increased pH might not completely inhibit the activity 
of all cathepsins.
SOHÁR:
It is known from several publications that pepstatin + 
leupeptin can reduce the increased proteinase activities 
in dystrophic skeletal muscles. Have you measured the
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effect of pepstatin or pepstatin together with leupeptin 
on lysosomal protein degradation?
GLAUMANN :
Yes, we have tested pepstatin on proteolysis in isolated 
lysosomes. Pepstatin is a weak inhibitor decreasing 
protein breakdown by 20%. Since pepstatin does not freely 
permeate membranes these experiments were performed with 
ruptured lysosomes. Pepstatin has some /10%/ additional 
inhibitory effect to leupeptin.
Concerning the second part of your question. I think 
both leupeptin and pepstatin inhibit protein breakdown 
as long as it is mediated by lysosomes, be it induced 
or basal state.
BARRETT:
Perhaps one reason for the incomplete inhibition of 
lysosomal enzymes in these systems may be the very high 
/1-2 mM/ concentration of the cathepsins in the lysosomes?
GLAUMANN :
The same result was found even after lysis of the 
lysosomes.
BAIC1:
Is it possible to speculate on the concentration of 
leupeptin in lysosomes after administration m  vivo?
GLAUMANN :
I don't really know. It has been measured, I guess, 
because it has been labelled.
3 0 C H U K :
Is there anything known whether neutral proteinases 
e.g. elastase-like or chymotrypsin-like /cathepsin G/ 
are also present in liver lysosomes as it is the case 
for polymorpho-nuclear granulocytes? Or are there only 
cathepsins there?
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GLAUMANN:
Well, there are a number of cathepsins there.
30CKUM:
Yes, but not chymotrypsin-like cathepsin G, so if there 
is a small amount of these neutral proteinases, this 
might be the reason why you cannot completely block 
the proteolysis.
KORÁNT:
What is the principal effect of reduced pH on increased 
rate of protein degradation: is it to activate the 
lysosomal cathepsins or to denature the intralysosomal 
proteins and make them better as substrates?
GLAUMANN:
To activate the enzymes.
KORÁNT:
Doesn't it also denature the substrate?
GLAUMANN:
Well, could well be, yes. Make it a better substrate.
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INTRODUCTION
Serine proteinases participate in several physiological and 
pathological processes which are regulated by protein proteinase 
inhibitors, either circulating or specifically acting on selected 
organs. These inhibitors can be divided, on the basis of their se­
quences and catalytic properties, into at least ten homologous 
families (Laskowski and Kato, 1980).
The bovine basic pancreatic trypsin inhibitor (BPTI), which 
is the prototype molecule of the Kunitz family, has been object 
of extensive investigations both from a structural and dynamic 
point of view (see: Laskowski and Kato, 1980 and references cited 
therein). However, to date, its physiological role is uncertain, 
and its distribution in the animal kingdom is very limited and 
puzzling. Conversely', the porcine (p.) and bovine (b.) pancreatic 
secretory trypsin inhibitor (PSTI), which belongs to the Kazal 
family and which is widely distributed among mammals, has been 
subject only of preliminary examinations. PSTI is secreted in the 
pancreatic juice with the zymogens, and its physiological role 
seems to prevent the premature activation of proteinase(s) within 
the pancreas itself (Greene et al., 1976).
In the present paper, we analyze in parallel thermodyna­
mics, kinetics and stereochemistry of binding of both native and 
chemically modified PSTI and BPTI to bovine ß-trypsin (trypsin), 
bovine trypsinogen (trypsinogen; both in the presence and absence 
of the effector dipeptide H-Ile-Val-OH), human urinary kallikrein 
(h.u. kallikrein), porcine pancreatic kallikrein Cp.p. kallikrein)
*
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and bovine Ct-chymotrypsin (chymotrypsin) describing the common 
structural elements which are believed to be responsible for the 
enzyme inhibition.
THERMODYNAMICS OF BPTI AND PSTI BINDING TO SERINE (PRO)ENZYMES
Equilibrium dissociation constants (K^ ) for the binding of 
the native and the chemically modified PSTI and BPTI to serine 
(pro)enzymes have been determined by measuring: (i) the loss of 
the enzymatic activity upon inhibitor binding (see: Antonini et 
al., 1983a and references cited therein); (ii) the spectral 
changes in the ultraviolet region accompanying the formation of 
the PSTI: and BPTI:(pro)enzymes adducts (see: Antonini et al., 
1983a and references cited therein); (iii) the spectral changes 
accompanying proflavine displacement upon inhibitors binding 
(see: Quast et al., 1978 and references cited therein); and (iv) 
by competition experiments involving two (pro)enzymes with diffe­
rent affinities for the inhibitor (Vincent and Lazdunski, 1976; 
Antonini et al., 1983a).
Values of obtained by the different methods agree very 
well one another and are independent on (pro)enzymes concentra­
tion. Moreover, under all the experimental conditions the inhi­
bitor : (pro) enzyme complexes formation conforms to a simple equi­
librium.
Table 1 shows the values of K^, at pH 8.0, for the binding 
of the native and the chemically modified p. and b. PSTI and 
BPTI to several serine (pro)enzymes.
In agreement with the exact predetermined complementarity 
of the (re)active sites of trypsin and BPTI, as shown by the 
comparative X-ray analysis on the free enzyme, free inhibitor 
and enzyme:inhibitor adduct (see: Huber and Bode, 1978 and re­
ferences cited therein), trypsin binds BPTI with the lowest K<j 
value known (0.5 to 1.5x10~*3M) (Vincent and Lazdunski, 1972; 
Finkenstadt et al., 1974). In accordance with the specificity 
properties of trypsin, which catalyses undistinguishably the 
hydrolysis of both arginine and lysine residues (Ascenzi et al.,
1982) , the chemically modified Arg15-BPTI binds to trypsin with 
the same value shown by the native BPTI, which has a lysine 
at site P-j (position 1 5 )  (Jering and Tschesche, 1976). Further­
more, both p. and b. PSTI, which show, respectively, a lysine 
and an arginine at site P1 (position 18) bind to trypsin with 
the same value (Schweitz et al., 1973; Menegatti et al.,
1983) .
It is of interest to remark that in spite of inherent dif­
ferences at the (re)active sites of the serine (pro)enzymes and 
inhibitors examined, the interaction between Asp189, present in 
the specificity pocket of serine (pro)enzymes acting on cationic 
substrates, and Lys15 or Lys18 (or Arg18), at the reactive 
site loops of the native BPTI and p. or b . PSTI, respectively,
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TABLE 1
Inhibitor (Pro)enzyme K, (M)Cl
-11p. PSTI trypsin 9.6x10 '
trypsinogen 2 .8x10 5
trypsinogen < 6 .0x1 0 - 7 ^
(+0.02 M H-Ile-Val-OH)
Chymotrypsin 7.1x10
-11b. PSTI trypsin 9.0x10
-1BPTI trypsin 0.5 to 1.5x10 ~
trypsinogen 2 .0x1 0 - 6
trypsinogen < 6 .0x1 0 - 7 ^
(+0.02 M H-Ile-Val-OH)
h.u. kallikrein 9.0x10
p.p. kallikrein 9.0x10 g
Chymotrypsin 9.5x10 9
-1 4Arg15-BPTI trypsin 6 .0x10 ' 
- 1 0p.p. kallikrein ^4.5x10 '
Chymotrypsin ** 1 . 4x1 0
- 6Phe15-BPTI trypsin 1.5x10 „ -9Chymotrypsin 2 .8x10
- 6Trp15-BPTI trypsin 2 .8x10
Chymotrypsin 2 .8x10 9
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^Maximum value that may be determined by the method used 
here (see: Antonini et al., 1983a).
Dissociation equilibrium constants (K^) for the binding of na­
tive and chemically modified p, or b. PSTI and BPTI to various 
serine (pro)enzymes (pH 8.0, 1=0.1; T=21 to 25°C).
is strictly conserved (Huber and Bode, 1978; Bolognesi et al., 
1982; Chen and Bode, 1983).
In the case of p. PSTI and BPTI binding to trypsinogen, 
rather low affinity values have been observed (Vincent and 
Lazdunski, 1976; Antonini et al., 1983a). In fact the specifi­
city pocket and the activation domains of the free proenzyme 
are not structured and the productive interaction Asp189-LysP^
(18 or 15 respectively) can occur only in parallel to partial 
activation of trypsinogen to a trypsin-like structure (Huber 
and Bode, 1978; Bolognesi et al., 1982). The observed increased 
affinity of both p. PSTI and BPTI for trypsinogen by the effec­
tor dipeptide H-Ile-Val-OH, is in accordance with the proposed 
structural mechanism for the activation of this proenzyme (Huber 
and Bode, 1978; Bode, 1979). Thus, BPTI binding to the trypsi- 
nogen:H-Ile-Val-OH complex is undistinguishable, on structural 
grounds, from that of the inhibitor to trypsin (Huber and Bode,
1978). The same relation, conceivably, holds for p. PSTI bin­
ding to the trypsinogen:H-Ile-Val-OH adduct (Antonini et al., 
1983a).
It is well known that both p.p. kallikrein and h.u. kalli- 
krein preferably catalyse the hydrolysis of arginine rather 
than lysine residues (Antonini et al., 1982; Ascenzi et al.,
1982). This peculiar catalytic behaviour has been related to the 
presence at position 226 of a serine residue which seems to play 
a dominant role in the binding of the arginine side chain (Bode 
et al., 1983; Chen and Bode, 1983) and is replaced by a glycine 
in trypsin (Bode and Schwager, 1975). Thus, Arg15-BPTI binds to 
p.p. kallikrein with a higher affinity than that of the native 
Lys15-BPTI (Jering and Tschesche, 1976) . The lower affinity of 
BPTI for both kallikreins as compared to that for trypsin has 
been related to the different geometries that the so called 
"kallikrein polypeptide loops" assume in these enzymes. In fact, 
these domains limit the accéssibility of macromolecular inhibi­
tors and substrates to the active site of both kallikreins (Bode 
et al., 1983; Chen and Bode, 1983).
The relatively low affinities of BPTI and p. PSTI for Chy­
motrypsin (Vincent and Lazdunski, 1973; Antonini et al., 1983a) 
may be essentially related to the absence of the salt linkage 
between Lys15 or Lys18, present at the P-j site of BPTI and p.
PSTI respectively, and the Asp189, since this residue is replaced 
by a neutral serine (Birktoft and Blow, 1972). In this respect, 
chemically modified BPTI inhibitors, in which Lys15 has been re­
placed by a tryptophan (Trp15-BPTI) or by a phenylalanine (Phe15- 
-BPTI) show higher affinities for Chymotrypsin (Jering and 
Tschesche, 1976). Conversely, Phe15-BPTI and Trp15-BPTI show 
lower affinities for trypsin if compared to the native BPTI 
(Jering and Tschesche, 1976).
As shown in Table 1, the affinity of p. and b. PSTI for 
trypsin, trypsinogen (in the presence and absence of H-Ile-Val-OH)
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and Chymotrypsin is systematically lower as compared to that of 
BPTI, moreover p. PSTI does not inhibit both kallikreins up to 
an inhibitor concentration of 3 mM (Antonini et al., 1983a). The 
low affinity of p. and b. PSTI for the (pro)enzymes examined has 
been related to the wider radius of the reactive site loop of 
these inhibitors as compared to that of BPTI (see Fig. 1). In 
fact, while upon BPTI binding trypsinogen adopts a structure 
which is coincident with that of activated trypsin (Huber and 
Bode, 1978), p. PSTI induces in the zymogen a novel conformation 
of the activation domain which differs from that of trypsin (Bo- 
lognesi et al., 1982), and may thus be energetically less favou­
rable. On the same basis, lack of p. PSTI binding to both kalli­
kreins may be explained (Antonini et al., 1983a).
The pH dependence of for p. PSTI and BPTI binding to 
trypsin, trypsinogen and Chymotrypsin is roughly the same bet­
ween pH 5 and 9.5 for both the inhibitors (see Fig. 2). In spite 
of difficulties in the determination of the acidic asymptotes of 
log K^, the data may be fitted with a simple pH transition with 
an average pK of 6.2. This finding implies an acid-pK, shift of 
a group upon inhibitor (s) binding from pKiV7.2,in the free (pro)- 
enzymes, to£y 5.2,in the (pro)enzymes:inhibitors adducts.
Inspection of the different active site residues capable of 
affecting p. PSTI and BPTI binding, suggests to assign the obser­
ved acid-pKa shift upon (pro)enzymes-inhibitors complexes format­
ion to His57. Inhibitor binding and the related acid pKa-shift 
are associated with considerable strengthening of the Ser1950G- 
-His57NE2 hydrogen bond, which is observed in all the trypsin- 
(ogen)-inhibitors adducts and is very weak in the free (pro)- 
enzymes (Huber and Bode, 1978; Bolognesi et al., 1982; Chen and 
Bode, 1983).
At pH values below 5, BPTI binding to trypsin is affected 
by a cooperative three proton transition (Finkenstadt et al., 
1974). On the other hand, p. PSTI and BPTI binding to Chymotryp­
sin is unaffected by pH (Vincent and Lazdunski, 1973; Antonini 
et al., 1983a). Probably one of the three residues affecting 
BPTI binding to trypsin, below pH 5, is Asp189 (Finkenstadt et 
al., 1974), which plays a dominant role in the catalytic path­
way, in spectral and ligand binding properties of serine protei- 
nases acting on cationic substrates (Ascenzi et al., 1982), and 
is replaced by a neutral serine in Chymotrypsin (Birktoft and 
Blow, 1972).
KINETICS OF BPTI AND PSTI BINDING TO SERINE PR0TEINA3ES
The kinetic data available up to now on the reactions of 
trypsin and Chymotrypsin with native and modified (P-|-P;j reaction 
site bond split) BPTI and b. or p. PSTI are consistent with the 
generally accepted reaction scheme:
22* 329
FIG. 1: C-alpha skeletal models of p. PSTI (a) and BPTI (b). 
The reactive site bonds of inhibitors (18-19 in p. PSTI and 
15-16 in BPTI) have been positioned, for ease of comparison, in 
approximately the same orientation. (Modified from Antonini et 
a l . ,  1983a).
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FIG. 2: pH dependence of the dissociation equilibrium constant 
(K^ ) for: (i) p. PSTI (A) and BPTI (A1) binding to trypsin; (ii) 
p. PSTI (B) and BPTI (B1) binding to trypsinogen; and (iii) p. 
PSTI (C) and BPTI (C') binding to Chymotrypsin at 21°C. Squares 
indicate values of obtained by the evaluation of the inhibi­
tory effect of p. PSTI and BPTI on the enzymes catalyzed hydro­
lysis of synthetic substrates. Asterisks indicate values of 
obtained by spectrophotometric titrations. Values of (O) for 
BPTI binding to trypsin (A': from Vincent and Lazdunski, 1 972; 
Finkenstadt et al., 1974), trypsinogen (B': from Vincent and 
Lazdunski, 1976) and Chymotrypsin (C': from Vincent and Lazdun­
ski, 1973) are reported for comparison. Continuous lines are 
the simple theoretical titration curves with the following pKa 
values: A: 6.15; B: 6.38; C: 6.25; A': 6.0; B': 6.30; C': 6.26. 
(Modified from Antonini et al., 1983a).
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-j- y
E + I L ^ =£ X C ^=i“ X ^=± Lr v —  I + E (1 )
xwhere E is the enzyme; I and I are the virgin and the modified 
inhibitors, respectively; L and 1/ are loose complexes of E with 
I and I , respectively; X and X are relative long lived interme­
diates observed in the reaction of trypsin with I and Ix, respec­
tively (Quast et al., 1978; Antonini et al., 1983b) and C is the 
stable inactive enzyme—inhibitor adduct.
With inhibitors in excess over the enzymes ( 5x H > .  
the time course of the reaction of trypsin and Chymotrypsin with 
BPTI and p. PSTI corresponds to a pseudo-first order process 
(see: Antonini et al., 1983b and references cited therein).
Under all the experimental conditions, the concentration depen­
dence of the rate is second order at low inhibitors concentrat­
ions, reflecting a relatively rapid pre-equilibrium followed by 
a limiting first order process.
The kinetics of the formation and dissociation of the 
complexes of native and reactive site bond split BPTI and p. or 
b. PSTI with trypsin and Chymotrypsin have been investigated 
using four different signals: (i) the spectral changes accompa­
nying proflavine binding or displacement as a consequence of ma- 
cromolecular inhibitors competition; (ii) the intrinsic optical 
density changes in the ultraviolet region accompanying the for­
mation or the dissociation of the enzyme-inhibitor complexes;
(iii) the spectral changes accompanying benzamidine binding or 
displacement as a consequence of macromolecular inhibitors com­
petition; (iv) -he loss and recovery of the enzymatic activity, 
upon binding or dissociation of inhibitors (see: Antonini et 
al., 1983b and references cited therein).
The values of the second order rate constants for the tryp­
sin- and Chymotrypsin:BPTI and - p. PSTI complexes formation, 
determined around neutrality and at low pH (3.5 to 4), are re­
ported in Table 2. Moreover, Fig. 3 shows the dependence of the 
apparent pseudo-first order rate constant for the trypsin:BPTI 
complex formation on the inhibitor concentration for the displa­
cement of proflavine, the intrinsic spectral changes in the 
ultraviolet region, the displacement of benzamidine and the loss 
of the enzymatic activity, at pH 6.8 and 3.5. The values of the 
kinetic parameters for the enzymes-inhibitors adducts formation, 
determined by the four different methods, agree one another, 
around neutrality. At pH 3.5, the kinetic parameters for the 
reaction of Chymotrypsin with BPTI and p. PSTI are independent 
on the different signals. On the other hand, the kinetic para­
meters for the trypsin-BPTI and -p. PSTI complexes formation 
differ widely for the processes followed with the different 
signals.
At pH 3.5, proflavine displacement from trypsin, upon BPTI 
binding, preceeds the intrinsic optical density changes, in the 
ultraviolet, and the latter preceeds the benzamidine displacement
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TABLE 2
Values of the second order rate constant (k , , .) for the bindinq of BPTI and p. PSTI to trypsin
and Chymotrypsin (1=0.1; 
Inhibitor Enzyme
T=21 to 
pH
25°C) . (0nU
-1 -1k, . . ( M s )  (on) x
Proflavine The uv optical Loss of the
displacement density changes enzymatic activity
BPTI trypsin 6.8 2.5x105 2.5x105 2.5x105
3.5 2.5x104 3.2x102 8.0x101
p. PSTI trypsin 6.8 1.1x106
3.5 8.0x103 1 .1x103 1.5x10 2
BPTI Chymotrypsin 8.0 6.7x105 7.0x105 1.1 to 5.3x105
4.0 0.7 to 2.0x103 2.0x103 2.0x103
p. PSTI Chymotrypsin 6.8 4.0x103 4.0x103 4.0x10 3
3.5 4.0x102 4.0x102 4.0x102
-6 -5 -4 -3 -2 -7
log [BP TI] (M)
FIG. 3: Dependence of the apparent pseudo-first order rate con­
stant (k) for trypsin-3PTI complex formation on BPTI concentrat­
ion for (i) the displacement of proflavine ( A ); (ii) ehe spectral 
changes in the ultraviolet region (□); (iii) the displacement of 
benzamidine (•); and (iv) the loss of the enzymatic activity (O) 
at pH 6.8 (a) and pH 3.5 (b) (T=21+0.5°C; [bPTi] }.5x  [e] H  The
continuous lines were calculated from the expression :
k = k+i/ (1 + K± / [BPTi])
where k+_^ is the limiting pseudo-first order rate constant and 
the pre-equilibrium dissociation constant. (Modified from Antoni- 
ni et al., 1983c).
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O
FIG. 4: Time course of the trypsin-catalysed hydrolysis of 
N- CL-carbobenzoxy-L-lysine p-nitrophenyl ester (ZLysONp), at 
pH 3.5 and 21+0.5°C. Trace a in the absence of both BPTI and 
proflavine; trace b in the presence of 1 mM proflavine; trace 
c same as b but after the addition of BPTI, indicated by the 
arrow. Trypsin concentration: 0.1 pM; ZLysONp concentration: 
85 fiM; BPTI concentration: 20 mM; A= 360 nm.
(Modified from Antonini et al., 1983c).
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and loss of the enzyme activity (which procede at the same time) 
by several orders of magnitude (see Fig. 3). These data led to 
the prediction that, at pH 3.5, BPTI addition to the trypsin- 
-proflavine complex would initially remove proflavine inhibition 
and, sin,ce the acridine dye is a competitive inhibitor for tryp­
sin, the enzyme would recover transiently its catalytic activity, 
before being irreversibly inhibited by completion of BPTI bin­
ding. The kinetic evidences shown in Fig. 4 verified this pre­
diction, indicating that during the trypsin-BPTI complex format­
ion one proflavine-displaced-(inhibitor-bound) intermediate 
occurs, which is not able to bind proflavine but may bind and 
hydrolyse the substrate. The catalytic properties of this tran­
sient are indistinguishable from those of free trypsin both in 
terms of kc and (Antonini et al., 1983c).
It may be remarked that between pH 3.5 and 8.0 the values 
of the dissociation constants for trypsin- and chymotrypsin-3PTI 
and —p. PSTI complexes are independent of the different signals.
Finally, it is of interest to observe that also the forma­
tion of the stable inactive BPTI-trypsin complex from trypsin 
and the reactive site bond split BPTI is a multistage process, 
characterized by the presence of the relatively long-lived in­
termediate X (see scheme 1). On the other hand in the case of 
Chymotrypsin, the reaction with the reactive site bond split 
inhibitor, may be regarded as an all-or-none process. The dis­
sociation of the modified BPTI from trypsin- and chymotrypsin- 
—inhibitor complexes may be regarded as a simple process (see: 
Quast et al., 1978 and references cited therein).
T h e  k i n e t i c  o b s e r v a t i o n s  h e r e  r e p ö r t e d  i n d i c a t e  t h a t ,  i n  
c o n t r a s t  w i t h  C h y m o t r y p s i n ,  t h e  r e a c t i o n s  o f  t r y p s i n  w i t h  t h e  
n a t i v e  a n d  m o d i f i e d  B P T I  a n d  p .  P S T I  i n v o l v e  s e v e r a l  d i s t i n c t  
i n t e r m e d i a t e s ,  r a t h e r  t h a n  b e i n g  a n  a l l - o r - n o n e  p r o c e s s ,  t h i s  
b e i n g  e x p e c i a l l y  e v i d e n t  a t  l o w  p H .
Although it is obviously impossible to explain these kine­
tic data in terms of static three-dimensional structures, the 
multistage processes observed in the BPTI: and p. PSTI-trypsin 
complexes formation is in keeping with the proposed reaction 
mechanism which takes into account a zipper-like sequential 
formation of hydrogen bonds, polar and apolar interactions at 
the contact area (Huber and Bode, 1978).
Acknowledgements: We wish to thank Professors R. Huber and W.
Bode for providing helpful criticism.
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INTRODUCTION
The aim of the present study is to compare side by side 
the catalytic properties, the chemical and the three-dimensional 
structures of some serine (pro)enzymes, namely bovine ß-tryp- 
sin (trypsin), bovine trypsinogen (trypsinogen):H-Ile-Val-OH 
adduct, bovine thrombin (thrombin), porcine pancreatic kal- 
likrein (p.p. kallikrein), human urinary kallikrein (h.u. kal- 
likrein), human urokinase (urokinase), the thrombin-like pro­
teinase from the Ancistrodon rhodostoma venom (Ancrhod), all 
acting on cationic substrates, as well as bovine a-chymotryp- 
syn (chymotrypsin), porcine pancreatic elastase (elastase) and 
free trypsinogen, acting on noncationic substrates.
The characterization of kinetic and thermodynamic proper­
ties of these (pro)enzymes has been conducted along the fol­
lowing lines of investigation: (i) steady-state and pre-steady- 
state kinetics of the catalyzed hydrolysis of a number of p- 
nitrophenyl esters of (L-)amino acids having cationic and non­
cationic side chains. Particularly, such studies have been per­
formed with N-a-carbobenzoxy-L-lysine p-nitrophenyl ester 
(ZLysONp) which results to be one of the most favorable sub­
strate for (pro)enzymes acting on cationic substrates; (ii) 
"promoter" effect of ethylamine on the catalyzed hydrolysis of 
the noncationic substrate N-a-carbobenzoxy-L-alanine p-nitro­
phenyl ester (ZAlaONp); (iii) inhibition Ly ethylamine, benza- 
midine and polybenzamidine derivatives of the catalyzed hydro­
lysis of ZLysONp; (iv) spectral properties of free (pro)enzymes. 
1 *Correspondence should be addressed to P. Ascenzi.
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The values of the individual equilibrium and kinetic con­
stants for the catalyzed hydrolysis of p-nitrophenyl esters 
examined have been analyzed (Gutfreund, 1972; Antonini and 
Ascenzi, 1981) in the framework of the minimum three-step cata­
lytic mechanism (scheme 1):
(P) E + S (P)E‘S
+ 2
-2
(P)E«P 
+ P1
(P)E + P2 (1 )
where (P)E is the (pro)enzyme, S is the substrate (i.e. the 
p-nitrophenyl ester of the N- GC -carbobenzoxy— (L-)amino acid),
K (=k ^/k i-s the pre-equilibrium dissociation constant for 
tlie formation of the (pro) enzyme, substrate complex (P)E-S,
(P)E*P is the acyl intermediate and and P2 are the hydrolysis 
products (i.e. p-nitrophenol and N- CL -carbobenzoxy-(L-)amino 
acid, respectively).
For all the (pro)enzymes examined the formation of the 
(P)E-S complex may be regarded as a pseudo first order process
with a minimum value of the second order rate constant of
6 -1 -1£^1x10 M s'. Moreover, values of k  ^and k_^ are always 
closed to zero.
The dependence of the initial velocity on substrate and 
(pro)enzyme concentration and the time course of the reaction 
follow simple Michaelis-Menten kinetics, under all the experi­
mental conditions,
It will be shown that serine (pro)enzymes acting on ca­
tionic substrates notably, trypsin, trypsinogen:H-Ile-Val-OH, 
thrombin, p.p. and h.u. kallikrein, urokinase and Ancrhod, but 
not Chymotrypsin, elastase and free trypsinogen, acting on 
noncationic substrates, contain a similarly located ionizable 
group, Asp189, the ionization of which affects the binding of 
cationic substrates, inhibitors and ligands, the rate of the 
acylation step and the spectral properties. Subtle changes in 
the specificity of (pro)enzymes examined are also reported and 
their structural grounds discussed.
THE (PRO)ENZYMES CATALYZED HYDROLYSIS OF ZLysONp
Fig. 1 shows the pH dependence of the values of steady- 
-state and pre-steady-state parameters for trypsin and Chymo­
trypsin catalyzed hydrolysis of ZLysONp (Antonini and Ascenzi, 
1981; Ascenzi et al., 1982).
Values of log k and log k /K for all (pro)enzymes cat cat macting on cationic substrates may Be fitted with two pH tran­
sitions (0/4.5 and 0/7). On the other hand, values of log k t 
and log k /K for Chymotrypsin, elastase and free trypsinogen 
may be fitted with a single pK value (0*7) (Ascenzi et al., 
1982; 1983a; 1983b; Antonini et al., 1982; 1983). Values of Km
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FIG. 1 : pH dependence of log k (O), log K (O), log k
(•), log k (A), log K (• ) ^ log k /K (’Ö) and log k+ /K
(•) for the trypsin (a,bfc) and chymo?rypsxn (a',b',c') cata- S
lyzed hydrolysis of ZLysONp at 21+0.5°C and 1=0.1M. Data for
the trypsin catalyzed hydrolysis of ZLysONp may be fitted with
the following pK values: k -4.6+0.1, 7.1+0.1; k -3.73+0.10,
7.05+0.10; k -6^9 5+0.10; KC-I.2+0.1; k /K (=k „/'R )-4 .5+0.1,— I j ~• q — c s t m 2 s —7.1+0.1. Values of Km (O) for the trypsxn catalyzed hydrolysis
of ZLysONp are pH independent with an average value of 124+25
pM. Data for the Chymotrypsin catalyzed hydrolysis of ZLysONp
may be fitted with the following pK values: k -7.05+0.10;
k -6.93+0.10; k+3~6 .9 3+0.10 ; k^ t/ ^  (=k+2/Ks) -^0+0.1 . Values
of K (#) and K (O) for the cfymotrypsxn catalyzed hydrolysis
of zEysONp are pjS independent with average values of 722+64 pM
and 568+62 pM, respectively.
(Modified from Antonini and Ascenzi, 1981; Ascenzi et al., 1982).
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are essentially independent of pH, between pH 2 and 8.5. (Ascen- 
zi et al., 1982; 1983a; 1983b; Antonini et al., 1982; 1983) 
except for Ancrhod (pK =4.3+0.1) (unpublished results).
The k+ 2 versus pH profile for (pro)enzymes acting on ca­
tionic substrates implicates two ionizing groups (pK (¥3.6 and 
ŰÍ7) . On the other hand for Chymotrypsin, elastase and free tryp- 
sinogen, values of k+2 depend on a single ionizing group (pK_^7), 
over the whole pH range explored (Ascenzi et al., 1982; 1983a; 
1983b; Antonini et al., 1982; 1983).
The value of K for the catalyzed hydrolysis of ZLysONp 
by (pro)enzymes acting on cationic substrates has been found to 
increase of about five folds going from pH d  6 to pH d  3. The 
data correspond to a simple titration curve with an average pK 
value of 4.2. The value of K is pH independent, over the same 
pH range for Chymotrypsin, efastase and free trypsinogen (Ascenzi 
et al., 1982; 1983a; 1983b; Antonini et al., 1982; 1983).
For all (pro)enzymes examined, values of k+^/K , determined
at different pH values, from experiments where are
in excellent agreement with those of k ,/K determined fromcat msteady-state experiments. This finding provides direct evidence 
for the conformity of the systems to the minimum three-step 
mechanism (scheme 1).
For all (pro)enzymes examined the pH dependence of k+  ^
conforms to a single ionizing group (pK (y7) (Ascenzi et al.,
1982; 1983a; 1983b; Antonini et al., 1^82; 1983), except for p.p. 
kallikrein in which k depends on two pK 's (4.6+0.15 and 
7.0+0.1) (Ascenzi et al., 1983b).
From the inspection of Fij. 1, it may be observed that in 
the catalyzed hydrolysis of ZLysONp by trypsin, as well as by 
other serine (pro)enzymes acting on cationic substrates, k+2 is 
rate limiting in catalysis at pH ^4, whereas at pH ^,6, k+2 
becomes rate limiting. On the ocher hand, the rate limiting step 
(k+2) for the Chymotrypsin, elastase and free trypsinogen cata­
lyzed hydrolysis of ZLysONp is pH independent (Ascenzi et al., 
1982, 1983a; 1983b; Antonini et al., 1982; 1983). As expected 
(Gutfreund, 1 972) when k _>k _ and fs ""|>fE "| , only at pH values+ Z +3 *- Q ml W Owhere the deacylation step is rate limiting m  catalysis, a burst 
of p-nitrophenol release (of amplitude A = Ct* , with a first 
order rate constant k) is detectable.
THE (PRO)ENZYMES CATALYZED HYDROLYSIS OF ZAlaONp
Fig. 2 shows the pH dependence of steady-state and pre- 
-steady-state parameters for the trypsin and Chymotrypsin cata­
lyzed hydrolysis of ZAlaONp (Kassera and Laidler, 1970; Antonini 
and Ascenzi, 1981; Ascenzi et al. 1982).
Values of k , k , k and k /K (=k /K ) for all the gat +2 +3 cat , m .+2, s . ,(pro)enzymes examined, may be fitted with a single pH transition
with an average pK of 7. Moreover, values of K and K are es-  ^ c a m s
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F I G .  2 ; pH d e p e n d e n c e  o f  l o g  k  (O) > l o g  K (O) / l o g  k  
( • ) »  l o g  k + _, ( A ) ,  l o g  Kg ( d i a l o g  k  ( * 0 )  a n d  l o g  k * 2 / K g
(@ ) f o r  t h e  t r y p s i n  ( a , b , c )  a n d  C h y m o t r y p s i n  ( a ' j b ' j C 1 ) c a t a l y ­
z e d  h y d r o l y s i s  o f  Z A l a o N p  a t  2 1 + 0 . 5  C a n d  1 = 0 . 1M. D a t a  f o r  t h e  
t r y p s i n  c a t a l y z e d  h y d r o l y s i s  o f  ZAl aON p  m a y  b e  f i t t e d  w i t h  t h e  
f o l l o w i n g  pK v a l u e s :  k  — 6 . 8 3 + 0 . 1 0 ;  k  - 6 . 8 3 + 0 . 1 0 ;  k  - 6 . 7 5 +  
+ 0 . 1 0 ;  k  / §  ( = k + 0 / K  ) -  b .’8 3 + 0 . 1  0 .  V a l u e s  o f  K (O) anci  K ( © )  
f o r  t h e  ? r y p s i n  c a t a l y z e d  h y d r o l y s i s  o f  ZAl aONp  a r e  pH i n d l p e n -  
d e n t  w i t h  a v e r a g e  v a l u e s  o f  8 8 + 1 8  pM a n d  1 1 7 + 2 2  pM,  r e s p e c t i v e l y  
D a t a  f o r  t h e  C h y m o t r y p s i n  c a t a l y z e d  h y d r o l y s i s  o f  Z Al aO N p  m a y  b e  
f i t t e d  w i t h  t h e  f o l l o w i n g  pK v a l u e s :  k  - 6 . 8 + 0 . 1 ;  k  - 6 . 9 + 0 . 1 ;  
k + 3 ~ 6 . 7 5 + 0 . l 0 ;  k ^  (=k  / S g ) - 6 . 7 2 + 0 . V a l u e s  o f  (O) a n d
K ( @ )  f o r  t h e  c f i y m o i i r y p s i n  c a t a l y z e d  h y d r o l y s i s  o f  z S l a O N p  a r e  
p i  i n d e p e n d e n t  w i t h  a v e r a g e  v a l u e s  o f  9 8 + 1 2  pM a n d  1 1 8 + 8  pM,  
r e s p e c t i v e l y .
( M o d i f i e d  f r o m  A n t o n i n i  a n d  A s c e n z i ,  1 9 8 1 ;  A s c e n z i  e t  a l . ,  1 9 8 2 )
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sentially pH independent between pH 2 and 8.5. At all pH's, 
values of k^^/K^, determined from experiments where IS j
arc in agreement with those of k determined where
f s l ^  5x [eJ  (Ascenzi et al. , 19 Antonini et al. , 1 983).
*- -* Since, under all the experimental conditions, k is rate
limiting in catalysis for all the (pro)enzymes examined, no 
burst phase is detectable.
THE EFFECT OF ETHYLAMINE ON THE (PRO)ENZYMES CATALYZED HYDROLYSIS 
OF ZAlaONp
The effect of adding ethylamine on the catalyzed hydro­
lysis of ZAlaONp by (pro)enzymes acting on cationic substrates 
is reflected in the increase (from 4 to 10 folds) of the rate 
of hydrolysis. Moreover, the pH dependence of the pre-steady- 
-state parameters for the hydrolysis of ZAlaONp by (pro)enzymes 
acting on cationicsubstrates, in the presence of saturating 
levels of ethylamine, show that at pH ^4, the k+  ^ step is rate 
limiting in catalysis, whereas at pH ^6, the k+  ^ step becomes 
rate limiting. On the other hand, in the absence of ethylamine, 
k ^  is rate limiting in the (pro)enzymatic hydrolysis of ZAlaONp, 
over the whole pH range explored. In contrast, chymotrypsin, 
elastase and free trypsinogen do not bind ethylamine and the 
catalyzed hydrolysis of ZAlaONp is unaffected by the presence 
of this alkylamino compound. Furthermore, at all pH values, 
both in the presence and absence of ethylamine, k remains the 
rate limiting step in catalysis and the values of K , in all 
cases, are pH independent (Antonini and Ascenzi, 19§ 1 ; Antonini 
et al., 1982; 1983; Ascenzi et al., 1982).
The dissociation constant for ethylamine binding to tryp­
sin varies with pH with a pK of 4.1+0.1 (see Fig. 3) (Antonini 
and Ascenzi, 1981; Ascenzi et al., 1982).
COMPARISON OF STEADY-STATE PARAMETERS OF THE (PRO)ENZYMES CA­
TALYZED HYDROLYSIS OF N-0t-CARBOBENZOXYGLYCINE p-NITROPHENYL 
ESTER (ZGlyONp), ZAlaONp, N- a-CARBOBENZOXY-L-LEUCINE p-NITRO- 
PHENYL ESTER (ZLeuONp), N- a-CARBOBENZOXY-L-ARGININE p-NITRO­
PHENYL ESTER (ZArgONp), ZLysONp AND N-a -CARBOBENZOXY-L-TYROSINE 
p-NITROPHENYL ESTER (ZTyrONp)
The values of k , and k /K for the catalyzed hydro- , . _ , ,cat. cat m. x .lysis of ZArgONp by (pro)enzymes acting on cationic substrates
change with pH and may be fitted with the acidic and neutral
transitions (pK Csd 4.5 and pK ad 7) observed for the hydrolysis
of ZLysONp; those for the hydrolysis of neutral substrates show
only the neutral transition (pK ^7) . On the other hand, the
values of k and k at/K for the catalyzed hydrolysis of all
the p-nitropfienyl es?ers By chymotrypsin, elastase and free
trypsinogen have the same pH dependence corresponding to a
single pH transition of pK ai7. Moreover, the values of K have  ^ c r a m
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FIG. 3: (a) pH dependence of the dissociation constant for
ethylamine binding (K , K.) to trypsin at 21+0.5°C and 1=0.1M. 
Triangles indicate va?ues1of K obtained from the promoter ef­
fect of ethylamine on the trypsin catalyzed hydrolysis of 
ZAlaONp. Circles indicate values of K. obtained from the inhi­
bition of the trypsin catalyzed hydrolysis of ZLysONp by ethy­
lamine. The data may be fitted with a single pH transition with 
a pK value of 4.1+0.1. (b) pH dependence of the dissociation
cons ?ant for benzamidine binding (K^ ) to Chymotrypsin (#) and 
trypsin (O) at 21+0.5°C and 1=0.1M. Values of have been 
obtained from the inhibition of the Chymotrypsin and trypsin 
catalyzed hydrolysis of ZLysONp by benzamidine. Values of 
for benzamidine binding to Chymotrypsin are pH independent with 
an average value of 0.011+0.002 M. Values of for benzamidine 
binding to trypsin may be fitted with a simple pH transition 
with a pK value of 4.15+0.10.
(Modified from Antonini and Ascenzi, 1981; Ascenzi et al., 1982; 
Menegatti et al., 1982).
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been found to be essentially pH independent in the pH range 
explored (2-8.5) for all substrates(Ascenzi et al., 1982; 1983a; 
1983b; Antonini et al., 1983) except for the Ancrhod catalyzed 
hydrolysis of ZArgONp (pK =4.80+0.15) (unpublished results).
Inspection of Table 1 shows that the catalytic parameters 
for the same substrates vary largely, reflecting the different 
specificity profiles of the various (pro)enzymes.
THE BINDING OF BENZAMIDINE AND POLYBENZAMIDINE DERIVATIVES TO 
SERINE (PROENZYMES
Fig. 3 shows the effect of pH on the inhibition constant 
of benzamidine on the trypsin and Chymotrypsin catalyzed hydro­
lysis of ZLysONp (Ascenzi et al., 1982; Menegatti et al.,
1982). The pH dependencies of the inhibition constants for the 
binding of benzamidine and polybenzamidine derivatives to seri­
ne (pro)enzymes acting on cationic substrates may be generally 
fitted with a simple pH transition with an average pK value 
of 4.1 (see: Menegatti et al., 1982 and references cited thérein).
Additional ionizing groups, well outside the recognition 
site, have been found to affect the binding of polybenzamidine 
derivatives (i.e. tetra-p-amidinophenoxy-propane; TAPP) to some 
serine (pro)enzymes acting on cationic substrates (see: Mene­
gatti et al., 1982 and references cited therein).
No pH effects on the value of the inhibition constant for 
the binding of benzamidine and its derivatives tó Chymotrypsin 
and free trypsinogen has been observed (Ascenzi et al., 1982; 
Menegatti et al., 1982; Antonini et al., 1983). Moreover, ela- 
stase does not bind at all benzamidine and polybenzamidine de­
rivatives (Menegatti et al., 1982).
Finally, in agreement with the specificity towards posi­
tively charged substrates, (pro)enzymes acting on cationic sub­
strates show generally an higher affinity for benzamidine and 
its derivatives than Chymotrypsin and free trypsinogen.
SPECTRAL PROPERTIES OF SERINE (PRO)ENZYMES
Fig. 4 shows the effect of pH on the spectral properties 
of trypsin, between 230 and 330 nm. The pH dependent spectral 
changes of free (pro)enzymes acting on cationic substrates 
reflect the ionization of a single group with an average pK 
value of 4.5 (see Fig. 4). On the other hand the absorption 
spectra of Chymotrypsin, elastase and free trypsinogen are 
unaffected by pH in the same wavelength range (Ascenzi et al., 
1982; 1983a; 1983b; Antonini et al., 1982; 1983).
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FIG. 4: (a) pH difference spectrum of trypsin at 21+0.5°C and
1=0.1M. The reference solution was at pH 7.5 and sample solut­
ion was at pH 2.7. (b) pH titration of trypsin at 21+0.5°C and
1=0.1M. The fit of data with a simple pH transition yields a 
pK value of 4.5+0.1.
(Modified from Ascenzi et al., 1982).
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CONSIDERATIONS ON STRUCTURE-FUNCTION RELATIONSHIPS
From the inspection of Table 1, it may be observed that, 
in regard to substrate specificity, arginine derivatives are 
more sensitive substrates for p.p. and h.u. kallikrein, throm­
bin and Ancrhod than the corresponding ones of lysine. The 
greater fate of catalysis is reflected in higher values of 
k /K . Moreover, in the case of Ancrhod, is also probably 
refíec ted in the different effect of pH on values of K for the 
catalyzed hydrolysis of ZArgONp and ZLysONp. The catalytic pa­
rameters for the trypsin catalyzed hydrolysis of substrates 
containing arginine and lysine, are undistinguishable. On the 
other hand, urokinase shows more favourable steady-state para­
meters in the hydrolysis of lysine rather than arginine deri­
vatives. Chymotrypsin, elastase and free trypsinogen show no 
preference for cationic substrates and their catalysis is 
unaffected by ethylamine.
The rate limiting step in the catalyzed hydrolysis of 
ZLysONp, ZArgONp, or ZAlaONp in the presence of ethylamine, by 
serine (pro)enzymes acting on cationic substrates changes with 
pH. For all these (pro)enzymes, k+  ^ is rate limiting in cata­
lysis at pH ^4, whereas at pH ^.6, k becomes rate limiting.
On the other hand, the rate limiting step (k+2)> f°r the Chymo­
trypsin, elastase and free trypsinogen catalyzed hydrolysis of 
both cationic and neutral substrates does not change with pH.
The pH dependence of the ratio k /K (=k /K ) for the/ c cL l m I ^  , s ,catalyzed hydrolysis of ZLysONp by (pro)enzymes acting on catio- 
nie substrates indicates (according to Peller and Alberty, 1959) 
that the free form of the (pro)enzymes undergoes two pH tran­
sitions with pK values of about 4.5 and 7. On the other hand, 
Chymotrypsin, efastase and free trypsinogen undergo only one 
acid-alkaline transition with a pK value of about 7.
The increase of the value of K for the catalyzed hydro­
lysis of ZLysONp by serine (pro)enzymes acting on cationic sub­
strates (as well as of K for the Ancrhod catalyzed hydrolysis 
of ZArgONp and ZLysONp) from pH 6 to 4, reflects, according to 
linkage relations (Wyman, 1964), an acid-shift in the pK value 
of the acidic group (pK 4.5 in free (pro)enzymes) on binding
ZLysONp amounting to 0.?-1 pH units (as shown from the pH de­
pendences of k ) .
In addition, the effect of pH on the dissociation con­
stant for the binding of ethylamine and benzamidine to serine 
(pro)enzymes acting on cationic substrates, implies a pK -shift 
from 4.5 in free (pro)enzymes, to Ci 3.7 in the complexes.
The absorption spectra of the free (pro)enzymes acting 
on cationic substrates change with pH according to a simple ti­
tration curve with an average pK value of 4.5. The pH diffe­
rence absorption spectra of free (pro)enzymes acting on cationic
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TABLE 1
Values of k /K (pM s ) for the (pro)enzymatic hydrolysis of cationic and neutral substrates 
at pH 8 (phoipha^e buffer, 1=0.1M; T=21+0.5 C).
(Pro) enzymes __________________________________ Substrates_____________________________
ZGlyONp ZAlaONp ZLeuONp ZArgONp ZLysONp ZTyrONp
Elastase 8.3x1o"3 1.5x10_1 2.4x10_3 1.6x10~4 -41.5x10 1 . 2x10_5
P.p. kallikrein 9 .6x10-3 7.3x10~3 4.6x10~3 2.5 1.1x10_1 5.4x10~5
H.u. kallikrein 4,3x10~3 6.7x10~3 — 2.7 7.1x10_1 5.0x10~4
Thrombin 6.1x10~3 8.6x10~3 3.1x10~2 2.3 5.9x10_1 2.8x10-1
Ancrhod 4.2x1o”3 3.3x10_3 — 1 .7 1.8x10_1 1.3x10_2
Trypsin 4.1x10_2 5.9x10~2 6.4x10~2 1 .4 1 .4 3.6x10_1
Trypsinogen: H-Ile~Val-OH -41.2x10 1.4x10_4 3.2x10~3 2.3x10_3 3.0x10~3 1.2x10~3
Urokinase 2.1x10~3 2.4x10~3 4.2x10~4 to 00 X o
I U) 1.5x10_1 -42.5x10
Trypsinogen 2.2x10"5 1.8x10~ 3 -45.2x10 2.8x10 5 3.6x10~5 4.2x10_4
Chymotrypsin 1.6x10~2 2.0x1 o""2 6.4x10_1 5.3x10~2 5.4x10~2 2.3
substrates are also similar (Antonini et al., 1982; Ascenzi et 
al., 1982).
The data here reported indicate that steady-state and 
pre-steady-state parameters for the catalyzed hydrolysis of p- 
nitrophenyl esters examined by all serine (pro)enzymes are af­
fected by a common neutral ionization which probably reflects 
the acid-base equilibrium of His57, involved in the catalytic 
triad (Kraut, 1977). Moreover, as postulated from Kassera and 
Laidler (1969), only serine (pro)enzymes acting on cationic 
substrates, Ancrhod and H-Ile-Val-OH:trypsinogen adduct, contain 
a similarly located ionizable residue, of pK CV 4.5 , in free 
(pro) enzymes, and Oi 3.7 in their complexes, which affec-ts the 
binding of cationic substrates, ligands or inhibitors, the 
spectral properties and the rate limiting step in catalysis.
Such residue should be absent in Chymotrypsin and elastase and 
differently located in free trypsinogen. From the inspection of 
the amino acid sequences and of the three-dimensional structures 
of the serine (pro)enzymes examined (except Ancrhod) (Magnusson, 
1971; Birktoft and Blow, 1972; Huber and Bode, 1978; Sawyer et 
al., 1978; Bode, 1979; Lottspeich et al., 1979; Schaller et al., 
1982; Bode et al., 1983; Chen and Bode, 1983), the residue may 
be identified with Asp189 which is present in serine (pro)enzymes 
acting on cationic substrates and is replaced by a neutral serine 
in chymotrypsin and elastase.
The role of Asp189 on the catalytic, ligand binding and 
spectral properties of serine (pro)enzymes acting on cationic 
substrates is outlined from the effect of the dipeptide H-Ile- 
-Val-OH on the physico-chemical properties of trypsinogen. It 
is well known that in free trypsinogen, Asp189 is pointed out 
to the solvent and the specificity site disordered (Huber and 
Bode, 1978). The interaction of H-Ile-Val-OH, which mimics the 
two N-terminal residues of the activated trypsin, with Aap194 
of the (p-guanidinobenzoate:)trypsinogen(:bovine basic pancrea­
tic trypsin inhibitor £(pGB :) trypsinogen ( :BPTI)Q complex (es) is 
accompanied by a series of conformational changes in the (pGB:) -- 
-zymogen(:BPTI) complexes, which assume trypsin-like properties. 
In this respect in the H-Ile-Val-OH:trypsinogen:BPTI complex, 
Asp189 assumes a geometry closed to that of ß -trypsin and the 
specificity pocket becomes ordered (Huber and Bode, 1978; Bode,
1979) .
The high specificity of p.p. kallikrein for the ó~guani- 
dino group rather than the £-amino one and the peculiar pH de­
pendence of k+  ^ in the hydrolysis of ZLysONp have been related 
to the presence at the specificity site of this proteinase of 
a serine residue at position 226. In fact this residue cannot 
only make a hydrogen bond with Asp189, but also can partially 
shield this residue from the bulk water. Ser226 is replaced by 
a glycine in trypsin (Bode et al., 1 983; Chen and Bode, 1983) .
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The peculiar catalytic and ligand binding properties of 
elastase as compared to that of Chymotrypsin, have been related 
to the presence at the recognition site, of two residues showing 
an high steric hindrance, notably Val216 and Thr226. These re­
sidues are replaced by two glycine side chains in Chymotrypsin 
and trypsin (Sawyer et al., 1978).
Finally, a tentative assignment can be given also for the 
additional ionizing groups affecting polybenzamidine binding to 
serine (pro)enzymes acting on cationic substrates. On the basis 
of simple stereochemical consideration, drawn on the analogous 
three-dimensional structures of ^-trypsin and of sequence com­
parison (Huber and Bode, 1978; Magnusson, 1971), only Glu149 and 
Asp192 residues of thrombin seem to meet the requirement for 
productive binding of a second TAPP benzamidine substituent. 
These two residues are unique to thrombin, while no other nega­
tively charged side chains appear to be accessible to TAPP once 
one of its benzamidine moiety is bound into the enzyme specifi­
city pocket (Menegatti et al., 1 982) .
Acknowledgements: We wish to thank Prof. G. Amiconi who read the 
manuscript and offered constructive criticism.
REFERENCES
Antonini, E., and Ascenzi, P. (1981); The Mechanism of Trypsin 
Catalysis at low pH. Proposal for a Structural Model. J. Biol. 
Chem., 256, 12449-12455.
Antonini, E., Ascenzi, P., Menegatti, E., Bortolotti, F., and 
Guarneri, M. (1982); Catalytic Properties of Human Urinary Kal­
likrein. 1. Biochemistry, 21_, 2477-2482.
Antonini, E., Ascenzi, P., Bolognesi, M., Guarneri, M., Menegat­
ti, E., and Amiconi, G. (1983); Catalytic and Ligand Binding 
Properties of Bovine Trypsinogen and its Complex with the 
Effector Dipeptide Ile-Val. A Comparative Study. Mol. Cell. 
Biochem. (in press).
Ascenzi, P., Menegatti, E., Guarneri, M., Bortolotti, F., and 
Antonini, E. (1982); Catalytic Properties of Serine Proteases.
2. Comparison between Human Urinary Kallikrein, and Human Uro­
kinase, Bovine -Trypsin, Bovine Thrombin, and Bovine Ci-Chymo- 
trypsin. Biochemistry, 21, 2483-2490.
Ascenzi, P., Menegatti, E., Guarneri, M., and Antonini, E.
(1983a); Catalytic Properties of Porcine Pancreatic Elastase:
A Steady-state and Pre-steady-state Study. Mol. Cell. Biochem. 
(in press).
351
Ascenzi, P., Amiconi, G., Bolognesi, M., Guarneri, M., Menegat- 
ti, E., and Antonini, E. (1983b); The pH Dependence of Pre- 
-steady-state and Steady-state Kinetics for the Porcine Pan­
creatic j^-Kallikrein-B Catalyzed Hydrolysis of N- CL -carboben- 
zoxy-L-arginine p-nitrophenyl ester. Biochim. Biophys. Acta 
(submitted).
Birktoft, J.J., and Blow, D.M. (1972); Structure Crystalline 
Ci -Chymotrypsin. V. The Atomic Structure of Tosyl- CC -Chymo­
trypsin at 2 8 Resolution. J. Mol. Biol., 6_8, 1 87-240 .
Bode, W. (1979); The Transition of Bovine Trypsinogen to a
Trypsin-like State upon Strong Ligand Binding. II. The Binding 
of the Pancreatic Trypsin Inhibitor and of Isoleucine-Valine 
and of Sequentially Related Peptides to Trypsinogen and to 
p-Guanidinobenzoate-Trypsinogen. J. Mol. Biol., 127, 357-374.
Bode, W., Chen, Z., Bartels, K., Kutzbach, C., Schmidt-Kastner,
G., and Bartunik, H. (1983); Refined 2 A X-ray Crystal Struc­
ture of Porcine Pancreatic Kallikrein-A, a Specific Trypsin- 
-like Serine Proteinase. Crystallization, Structure Determi­
nation, Crystallographic Refinement, Structure and its Compa­
rison with Bovine Trypsin. J. Mol. Biol., 164, 237-282.
Chen, Z., and Bode, W. (1983); Refined 2.5 8 X-ray Crystal Struc­
ture of the Complex Formed by Porcine Kallikrein-A and the 
Bovine Pancreatic Trypsin Inhibitor. Crystallization, Patter­
son Search, Structure Determination, Refinement, Structure and 
Comparison with its Components and with the Bovine Trypsin- 
-Pancreatic Trypsin Inhibitor Complex. J. Mol. Biol., 164, 
283-311.
Gutfreund, H. (1972); Enzymes: Physical Principles. Wiley In­
terscience, London.
Huber, R., and Bode,'W. (1978); Structural Basis of the Acti­
vation of Trypsin. Acc. Chem. Res., 11, 114-122.
Kassera, H.P., and Laidler, K.J. (1969); Mechanisms of Action 
of Trypsin and Chymotrypsin. Can. J. Chem., 41_, 4031-4039.
Kassera, H.P., and Laidler, K.J. (1970); Transient-phase Studies 
of a Trypsin-catalyzed Reaction. Can. J. Chem., £8^ , 1 793-1802.
Kraut, J. (1977); Serine Proteases: Structure and Mechanism of 
Catalysis. Ann. Rev. Biochem., 4_6, 331 -358.
Lottspeich, F., Geiger, R., Henschen, A., and Kutzbach, C.
(1979); N-Terminal Amino Acid Sequence of Human Urinary Kal­
likrein. Homology with Other Serine Proteases. Hoppe-Seyler1s 
Z. Physiol. Chem., 360, 1947-1950.
Magnusson, S. (1971); Thrombin and Prothrombin. In: The Enzymes 
(Boyer P.D. ed.) Academic Press, New York and London, vol. 3, 
pp. 277-321 .
Menegatti, E., Guarneri, M., Ferroni, R., Bolognesi, M., Ascen­
zi, P., and Antonini, E. (1982); Tetra-p-amidinophenoxy-pro- 
pane as a Probe of the Specificity Site of Serine Proteases. 
FEBS Letters, 141, 33-36.
352
Peiler, L., and Alberty, R.A. (1959); Multiple Intermediates in 
Steady-state Enzyme Kinetics. I. The Mechanism Involving a 
Single Substrate and Product. J. Am. Chem. Soc., 81_, 5907- 
-5914.
Sawyer, L., Shotton, D.M., Campbell, J.W., Wendell, P.L., Muir- 
head, H., Watson, H.C., Diamond, R., and Ladner, R.C. (1978); 
The Atomic Structure of Crystalline Porcine Pancreatic Elasta 
se at 2.5 8 Resolution: Comparison with the Structure of CL- 
-Chymotrypsin. J. Mol. Biol., 113, 137-208.
Schaller, J., Nick, H., Rickli, E.E., Gillessen, D., Lergier, 
W., and Studer, R.O. (1982); Human Low-Molecular-Weight 
Urinary Urokinase. Partial Characterization and Preliminary 
Sequence Data of the Two Polypeptide Chains. Eur. J. Biochem. 
125, 251-257.
Wyman, J. (1964); Linked Functions and Reciprocal Effects in 
Hemoglobin: A Second Look. Adv. Protein. Chem., 19, 223-286.
353

Symposia Biologioa Hungarioa 25 (1984)
PRE-STEADY-STATE KINETIC ANALYSIS OF THE INTERACTION 
OF PROTEINASES WITH SLOW-BINDING INHIBITORS
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Department of Rheumatology, University Hospital 
Zurich, Switzerland
This report reviews a method for determining the rate 
constants for the formation and dissociation of a re­
versible enzyme-inhibitor complex, based on the analy­
sis of reaction progress curves. The concepts of slow- 
binding and tight-binding inhibition are discussed 
taking as example the cathepsin B-leupeptin system. 
Practical advices are given for a more general appli­
cation of the method in the field of proteinases.
INTRODUCTION
The reaction of proteinases with naturally occurring prote­
in inhibitors is usually characterized by a very high affinity 
between the reaction partners and the same is also valid for 
some low-molecular weight inhibitors.
Slow-binding and slow, tight-binding inhibiton processes 
represent probably a more generalized phenomenon than previous­
ly realized. For instance, the interaction of pepsin with peps- 
tatin (Rich and Sun 1980) and of cathepsin B with leupeptin 
(Baici and Gyger-Marazzi 1982) are two examples of slow, tight- 
binding inhibition. These two cases fit very well into the con­
cept of enzyme hysteresis (Frieden 1970). Recently, a slow, 
tight-binding mechanism was demonstrated for the inhibition of 
human leukocyte elastase by eglin, an inhibitor protein from 
the leech Himdo medioinalis (Baici and Seemüller 1983).
Slow processes characterize the binding of oxidized human 
plasma ai-proteinase inhibitor to human leukocyte elastase, of 
native human plasma ai-proteinase inhibitor to human pancreatic 
cationic trypsin, plasmin and thrombin (Beatty et ál. 1980), of 
human plasma inter-a-inhibitor to trypsin and Chymotrypsin 
(Aubry and Bieth 1976).
The knowledge of the detailed inhibition mechanism is of 
paramount importance in the field of proteinase inhibitors sin­
ce this is an elegant way to predict their physiological role.
In particular, not only Ky, but also the individual rate consta­
nts kon and kGff for formation and dissociation of the complex, 
respectively, should be taken into account (Bieth 1980).
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An indirect method using competition kinetics has been em­
ployed for measuring kon and kojr£ in the trypsin-pancreatic try­
psin inhibitor system (Vincent and Lazdunski 1972). The same 
technique has been succesfully applied to characterize the asso­
ciation of human leukocyte elastase with di-proteinase inhibitor 
by allowing this enzyme and bovine Chymotrypsin to compete for 
the binding with the inhibitor (Beatty et al. 1 980) . An extensi­
on of this method has keen reported by Gauthier et al. (1982) 
for determining the rate of association of human leukocyte ela­
stase with human bronchial inhibitor (leukocyte elastase was 
allowed to compete for the binding with aj-proteinase inhibitor 
and bronchial inhibitor and the residual ax-proteinase inhibitor 
was assayed with pancreatic elastase).
These methods are applicable as long as appropriate inhi­
bitors and competition systems are available for the enzyme con­
sidered .
The present report reviews a relatively simple technique, 
which is independent on coupled reactions, and allows the direct 
determination of the association and dissociation rate constants 
for enzyme-inhibitor systems characterized by a slow-binding or 
a slow, tight-binding process.
DEFINITIONS AND NOMENCLATURE
The nomenclature of slow-inhibition and tight-binding in­
hibition is not yet universally accepted. A criterion has been 
proposed by Agarwal et al. (1977) for classifying reversible en­
zyme inhibitors in three categories depending on the shape of 
reaction progress curves. To determine the class to which an in­
hibitor belongs, the enzyme is assayed in two ways: 1) enzyme 
and inhibitor are preincubated and the reaction is started by 
adding the substrate; 2) substrate and inhibitor are preincuba­
ted and the reaction is started with the enzyme. When the time 
courses of the two assays are identical the inhibitor is classi­
fied as readily reversible , when they are different but attain the 
same steady-state velocity within a reasonable period of time 
the inhibitor is called semi-tight-binding, and when the reaction 
profiles are different and do not attain the same steady-state 
velocity over a long period of time the inhibitor is said to be 
tight-binding. These definitions are justified by the fact that 
with increasing strength of interaction between enzyme and inhi­
bitor, a stage is reached in which the equilibrium of the reac­
tion can not be established rapidly.
In a concise review, Morrison (1982) pointed out that the 
slow establishment of equilibrium for the formation of an enzy­
me-inhibitor complex is not an unique feature of tight-binding 
inhibitors. In fact, tight-binding inhibitors are known, for 
which the formation of the El complex is a fast process and, 
conversely, slow-binding can occur without concomitant tight- 
binding (Williams et al. 1980, Williams and Morrison 1979). 
Therefore, other nomenclatures were proposed: slow, tight-binding 
as an equivalent of the above mentioned semi-tight-binding 
(Williams et al. 1 979) and very slow tight binding as a synonim of
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tight-binding (Williams and Morrison 1979). In any case, a sharp 
line of demarcation can not be drawn between various inhibitor 
classes because of the subjectivity in defining the time scale 
during which the inhibition process is observed and a critical 
Ki value which defines the limits of tight-binding and classical 
inhibition.
In this report the nomenclature proposed by Morrison (1982) is 
adopted and is schematically reproduced in Table 1.
TABLE 1
Classi fication of reversible enzyme i nhib itors .
Class of inhibitor
Relative concentrations 
of enzyme and inhibitor 
[E]„ and [ I]0
Rate of establishment 
of the equilibrium 
E + I El
Classical [ I] O »  [E]0 fast
Tight -binding [I]o = [E]0 fast
Slow-binding [I]o>> [E]o slow
Slow, tight-binding [I]o 3 [ E] o slow
THEORETICAL REMARKS
The treatment presented below applies to the model shown in 
Scheme 1, which represents a fully competitive, reversible in­
hibition mechanism. It is assumed that: a) Steady-state condi­
tions are reached rapidly between enzyme (E), substrate (S) and 
the ES complex, whereas a slow process characterizes the binding 
of inhibitor (I) to the enzyme; b) The reverse reaction (cataly­
tic step) is negligibly slow. Further necessary conditions, 
which can be realized experimentally, are: c) [E]0<<[I]0, which 
means also [I]0=[I]; d) [I]0>>Ki; e) [S]0» [ E ] 0; f) The experi­
ments are performed only while the conversion of substrate to pro­
duct has no effect on the reaction velocity (substrate depletion 
and accumulation of product).
E + S ES— ► .... — *■ E + Products
+
I
kon
Ki ko f f / k on
Scheme 1
El
Time-dependent equations for the mechanism in Scheme 1 and also 
for more complex systems have been reported (Cha 1975, 1976,
1980). In the general case (Cha 1980) the restrictions c) and d) 
above are not necessary, but in this case the graphical method 
described below is no longer applicable. This is due to the fact 
that for [E]0=[I]o there will be a substantial proportion of I
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bound in the El complex and the condition [I]0=[I] will no lon­
ger be valid. In this case, a factor accounting for the deple­
tion of free inhibitor can be introduced in the equations and 
calculations must be performed using computer iterative procedu­
res (Cha 1980, Williams et al. 1979). For the derivation of the 
basic rate equations the reader is referred to the cited litera­
ture. Since the algebraic symbolism used there is somewhat cum­
bersome for the treatment of Scheme 1, the equations described 
by Baici and Gyger-Marazzi (1982) will be adopted here.
There are two fundamental experimental conditions which can 
influence the shape of the reaction progress curve: Enzyme pre­
incubated or not preincubated with the inhibitor. The effect on 
the reaction profile will be macroscopic because the rate equa­
tion for the appearance of product contains also the [EI]0 term,
i.e. the concentration of the El complex at the beginning of the 
reaction. Typical curves for reversible slow-binding inhibition 
are shown in Fig. 1, while the integrated rate equations are:
v k v k [I] . ,[P] = - 2- 2*1 t + _o_on--- d.e-Xtj
X (1+a)X2
(1 )
v k v k ,,[P]* . -2-2ÍÍ t _ _2_off n _e-Xt) (2)
The asterisk in Eq. (2) and in the following expressions deno­
tes that the enzyme has been preincubated with inhibitor, whe­
reas symbols without asterisk mean no preincubation. v0 is the 
initial velocity in the absence of inhibitor, a=[S]/Kin and X is 
an apparent pseüdo-first-order rate constant which describes the 
exponential approach to the steady-state:
X [I] + k
1 + a off
(3)
After a given time the curvatures shown in Fig. 1B, C approach 
a linear steady-state phase and the exponential terms in Eqs.
(1) and (2) become negligibly small. Therefore the two equations 
can be rewritten as follows:
[P]
v k v k [I]o off . o on ------ t + --------
X (1 + a ) X 2
(4)
v k v k „
[Pj* = 0 off t - °- of-£ (5)
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Fig. 1. Proqress curves for slow-binding inhibition.(A) Control 
curve in the absence of inhibitor; (B) Inhibitor not 
preincubated with enzyme; (C) Enzyme and inhibitor pre­
incubated. Curves (B) and (C) were generated using Eqs. 
(1) and (2), respectively.
Equations (4) and (5) describe straight lines with the same slope 
and different intercepts. The slopes are equal to vj_, the inhi­
bited reaction velocity in the steady-state for fully competiti­
ve inhibition:
Slope = v^ =
v k o off
1
V[S]/K ______ m
+ m  + HiK K .
Equations (4) and (5) are very useful for the graphical calcula­
tion of the rate constants. Extrapolating back the linear porti­
ons of curves B and C in Fig. 1 we obtain intercepts with the 
[P]-axis:
I T
v k [I]o on
(1+a)X'
(6 )
v k o off
and intercepts with the time axis:
(7)
x
kon [I]
'off ( 1 + 0 ) X
(8)
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= 1 / X ( 9 )
V a r i o u s  c o m b i n a t i o n s  o f  E q s .  ( 6 ) - ( 9 )  a l l o w  t h e  c a l c u l a t i o n  
o f  k Q n , k  ^  a n d  EC . O f  t h e  s e v e r a l  p o s s i b l e  c o m b i n a t i o n s ,  t h e  
f o l l o w i n g  a r e  v e r y  u s e f u l .  F r o m  E^qs.  ( 8 )  a n d  ( 9 ) ,  i n t r o d u c i n g  
t h e  e x p l i c i t  f o r m u l a  f o r  X ( E q .  3 ) :
off
(1 0 )
T + T*
C o m b i n i n g  E q s .  ( 6 ) ,  ( 7 )  a n d  ( 1 0 ) :
if (1 + a )
o n
| í r *  ! ( t *  + I T I ) [ I ]
(1 1 )
S i n c e  T  a n d  i t *  a r e  n e g a t i v e  n u m b e r s ,  t h e i r  a b s o l u t e  v a l u e s  | t j  
a n d  I it*!  a r e  c o n s i d e r e d .  C o m b i n i n g  P q s .  ( 4 ) ,  ( 5 ) ,  ( 8 )  a n d  ( 9 ) :
v  -  v .  1 o 1
off (1 2 )
I n  s o m e  i n s t a n c e s  t h e  f o l l o w i n g  t r a n s f o r m a t i o n  o f  E q .  ( 6 )  c a n  
b e  u s e d  (w h e n  i t  a n d  X a r e  k n o w n  w i t h  p r e c i s i o n )  :
t t  ( 1  + a '  X 2
v o m
R e a r r a n g i n g  E q .  ( 8 )  i n t o  t h e  r e c i p r o c a l  f o r m  we o b t a i n :
1
K . k  „ ( 1 + 0 )  
l  o f f
1
[ I ]
+ k
o f f
(13)
( 1 4 )
T h u s ,  a  p l o t  o f  1 / | t | v e r s u s  1 / [ I ]  w i l l  g i v e  a  s t r a i g h t  l i n e  
w i t h  a n  o r d i n a t e  i n t e r c e p t  c o r r e s p o n d i n g  t o  k  ^  a n d  a b s c i s s a  
i n t e r c e p t  e q u a l  t o  - 1 / ( 1 + a ) K . .
T h e  v a l u e s  o f  t t  a n d  X t o  b e  u s e d  i n  E q .  ( 1 3 )  c a n  b e  o b t a i ­
n e d  w i t h  s u f f i c i e n t  a p p r o x i m a t i o n  f r o m  a  s e m i l o g a r i t h m i c  p l o t  
a c c o r d i n g  t o  G u g g e n h e i m  ( 1 9 2 6 )  a p p l i e d  t o  a  r e a c t i o n  p r o g r e s s  
c u r v e  s t a r t e d  b y  a d d i t i o n  o f  t h e  e n z y m e  ( F i g .  1 B ) .  I n  o r d e r  t o  
b e  s u c c e s s f u l ,  t h i s  a n a l y s i s  m u s t  b e  p e r f o r m e d  a t  t h e  v e r y  b e ­
g i n n i n g  o f  t h e  p r o g r e s s  c u r v e .  I n  o t h e r  w o r d s ,  t h e  s e m i l o g a r i t h ­
m i c  p l o t  s h o u l d  b e  m a d e  a t  t i m e  p o i n t s  f o r  w h i c h  t h e  f i r s t  t e r m  
o n  t h e  r i g h t  s i d e  o f  E q .  ( 1 )  i s  n e g l i g i b l e .  T h i s  m e t h o d  a l l o w s  
t h e  c a l c u l a t i o n  o f  t t  b y  m e a n s  o f  t h e  f o l l o w i n g  r e l a t i o n :
tnt
1 -  e
-X&t ( 1 5 )
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Where At is the time interval used for calculating the semiloga- 
rithmic plot and X and int are the slope and the intercept of 
the plot with the ordinate axis, respectively.
ANALYSIS OF A REAL CASE
The slow, tight-binding inhibition of cathepsin B by leupeptin.
Full details on the purification of human spleen cathepsin 
B and on the inhibition mechanism of this enzyme by leupeptin 
were reported by Baici and Gyger-Marazzi (1982). This system 
will be briefly discussed here to illustrate the procedures for 
calculating kQn and k ^  (Scheme 1) from progress curves.
Fig. 2 shows some profiles of reactions started by adding the 
enzyme. The substrate used was N-carbobenzoxy-L-phenylalanyl- 
L-arginine-7-amino-4-methylcoumarvlamide (Z-Phe-Arg-NMec) and 
the reaction conditions are given in the legend of the figure.
Fig. 2. Inhibition of human spleen cathepsin B by leupeptin.
The curves represent continuous-recording traces for the 
release of 7-amino-4-methylcoumarin monitored fluorime- 
trically. The solution contained 2.0 mM EDTA, 2.0 mM 
dithiothreitol, 0.18 mM Z-Phe-Arg-NMec in 0.1 M phospha­
te buffer, pH 6.00. Leupeptin concentrations were (nM):
0 (A) , 27 (B) , 44 (C) , 87 (D) and 148 (E) . Reactions 
were started by the addition of cathepsin B that was pre­
activated with 2.0 mM dithiothreitol for 15 min. The fi­
nal concentration of the enzyme was 0.22 nM, based on 
protein content and a molecular weight of 27,000.
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Fig. 3 shows experiments in which the enzyme was preincuba­
ted {curve C) or not preincubated (curve B) with the inhibitor 
and illustrates practically what is shown in the simulated cur­
ves in Fig. 1. From Fig. 2 we obtain the following information: 
1) The slppe of curve A corresponds to v0; 2) The slopes of the. 
linear parts of curves B-E correspond to the inhibited steady- 
state vélocities y.; 3) Extrapolating back the linear parts of 
curves B-E we obtain four values for t t  and t .  The reciprocals of 
the t values may be plotted versus the reciprocals of the corre­
sponding leupeptin concentrations (not shown) giving a straight 
line with an ordinate intercept of 7.9 x 10-l*s_l = kQff, and an 
abscissa intercept of -1.3 x 108M- 1 corresponding to -1/(1+a)K . 
Since K =0.23 mM and [S] = 0.18 mM (Baici and Gyger-Marazzi 
1982), m the ratio a = [S]/K = 0.78 and K. = 4.3 nM. 
Alternatively, k can be calculated by means of Eq. (12). 
k can now be calculated from K. and k or using Eq. (13)
wiSh the values of A and it  obtained from semilogarithmic plots.
-1 5 -1 0 -5 0 5 1 0 1 5 20
Time (min)
Fig. 3. Inhibition of human spleen cathepsin B by leupeptin.
(A) No inhibitor added; (B) and (C) leupeptin 44 nM. 
In curve B the reaction was started by adding the en­
zyme and in curve C by adding the substrate (preincu­
bation of enzyme and inhibitor for 20 min). All other 
conditions as in Fig. 2.
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The information given b y  Fig. 3 is manyfold: t t  = 1.26 yM,
| TT* | = 0.22 yM, | t | + t* = 1 269 s. From these values kon and 
kQff can be calculated with the aid of Eqs. (11) and (10), resp­
ectively: kQn = 1.82 x 1 05 M-1s-1; ^Qff = 7.88 x 10~‘*s~1;
K. = k ,,-/k = 4.3 nM.l off on
From the calculations above it is evident that the analysis
has a high degree of internal consistency. Several experiments 
as those shown in Figs. 2 and 3 afforded the following average 
values ± S.D.: kon = 1.8 ± 0.1 x 10s M-1s-1;k0ff = 7.9 ± 0.1 x 
10“* s-1;K. = 4.4 ± 0.3 nM.l
For the cathepsin B-leupeptin system it has been also pos­
sible to measure using a classical steady-state approach. 
Using the specific velocity plot (Baici 1981) a value of 
5.0 ± 0.4 nM could be calculated (Baici and Gyger-Marazzi 1982) 
This value is in reasonable agreement with the figure of 4.4 nM 
obtained by pre-steady-state analysis and suggests that k and
k were determined correctly, off 1
C R I T I C I S M ,  COMMENTS AND PRACTICAL ADVICES
The success of the pre-steady-state kinetic analysis disc­
ussed above is subordinated to several factors. As explained in 
the theoretical part, no limitations are set as concerns the 
relative concentrations of enzyme and inhibitor if the complete 
equation is used (Cha 1980). This method implies the use of a 
statistical approach using computer techniques which may not be 
accessible to all investigators. The recent progress made in the 
synthesis of peptide substrates having very sensitive fluoroge- 
nic leaving groups (most notably peptide substrates containing 
7-amino-4-methylcoumarin) offers powerful assay methods for the 
assay of several proteinases. Owing to the high sensitivity of 
the fluorimetric technique, the condition [E]o<<[I]0 can proba­
bly be realized for several slow, tight-binding proteinase in­
hibitor systems. The lower limit of enzyme concentrations which 
can be used will depend on the stability of the enzymes in very 
diluted solution (denaturation, adsorption, etc.).
W h e n e v e r  p o s s i b l e ,  e x p e r i m e n t s  s h o u l d  b e  p e r f o r m e d  u s i n g  a  
s e n s i t i v e  f l u o r o g e n i c  s u b s t r a t e  a n d  a t  i n h i b i t o r  c o n c e n t r a t i o n s  
w h i c h  a r e  t e n  o r  m o r e  t i m e s  t h a t  o f  t h e  e n z y m e :  I n  t h i s  w a y  t h e  
t i g t h - b i n d i n g  c o n d i t i o n  w i l l  b e  e l e g a n t l y  c i r c u m v e n t e d  a n d  t h e  
s l o w - b i n d i n g  p r o c e s s  c a n  b e  e a s i l y  a n a l y s e d .  O f  c o u r s e ,  c o n t i n u ­
o u s  m o n i t o r i n g  o f  t h e  r e a c t i o n  i s  e s s e n t i a l .
It is very important that the slow kinetics are studied 
under conditions in which substrate depletion and product accu­
mulation are negligible (in other words, the control curve A in 
Fig. 1 should be observed and must remain linear for a time 
corresponding to that of curves B and C). The occurrence of a 
linear steady-state after the lag phases (Fig. 1 B, C) is a de­
monstration that the slow-binding process is reversible.
By inspection of Fig. 1 and Eqs. (6)-(9) it is clear that 
it* and t* can be determined with less precision than tt and x. 
In particular, for relatively high inhibitor concentrations, 
both t t *  and x* become very small. On the contrary, experiments 
in which the reaction is started by adding the enzyme [Eqs. (1) 
and (4), Fig. 1B] give more accurate results, as it has been ve­
rified experimentally (Baici and Gyger-Marazzi 1982, Baici and 
Seemüller 1983, Hanozet et ál. 1981). For this reason, the calcu­
lation of kon and kDff by using equations requiring the concomi­
tant presence of x *  and tt* with x and/or n [as Eq. (11)] should
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only be performed if x *  and i t *  can b e  measured with high accura­
cy.
The use of Eq. (13) requires careful attention. In fact, it 
can be criticized that the values of n and A are obtained using 
the semilogarithmic plot proposed by Guggenheim (1926) to analy­
se first—order reaction kinetics. Strictly speaking, this method 
is exactly applicable to a purely exponential reaction profile, 
whereas Eq. (1) (Fig. 1B) is the sum of an exponential term and 
of a linear term. However, if the analysis is made using the 
very beginning of the progress curve, the exponential term in 
Eq. (1) will be much greater than the linear one, thus justify­
ing the approximation. The following are controls for internal 
consistency: 1) The semilogarithmic plot is a straight line only 
if the method is correctly applied or is curved upwards if the 
time interval used is too large; 2) The value of tt can be compa­
red with that obtained by extrapolation of the steady-state cur­
ve. Using simulated curves it could be verified that this appro­
ximation gives kon values within 3% of the true value when [I] 
is at least 10K^, and the precision increases with increasing 
[I]/K-l ratio. Thus, the uncertainty introduced in the determi­
nation of kon by using Eq. (13) is certainly less than the ove­
rall experimental error.
Besides the relatively simple competitive mechanism shown 
in Scheme 1 other pathways implying slow-binding or slow, tight- 
binding inhibition could exist. General expressions for non-com­
petitive and uncompetitive inhibition and an extension of the 
rate equation to two-substrate reactions have been analysed by 
Cha (1980). Also for these mechanisms the graphical method can 
be used if the conditions above apply.
CONCLUDING REMARKS
The pre-steady-state kinetic analysis of progress curves 
for reactions involving slow, (tight)-binding inhibitors offers 
a relatively simple tool for evaluating the individual rate con­
stants of the inhibition process.
The importance of knowing kon and k0f£ for El formation and 
dissociation has been emphasized by Bieth (1980) and will be no 
longer discussed here. The only concept I .would like to remember 
is that kon is a direct measure of the time required for a pro­
teinase to be inhibited in vivo. Thus, an inhibitor, although 
efficient in vitro, may be physiologically irrelevant if its con­
centration is insufficient to achieve a sufficiently rapid en­
counter with the enzyme. The cathepsin B-leupeptin system analy­
sed above illustrates well this concept. From K-^  s 5 nM we would 
suppose that a tenfold excess of leupeptin over this value could 
effectively inhibit cathepsin B. However, from kon = 2 x 105 
M_1s-1and a leupeptin concentration of 50 nM, we can calculate 
a delay time for inhibition of 500 s, which is about 8 minutes 
[delay time for inhibition = 5 x ti/2 = 5/(kon[I]}(Bieth 1980)]. 
In order for leupeptin to be a physiologically significant in­
hibitor of cathepsin B, its concentration at the target site 
must be at least 10 pM (binding faster than 2s), otherwise the 
extracellularly released enzyme will bind its natural substrates
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1faster than the inhibitors.
In the past history of enzymology, a relatively limited 
number of detailed studies have been made using the kinetic 
approach outlined in this paper. In the particular field of pro­
teinase inhibitor^ the concepts of slow-binding, tight-binding 
and slow, tight-binding inhibition were discussed in only few 
cases. It is well possible that several pertinent examples have 
been overlooked or not sufficiently analysed in the literature.
The slow process accompanying tight-binding inhibition may 
in several instances be a manifestation of enzyme hysteresis 
(Frieden 1970) and, therefore, may be related to some important 
regulatory function of the enzyme-inhibitor system.
From the mechanistic point of view, slow, tight-binding 
proteinase inhibition may involve slow interactions of E and I 
or slow isomerizations of rapidly formed El complexes. Further­
more, transition state analogues may give rise to kinetic patt­
erns falling in the category of slow, tight-binding inhibition. 
An accurate analysis of the pre-steady-state kinetics will cer­
tainly help interpreting these features.
I suggest that the concepts of slow-binding inhibition, 
slow, tight-binding inhibition and enzyme hysteresis be reeva­
luated, correctly used and, in the pertinent cases, be introdu­
ced in the current terminology of proteinase inhibitors.
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DISCUSSION
TURK:
Did you compare your experimental results with those 
obtained by the classical method?
BAICI:
Yes, I did. In the case of cathepsin B-leupeptin system 
the agreement between K^'s from pre-steady-state and from 
steady-state analysis is satisfactory (4.4±0.3 nM com­
pared with 5.0±0.4 nM). The agreement was also satisfac­
tory for the elastase-eglin system (0.8 nM from pre-steady- 
state compared with a value of 0.5-1.5 nM from steady- 
state analysis).
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INTRODUCTION
Severe injury or infection trigger the so-called inflammatory 
response of the organism. This response includes besides other 
reactions the activation of Immoral systems such as clotting, 
fibrinolysis, complement and kall ikrein-kinin cascades, and of 
various cellular' systems, especially of phagocytes, mast cells 
and lymphocytes, but also of stress hormone producing cells.
Phagocytes such as polymorphonuclear granulocytes and macro­
phages contain high numbers of lysosomes equipped with a power­
ful hydrolytic or proteolytic potential (Dingle, 1977). Nor­
mally the call uses this enzyme equipment, in addition to oxi­
dizing .agents, lor mainly two purposes (Klebanoff and Clark,
1 f) 7 C ) :
(i) the maintenance of the intracellular protein catabolism in­
cluding the degradation of wasted endogenous substances, and
(ii) the defense of invasive organisms by degradation after 
phagocytosis of viruses and bacteria.
If released extracellularly, they may enhance the inflammatory 
response via two major routes (Fig. 1):
An extented version of this article will be published in Cli­
nical Chemistry (H. Fritz et al.: Granulocyte Proteinases as 
Mediators of Unspecific Proteolysis in Inflammation. A Review).
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Granulocytes Macrophages Endothelial cells Mast cells
; I i_ _ _ _ _ _ _ _ _ _ i___
L i b e r a t i o n  of P r o t e i  n a s e s
1
S e l e c t i v e  p r o t e o l y s i s
J
Uns pe c i f i c  p r o t e o l y s i s
• proenzyme/cofactor activation • inactivation by degradation
" biol active peptides released • toxic peptides produced
Specific consumption reaction Unspecific consumption reaction
E + I [El ] AT m acti„!!2i!=ü*ATminnctlít
Fig. 1. Proteolytic processes due to liberation of lysosomal 
proteinases from various body cells.
Selective proteolysis leads to proenzyme and/or cofactor acti­
vation including the formation of biologically highly potent 
peptides, as for example kinins and anaphylatoxins. The pro­
teinases formed are eliminated by specific interactions with 
their target inhibitor proteins. Hence, reaction mechanisms 
of high selectivity are responsible for the so-called specific 
consumpt ion of factors of the clotting, fibrinolysis, comple­
ment and kallikrein-kinin cascades.
Unspecific proteolysis means inactivation of soluble factors or 
destruction of structural elements simply by proteolytic di­
gestion. Such unspecific consumption reactions may be accom­
panied also by the production of toxic peptides like, for ex­
ample, the clot formation inhibiting fibrin/fibrinogen degra­
dation products.
LYSOSOMAL PROTEINASES
Of the lysosomal proteinases known so far, elastase and
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cathepsin G, the neutral proteinases from polymorphonuclear 
granulocytes, deserve special interest. Like the acidic thiol 
and aspartate proteinases, the various cathepsins, they are 
stored in the lysosomes in fully active form. The most strik­
ing feature of both, elastase and the chymotrypsin-like cathep­
sin G, is an almost unlimited cleavjage specifity (Fig. 2).
Lysosomal Proteinases (preformed)
neutral (pH 6-9)
• Elastases
• Cathepsin G
° Collagenases
0 Kininogenases 
(Kallikreins)
cleavage specificity:
acidic (pH 3-7)
• Cathepsin B
• Cathepsins H, L
• Cathepsins A, C
• Cathepsin D 
(Leukokininogenase)
* broad; ° high
Fig. 2. Lysosomal proteinases of neutrophils.
They are able to degrade numerous humoral factors including 
proteinase inhibitors as well as structural elements like 
elastic and collagen type III and IV at physiological pH. The 
potential lysosomal digestion capacity in humans is clearly 
demonstrated by the calculated synthesis rate of more than 1 g 
of neutral proteinases per day. However, inside the cells, the 
lysosomal proteinases are kept under control by either assem­
blage in membrane coated organelles or by proteinase inhibi­
tors present in the cytosol.
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PLASMA PROTEINASE INHIBITORS
Lysosomal proteinases escaping from their natural target cells 
are faced usually with potent antagonists, the wellknown pro­
teinase inhibitor proteins (Travis and Salvesen, 1983).
cx_,-Macroglobulin (cc^ M) inhibits effectively serine proteinases 
as well as thiol, aspartate and metallo proteinases,- due to 
its high molecular weight, its function is normally restricted 
to the vascular bed.
-Proteinase inhibitor (cx^ PI), the major antagonist of the 
lysosomal neutrophil elastase, is present in remarkable high 
concentration in blood, but occurs also in interstitial fluid 
and mucous secretions.
-Antichymotrypsin (a^AC), a rapidly responding acute phase 
reactant - it can reach up to six times its normal concentra­
tion during the inflammatory response - is a potent inhibitor 
of lysosomal neutrophil cathepsin G and mast cell chymase.
Compared to q^PI and ct^ AC, the plasma concentrations of the 
other given inhibitors are clearly lower. Nevertheless, the 
proteinase inhibitor proteins represent approximately 60 % of 
the residual plasma proteins after removal of albumin and the 
immunoglobulins. This is an indirect indication upon the sig­
nificance of proteinase inhibitors as regulatory proteins of 
the organism.
The association between known plasma proteinase inhibitors and 
their target enzymes is schematicá1ly compiled in Fig. 3.
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Fig. 3. Activation and consumption reactions: specific acti­
vation of blood systems by system-specific proteinases (left 
part); unspecific degradation of plasma factors by lysosomal 
proteinases (right part); complex formation with proteinase 
inhibitors and elimination of the enzyme-inhibitor complexes 
by phagocytes of the reticulo endothelial system (RES; cen­
tral part).
Excessive activation of blood systems may be controlled pri­
marily by three inhibitors: antithrombin III (AT III) regulates 
clotting, cr,-plasmin inhibitor (a^PI) fibrinolysis, and C1- in­
activator (C1-INA) both, the classical complement pathway and 
the intrinsic coagulation cascade, the latter by inhibition of 
plasma kallikrein and Hageman factor, respectively its low 
molecular weight fragment.
The occurrence of complexes between a^-macroglobulin and plasma 
kall'ikrein or plasmin in plasma under certain pathological con­
ditions indicates that this multifunctional glycoprotein is 
also involved in the regulation of the blood system cascades. 
However, present evidence suggests a predominant protective
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role of a^-macroglobulin in prevention of unspecific proteo-, 
lysis by inhibition of all types of liberated lysosomal pro- 
teinases. Remarkable, in humans is, in contrast to a^PI
and o^AC, not an acute phase reactant, although it is supposed 
to be the most important endogenous plasma proteinase inhibitor.
Inhibition of activated or liberated proteinases by the given 
inhibitors means that formation of vasoactive or toxic pep­
tides such as kinins or anaphylatoxins as well as proteolysis- 
induced stimulation of cellular systems like, for example, 
thrombin-indueed platelet aggregation or the anaphylatoxin- 
induced chemotactic response of granulocytes, is also depres­
sed. Therefore, reduction of the proteinase inhibitory potential 
of the organism by unspecific proteolysis represents one of the 
most striking pathological effects caused by lysosomal protein­
ases. As we could show some years ago, AT III, for example, is 
rapidly inactivated in the presence of catalytic amounts of 
neutrophil elastase (Jochum et al., 1991 a).
The same holds true for cx^ PI and C1-INA (Brower and. Harpel, 
1962). Even- a PI, the major antagonist of neutrophil elastase, 
can be proteolytically inactivated by a lysosomal metallo en­
zyme from macrophages (Bandaet al., 1950). Moreover, oxidation 
of the methionine residue in the enzyme-reactive site of - 
proteinase inhibitor leads to a significant reduction of the 
affinity of this inhibitor to neutrophil elastase (Beatty et 
al., 1980). Such oxidizing agents, for example, Superoxide, 
hydroxyl radicals and hydrogen peroxide, are produced in high 
amounts in the phagolysosomes to facilitate intracellular pro­
tein breakdown and may be released simultaneously with the 
lysosomal enzymes under pathological conditions (Klebanoff and 
Clark, 1978).
Hence, severe injury or infection can induce consumption of 
proteinase inhibitor proteins via three pathways:
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(i) complex formation with liberated lysosomal or activated 
plasma proteinases,
(ill inactivation by proteolytic degradation, and 
(iii) inactivation by oxidative denaturat ion.
The latter mechanism deserves special interest in view of the 
proposed pathological effectiveness of neutrophil elastase. 
Although the oxidized -proteinase inhibitor is still capable 
to react slowly with neutrophil elastase, the complex thus for­
med is readily dissociated by substrates exhibiting high affi­
nity for elastase, for example, elastin, that means, the oxidi­
zed inhibitor cannot hinder elastase to digest natural target 
substrates. Remarkable, in contrast to the native inhibitor, 
oxidized a -proteinase inhibitor does not react at all with 
pancreatic elastase.
RELEASING PROCESSES AND MEASUREMENT OF LIBERATED LYSOSOMAL 
PROTEINASES
Most intriguing is the question concerning the mechanisms re­
sponsible for a more or less dramatic escape of lysosomal 
factors from within the cells (Fig. 4).
Whereas only small amounts should leak out during normal phago­
cytosis, relatively high amounts could be excreted during frus­
trated phagocytosis when the phagocyte is unable to take up a 
comparatively huge structural element, as for example a vas­
cular plasma membrane or parts of cartilage. Disintegration 
processes caused by endogenous or exogenous endotoxins, even­
tually in combination with complement lysis, are most dramatic 
events leading to release of all lysosomal or phagolysosomal 
constituents.
Neutrophil elastase liberated under such conditions is present 
in the circulation primarily in form of the elastase-a^-protein­
ase inhibitor (E-a PI) complex (Fig. 5). A small amount of neu­
trophil elastase may be bound also to a^-macroglobulin (a^M), 
however, compared to the E-a.jPI complex the E-a?M complex is
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much more rapidly eliminated frc»:; the circulation (t^y7 10
min versus t ^ ^  1 h) so that estimation of E-cx^ M complexes in
plasma needs special assays of extreme sens it iv ity_.
Mechanisms Enabling Lysosomal Proteinase Release 
Phagocytotic Processes
* regurgitation during feeding" or " f ru s tr a te d  p h ag o cy to sis"
««•bran» surfot*
Disintegration Processes
( e g of membrán« by endotoxins, complement lysis )
"cell d e a th "  or " perforation from within"
Fig. 4. Various releasing processes of lysosomal proteinases 
from within the cell.
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Fig. 5. Liberation of lysosomal elastase (E) due to different 
stimuli and complex formation with -proteinase inhibitor 
(a^PI) as well as (to a much less extent) a^-macroglobulin
(a2m.
E-g^PI levels (Fig. 6) can be measured exactly with a newly 
developed enzyme-linked immunoassay (Neumann et al., 1981). 
Briefly, plasma samples or other body fluids are incubated in 
plastic tubes coated with sheep antibodies directed against 
human neutrophil elastase. After two washing steps, the surfa­
ce-fixed E-a^PI complex is exposed to rabbit antibodies direc­
ted against human a^PI. These antibodies are labelled with al­
kaline phosphatase. Under the conditions used, the amount of 
bound alkaline phosphatase is proportional to the concentration 
of E-a^PI in the applied sample.
M S  * O ©
ab to + etastase 
elastase «1 PJ 
complex
ab-E/E-a^PJ + abtoa^-PJ
labelled with alkaline 
phosphatase ( A P !
ab-E /E-aiPJ/aba, PJ (-API
t
substrate
product
photometer 
0 0  4 0 5
Fig. 6. Principle of the enzyme-linked immunoassay used for 
determination of the elastase-a^-proteinase inhibitor complex 
(E-a1PI 3.
ab-E = antibodies against human granulocytic elastase 
ab-a^PI (-AP) = antibodies against human -proteinase inhi­
bitor, labelled with alkaline phosphatase.
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CLINICAL STUDIES
Multiple organ failure during severe inflammation or after 
polytrauma concerns primarily lungs, liver and kidneys. These 
organs are especially rich in the formerly mentioned cells con­
taining high numbers of lysosomes. In addition, rapid accumu­
lation of polymorphonuclear granulocytes in the lungs during 
the inflammatory response is also a well-known phenomenon. 
Hence, a connection between the clinically observed sequence 
of organ failure and the inherent lysosomal functional capa­
city of an organ should be seriously considered.
Neutrophil elastase release after major abdominal surgery
In our first prospective clinical study the plasma levels of 
the E-cc^ PI complex were measured in suitable intervals in more 
than 120 patients subjected to major abdominal surgery followed 
either by uncomplicated recovery or infection. Of the latter 
group, only 30 patients fulfilled previously defined and ge­
nerally accepted septic criteria (Jochum et al., 1983). Of 
these patients fourteen survived the infection (group B), 
whereas sixteen died due to severe septicemia (group C). The 
eleven patients of the control group A recovered from the 
operation without complications.
Compared to healthy individuals or preoperative values 
(below 110 ng/ml), the operative trauma caused an up to three­
fold increase of the E-a^PI plasma levels (Fig. 7).
The elevated preoperative mean value of group C was caused by 
6 patients being infected already before operation; the slight 
early postoperative decrease was probably due to surgical eli­
mination of the infection focus.
In contrast to group A, group B and C patients maintained 
moderately elevated E-oi^ PI levels for several days after oper­
ation. At the time of diagnosis of septicemia, highly signifi­
cantly elevated E-a^PI levels were measured corresponding to
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an up to sixfold respectively tenfold increase in group B and
C. Individual peak levels were found to be as high as 2 500 ng/ 
ml in both groups.
b e f o r e  o p  a f t e r  o p .  b e f o r e  o n s e t  c o u r s e  D  R  D  
s e p s i s  o f  s e p s i s  o f  s e p s i s
A 8 as. as p<0 .0005  -  p <0.0025
A C p< 0.025 p< 0.0l p< Ó.0005 ~  p<0.0005 P<0.012
B : C p <  0.025 as. p<  0.0125 as. p<0.0005 p <0 .0 !25
Fig. 7. Plasma levels of elastase-a^-proteinase inhibitor 
complex [E-a^PI) in patients subjected to major abdominal sur­
gery .
A = patients (n = 11) being without postoperative infection
B = patients (n = 14) surviving postoperative septicemia
C = patients (n = 16) dying as a result of septicemia.
The E-a^PI levels are given as mean values (- SEM) for the day 
before operation, the day after operation as well as for the 
postoperative phase before sepsis, at onset of sepsis and du­
ring septicemia. Last determination were done on day of dis­
charge (D) for group A, on day of recovery (R) for group B, 
and before death (0 or | ) for group C.
nv = normal value
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Most interestingly, in patients with persisting septicemia the 
E-a^PI levels remained high until lethal outcome (group C) 
whereas recovery from septicemia was reflected by a concomi­
tant decrease of the E-cx^ PI levels to the normal range.
Parallel to the E-a^PI levels the plasma concentrations of 
other factors, expected to show a typical response to inflam­
matory stimuli, were also measured. The concentration pattern 
of antithrombin III, the most important regulatory inhibitor 
protein of the clotting cascade, turned out to be just opposite 
to that of the E-a^PI complex (Fig. 8). Especially at onset of 
sepsis and during septicemia, antithrombin III levels are rea­
ched, which have to be considered as clinically critical as 
far as the risk of hypercoagulability or disseminated intra­
vascular coagulation is concerned.
‘ AT III 120.
c‘- v>ßv?,
Fig. 8. Plasma levels of 
the inhibitory activity of 
antithrombin III (AT III) 
compared to the amount of 
the elastase-a.^-proteinase 
inhibitor complex (E-a^PI) 
in patients subjected to 
major abdominal surgery.
For details, see legend to 
Fig. 7.
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The concentration patterns found for coagulation factor XIII 
(F XIII), the fibrin stabilizing transglutaminase, and a^~ 
macroglobulin were very similar to that of antithrombin III, 
as summarized in Fig. 9:
Plasma levels, elevated ( I ) or decreased ( I ): 
( M) highly signif. (I) signif. (n) normal
Parameter Sepsis Prefinal Survival
E- ex, PI complex c ♦1 n
Antithrombin ID a ll II n
Factor Xffl a II ll n
ocj- Macroglobulin a ll ll n
c ll ll n-|
C- reactive protein c ft it n
ot, - Proteinase inhibitor a "M n-f n-f
0,2-Ptasmin inhibitor Q n n n
a ,  -Antichymotrypsin c i n n
C1 Inactivator a n-f n n-f
c n n n
a activity assay c concentration assay
Fig. 9. Correlation bet­
ween plasma levels of 
E-a^PI and other plasma 
factors in patients suf­
fering from septicemia 
after major abdominal sur­
gery .
High levels of E-a^PI were found at onset of sepsis and prefi- 
nalj these values normalized in survivors. Simultanously, low 
levels of AT III, a^M and F XIII occurred in sepsis and pre- 
final, whereas they normalized in survivors. The levels of the 
acute phase reactant C-reactive protein (CRP) paralleled main­
ly the E-a^PI, but turned out to reflect the course of sepsis 
much less specifically.
In contrast, the other given proteinase inhibitors did not show 
significant correlations to E-a^PI. This behaviour might be es­
pecially caused by the fact that these proteinase inhibitors
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are acute phase reactants as well. Therefore, the consumption 
of the inhibitors due to complex formation with their target 
enzymes or other inactivation reactions might be compensated 
by the enhanced production of these proteins during inflam­
mation .
Summing up, the results of this clinical study clearly showed 
that in inflammatory diseases a correlation exists between the 
release of a lysosomal enzyme marker, the neutrophil elastase, 
and the clinical situation of the patient, respectively the 
consumption of selected plasma factors. We take this as a clear 
indication that liberated lysosomal factors and especially neu­
trophil proteinases contribute significantly to the inflamma­
tory response of the organism by unspecific degradation of plas­
ma and other factors. This view is also supported by results of 
experimental animal studies performed more recently (dochum et 
al., 1981b]. Early application of potent exogenous proteinase 
inhibitors could prevent or at least diminish highly signifi­
cantly endotoxin-induced consumption of various plasma factors 
including AT III and F XIII.
Neutrophil elastase release after polytrauma
In a preliminary study release of granulocytic elastase into 
plasma was followed up every 4 hours in patients who suffered 
from multiple trauma. The increase of the E-a^PI complex up to
16 hours after accident coincided clearly with the severity of 
the injury (Fig. 10), the degree of injury being established 
on the basis of a hospital internal scale ranging from 1 - 2 0  
points. Group I patients (5 to 7 points) showed a maximal in­
crease of E-a^PI up to 5-fold above normal values and group II 
patients (9 to 11 points) up to 10-fold. In group III (14 to
17 points) peak levels higher than 20-fold above normal were 
measured. During the further observation period (up to 100 h) 
a significant decrease of E-a^PI plasma levels towards normal 
values was observed in all patients.
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Ill (n= 4)
II (n = 11) 
I (r» = 12)
Fig. 10. Plasma levels of E-oi^ PI complex in patients after 
multiple trauma. On the basis of a hospital ^internal £cale with 
20 £oints (HISP) patients were allied to 3 groups reflecting 
the severity of injury (I milde; II severe; III highly severe):
Group pat ients (n) HISP
I 12 6.3 + o CD
II 11 10.0 + 1 .0
III 4 15.3 + 1 . 0
Normal range of E-<X|PI: BO - 110 ng/ml
Surprisingly, no correlation between the amount of complexed 
elastase and other plasma factors, e. g. antithrombin III, fac­
tor XIII, prothrombin, a^-macroglobu1 in, plasminogen, and 
a^-antiplasmiri could be demonstrated so far.
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To see, whether this might be due to massive blood transfusions 
in polytrauma patients, we measured the activities of several 
plasma proteins in stored blood as a function of the storage 
period. The activities of the plasma proteins antithrombin III, 
prothrombin and oC~macroglobulin were in the range of normal 
freshly drawn blood and stayed quite stable throughout the sto­
rage period, whereas the complexed elastase increased consi­
derably up to more than 60-fold of normal within 35 days (data 
not shown). From these observations and the results seen in 
polytrauma patients we draw two conclusions:
(i) Due to massive blood transfusions and relatively long half 
life periods of the blood proteins probably also in the circu­
lation, the concentration of these factors in patients'plasma 
are nearly not influenced by the early endogenous liberation
of granulocytic elastase after polytrauma.
(ii) High levels of complexed elastase in patients’ plasma 
might be also caused by blood transfusions.
However, in a more detailed investigation comparison of the 
E-CX^ PI levels in patients’ plasma with hypothetic levels - 
considering both: the amount of complexed elastase administered 
with the transfused blood and the elimination of the complex 
from the circulation (t^^ approx. 1 h) - showed no coin­
cidence at all. Probably, in patients receiving massive blood 
transfusions a relationship between neutrophil elastase re­
lease and consumption of humoral factors is measurable only lo­
cally, e. g .  in lung lavage fluid or blood samples of the 
wounded or inflamed area. Nevertheless, the high E-DC^ PI levels 
occuring in severely injured patients are a clear indication 
of a strong inflammatory response ongoing in the organism.
CONCLUSIONS
In severe inflammatory processes,mu It iple trauma or shock var­
ious cells like neutrophils, macrophages, endothelial cells and 
mast cells are stimulated or disintegrated. In this way a high
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potential of lysosomal enzymes is released of which the pro- 
teinases are of special pathogenic effectiveness. Recent stu­
dies in our laboratory and by others (Egbring at al., 1977) in­
dicate strongly that substrate-unspecific proteolysis by lyso­
somal proteinases, especially by the neutrophil elastase, con­
tributes to a significant degree to the consu ption and/or de­
gradation of extracellular substances in such diseases. The 
amount of the E-a^PI complex reflects the intensity of both 
the inflammatory stimulus and the response of the neutrophils. 
Hence, in most cases an increase of the E-a^PI level in the 
circulation represents a systemic signal of a local inflam­
matory event. Therefore, the clinical situation of the pa­
tient has to be carefully considered for diagnostic interpre­
tation of E-a^PI levels in plasma. Neverthe ess, to avoid a 
deleterious endogenous proteinase-proteinac. inhibitor imba­
lance, early administration of convenient exogenous inhibitors 
directed against lysosomal enzymes should have a positive 
therapeutic effect also in humans.
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DISCUSSION
ELŐDI, S.:
Did you measure the amount of AT-III in septic patients?
If the amount of antigen is in the normal range, one could 
differentiate whether the decreased activity is either 
due to consumption or to proteolytic damage on the in­
hibitor, since AT-III modified by proteolysis may still 
hold antigenic properties.
JOCHUM:
Unfortunately, immunological methods such as one- or two- 
dimensional immunoelectrophoresis can not differentiate 
between antithrombin III complexed with thrombin and anti­
thrombin III degraded by elastase. We have done these 
experiments several years ago.
BOHLEY:
I wonder in what kind of lysosomes metallo-prcteinases may 
occur.
JOCHUM:
It was reported that macrophages contain an elastase-like 
proteinase which was identified as a metallo-proteinase.
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EGBRING, R., SEITZ, R., KRÜGER, J., KARGES, K.E., FUCHS, G., 
KLINGEMANN, H.-G. and LERCH, L.
Department of Hematology, University Hospital of Marburg, and 
Research Laboratories of Behringwerke 
Margburg, FRG
Infectious diseases, with or without spreading of Gram­
negative and Gram-positive bacteria or viruses in the blood, 
rarely lead to microcirculatory disturbances and subsequently 
to coagulation defects.
As a result of the impairment of the hemostatic balance 
microthrombosis and/or bleeding disorders can influence the 
course of the illness.
Depending on the bacterial involvement and its vehemence 
there are several pathological processes which may affect the 
hemostatic potential.
Blood cells, mainly thrombocytes, coagulation proteins and 
inhibitors may be reduced in the blood stream, not only by lack 
of synthesis, but frequently following increased consumption 
(7, 8 , 10, 11, 12, 15, 24) .
Consumption of coagulation factors and inhibitors may be 
due to:
1 . extrinsic or intrinsic activation of blood coagulation
2 . the enhancement of the fibrinolytic system
Abbreviations: c«2M: o^-macroglobul in; a-|PI: ou -proteinase in­
hibitor; ELP: elastase (-like proteinase); AT III: antithrombin 
III; 012AP: a.2 antiplasmin; a-|PI-ELP: a-| proteinase inhibitor- 
elastase complex; 012AP-PI: 0.2 antiplasmin-plasmin complex;
AT III-THR: antithrombin Ill-thrombin complex; DIC: dissemi­
nated intravascular coagulation; ETC: endotoxin; FDP: fibrin 
degradation products; FFP: fresh frozen plasma; PCC: prothrom­
bin complex concentrate; PTT: partial thromboplasmin time;
TT: thrombin time; PMN: polymorphonuclear leucocytes.
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3. denaturation of plasma proteins and inhibitors by re­
leased cell proteinases, such as elastase and cathep- 
sin G from mononuclear or polymorphonuclear leucocytes 
(Table 1).
To differentiate these po3yetiological defects only in­
direct signs have been evaluated for diagnosis so far. For 
instance, the occurrence of fibrin degradation products or the 
decrease of substrates such as prothrombin and other coagula­
tion factors, plasminogen or inhibitors as antithrombin III 
(AT III), a2 antiplasmin (c^AP) and, in the case of elastase, 
proteinase inhibitor (a^PI) (2, 3, 4, 9, 20, 24).
Recently the diagnostic approaches have been improved by 
measuring neoantigen complexes of proteinase inhibitor-elas- 
tase (a^PI-ELP) and antiplasmin-plasmin (c^AP-Pl) (Table 1) 
(9, 10, 13).
The determination of antithrombin Ill-thrombin complexes 
(AT III-THR) is not possible since monospecific antibodies 
against this neoantigen are not yet available.
Therefore evidence of disseminated intravascular coagula­
tion (DIC) has to be proven by assaying all the involved coagu­
lation factors and inhibitors. In vivo hyperfibrinolysis can 
be -demonstrated not only by the decrease of involved coagula­
tion and fibrinolytic factors, but also via the appearance of 
o^AP-Pl complexes (10).
This is equally possible in the case of elastase release 
from polymorphonuclear granulocytes, because the neoantigen 
a^PI-ELP complex is not only demonstrable by determining the 
inhibitor with two-dimensional immunoelectrophoresis, but 
also by estimation of a^PI-ELP complexes with antisera against 
elastase alone (1 0 ).
The immuno-chemical estimation of the a^PI-ELP complexes 
can be carried out by several methods: 1 ./ one- and two-dimen­
sional immunoelectrophoresis (not a very sensitive estimation); 
2./ ZIA (zonal immuno-assay); 3./ RIA (radioimmunoassay);
4./ ELISA (enzyme-linked immunosorbent assay).
With this highly sensitive enzyme-linked immuno-assay 
Duswald and Jochum showed elevated a^PI-ELP complexes in 
patients after major abdominal surgery and, to a higher extent,
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Table 1
Possible ways for activation and limited or unlimited proteolysis of coagulation factors
in microcirculatory disturbances (1 0)
SPECIFIC ACTIVATION NON-SPECIFIC PROTEOLYSIS
LOCAL AND GENERALIZED PRIM. OR SEC. PROTEASES RELEASED FROM
DISSEMINATE INTRAVASCULAR HYPERFIBRINOLYSIS LEUCOCYTES BACTERIA VIRUSES
COAGULATION
ENDOGENOUS EXOGENOUS
ACTIVATION XII , XI , IX VII
PROTEOLYSIS VIII , v. XIII V, XIII
WITH INCREASED 
CONSUMPTION
V, XIII
IIf II, V, VIII 
XII, XIII
Fibronect in 
Kininogen,
LIMITED PROTEOLYSIS
SPECIFIC
INHIBITORS
NEO ANTIGEN 
/COMPLEX/
PROTHROMBIN U. FIBRINOGEN V, VIII, FIBRINOGEN/II/ /!/
ANTITHROMBIN III /AT III/ (X ANTIPLASMIN
i i T P/
ANTITHROMBIN III-THROMBIN öt ANTIPLASMIN-I -Pla9min_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ I
S P E C I F I C  —  ■» C O N S U M P T I O  N*-
AT III, (X AP FIBRINOGEN AND
2 OTHER PROTEINE
Plasminogen
* iMlnlplaamlnogen
<*1 ANTITRYPSIN
ANTITRYPSIN- 
1 ELASTASE
U N S P E C I F I C
LaJvO
if they revealed septic complications (5, 16, 17).
Patients in a polytraumatir condition also contain ele­
vated levels of ELP neoantigen 15)
Table 2
Natural substrates of neutral proteinases from
polymorphonuclear leucocytes (24)
ELP CLP Nonspecificcollagenase
Elastin
Proteoglycan
Fibronectin
Proteoglycan
Fibronectin
Proteoglycan
Collagen type I,II,III, 
IV
Collagen type II Collagen type 
I,II,III
Fibrinogen/fibrin Fibrinogen/fibrin Fibrinogen
Factor Vx ,VII,VIII,XI, 
XIII (18) 
Antithrombin III34 
a2-plasmin inhibitor 
(19)
Factor V,VII,VIII 
XIII
,XII,
C1s, C4, C2, C3 , C1q, C1s, C4, C2, C3 C1s, C4, C3
C5X , C9, factor Bx 
C1-inactivator
C5 , C9 C5
IgG, IgM, Bence-Jones
Protein
Kininogen
Specific collagenase
IgG, Bence-Jones 
Angiotensinogen
Protein
Gelatinase Specific collagenase24 
Gelatinase
xSubstrates which become transiently activated
By the influence of endotoxin (ETC) on granulocytes, pro­
teolytic enzymes (such as elastase and cathepsin G) are released 
into the circulation. These may destroy plasma proteins before 
their inhibition by proteinase inhibitors (a^PI, a2M). Elastase 
is able to degrade several coagulation factors, as shown in 
Table 2; cathepsin G, too, may degrade some of these coagula­
tion proteins. Both enzymes destroy the above mentioned coagu-
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lation substrates synergistically. The release of both enzymes 
from granulocytes is possibly responsible for in vivo denatura- 
tion of plasma proteins despite the apparently high antiprotease 
potential in the blood (7, 8 , 22).
The inhibitor capacity may be reduced not only by building 
complexes with the enzymes, but also, according to Travis, if 
a^PI is oxidized (23).
In order to demonstrate a correlation between elevated 
levels of a^PI-ELP and coagulation defects in particular of 
factor XIII deficiency we examined in 1977 seven typical pa­
tients with different forms of septicemia and could demonstrate 
that factor Xílí activity and subunit A+S was decreased, if 
a^PI-ELP was elevated (7, 8 ).
Here five out of seven patients with severe septicemia 
displayed a factor XIII activity and concentration of below 
50 % of normal. In these patients subunit A and activity as 
well as the carrier protein subunit S were found to be diminish­
ed (Table 3) .
In six out of seven patients a^PI-ELP complexes could be 
demonstrated. Therefore we had expected a correlation between 
factor XIII deficiency and these complexes because other signs 
of DIC were negative.
In 75 patients with different infections, investigated be­
tween 1974 and 1 978 , we were able to demonstrate a correlation 
between factor XIII deficiency and a^PI-ELP in plasma and/or 
endotoxin in the blood was found. As can be seen in Table 4:
In one third of the patients endotoxin and a^PI-ELP complexes 
could be found. Of these, eleven patients have shown factor XIII 
activity below 50 % of normal, while patients without complexes 
and endotoxin showed normal or only moderate deficiency of 
factor XIII. Patients with endotoxin alone showed factor XIII 
deficiency in one third of the cases, but no a^PI-ELP com­
plexes could be detected using one-dimensional immunoelectro- 
phoresis.
This method is not sensitive enough to evaluate enzyme 
inhibitor complexes in the range of 80-390 ng/ml. For this 
range a radioimmunoassay (RIA) for ELP has to be used, and
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Table 3
Plasma-bound ELP, clinical data and coagulation factor levels in 7 patients
P a t i e n t s Di a g n o s i s  E x c i t e r "
End o - A>9 E L P /
/ m l  P l a s m a
with
A T  *  
/ m g / d l /  /i
septicemia
T h r o w -  L e u k o -  
M  b o c y t e s  cyt e s
(7)
F e v e r B l e e d i n gT e n d e n c y
Fact o r  
XIII /%/
F a c t o r  X I I I  
S u b u n l t a  Fi b r i n -  
/ % /  ogen FDP/ p g / m l /
P r o ­
t h r o m b i n  
T i m *  / %/
A S
N o r m a l
/ n - 15/
- 9 9 188 2 2 4 3 0 0 4 -9 - - 10 0 100 1 0 0  256 < 1 0 0
Fie M u l t i p l e  E . c o l i  
li v e r  obscesses, 
E . c o lisepsis
NO 51 6 5 0 6 2 3 4 0 30.8 9 25 22 2 7  1 80 NU 93
M U  I Cho l e c y s t i t i s ,  K . p n e u m .  
l i v e r  obscess, 
s e pticemia
9 3 . 9 55 0 158 3 5 0 1 0 . 7 9 44 43 4 7  6 8 0 30 6 0
# ol S epticemia, E . c o l i  
acu t e  renal 
failure, 
p n e umonia
2 5 . 0 355 1 20 4 . 5 4 2 . 6 35 38 4 0  380 80 39
R om Septic e m i a ,  E . c o l i  
p u trid e n d o m e ­
tritis, residue 
o f  decidua, 
p a r a l y t i c  ileus
9 6 . 5 2 15 81 N O 1 4 . 0 50 40 2 5  182 NO 22
D u n Septic e m i a ,  S . a u r e u s  
a c u t e  renal 
failure, e n d o ­
card i t i s
9 9 6 0 5 1 80 4 - . 0 14.1 9 70 6 5 7 5  7 70 70 92
Ina Septic e m i a ,  E . c o l i  
pye l o n e p h r i t i s
* 0 . 1 6 42 5 2 4 0 1 1 4 1 5 . 5 ♦ * 9 75 57 9 3  6 40 70 56
M in Septic e m i a ,  E . c o l i  
b r o n c h o p n e u m o n i a . 
p e r i c arditis
* 0 . 1 0 4 4 0 108 1 76 1 6 . 8 9 48 17 4 7  764 70 45
Table 4
Factor XIII activity in 75 patients with septicemia correlated 
to endotoxin and antitrypsin-elastase complexes (1 0)
Plasma contains Factor
> 50 %
XIII activity (6 )
< 50 % < 25 %
a1AT-Elastase and endotoxin 17 7 4
Endotoxin alone 21 5 3
none 1 2 4 -
50 18 7
another highly sensitive enzyme-linked immunoassay (ELISA) is 
now available for this purpose as proposed by Jochum (16, 17). 
Some further example should demonstrate the possible role of 
elastase in coagulation disturbances and in particular in fac­
tor XIII deficiency (6 ). During urokinase therapy no one would 
expect a change in factor XIII activity, since plasmin is 
known not to degrade factor XIII. But in a patient treated 
with urokinase, factor XIII decreased to 53 % twelve days af­
ter starting the therapy (Table 5) (10).
This decrease, however, is caused by a septic complica­
tion during the therapy. After the onset of fever, induced by 
septic thrombosis, ct^PI-ELP complexes have been evaluated 
(Table 5). Therefore, besides disseminated intravascular coa­
gulation, ELP destruction of factor XIII must be considered. 
The behavior of o^AP-Pl and c^AP is demonstrated in Fig. 1 .
The next example shows the course of a severe septic 
complication in a seventeen-year-old girl with bleeding as a 
result of bone marrow aspiration over a period of 20 hours.
In this case no o^AP-Pl, but a^PI-ELP could be shown in the 
one-dimensional immunoelectrophoresis (Fig. 2) (10).
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u-lv£>O Table 5
Some coagulation data and the results of a^PI-ELP level in a patient exhibiting 
septic complications in the second week of urokinase treatment
Sample Date Time
Transglut. 
70-100 % 
F XIII
100
a2AP
EDJE 
% 1 00 % 
a2AP-Pl
Partigen 
AT III
Partigen 
Plasminog.
EDJE
0
Elastase
Treatment with 
Urokinase=U 
Heparin=H
0 18.7.80 1 0°° 96 100 0 33.6 15.0 0 0
1 18.7.80 1 8°° 96 81 100 33.6 1 2 . 6 0 U
2 18.7.80 1 8 0 0 92.5 57 100 26,6 10.4 0 Ü
3 19.7.80 900 76.25 49 92 33.6 8 . 0 0 U
4 19.7.80 1100 85 46 100 28.8 7.6 0 u
5 19.7.80 1 8°° 106.5 41 8 4 24.4 6.4 0 u
6 19.7.80 2400 78.75 41 77 28.8 6 . 8 0 u
7 20.7.80 1115 81 36 77 26.6 5.4 + u
8 20.7.80 2300 65.75 25 63 28.8 7.6 + u
9 21.7.80 1  1  O O 81 36 89 31.2 6.4 + u
1 0 21 .7.80 23°° 79.75 38 77 28.8 6 . 8 + u
12 22.7.80 1 15 60.5 38 84 36.0 5.6 + u
13 22.7.80 1100 55.75 52 0 46.2 8 . 0 + 0
14 23.7.80 1 -\ OO 71 81 0 31.2 9.4 0 0
1 5 24.7.80 -j -| O O 53.5 89 0 36.0 13.8 0 0
16 25.7.80 900 63.3 1 0 0 0 48.8 2 1 . 8 0 0
17 25.7.80 1 8 0 0 67.85 76 1 0 0 36.0 1 2 . 8 + U
18 26.7.80 1100 57.5 44 84 28.8 1 0 . 0 + u
19 27.7.80 95 27 56 26.6 6.4 0 u
2 0 28.7.80 74 25 56 36.0 8.4 0 u
21 29.7.80 57 2 0 84 26.6 7.6 0 u
22 29.7.80 1100 71 25 89 18.0 6 . 0 0 u
i©i^AP-Tl.
í » i .
A
*
A
>
A A
•W wf
* *
Fig. 1: Behavior of 012AP-PI complexes (1b) and Q12AP (1a) during urokinase 
therapy. After starting the therapy 012AP-PI complexes arose and 
the specific inhibitor decreased. During an interruption of the 
therapy, a^AP increased (a 13-16) and the neoantigen 012AP-PI (b 13-16) 
disappeared promptly (2 ).
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Table 6/a
Coagulation data of a 17 year7old girl with chronic hepatitis 
and severe septic complication
Date F XIII (%)
Fibri­
nogen
%
AT III 
(%)
a2~AP ELP c^AP- 
(%) Pl- 
(yg/inl/Neo.
Plasmi­
nogen
(%)
Platelet
count
22.4. 37.5 1 4 50 38 0.5 0 67.000
23.4 37.5 60 62 38 0.3 0 100
24.4. 64 70 63 - 0.3 0 151 .000
25.4 58 82 5,0 0.3 0 108.000
26.4 37.5 60/78 100 57 0.3 0 90 132.000
27.4 37.5 100 1 00 59 0.3 0 88 154.000
28.4 50 1 21 1 CO 69 0 0 82
29.4 50 1 40 70 63 0 0 275.000
30.4 50 1 20 80 69 i 0 63 305.000
1.5. 95
3.5. 1 40 67 75 0 0 377.000
4.5. 64 0 0 364.000
6.5. 50 1 78 74 64 0 0 92
7.5. 50 220 75 100
8.5. 50 220 75 100
10.5. 37.5 170 80 76 0 0 100
12.5. 76 0 0
14.5. 50 167 82 50
17.5. 75 178 64 76 0 0 84
18.5 81 0 0 286.000
19.5. 75 1 75 65 120
26.5. 50 230 100 84 0 0 11 0
2 .6 . 88 0 0
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Table 6/b
Coagulation data of a 17 year-old girl with chronic hepatitis 
and severe septic complication
Date Quick(%)
PTT
(s)
TT
(s)
F II 
(%)
F V 
(%)
F VII 
(%)
F VIII 
(%)
F IX 
(%)
F X 
(%)
F XI 
(%)
F XII 
(%)
22.4. 12 119 180 17 30 29 44 62 23 40 30
23.4. 48 119 180 51 70 45 100 43 44 40 48
25.4. 26 80 36/44
26.4. 49/51 84/80 43 35/44 37/40 32/34 50/68 34 42 40 47
27.4. 70 52 22 45 95 53 1 0 0 70 66 77 100
28.4. 75 58.3 28.3 90 1 0 0
29.4. 100 41.9 22
30.4. 80 46.5 21.7
1 .5. 60 37 2 2 . 6
3.5. 81 46.4 21 . 2
4.5. 81 40.8
6.5. 75 40.4 20 100 58 100
7.5. 75 36.8 19.3 100
8.5. 75 36.8 19.3 100
10.5. 65 34 20 1 00
14.5 90 34 19.2 65
17.5 82 37 2 2 . 2 68
19.5. 85 34.3 17.6 100
26.5 75 33 18.4 84
1*u  ’
a.
3 A A » U & &
■iOX <o 3
b. A
o o  ó  6
-TiC/
Fig. 2 :
Effect of a-|AT-ELP complexes 
in a 17 year-old girl during 
a severe septicemia (a),
012AP, (b) 012AP-PI,
(c) a-jAT-ELP complexes in 
one dimensional immuno- 
electrophoresis with anti­
sera against the inhibitor
(a) , the neoantigen c^AP-Pl
(b) and against elastase (c).
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In this patient fibrinogen was found to be diminished to 
20 mg% and factor XIII to 30 % of normal activity (Table 6 a, b) • 
Unspecific and/or thrombin induced consumption of factor XIII 
and other coagulation factors and inhibitors makes a substitu­
tion with plasma fractions and AT III necessary. As shown in 
Fig. 3, nearly 6 litres of plasma equivalents and 6500 U/AT III 
had to be substituted to prevent bleeding tendency and coagula­
tion defects.
During replacement therapy, fiorinogen, factor XIII and 
antithrombin increased. Despite the fact that no platelets 
were substituted, the thrombocytes increased during the sub­
stitution with AT III and plasma equivalents to normal values. 
The elevated level of a^PI-ELP decreased in a few days to 
normal values. With one-dimensional immunoelectrophoresis this 
neoantigen was no more detectable.
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4-250 4■ 250 5-250 4pep ▼ ▼ » ,p2-^50 1-250 4-250 4-Z50 ' t
> Substitution
Fig. 3: Behavior of factor XIII, fibrinogen, AT III and
thrombocytes under substitution with fresh frozen 
plasma and antithrombin III concentrates. Under 
this treatment not only the substituted factors 
but also platelet count increased (from 17.000 to 
about 200.000, within 9 days).
In contrast, in 3 patients with meningococcal septicemia 
not only a^PI-ELP but also c^AP-Pl could be detected simultane­
ously. Therefore besides DIC degradation by elastase and plas- 
min may be responsible for consumption of coagulation factors.
Early substitution with plasma derivates as AT III and 
FFP, cryoprecipitate and PCC is successful.in preventing further 
consumption of coagulation factors and severe hemorrhage (1 ).
Malaria tropica is often complicated by severe "DIC".
This could be confirmed in one young patient with malaria tro­
pica (Pi. falciforme and PI. ovale) who had low levels of 
coagulation factors, inhibitors and thrombocytopenia. The pa­
tient was oliguric and severely ill. On admission only 
a^PI-ELP was elevated to 400 ng/ml. Although no o^AP-Pl com­
plexes could be detected plasminogen was decreased to 15 % of 
normal. This could be the cause of reduced fibrinolytic activ­
ity in the kidney.
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Therefore besides application of AT III concentrate we 
also have substituted with plasminogen (Fig. 4). Under this 
substitution therapy coagulation factors, inhibitors and plate­
lets returned to normal levels. The bleeding tendency discon­
tinued and the patient became poliguric.
FFP(E) 2
AT 111 2000
Plasminogen 4000
Heparin 1-8000 2-8000
FXm F VII FV Quick AT III
1000 1000 1000 1000 
2000 2000 2000 
2-10000 2-10000
Boi.G 28 10S8
Fibri- P lasm r aj-A nti- 
nogen nogen plasmin
ELP O4,ug 0 0 0 0 0 0 0 0 0
Ncoantigen 0 0 0 0 0 0 0 * 0 0
Fig. 4: Behavior of factor XIII, fibrinogen and plasminogen 
under substitution with fresh frozen plasma, anti­
thrombin III concentrates and plasminogen. Under the 
treatment not only the amount of substituted factors, 
but the platelet count increased (from 2 0 . 0 0 0 to 
about 200.000, within 4 days, patient with tropical 
malaria) (2 0 ).
Disorders with Factor XIII deficiency possibly caused 
by elastase like proteases released from granulocytes (1 1)
1. / Erosive hemorrhagic gastroduodenitis with fibrino­
lysis and low Factor XIII
2. / Generalized proteolysis in a young woman with Weber- 
Christian disease
3. / Factor XIII dificiency in Hennoch-Schönlein's purpura
4. / Acute myelocytic leukemia
5. / Promyelocytic leukemia
6 . / Other myeloproliferation diseases
402
7. / In Septicaemia
8 . / Major abdominal surgery
9. / Combustio
10. / Multiple fractures
11. / Fatal iron intoxication
DISCUSSION
The main function of granulocytes is providing protection 
against microorganisms by phagocytosis and intracellular kill­
ing. Besides this function these cells may apparently digest 
alien proteins. From 1968-1975 it became apparent that the 
granulocytes are secretory cells, which, by secreting neutral 
proteinases, interfere with the regulation of the inflammatory 
response. In case of a failure of the protective proteinase in­
hibitor system, the granulocyte proteinases are responsible for 
severe tissue destruction under several clinical conditions, 
as seen in Table 7:
The destruction of elastin containing structures in lung 
connective tissue and of joint tissue and of the glomerular 
basement membrane in patients with ARDS syndrome and pulmonary 
emphysema, rheumatoid arthritis and nephrotic syndrome may be 
due to a pathological effect after the release of lysosomal en­
zymes from granulocytes (24) .
In the early state of the white cell maturation blast 
cells do not contain any lysosomal proteinases. Later matured 
cells produce these enzymes up to the polymorphonuclear gra­
nulocytes. In some forms of acute granulocytic leukemia the 
release of these proteinases contributes to the hemostatic 
defects in the patients as we demonstrated in the early seven­
ties (7). As was subsequently found in 1975, the proteinase 
release from granulocytes plays a more important role in pa­
tients suffering from various infectious diseases (1 0).
Later others also found (16, 17) that elastase and 
cathepsin G were responsible for the severe coagulation defects 
in patients after major surgery with and without septic compli­
cations .
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Table 7
Possible pathophysiological role of neutral proteinases from 
polymorphonuclear leucocytes (24)
Disease Symptoms Possible aethiology Substrates
Septicemia Coagulation
defects
Enzyme release by endo­
toxin, immune complexes
Fibrinogen, factor 
XIII and other coa­
gulation factors and 
inhibitors
ARDS- 
syndrctne 
(polytrau­
ma , septi­
cemia)
Fluid lung 
(capillar 
injury, al­
veolitis)
Accumulation of aggre­
gated PMN in the lung
Lung connective tis­
sue + basement mem­
brane (collagen, 
elastin, proteoglycan 
fibronectin)
Pulmonary
emphysema
Destruction 
of elastin 
containing 
structures
Genetic a-jPI defi­
ciency: inactivation 
of ot-|PI by tobacco 
smoke
Lung connective 
tissue
Rheumatoid
arthritis
Synovitis, 
destruction 
of joint 
tissue
IgG altered by the 
enzymes ■* formation 
of rheumatoid factor 
IgG - immune-com­
plexes ■+■ enzyme 
release
Joint connective tis­
sue (collagen, pro­
teoglycan)
Gout Synovitis, 
destruction 
of joint 
tissue
Enzyme release by 
phygocytosis of 
urate cristalls
Joint connective tis­
sue (collagen, pro­
teoglycan)
Immune
complex
nephritis
Nephrotic
syndrcma,
renal
failure
Local accumulation of 
immune complexes -*■ glo­
merular injury by PMN 
enzyme release
Glomerular basement 
membrane
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The actual effect of proteinases such as elastase or 
cathepsin G on blood proteins such as coagulation factors and 
inhibitors has not yet been established (14, 16). The action on 
these proteins must be possible despite high antiprotease po­
tential in the plasma. There are several hypotheses which point 
to the fact that degradation of proteins may indeed occur in 
vivo.
1. / The inhibitor is complexed with proteinases
2. / The inhibitor is oxidized and no longer effective
3. / The inhibitor may be consumed, in particular at local
sites of inflammation where very high enzyme activities 
may be present.
There are many possible indirect signs that degradation 
of coagulation factors and inhibitors is due to proteinase 
action.
1. / The appearance of fibrin degradation products distinct
from plasmin digestion.
2. / The reduction of both subunits A and S of factor XIII.
During coagulation only subunit A is consumed (7, 8,
1 0 ) .
3. / The diminution of AT III cannot only be related to
thrombin mediated consumption, because AT III is a 
substrate of ELP and is cleaved near the active site 
of the molecule (16). Despite the small immunochemical 
denaturation of the single chain molecule, AT III 
becomes inactive.
The coagulation examinations in 75 patients (selected 
patients from 1974-1978) revealed in one third severe, in one 
third moderate and in one third no coagulation defects. The 
relatively high percentage of patients with no coagulation 
defects may be a result of the mild course of the infectious 
disease or the supposed increased turnover of clotting factors 
may be compensated by all inhibitors present. As demonstrated 
in Table 4, factor XIII deficiency may be correlated to the 
appearance of o^PI-ELP in the patients plasma.
Besides the demonstration of elastase three patients with 
meningococcal septicemia revealed o^AP-Pl complexes. Thus we 
had to assume that in these cases two distinct reactions were
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responsible for the degradation of some coagulation factors.
It is necessary to mention the fact that with one dimensional 
immunoelectrophoresis oi^PI-ELP complexes could only be de­
monstrated above 390 ng/ml ELP (21) .
In the six examples where we demonstrated the course of 
the illness we found, using one dimensional immuno-electro- 
phoresis, elevated ot^PI-ELP in a well demonstrable concentra­
tion .
While the patients under urokinase treatment and in three 
patients with septicemia due to n-meningitis infection revealed 
both antigens, the 17-year-old girl and the young patient with 
malaria demonstrated only, but highly elevated a.PI-ELP com­
plexes. As demonstrated in the figure showing the courses of 
the illness, the severe coagulation defects had to be treated 
with plasma derivates such es PCC, AT III and FFP, which con­
tained not only factor V but a^PI and a^AP.
Only the patient with malaria became oliguric and de­
monstrated additionally low plasminogen levels. In this case 
additional plasminogen substitution as proposed by Dr. Karges, 
was applied in order to treat the microcirculatory disturbances 
close to the glomerular apparatus in the kidneys.
In conclusion
1. / The determination of the neoantigens a^PI-ELP and 
c^AP-Pl is suitable to differentiate the cause of hyperfibrino­
lytic states.
2. / DIC is not well understood if one considers only 
thrombin and/or plasmin mediated proteolysis, degradation and 
increased consumption of coagulation factors and inhibitors.
3. / To affect coagulation disturbances in DIC anticoagu­
lant treatment with heparin alone is not sufficient to stop 
the circulus vitiosus of protein consumption or in particular 
the "abnormal proteolysis syndrome" (11) as it occurs in pa­
tients with septicemia (10).
4. / Besides coagulation proteins and fibronectin probably 
inhibitors such as AT III, a.-PI and c^AP have to be substituted 
additionally with concentrates or - if not available with FFP to 
avoid bleeding tendency and to improve the hemostatic balance at 
the same time.
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1 " Jozef Stefan" Institute, Ljubljana, 
and2KRKA, Novo mesto, Yugoslavia
INTRODUCTION
Streptomycet.es are known to synthesize a variety of pro­
teases but aside from Streptomyces griseus, proteolytic enzyme 
system of other Streptomyces species has not been extensively 
described. In our study of S. rimosus extracellular enzymes we 
have detected at least eight proteolytically active components 
(Pokorny et al., 1979). We have also isolated three of them. 
Serine alkaline proteinase was characterized to the greatest 
extent (Renko et al., 1981a) while trypsin-like and elastase- 
like enzymes were partially described (Vitale et al., 1980; 
Renko et al., 1981b).
In continuation of S. rimosus proteolytic enzymes study 
trypsin-like proteinase, alkaline metallo-proteinase and 
leucine aminopeptidase were purified and their properties de­
termined .
MATERIALS AND METHODS
The source of enzymes was culture filtrate of S .rimousus 
grown under conditions for Oxytetracycline production, clari­
fied by centrifugation (2400xg,30 min) and concentrated 20-fold 
by ultrafiltration through Diaflo hollow fiber H1P10. Concen-
Abbreviations: PMSF: phenylmethane-sulphonylfluoride;
TLCK: L-1-chloro-3-(4-tosylamido)-7-amino-2-heptanone; 
TPCK: L-1 -chloro-3- (4-tosylamido) -4-phenyl-2-butanone
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trated filtrate was dialyzed against 0.01 M Na-acetate buffer, 
pH 5.8, and applied to a CM-Sephadex C-50 column, or was 
directly fractionated by acetone precipitation.
Enzyme assay
Hydrolysis of hemoglobin, casein, azocoll, gelatine and 
elastin was determined as previously described (Pokorny et al., 
1979). Hydrolysis of N a-benzoyl-2-naphthylamide (BANA), ami­
no acid- and peptide-2-naphthylamides (2-NA) was estimated by 
colorimetric method of Nagatsu et al. (1970)
Trypsin-like activity towards N a-benzoyl-DL-arginine-p- 
nitroanilide (BAPNA) and N cx-benzyloxycarbonyl-norleucyl- 
prolyl-arginine-p-nitroanilide (Z-Nle-Pro-Arg-Nan; kind gift 
of Prof. P. Elődi, Debrecen, Hungary) was measured in 0.05 M 
TrisHCl buffer, pH 8.0, containing 10  ^M CaC^, at 30°C, with 
continuous recording of absorbancy at 405 nm. The same method 
was used for the determination of leucine aminopeptidase. The-3reaction mixtures contained 2x10 leucine-p-nitroanilide 
(Leu-p-Nan) in 0.1 M TrisHCl buffer, pH 8.2, supplemented with 
5x10  ^M CaC^- The temperature was 37°C. Inhibitors and ac­
tivators were incubated with the enzymes for 5 to 15 minutes 
prior to the start of the reaction.
Hydrolysis of peptides was followed by thin-layer chro­
matography on silica gel plates with n-butanol-acetic acid- 
water (60:15:25) as solvent.
Polyacrylamide gel electrophoresis, molecular weight de­
termination and protein assays were performed as previously 
described (Renko et al., 1981a,b).
RESULTS AND DISCUSSION
Enzyme isolation
Two proteinases and one aminopeptidase were isolated 
from S.rimosus culture filtrates following the procedure out­
lined in Fig. 1.
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CULTURE FILTRATE 
(concentrated)
CM-SEPHADEX 25-75 % ACETONE\ IAH-SEPHAROSE AH-SEPHAROSE SEPHADEX G-50I J
CM-CELLULOSE CM-CELLULOSE1Trypsin-like Leucine amino- Alkaline metallo­
proteinase peptidase -proteinase
Fig. 1 : Purification scheme of S. rimosus proteinases
Chromatography on CM-Sephadex C-50 in 0.01 M Na-acetate 
buffer, pH 5.8, yielded trypsin-like and leucine aminopeptidase 
activity in separate fractions. The first one was eluted from 
the column with the starting buffer and the second one upon 
the addition of 0.4 M NaCl. AH-Sepharose 4B (Aminohexamethyl- 
ene-Sepharose) chromatography of both enzymes was performed 
in 0.01 M Na-acetate buffer, pH 5.5, with a linear gradient 
of NaCl (0.0-1.0 M).
Final purification of trypsin-like proteinase was 
achieved on a CM-cellulose column in 0.001 M Na-acetate buffer, 
pH 4.5, using 0.0-0.3 M NaCl gradient as eluant.
This procedure gave 550-fold purification with a yield of 
19 % (Table 1). Thus, it represented an improvement over one 
used earlier (Renko et al., 1981b).
AH-Sepharose chromatography was the final step for the 
leucine aminopeptidase purification summarized in Table 2.
At the end of the fermentation process aminopeptidase activity 
unlike proteolytic activity was very low. This made culture 
filtrates poor sources for the enzyme isolation, which con­
tributes to the low yield.
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Table 1
Purification of S. rimosus trypsin-like proteinase
Purification
step
Vol.
(ml)
Protein
(mg/ml)
Specific
activity34
Yield
(%)
Culture filtrate 10,000 10.000 0.054 100
Dialyzed concentrate 500 17.50 0.360 58
CM-Sephadex 1,150 0.52 2.960 33
AH-Sepharose 4B 420 0.11 29.740 25
CM-Celluiose 160 0.22 29.790 19
^Determined with BAPNA at pH 8.0, and expressed as 
AAiio/min mg, measured at pH 2.0.
Table 2
Purification of S. rimosus leucine aminopeptidase
Purification Vol. Protein Specific Yield
step (ml) (mg/ml) activity34 (%)
Culture filtrate 18,100 6.90 - -
Dialyzed concentrate 1,130 18.00 0.85 100.0
CM-Sephadex C-50 1 ,550 2.80 0.76 19.0
AM-Sepharose 4B 35 0.13 103.90 2.7
^Determined with Leu--2-NA at pH 7.4 in the presence of
5x10-3 M CaCl2, and expressed as AA530/min mg.
The isolation of the metallo-proteinase started with 
acetone precipitation. The precipitate formed at 25-75 % 
acetone was dissolved and subjected to Sephadex G-50 gel 
filtration in 0.1 M Na-phosphate buffer, pH 8.0. Fractions 
containing low molecular weight material with proteolytic 
activity were chromatographed on CM-cellulose in 0.1 M Na-
phosphate buffer, pH 8.0, with 0.00-0.15 M NaCl. The purified
_2metallo-proteinase was treated with 10 M EDTA and dialyzed 
against 0.01 M NaCl for storage in an inactive form. Deter­
mination of the yield was hindered by the presence of other 
proteinases in the culture filtrate.
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All three isolated enzymes were electrophoretically homo­
geneous as illustrated in Fig. 2.
(a) Trypsin-like proteinase (100 yg)
(b) Leucine aminopeptidase (20 yg)
(c) Alkaline metallo-proteinase (90 yg)
(d) Alkaline metallo-proteinase (300 yg)
Fig. 2: Polyacrylamide gel electrophoresis of S.rimosus
proteases; (a) pH 8, 7 % gel. (b-d) pH 4.4, 15 % gel.
Properties of the enzymes
Molecular and catalytic properties of the enzyme isolated 
first, are presented in Table 3.
Table 3
Properties of S. rimosus trypsin-like proteinase
Activity: Digests proteins, BANA, BAPNA
pH optimum: pH 8.4-8.8
Temp, optimum: 45°C (pH 8.4)
Stability: pH range 5.5-9.0
Mol. weight: 27,000 (gel filtration), 29,000 (SDS PAGE)
pi: 4.5
Inhibitors: PMSF, TLCK, soybean trypsin inhibitor, 
leupeptin
In view of its ability to hydrolyze characteristic tryp­
sin substrates and its susceptibility to inhibitors, the enzyme 
is classified as a trypsin-like serine proteinase. Unlike 
"paromotrypsin” isolated from S.rimosus by Chauvet et al. (1976)
and pancreatic trypsin, it has a low pi and correspondingly 
higher content of the acidic amino acids (Table 4).
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Table 4
Amino acid composition of S. rlmosus trypsin-like proteinase
Lysine 16 Glutamic acid 24 Methionine 2
Histidine 3 Proline 9 Isoleucine 8
Arginine 4 Glycine 37 Leucine 16
Aspartic acid 23 Alanine 35 Thyrosine 5
Threonine 16 Cysteine 2 Phenylalanine 6
Serine 25 Valine 12 Tryptophan ND
Another noteworthy characteristic is the presence of two 
cysteine residues versus 12 in trypsin. This low content of 
disulphide linkages seems to be a common feature of trypsin­
like proteinases fr i streptomycetes irrespectively of their 
pi (Yoshida et al. 1971).
The specificity of the enzyme, estimated semiquantita- 
tively with different peptides as substrates, showed its re­
quirement for arginine at S1 position (Table 5).
Table 5
Specificity of S. rimosus trypsin-like proteinase
Substrate, split bond Relative rate54
Arg-Phe
iArg-Phe-Ala
4-Met-Arg-Phe
4Leu-Trp-Met-Arg-Phe-Ala
4Arg-Val-Tyr-Ile-His-Pro-Phe
4Asp-Arg-Val-Tyr-Ile-His-Pro-Phe
Z-L-Arg-2-NA
+ +
+ + +
+ + + + + 
+ +
Estimated visually by thin layer chromatography.
418
The results also revealed the ability of the S.rimosus 
trypsin-like proteinase to split off amino-terminal arginine, 
which could not be demonstrated for bovine trypsin under the 
same conditions. The possibility of contamination with arginine 
aminopeptidase was ruled out by the constancy of endo- and 
exo-peptidase activity ratio in the fractions obtained by gel 
filtration and polyacrylamide gel electrophoresis of the en­
zyme. The pH optima for the hydrolysis of casein, BANA, and 
Arg-2-NA were also identical.
Substrate preferences of the trypsin-like proteinase and 
pancreatic trypsin were compared on the basis of equal caseino- 
lytic activities (Table 6).
Table 6
Relative specificity of trypsin-like proteinase and trypsin
Relative reaction rate (%)
Substrate Trypsin-like XTrypsin
Casein 100.0 100.0
Bz-DL-Arg-2-NA 19.4 0.5
Bz-DL-Arg-p-Nan 65.6 3.7
Z-Nle-Pro-Arg-p-Nan 2074.0 344.7
L-Arg-2-NA 0.2 0.0075
a x xB o v i n e  p a n c r e a s ,  T P C K - i n h i b i t e d  ( S e r v a ) . A c t i v i t y  d e t e r ­
m i n e d  a s  p m o l e s  o f  l i b e r a t e d  a m i n o  g r o u p s .
Z-Nle-Pro-Arg-Nan (Pozsgay et al., 1981) was by far the 
best substrate for both enzymes. However, relative activities 
toward synthetic substrates were higher for the trypsin-like 
proteinase than for trypsin. Concomitantly, Km values of
S .rimosus enzyme were lower than that of bovine trypsin, in­
dicating its higher affinity for them. Similar observations 
were made for S , erythreus, S. fradiae and S. griseus tryp­
sin-like proteinases (Yoshida et al., 1971). This relative 
preference for amidase substrates seems to be a general char­
acteristic of streptomycetes "trypsins".
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Characteristics of the second enzyme, isolated as leucine 
aminopeptidase (LAP), are shown in Table 7.
Table 7
Properties of S. rimosus leucine aminopeptidase
Substrate: Leucine-p-nitroanilide, Km: 7.9x10 4 M
pH optimum: pH 8.0-8.2
Temp, optimum: 55°C (pH 8.0)
Stability: pH range 5-10; temperatures to 7 0°C
Mol. weight: 27,500 (gel filtration)
pi: 7.3
Inhibitors: Ca2+, EDTA, o-phenanthroline 
bestatin, puromycin
, amastatin,
Activators: Ca2+, (Co2+)
The enzyme needed Ca^+ ions for its full activity, and 
showed good thermal and pH stability like other Streptomyces 
leucine aminopeptidases. Smaller molecular weights than that 
of mammalian LAP might also be a common property of these en­
zymes (Uwajima et al,, 1973; Vosbeck et al., 1973; Kastrikina, 
1980).
S. rimosus leucine aminopeptidase was more sensitive to 
amastatin than to bestatin, whereas hog kidney LAP has greater 
susceptibility to bestatin (Suda et al., 1976; Aoyagi et al.,
1978). At the same time inhibitory activity of bestatin
-4against S ■ rimosus LAP was much lower (IC,.q = 2.1x1 0 M) than
activity against hog kidney enzyme (IC,. Q = 3.4x1 0 ® M) determined 
in parallel. This difference indicates structural differences 
at the active site.
The specificity of the enzyme was determined with amino 
acid naphthylamides as substrates. It hydrolyzed only Leu-2-NA, 
Phe-2-NA and Met-2-NA significantly. Activities toward these 
substrates could not be separated by gel filtration or poly­
acrylamide gel electrophoresis, and their ratio was 1:0.51:0.37 
(Co^+ as activator). The preference for the bulky and hydro- 
phobic residues of leucine and phenylalanine was reported for 
LAP from S. peptidofaciens (Uwajima et al., 1972), and S. 
griseus which also hydrolyzed prolyl, tyrosyl, alanyi and
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methionyl bonds (Vesbeck et al., 1975).
Table 8 summarizes the properties of the third enzyme 
from S. rimosus culture filtrates.
Table 8
Properties of S. rimosus alkaline metallo-proteinase
Activity: Digests casein, gelatine , hemoglobin
pH optimum: pH 8.0-9.0
Temp, optimum: 50°C (15 min incubation, pH 8.5)
Stability: pH range 5.0-9.5, temp. to 30°C
Mol. weight: 12,500 (SDS-PAGE)
pi: 9.9
Inhibitors: EDTA-o-phenanthrolin
Activators: Zn2+, Co2+, Mn2+, Ca2+
The high pH optimum, inactivation by 10  ^M EDTA and 
restoration of activity by divalent cations allow the enzyme 
to be classified as an alkaline metallo-proteinase. The most 
efficient cation was Zn^+, which could restore full enzyme 
activity at a concentration of 5x10-5 M, followed by Mn2+, Co2 + 
and Ca +. At higher concentrations Zn acted as an inhibitor.
The alkaline metallo-proteinase hydrolyzed gelatine, azo­
casein and azocoll, but had no activity on elastin or collagen. 
It did not split collagenase substrate of Wunsh and Heidrich 
(1963), hexapeptide Leu-Trp-Met-Arg-Phe-Ala, N-glutaryl-Gly- 
-Gly-Phe-2-NA, Leu-Gly-Gly-2-NA or Gly-Pro-Leu-2-NA.
The enzyme is thermolabile and is one of the smallest pro­
teolytic enzymes described so far. It resembles Myxobacter 
strain Al-1 protease I (Morihara, 1974). To our knowledge 
similar enzymes have not been isolated from Streptomyces 
species previously.
The isolation and characterization of the trypsin-like 
proteinase, leucine aminopeptidase and alkaline metallo-pro­
teinase from S, rimosus provide data necessary for elucidation 
of the proteolytic enzyme system of this industrially important 
microorganism. Knowledge of their properties could also contri­
bute to the better understanding of the entire classes of these 
enzymes.
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D ISC U SSIO N
HOTTER:
Did you assay whether your enzyme (leucine aminopeptidase) 
is able to hydrolyze dipeptides and leucine amide? Can 
this enzyme be activated by manganese ions? How long was 
the preincubation time in your experiments? In the case 
of human LAP you would need 1-2 hours.
V IT A L E :
S. rimosus leucine aminopeptidase hydrolyzes dipeptides, 
whereas leucine amide was not tested. The enzyme was 
activated by Mn + to a very small extent. Preincubation 
time ranged up to 20 min.
STEPANOV:
How did you measure the molecular weight of the metallo 
proteinase which seems to be unusually low?
V IT A L E :
It was assayed by SDS-polyacrylamide gel electrophoresis 
and gel filtration. The enzyme also passed PM-10 ultra­
filter.
GLAUMANN:
Are Streptomyces proteinases synthesized as proforms? 
V IT A L E :
As f a r  a s  I  k n o w ,  t h e y  a r e  n o t .  I t  i s  b e l i e v e d  t h a t  t h e s e  
p r o t e i n a s e s  a r e  e x t r u d e d  i n t o  t h e  m e d i u m  a s  u n f o l d e d  
c h a i n s  r e s u m i n g  t e r t i a r y  s t r u c t u r e  o u t s i d e  t h e  c e l l .
GLAUMANN:
A r e  t h e y  g l y c o p r o t e i n s ?
VITALE:
No, they aren't.
424
Symposia Biologica Hungarioa 26 (1984)
ACID PROTEINASES OF MICROBIAL ORIGIN
KREGAR, X., KOTNXK, M., PUC1, A. and TURK, V.
Department of Biochemistry, J. Stefan Institute,
E. Kardelj University and
^Lek, Pharmaceutical and Chemical Works, 
Ljubljana, Yugoslavia
I N T R O D U C T I O N
There are many reasons for the growing interest in prote­
olytic enzymes of microorganisms over the past ten years. 
Microbial proteinoses are widely used in various industrial 
processes, e.g. in food industry, tanning industry and in 
production of detergents. They are also valuable reagents in 
clinical and research laboratories. The study of proteolytic 
enzymes of various microorganisms also contributed to our 
understanding of the role played by these enzymes in processes 
of intracellular protein turnover, digestion, protein trans­
location, selective modification of proteins by limited prote­
olysis, etc. The pathogeneicity of some microorganisms to 
animals and plants may involve proteolysis in penetration of 
the host organism and in counteracting its defence. Therefore 
the study of proteinases may help us to understand pathogene­
sis and its possible control. Some of the microbial proteoly­
tic systems are very complex and contain numerous enzymes
Abbreviations: DAN: diazoacetyl-D,L-norleucine methyl ester;
EPNP: 1,2-epoxy /p-nitrophenoxy/ propane; 
pCME: p-chloro-mercuribenzoate; TLCK: tosyl- 
lysyl chloromethyl ketone; TPCK: tosyl-phenyl- 
alanyl chloromethyl ketone; PMSF: phenylir.ethane 
sulphonylfluoride.
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/Spady and Gaertner, 1978; Ac:- fetter et al., 1981/. Protein- 
ases of eucariotic microorganisms have been recently reviewed 
by North /1982/.
Our work involves two microorganisms. Aspergillus niqer 
is used for industrial production of citric acid, and Claviceps 
pu rpu rea for the production of physiologically important ergot 
alkaloids. Besides the desired product, both microorganisms 
also secrete proteolytic enzymes. The possible use of waste 
culture broth as a source of enzymes for industrial application 
was the main reason for studying A. niqer C, purpurea production 
of ergot alkaloids depends on tryptophane as a precursor. This 
amino acid may also be derived from processes of protein 
degradation in which proteinases are involved /Rehacek et al., 
1971; 1972/. A detailed knowledge of the proteinases would 
help to clarify their possible role in alkaloid biosynthesis.
MATERIALS
A, niqer ATCC 10577 was grown as a surface culture for 
industrial citric acid production. At the end of the fermen­
tation the biomass was separated from the culture liquid and 
resuspended in tap water. After 24 hrs it was filtered and 
the filtrate was used as the source of enzymes.
C. purpurea was grown under conditions required for ergot 
alkaloid biosynthesis in a submerged culture. After 240 hrs 
fermentation, broth was withdrawn and mycelia removed by 
centrifugation.
RESULTS AND DISCUSSION
Separation of concentrated culture filtrates of A. niqer 
and C. purpurea on Sephadex G-100 showed that many proteinases 
were present which differed in molecular weight and in optimal 
pH for hydrolysis of substrates. Subsequent testing with 
proteinase inhibitors revealed in both cases the presence of 
aspartic proteinases and proteinases which were sensitive to 
phenylmetane-sulphonylfluoride /PMSF/ Kregar et al., 1981;
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Suhar et al., 1982/. We developed a purification procedure 
for the isolation of enzymes that have an acidic pH optimum 
but differ in their catalytic mechanism. The purification 
scheme for C. purpurea culture liquid is shown in Fig. 1, and 
for A. niger culture filtrate in Fig. 2.
CULTURE LIQUID 
SUPERNATANT 
CONCENTRATE 
SEPHADEX G-100
FRACTION 1 FRACTION 2
CM-SEPHADEX pH 8.0 PEPSTATIN-SEPHAROSE
FRACTION 1A FRACTION IB CM-SEPHADEX pH 5.0
CM-SEPHADEX pH 6.0 ASPARTIC PROTEINASE
SEPHADEX G-150
SERINE PROTEINASE
Fig. 1. Purification scheme of C, purpurea proteinases.
Aspartic proteinases
The isolation of aspartic proteinases was achieved by 
affinity chromatography on the immobilized pentapeptide in­
hibitor, pepstatin with additional gel and ion exchange 
eh roma tography steps /Kregar et al., 1981; 1983/. The enzymes 
isolated from both microorganisms were electrophoretically 
homogenous. Biochemical characterization revealed that both 
proteinases have very similar properties /Table 1/. The 
results obtained show that A. niger excretes an aspartic 
proteinase, also under conditions for citric acid production. 
Aspartic proteinases from A. niger have been isolated by 
Bosmann /1973/, and from A, niger var. macrosporus by Iio and 
Yamasaki /1976/. Although both aspartic proteinases differ 
from our enzyme in molecular weight, they are very similar in
427
other properties and appear to be essentially the same enzymes. 
Aspartic proteinases isolated from other Aspergilli show many 
similarities with our enzyme /Tsujito and Endo, 1977/, partic­
ularly in respect to pH optimum, isoelectric point and pH 
stability. A. niger proteinase is also similar to other as­
partic proteinases of microbial origin /Matsubara and Feder, 
1971/.
CULTURE FILTRATE
ICONCENTRATE
IMETHANOL PP 
50-75%
ISEPHADEX G-100
IFRACTION 2 FRACTION 3
IDEAE-CELLULOSE pH 5.0
IPEPSTATIN-SEPHAROSE
IASPARTIC PROTEINASE 
Fig. 2. Purification scheme of A, niger proteinases.
C, purpurea enzyme also exhibits the typical properties 
of an aspartic proteinase. A pronounced similarity can be 
found with C, albicans acid proteinase /Rüchel, 1981/. Both 
enzymes have almost identical molecular weight, isoelectric 
point, are completely inhibited by pepstatin and show low 
reactivity with diazoacetyl-D,L-norleucine methyl ester /DAN/ 
and 1,2-epoxy/p-nitrophenoxy/propan /EPNP/. The majority of 
pepstatin sensitive aspartic proteinases of microbial origin 
were found to be very sensitive to these active site directed 
reágents. On the other hand, cathepsin D, a mammalian aspartic 
proteinase which is extremely sensitive to pepstatin, also 
showed a low reactivity with DAN and EPNP /Kregar et al.,
1977/. Preliminary experiments on the determination of secon­
dary structure by CD measurements revealed a similarity 
between A, niger and C, purpurea aspartic proteinases.
FRACTION 1 
!DEAE-CELLULOSE 
pH 4.5
SERINE PROTEINASE
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Table 1
A. niger C. purpurea
Molecular weight:
gel chromatography 38 000 43 000
SDS electrophoresis 43 000 41 500
Isoelectric point 4.0; 4.6 4.6
pH optimum 3.5 3.5
Inhibition:
pepstatin 2 0  pM 1 0 0 % 1 0 0 %
PMSF 5 mM 0 % 0 %
DAN 5 mM n . d . 40%
EPNP 50 mM n . d . 40%
Serine proteinases
The next group of acid proteinases eluted in the 90 000- 
100 000 molecular weight range. Using additional ion exchange 
eh roma tography on DEAE-cellulose at pH 4.5, an electropho- 
retically pure enzyme from A. niger was obtained. This was 
not possible with C. purpurea enzyme, where two ion exchange 
eh roma tography steps and rechromatography on Sephadex G-150 
yielded an incompletely pure enzyme. The characterization of 
both enzymes showed that they have an acid pH optimum for 
hydrolysis of hemoglobin at pH 4.0 /Fig. 3/, but they were 
not inhibited by pepstatin. A molecular weight of 115 000 
was determined by gel chromatography for both proteinases, 
and 100 000 by SDS electrophores is for A. niger enzyme. The 
enzymes were stable between pH 3.0-3.0, and were inhibited by 
soman and by PMSF to the extent of approximately 60%. Some
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Comparison of some properties of aspartic proteinases 
from A. niqer and C, purpurea
other potential inhibitors were tested on C. purpurea enzyme 
but they showed no effect /Table 2/. A. niger proteinase was 
stable to 60°C and this temperature was also optimal for 
hydrolysis of hemoglobin. Whereas A. niger enzyme exhibited 
proteolytic activity toward N-a-benzoyl-D, L-arginine-2- 
naphthylamide, C. purpurea proteinase, on the other hand, 
did not cleave either this substrate or N-a-benzoyl-Arg-p- 
nit roanilide.
Fig. 3. pH dependence of hemoglobin hydrolysis by A, niger 
/--- / and C. purpurea /----/ serine proteinase.
The summarized properties of the proteinases from both 
microorganisms again display many similarities /Table 3/. 
According to their inhibition with soman and PMSF, they can 
be classified as serine proteinases, although they are 
different from the majority of other serine proteinases which 
show their maximal activity in the neutral or alkaline pH 
range. There is a report, however, on a serine proteinase 
from the maize root which degraded hemoglobin maximally at 
pH 4 /Shannon, 1979/, and on Streptomyces rimosus serine 
proteinase exhibiting an acid and an alkaline pH optimum for 
hydrolysis of hemoglobin /Renko et al. , 1981/. Also, serine
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Table 2
Effect of some potential inhibitors on C. purpurea
serine proteinase
Effectorx % inhibition
Pepstatin 20 i^M 2
EDTA 0
pCMB 0
PMSF 66
DAN 2
TPCK 8
TLCK 6
Benzamidine 0
p-NH^-benzamidine 17
x5 mM final concentration
proteinases are generally of low molecular weight, usually 
around 25 000. Larger enzymes have been reported, e.g. in 
A. niger /Bosmann, 1973/, A. nidulans /Stevens and Stevens, 
1980/, Phycomyces blakesleeanus /Fiecher and Thompson, 1979/ 
and the already mentioned proteinase from the maize root 
/Shannon, 1979/. A serine proteinase with a molecular weight 
of 126 000, the largest one reported so far, was found in 
Blakeslea trispora /Govind et al., 1981/. The serine proteinase 
isolated from A, niger by Bosmann /1973/ had a molecular 
weight of 68 000, but it degraded acetylhemoglobin optimally 
at pH 7.4.
Our results indicate pronounced similarities in protein­
ases excreted by two microorganisms of the Ascomycete class. 
They are found in two different subclasses, however, but the 
classification is based on morphological criteria only.
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Table 3
A. niger C. purpurea
Molecular weight:
gel eh roma tography 115 000 113 000
SDS electrophoresis 1 0 0  0 0 0 n.d.
pH optimum:
hemoglobin 4.0 4.0
casein 2 . 0 n.d.
pH stability 2 - 8 3 - 8
Inhibition
pepstatin 2 0  i^M 0 % 0 %
soman 5 mM 60% n.d.
PMSF n ,d. 65%
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DISCUSSION
BARRETT:
Does your serine acid proteinase have any resemblance to 
the pepstatin resistant acid proteinase that has been 
described for another microorganism by Oapanese workers? 
KREGAR:
Yor are probably referring to Scytolidium proteinases. 
They are not inhibited by pepstatin, but they have very 
low molecular weight /around 22 000/.
STEPANOV:
What about the inhibition actually?
KREGAR :
We preincubated the enzyme with pMSF and sort,an /a DFP 
analogue/ for 30 min. The residual activity toward 
hemoglobin was determined afterwards. We have not gone 
into the details of this inhibition yet.
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ENDO-PROTEASES AS REGULATORS OF VIRUS REPLICATION
KORÁNT, B.D. and LONBERG-HOLM, K.
Central Research and Development Department
E.I. du Pont de Nemours and Company 
Experimental Station 
Wilmington, USA
ABSTRACT
Picornaviruses suppress cellular protein degradation and 
produce their own highly specific endo-protease. The viral 
enzyme processes viral precursors to yield the coat proteins, 
which then assemble. Options for inhibiting viral proteases 
are discussed, including the role of serum protease inhibitors 
in blocking viral proteolysis. One such inhibitor was used to 
purify and characterize the poliovirus protease. A virulent 
and an attenuated strain of poliovirus were compared with 
regard to their abilities to induce cleavage of the subunit 
of a serum protease inhibitor; the virulent virus was able to 
process the inhibitor with greater efficiency.
INTRODUCTION
Viral protein synthesis and processing in cells infected 
by picornaviruses has been extensively studied. A favorable 
feature for these studies is the drastic inhibition of cellu­
lar protein synthesis /and protein synthesis of most other 
coinfecting animal viruses/ by the small positive-stranded 
RNA viruses. This effect permits radioisotope labeling solely 
of viral proteins shortly after infection.
The extensive proteolytic processing used in forming the 
proteins of picornaviruses has made them a useful model for 
the study of biological regulation by proteases. In this
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communication, the ability of the virus to block cellular 
protein degradation is compared with shut-off of cellular 
protein synthesis following infection. Alpha-l-macroglobulin, 
a serum protease inhibitor, was then used to identify the 
polioviruá-coded protease, and characteristics of the enzyme 
are predented. It was also found that poliovirus strains dif­
fering in their degree of virulence for man show variability 
in their interaction with a serum protease inhibitor, and 
clinical implications of this are discussed.
MATERIALS AND METHODS
Growth of poliovirus and hela cells in culture has been 
described previously /Koránt, 1972/. Labeling of viral pro­
teins and subsequent analysis in polyacrylamide slab gels has 
also been published /Koránt et al,, 1979/. Details of indivi­
dual experiments are given in the text. Isotopes used in these 
studies were purchased from New England Nuclear Corp., Boston, 
Massachusetts, USA.
RESULTS
Inhibition of Cellular Protein Degradation Following 
Virus Infection. The shut-off of host protein synthesis by 
picornaviruses has been of long-standing interest as a dra­
matic example of translational control. Following infection 
there is usually, but not always, viral-induced inactivation 
of factors required in translation of cellular proteins, 
particularly the binding of cellular mRNA to the small ribo- 
somal subunit. We previously carried out cell-free studies on 
the suppression of ribosome-associated proteolytic activity 
following viral infection /Koránt and Lonberg-Holm, 1981; 
Langner et al,, 1982/.
We have examined the in vivo effect of infection of 
transformed human epithelial cells /WISH/ by poliovirus type 
2 on degradation of cellular proteins. The cells were cultured 
for 17 hours in medium supplemented with / ^ 4C/ labeled amino
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acid mixtures either in the absence of amino acid analogs, or 
in their presence. They were then challenged with 10 infec­
tious virus particles per cell and protein degradation assayed 
by precipitation of labeled intracellular and extracellular 
proteins with trichloroacetic acid. The virus used was highly 
purified by zonal and equilibrium centrifugation followed by 
dialysis, to avoid non-specific effects.
Table 1
Protein degradation in virus-infected cells
Sample Rate of Degradation /% per hr/
WISH cells 1.4
WISH cells + poliovirus 2 00•o
WISH cells + 
analogs
amino acid 2 .6
WISH cells + analogs + polio 2 0.9
The results of the study are shown in Table 1. The abil­
ity of WISH cells to degrade proteins is significantly impaired 
following virus challenge, a result which conforms to our 
earlier results on cell-free degradation /Koránt and Lonberg- 
Holm, 1981/. The virus suppresses turnover of analog-con­
taining proteins to an even greater extent, when the percen­
tage of degradation is compared with that of "normal" pro­
teins; however, a basal level of degradation continues after 
virus challenge for analog-containing as well as unmodified 
proteins. Similar results have been reported previously in 
bacteria infected with viruses /Simon et al., 1978/.
Based on the experiment shown in Table 1, we have com­
pared the viral inhibition of cellular protein synthesis with 
the suppression of degradation. The results are summarized in 
Table 2. There are clearly many parallels between the two 
events, a result which implies that the same mechanism and 
possibly the same hypothetical viral product may be irvolved.
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It would be helpful in studying the mechanism if viral mutants 
were available which were not able to suppress these cellular 
events. It is not straight—  forward to select such mutants, 
since virus production is not markedly affected by an inabil­
ity of the virus to inhibit cellular translation. We are de­
vising a scheme presently to try to identify mutants which do 
not block degradation.
Table 2
Inhibition of protein synthesis or degradation by picornavirus
Characteristic Synthes is Deg rada t ion
Time after infection Immediate Immed ia te/ea rly
Dependent on multiplicity + +
Requires protein synthesis + +
Requires viral genome - -
replication
Inactivation of cap-binding +
p rotein
Required for virus production -
Viral mutant known not to _ _
inhibit production
Proteolytic Processing of Viral Polypeptides. The mRNAs 
of picornaviruses appeared at one time to be unique in the 
sense that they coded for several proteins, but used only a 
single translation start signal. Their translation product is 
a polyprotein containing several domains, each with a distinct 
function. Gene expression is controlled by elaborate post- 
translational proteolytic events, which generate viral struc­
tural proteins, polymerases, etc. /reviewed in Perez-Bercoff, 
1973/. However, it has become apparent that this type of 
regulation is not limited to picornaviruses. In fact, most 
animal viruses use some degree of proteolytic processing for 
structural proteins. And it has recently become clear that
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there are also polyprotein precursors for some classes of 
cellular proteins. The neuropeptide hormones provide several 
very clear examples of large mRIMAs with single initiation 
si t e s , producing a number of different protein/peptide 
products by cleavage.
While many animal viruses /and others infecting insects, 
plants and bacteriophages/ use proteolytic processing during 
virion assembly, the picornaviruses are the most outstanding 
example, because they use cleavages to form all viral poly- 
pep t ides .
With picornaviruses, the cleavages of the structural 
precursors do not cause the products to separate. To the 
contrary; there is alteration in conformation, antigenic 
structure and isoelectric point and the cleavage products 
assemble into larger and more complex structures, culminating 
in the viral capsids. When the RNA associates with the capsids 
it is locked in by a final protein cleavage which also places 
the virion into a specific native configuration which recog- 
nixes cellular receptors. Proteolytic cleavages regulate RNA 
synthesis as well, by activating and deactivating the viral 
polymerase, and also by generating the genome-linked peptide. 
For a review of protein cleavage pathways of picornaviruses 
see Rueckert in Perez-Bercoff , 1978.
Although the phenomenon of protein cleavages in virus- 
infected cells is thoroughly documented, the actual function 
or role of the cleavages is not clear. For example, the 
extensive proteolysis of the picornavirus structural precursor 
does not cause dissociation of the products, but rather alters 
their folding. Why this cannot be accomplished without 
cleavage remains to be understood. It seems likely that 
cleavage is used for modulation of protein function in a 
system where transcriptional and translational controls are 
not favored.
Cleaved Sites in Viral Precursor Proteins. In the past 
several years the amino acid sequences of the cleavage recog­
nition sites have become known for several picornaviruses.
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This data has in part been provided by end-group analyses of 
viral proteins, but more information has been deduced from 
sequencing of viral genomes, mRNA, or DNA complementary to 
the viral RNA, The latter technique has permitted analysis of 
large portions of picornavirus RNAs and the entire sequence 
of a poliovirus /Kitamura et al., 1981/.
Table 3
Protein cleavage sites
Poliovi rus leu th'r th r tyr/gly phe giy his/nascent/ asp ala me t tyr/gly th r asp giy
Poliovirus p ro arg leu gln/gly leu p ro valx
/intermediate/ ala leu ala gln/gly leu giy ginxala leu phe gln/gly p ro leu gin
ala met gin gln/gly ile th r asn
val ile lys gln/gly asp ser t rp
a la giy his gln/gly ala ty r th r
Poliovi rus p ro me t leu asn/se r p ro asn ile
/maturation/
FMDVXX p ro ser lys gln/gly ile phe p ro
/structural/ pro arg th r gln/th r th r ser th r
lys gin leu leu/asn phe asp leu
FMDV glu/gly leu ile val
/non-st ructural/
FMDV ala leu leu ala/asp lys lys th r
/ma tu ra tion/
x rapid
x x foot and mouth disease virus
Comparisons of the cleaved sites in precursor proteins 
of two picornaviruses are shown in Table 3. The picornavirus 
sequences have several rather distinct classes of cleaved 
sites. First are the nascent cleavages sites, processed almost 
instantly during translation. They are reminiscent of chymo- 
tryptic cleavage sites; the new carboxyl termini being do­
nated by aromatic /tyrosine/ or hydrophobic residues. Next 
are the rapidly processed sites, such as those in structural 
precursors /half-life of 5 minutes in infected cells/. For
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the picornaviruses these contain glutamine-glycine or glutamic 
acid-X residues, often surrounded by hydrophobic /leucine, 
isoleucine, valine/ sequences. Sites which are more slowly 
cleaved also contain glutamine or glutamic acid, but are in 
more neutral or hydrophilic regions of the precursors, which 
may alter their affinity for the participating proteases. 
Lastly, there are distinctly specific sites which are pro­
cessed during combination of the viral RNA and the coat pro­
teins, the so-called maturation cleavage. The occurrence of 
highly conserved peptide regions at processing sites of viral 
precursor proteins may offer an avenue for design of selective 
inhibitors.
Origin of the Processing Proteases. At the outset, it 
should be emphasized that the important cleavages of picorna- 
virus precursor proteins in infected cells do not resemble 
the normal degradation of intracellular proteins. As a rule, 
the proteolytic cleavages of viral proteins are at rare, 
highly site-specific regions /see Table 3/, and no soluble 
peptides or amino acids are released.
From a number of lines of evidence, it appears that 
initial cleavages of nascent viral polypeptides are carried 
out by cellular proteases associated with the translational 
apparatus. These may be the membrane-bound proteases which 
process signal sequences from nascent cellular secretory 
proteins. Another candidate is a ribosomal protease of animal 
cells /Langer et al., 1982/. The cleavage specificity is 
reminiscent of chymotrypsin, a serine-active site protease. 
Both the nascent cleavage reactions and the ribosomal prote­
ase are blocked by diisopropylphosphfluoridate /DFP/ a classic 
inhibitor of serine proteases.
A body of evidence from several laboratories established 
that the intermediate protein cleavages of picornavirus pre­
cursors, some of which yield the viral structural proteins, 
are carried out by a virus-coded protease. The enzyme activity 
is not detected in extracts of uninfected cells, but is found 
in lysates of infected cells in quantities which increase in
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time after infection and with the amount of infecting virus 
/Koránt et al,, 1979/. Cell-free protein synthesizing systems, 
programmed with picornaviral RNA, produce a specific proteo­
lytic activity which also processes the capsid polypeptides 
/Pelham, 1978/, In both infected cells and cell-free extracts 
it was shown that the protease is not efficient at cleaving 
proteins of heterologous viruses or cellular proteins /Koránt, 
1977; Shih et al., 1982/.
The picornavirus protease is apparently a member of the 
class of proteases with cysteine at the active site, based 
on inhibitor sensitivity /Koránt, 1973; Pelham, 1978/. In 
general, cysteine proteases are not highly specific with re­
gard to substrates cleaved, and thus the specifity deter­
minants of the viral enzymes are of innate biochemical inter­
est. Glutamine or glutamic acid cleaving proteases are de­
scribed in bacteria, but have not been well-characterized.
Inhibitors of Viral Protein Cleavages. This topic has 
been reviewed recently /Koránt, 1981/. The approach seems to 
be promising for design of antiviral agents for those animal 
viruses which produce their own specific proteolytic enzymes, 
that is picornaviruses, retroviruses and adenoviruses, and 
possibly alphaviruses, myxo- and paramyxoviruses, poxviruses, 
and herpesviruses.
The mode of action of cleavage inhibitors can be classi­
fied in either of two general categories; alteration of the 
substrate to prevent its proper cleavage, or inhibitors of 
the protease catalytic activity. The first category contains 
certain protein modifying reagents, amino acid analogs, high 
or low temperature and some metal ions, zinc being the most 
often reported. Inspection of this category reveals that none 
of these treatments is likely to lead to specific alteration 
of viral proteins.
The second approach is targeted at the proteolytic en­
zymes. The picornavirus protease is very sensitive to inhibi­
tors of thiol proteases, eg mercurials, N-ethyl maleimide, 
and iodoacetate. We have begun to design inhibitors which
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mimic the structure of the cleavage sites, based in part on 
their peptide sequences. For example, we found that carbobenz- 
oxy leucine chloromethyl ketone was an irreversible inhibitor 
of poliovirus protease /Koránt et al., 1979/ and showed also 
that it blocked viral protein cleavages and virus production 
/Koránt, 1981/.
Inhibitors of viral protein cleavages are readily tested 
for picornaviruses. The test can be made at a time after in­
fection when the cellular protein synthesis is completely 
inhibited and only virus proteins are labeled with radioactive 
amino acids. The viral proteins are size-separated in poly­
acrylamide gels and any inhibition of cleavage can readily be 
detected. Variations on the assay involve mixing purified 
viral protease with radioactive viral precursors obtained 
from cell-free translation or with synthetic substrates. The 
results may then be visualized by autoradiography of dried 
gels. A spectrophotometer may also be used if the cleaved 
substrate is chromogenic.
We have recently found that certain natural protease 
inhibitors prevent viral protein cleavages /Koránt and 
Lonberg-Holm, 1981/. Human alpha-2-macroglobulin or rat 
alpha-l-macroglobulin blocked poliovirus protease action in 
extracts, and covalently bound the enzyme. This finding has 
been useful in characterizing the viral protease. The iden­
tity of the picornavirus protease has been a matter of some 
controversy. An initial report claimed that a structural 
polypeptide of EMC virus possessed protease activity 
/Lawrence and Thach, 1975/. However, a subsequent study 
indicated that a non-structural translation product was 
required and it was then proposed that a polioviral non- 
structural polypeptide of approximate molecular weight 
40 000 was the polioviral processing protease /Koránt et al., 
1979/. This result was then challenged by three groups, based 
on independent purification methods or antibody studies 
/Palmenberg et al., 1979; Gorbalenya et al., 1981; Havecak et 
al., 1982/.
We have re-examined this question by analyzing the amino
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acid sequence of the poliovirus protein bound to a serum 
protease inhibitor. Cells infected with poliovirus type 1 for 
three hours were placed in amino-acid free medium and the vi­
ral proteins were labeled with single radioactive amino acids 
for 90 minutes. At that time, cell extracts were prepared by 
mechanical breakage of the cell membrane, and the cytoplasmic 
fraction, containing the labeled viral proteins, were incuba­
ted with purified rat alpha-l-macroglobulin, a large protein 
protease inhibitor present in rat serum. The incubation at 
37° was continued for 60 minutes, and then further reaction 
was prevented by adjusting the samples to contain 1% sodium 
dodecyl sulfate /SDS/, mercaptoethanol and 8 M urea, and 
boiling. The extracts were then separated on 7.5% polyacryl­
amide gels in SDS, and dried directly without chemical fixa­
tion, Radioactive complexes of viral protein and alpha-l-macro­
globulin subunit were identified in autoradiographs of the 
dried gels, cut from the gels, and eluted by electrodialysis. 
The sequence of the amino-terminal portion of the bound polio- 
viral protein was determined by automated Edman degradation 
and liquid-scintillation counting of the fractions after each 
Edman cycle. The results will be presented in detail else­
where, but clearly identify the bound viral protein with a 
segment of the coding region of the viral RNA. The RNA se­
quence is from nucleotide 5430 to 5978 /Kitamura et al.,
1981/. The protease amino acid composition was deduced from 
the RNA sequence and is presented in Table 4. The enzyme is 
apparently of the thiol class of proteases, and there are 
three cysteines present in the sequence. A poliovirus variant 
is known in which the third cysteine is converted to a 
methionine, leaving the enzyme functional /Cann et al., 1983/. 
We believe the active site cysteine in the protease of polio­
virus type 1 is at position 153 /our unpublished results/. 
Further studies are in progress.
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Table 4
Amino acid composition of poliovirus type 1 protease
Amino Acid Mole Percent*
Arginine 5
Lys ine 4.5
Aspartic Acid 4.5
Glutamic Acid 5
Aspa ragine 5
Glu tamine 4
Glycine 9.8
Alanine 8.5
Se rine 5
Th reonine 9.8
Me thionine 2.9
Leucine 4.5
Isoleucine 7.4
Valine 8
His tidine 2 .2
Phenylala nine 4
Tyrosine 2 .2
T ryptophan 0
Proline 4.5
Cys teine 1.7
from RNA sequence
Interaction of Viral Proteases with Serum Protease 
Inhibitors. In using the binding of poliovirus protease to 
alpha-l-macroglobulin as a purification step, we noted that
there was breakdown of the inhibitor during the course of
125incubation. This has been examined in detail, using / 1/
labeled rat alpha-l-macroglobulin. As shown in Figure 1, 
after even a 60 minute exposure to extracts of cells infected 
with a virulent strain of poliovirus, breakdown by limited
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proteolysis of the alpha-l-macroglobulin subunit can be ob­
served. By comparison, uninfected cell extracts show no 
ability to process the inhibitor. Surprisingly, extracts of 
cells infected with an attenuated, oral vaccine strain of 
type 1 poliovirus were deficient in the ability to cleave the 
protease inhibitor subunit. Only prolonged reaction /24 hours/ 
showed that the attenuated virus could cleave the inhibitor, 
but this was also observed to s degree in extracts of unin­
fected cells.
The genetic and biochemical basis of poliovirus attenu­
ation is not understood, but it is possible that an altered 
viral protease is co-selected with the loss of virulence. It 
is also possible that infection by the virulent strain, but 
not the attenuated, activates cellular proteases which pro­
cess the alpha-l-macroglobulin subunit. However, there is 
little evidence to suggest leakage of lysosomal hydrolases 
info the cytoplasm of infected cells, nor are cellular pro­
teins non-selectively degraded following infection /Koránt 
et a l ., 1980/.
DISCUSSION
The study of proteolysis associated with replication of 
viruses is crucial to understanding the function and assembly 
of viral proteins. It may also lead to a fuller appreciation 
of the various controls of protein degradation in uninfected 
cells. As shown in this study, viral infection suppresses the 
usual turnover of proteins which occurs in cells in culture. 
The data presented indicate the role of a viral product in 
blocking the degradative pathway/s/. This function would 
appear to be of obvious advantage to the virus, since in 
principle it would protect viral structural proteins from 
attack by cellular protease activities. We are hopeful that 
characterizing the mechanism of viral suppression of degrada­
tion will help to clarify the basis of selection of certain 
classes of proteins for intracellular destruction.
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VFigure 1 Legend. Cleavage of alpha-l-macroglobulin subunit 
in cell extracts
Purified rat serum alpha-l-macroglobulin was radio- 
iodinated and adged to homogenates of Hela cells. After 
incubation at 30°for the times indicated, the samples were 
treated as described in Results and the proteins analyzed 
on a polyacrylamide slab gel in SDS-cortaining buffer. After 
electrophoresis, gels were dried and used to expose x-ray 
film for 24 hours.
Lanes a through e - polio 1 /virulent/ infected for 
increasing times /hourly intervals/; expose alpha-l-macro- 
globulin for 60 min. Lanes f through j - same, but expose 
alpha-l-macroglobulin for 24 hours; k - alpha-l-macroglobulin, 
no incubation; 1 - incubated 24 hours, no extract added; 
m - incubated 60 min. with uninfected Hela cells; n - incuba­
ted 24 hours with uninfected Hela cells; o - polio 1 /attenu­
ated/ 60 min, after infection, 60 min. incubation; p - 4 hours 
after infection, 60 min. incubation; q - polio 1 /attenuated/, 
60 min. after infection, 24 hour - incubation; r - 4 hours 
after infection, 24 hour - incubation.
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The picornaviruses, of which poliovirus is a prototype, 
ensure proper processing of their structural proteins by 
encoding a proteolytic enzyme of exquisite specificity. Only 
a very few sites are cleaved by this enzyme in viral precursor 
proteins, and virtually no activity of the enzyme is detected 
on heterologous proteins, The primary sequences recognized by 
viral proteases are becoming known, but there may well be 
even more extended regions of protein-protein recognition in 
order for the viral protease to act. The viruses seem to 
provide a good model for beginning the study of high-speci­
ficity endoproteases involved in regulatory pathways. Cellular 
analogs may include the proteases which process the neuro­
peptide hormones from precursor polyproteins.
Ultimately, our major goal is specific inhibition of the 
virus replication process. Inhibitors of clinical importance 
will possibly be synthetic mimics of cleavage sites /Barrett, 
1980/, We have also found an ability of naturally-occurring 
serum protease inhibitors, such as alpha-2-macroglobulin, to 
block viral protease action in cell lysates. Such endogenous 
inhibitors may play an important role in limiting patho­
genesis arising from certain infections, particularly those 
where a unique, virus-coded enzyme is present. In this regard, 
we find it intriguing that a highly virulent virus is able to 
inauce degradation of a serum protease inhibitor. It is pos­
sible that, to a degree, virulence may result from the virus' 
ability to inactivate such a host line of defense. Moreover, 
the fragments of serum protease inhibitors generated by expo­
sure to infected cell lysates may themselves have toxic pro­
perties which contribute to the clinical severity of the 
disease. Further comparisons of wild-type viruses and their 
attenuated derivatives, focusing on their interaction with 
endogenous protease inhibitors, may help to clarify the 
biochemical basis of viral pathogenicity.
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DISCUSSION
BARRETT:
Have you prepared diazomethyl ketones to inhibit 
the virus protease, as cysteine proteases should be 
sensitive?
K O R Á N T :
Yes, we have tried, but we have had no luck at 
finding antiviral activity. The experiments were 
all done with infected cells.
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GLAUMANN :
What was your protocol for microinjection of the 
alpha-l-macroglobulin into cells?
K O R Á N T :
The cells are fused with PEG, then injected with 
virus and finally microinjected with the inhibitor. 
Labelled methionine is added to visualize the viral 
p roteins .
BARRETT:
It's good to see that someone is finding a use for 
the ability of certain antiproteases to form co­
valent bonds with proteases.
K O R Á N T :
Yes, the reaction has been of great use to us.
BA R R E T T :
You should be interested in the antiviral activity 
of endogenous cysteine protease inhibitors.
K O R Á N T :
Yes, we are very interested in them, and plan to 
examine their activity against selected viruses.
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INTRODUCTION
Over the past 50 years, a number of proteinases have been 
found and/or isolated from fruits, seeds, leaves and late:: of 
several plants, but only recently their role in cellular pro­
cesses and plant metabolism has been studied.
Most plant proteinases appear to be sulfydryl enzymes with 
pH optima ranging between 5 and 8. However, in recent years se­
veral endopeptidases that do not involve a sulfydryl group for 
catalytic activity have been reported in plant tissues. The 
latter enzymes fall into two groups: an acid group (pepsin­
like), having pH optima at 3-4, and an alkaline group, with pH 
optima at 7.5-8.5, that appears to resemble the serine prote­
inases found ubiquitously in animals and microorganisms. It has 
always been puzzling that plants seem to use primarily sulfyd­
ryl proteinases for protein degradation, whereas microorganisms 
and animals utilize primarily serine proteinases (see: Ryar. and 
Walker-Simmons, 1981 and references sited therein).
The aim of the present study is to compare side by side 
the catalytic and inhibitor binding properties of the leucine 
specific serine proteinase from spinach leaves with those of 
sulfydryl proteinases, notably papain, ficin and bromelains.
Correspondence should be addressed to P. Aducci.
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As in the case of mammalian proteinases, both serine and 
thiol plant proteinases catalyze the hydrolysis of low molecular 
weight substrates via a mechanism involving a minimum of two in­
termediates :
E+S E • S E-P 
+ P„
E + P2
In the case of reactions catalyzed by papain, ficin and brome­
lains, the intermediate E-P is considered to be an ester formed 
between the acyl moiety of the substrate and the cysteine-SH 
group (Lowe, 1977), whereas in the case of the spinach leaf 
leucine specific serine proteinase, E-P is assumed to be a hyd­
roxyl-acyl-enzyme intermediate.
The knowledge of catalytic and inhibitor binding proper­
ties, supplemented with structural data so far available for 
plant and mammalian proteinases, allows a rather detailed de­
scription of their catalytic behaviour.
Catalytic properties of the spinach leaf leucine specific
serine proteinase
The presence of proteinases and related specific inhibi­
tors in spinach leaves (Spinacia oleracea L.) has been recent­
ly reported (Satoh and Fujii, 1982; Watanabe and Kondo, 1983).
On the other hand, no gelatinolytic and/or proteolytic activ­
ities have been found by Yamaguchi et al. (1982).
The presence of proteinases in the crude juice of spinach 
leaves has been assayed measuring the hydrolysis of the follow­
ing p-nitroanil.ides and p-nitrophenyl esters of (L-) amino 
acids+: N-oi-L-leucine p-nitroanilide (LeuNHNp), N-a-L-alanine
+All reagents, substrates and inhibitors used in the present study were of 
the highest purity commercially available or synthesized according to lit­
erature methods (see: Ascenzi et al., 1982). Leupeptin and the porcine 
pancreatic secretory trypsin inhibitor (PSTI) were generous gifts of 
Dr. G. Borin and Prof. E. Menegatti, respectively.
The enzymatic assays and inhibitor binding measurements were performed as 
previously reported (Ascenzi et al., 1982; Antonini et al., 1983). In order 
to ensure the banogeneity of the system, 3% ethanol/water (v/v) or 3% ace­
tonitrile,'water (v/v) reaction mixtures were employed. No effect of etha 
or acetonitrile (up to 5%) in the reaction mixtures has been observed.
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Table 1
Relative activity for the catalyzed hydrolysis of a number of 
p-nitroanilides and p-nitrophenyl esters of (N-g-substituted 
L-)amino acids by the crude juice of spinach leaves (pH 7.5, 
phosphate buffer, 1=0.1 M; T=23.5±1 °C)
Substrates Relative activity (%)
AlaNHNp 23.9
LeuNHNp 100.0
LysNHNp 8.9
BzLysNHNp 10.2
BzArgNHNp 10.9
SPheNHNp 0
AcTyrNHNp 0
ZGlyONp 5.0
ZAlaONp 25.1
ZValONp 33.1
ZIleONp 31 .6
ZLeuONp 100.0
LysONp 10.0
ZLysONp 10.1
ArgONp 11.2
ZArgOnp 9.5
ZPheONp 0
ZTyrONp 0
-2Substrate saturating concentration was 1x10 M.
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p-nitroanilide (AlaNHNp), N-a-benzoyl-L-arginine p-nitroanilide 
(BzArgNHNp), N-a-benzoyl-L-lysine p-nitroanilide (BzLysNHNp), 
N-a-L-lysine p-nitroanilide (LysNHNp), N-a-succinyl-L-phenyl- 
alanine p-nitroanilide (SPheNHNp), N-a-acetyl-L-tyrosine p-nit- 
roanilide (AcTyrNHNp), N-a-carbobenzoxy-L-leucine p-nitrophenyl 
ester (ZLeuONp), N-a-carbobenzoxy-L-alanine p-nitrophenyl ester 
(ZAlaONp), N-a-carbobenzoxyglycine p-nitrophenyl ester 
(ZGlyONp), N-a-carbobenzoxy-L-isoleucine p-nitrophenyl ester 
(ZIleONp), N-a-carbobenzoxy-L-valine p-nitrophenyl ester (ZVal- 
ONp), N-a-carbobenzoxy-L-lysine p-nitrophenyl ester (ZLysONp), 
N-a-L-lysine p-nitrophenyl ester (LysONp), N-a-carbobenzoxy- 
-L-arginine p-nitrophenyl ester (ZArgONp), M-a-L-arginine 
p-nitrophenyl ester (ArgONp), N-a-carbobenzoxy-L-phenylalanine 
p-nitrophenyl ester (ZPheONp), N-a-carbobenzoxy-L-tyrosine p- 
nitrophenyl ester (ZTyrONp) and p-nitrophenyl p-guanidinoben- 
zoate (pNGB).
At fixed pH (between pH 5 and 9.5), ionic strength ( 0.1 M) 
and temperature ( 23.5±1 °C), the leucine derivatives show the 
highest hydrolysis rate, indicating that a leucine specific 
proteinase is the most representative enzyme in the crude 
juice of spinach leaves. Lower hydrolytic activities towards 
glycine, alanine, valine, isoleucine, lysine and arginine de­
rivatives have been observed. Moreover, the hydrolysis of tyro­
sine and phenylalanine derivatives is not catalyzed by the 
crude juice of spinach leaves (see Table 1).
In order to check the possibility that the catalytic ac­
tivities observed depend on the same proteinase, the hydrolysis 
of some p-nitroanilides of L-amino acids was measured after 
polyacrylamide gel electrophoresis of the spinach leaf crude 
juice. Fig. 1 shows the dependence of the relative activity 
for the hydrolysis of LeuNHNp, AlaNHNp, BzLysNHNp, LysNHNp, 
and BzArgNHNp on the relative electrophoretic mobility. For 
all the p-nitroanilides examined, the maximum of their cata­
lyzed hydrolysis corresponds to a value of u equal to 
C.58+0.05. Moreover, in order to check the hypothesis of 
various proteinases present with different specificities but 
with the same relative electrophoretic mobility, the catalyzed
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Fig. 1: Dependence of the relative enzyme activity for the
hydrolysis of LeuNHNp (A), AlaNHNp (B), BzLysNHNp (C), 
LysNHNp (D) and BzArgNHNp (E) by the crude juice of 
spinach leaves on the relative electrophoretic mobil­
ity (y) . The enzymatic assay was performed on sliced 
polyacrylamide gels. The data have been obtained at 
pH 7.5, phosphate buffer, 1=0,1 M; T=23.5±1 °C.
hydrolysis of all p-nitroanilides examined was determined 
after the selected inhibition of the leucine specific activity 
by N-a-tosyl-L-leucine chloromethyl ketone (TosLeuCK) (see 
below). In the presence of TosLeuCK (100 yM) , not only the 
hydrolysis of LeuNHNp was inhibited, but also that of the other 
anilides derivatives. These findings suggest that possibly one 
leucine specific proteinase is involved in the hydrolysis of 
all the synthetic substrates here employed. Nevertheless, the 
small but significant catalyzed^ hydrolysis of anilides of
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(L-)amino acids by the crude juice of the spinach leaves at p 
values different from the maximum (0.58±0.05) (see Fig. 1) 
should indicate the presence of lower concentrations of other 
amidase activities.
The absence of any effect of substitutions at the N-a-po- 
sition on the hydrolysis rate of both esters and anilides sug­
gests that the spinach leaf leucine specific proteinase is an 
endopeptidase.
According to the relative hydrolysis rate catalyzed by the 
partially purified spinach leaf leucine specific proteinase^ as 
well as by the crude juice, the specificity towards the sub­
strates considered can be arranged as follows:
Gly < Ala < Val -—• Ile < Leu > Arg —  Lys
over the whole pH range explored (5-9.5) (see Table 1 and Fig. 
2). According to general views (Kraut, 1977; Steitz and Shul- 
man, 1982), the effect of the amino acid side chains on the 
hydrolysis rate suggests that the acylation step is rate lim­
iting in catalysis between pH 5 and 9.5.
From the inspection of Fig. 2 it may be observed that at 
all pH values, p-nitrophenyl esters show a systematic higher 
hydrolysis rate as compared to that of the corresponding p- 
nitroanilides. This finding may be related to the fact that 
the leaving group present in p-nitrophenyl esters is very good 
as compared to that of p-nitroanilides, which is very poor.
The values of steady-state parameters (V and K ) for 
the spinach leaf leucine-specific proteinase catalyzed hydro­
lysis of LeuNHNp have been determined at pH 7.5 (see Fig. 3) . 
Under all experimental conditions, the dependence of the ini­
tial velocity upon substrate and enzyme concentrations and the 
time course of the reaction follow simple Michaelis-Menten 
kinetics.
The spinach leaf leucine specific proteinase has been partially purified 
by ion-exchange chromatography on DEAE-BIOGEL A (100-200 mesh) (Bio-Rad, 
Richmond, USA).
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Fig. 2: Effect of pH on the maximal velocity for the spinach 
leaf leucine specific serine proteinase catalyzed 
hydrolysis of ZLeuONp (A, O ), ZGlyONp (A*), ZAlaONp 
(A,Q ), ZXleONp (A, ♦ ), ZValONp (A, O ) , ZLysONp (A, A ) , 
LysONp (A,A ), ZArgONp (A,V ), ArgONp (A,T ), LeuNHNp 
(B, O ) , AlaNHNp (B, □ ) , LysNHNp (B,A ) , BzLysNHNp 
(B, A ) and BzArgNHNp ( B V ) ,  The velocity is expressed 
as micromoles of substrate hydrolyzed per minute per 
milliliter (1 milliliter contains 0.04 mg of total 
proteins). The solid lines are the theoretical curves 
for two ionizing groups of pKa values of 7.1 and 8.2, 
respectively. ZLysONp, LysONp, ZArgONp and ArgONp 
show high alkaline hydrolysis rates and therefore may 
be usefully employed as substrates only up to pH 8 
(Ascenzi et a,l. , 1 982). Substrate saturating con­
centration was 1x10”2 m at all pH values. The data 
have been obtained in acetate buffer, pH 5-6; phos­
phate buffer, pH 6-8.5; and borate buffer, pH 8.5-9.5, 
all at 1=0.1 M (sodium salts); T=23.5±1 °C. No spec­
ific ion effects were found by using different buf­
fers overlapping in pH.
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Fig. 3: Dependence of the initial velocity for the spinach 
leaf leucine specific serine proteinase catalyzed 
hydrolysis of LeuNHNp on the substrate concentration. 
The velocity is expressed as micromoles of substrate 
hydrolyzed per minute per milliliter (1 milliliter 
contains 0.04 mg of total proteins). The solid line 
is the theoretical curve calculated with the follow­
ing values of steady-state parameters: Km =50.1 pM 
vmax=4-25 micromoles of substrate hydrolyzed per 
minute per milliliter. The data have been obtained 
at pH 7.50, phosphate buffer, 1=0.1 M; T=23.5±1 °C.
I n  a g r e e m e n t  w i t h  t h e  o b s e r v e d  p e c u l i a r  s p e c i f i c i t y  o f  
t h e  s p i n a c h  l e a f  l e u c i n e  s p e c i f i c  p r o t e i n a s e ,  t h e  i n h i b i t o r  
e f f e c t  o f  t h e  b o v i n e  b a s i c  p a n c r e a t i c  t r y p s i n  i n h i b i t o r  ( B P T I ) ,  
P S T I , s o y b e a n  t r y p s i n  i n h i b i t o r  ( S T I ) ,  l e u p e p t i n , T o s P h e C K ,  
T o s L y s C K  a n d  o f  t h e  a c t i v e  s i t e  t i t r a n t  pN GB , a l l  c o n t a i n i n g  
a  c a t i o n i c  o r  a r o m a t i c  s i d e  c h a i n  a t  t h e  r e a c t i v e  s i t e ,  o n  t h e  
c a t a l y z e d  h y d r o l y s i s  o f  e s t e r s  a n d  a n i l i d e s  i s  n e g l i g i b l e  a s
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compared to that of TosLeuCK (inhibitor concentration was 
100 uM).
For all the substrates examined, the pH dependence of the 
hydrolysis rate, catalyzed by the spinach leaf leucine specific 
proteinage, depends on two ionizing groups with pK values of
3 .
7.1 and 8.2 respectively (see Fig. 2). In this respect, the pH 
dependence of the spinach leaf leucine specific proteinase ca­
talyzed hydrolysis of anilides and esters is closely similar 
to that observed for animal serine proteinases, notably bovine 
ß-trypsin and bovien a-chymotrypsin (see: Antonini and Ascenzi, 
1981; Ascenzi et al., 1982; and references cited therein) as 
well as for the proteolytic activity present in the juice of 
alfalfa (Medicago sativa L.) (Tozzi et al., 1981). In animal 
proteinases, the observed ionizations have been assigned ten­
tatively to the acid-base equilibria of His57, involved in the 
catalytic triad, and of the N-terminal Ile16. The deprotona­
tion of Ile16 is accompanied by the cleavage of the salt bridge 
between the N-terminal residue and the Asp194, and induces the 
inactivation of the enzyme (see: Kraut, 1977; Steitz and Shul- 
man, 1982 and references cited therein).
The presence of a histidine residue involved in the cata­
lytic site of the spinach leaf leucine specific proteinase has 
been checked by inactivating the enzyme with N-a-tosyl chloro- 
methyl ketones of N-a-L-amino acids. As reported above, only 
TosLeuCK inhibits the spinach leaf leucine specific proteinase, 
suggesting that an imidazole ring is involved in the active 
center.
The amidase and esterolytic activities of the spinach 
leaf leucine specific proteinase are essentially insensitive 
to some cations (Ca^+, Fe +, Cu^+), chelating agents (ethylene- 
diaminetetraacetate disodium salt: EDTA) and reduced and oxi­
dized sulfydryl group reagents (L-cysteine, p-chloromercuri- 
benzoic acid), whereas they are sensitive to low concentra­
tions (100 pM) of phenylmethylsulfonyl fluoride (PMSF).
The insensitivity to thiol reagents and cations, as well 
as the sensitivity to PMSF, suggests that the spinach leaf 
leucine specific proteinase contains a high nucleophilic se­
rine residue at the active site.
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The molecular weight of the spinach leaf leucine specific 
proteinase is 60,000±6,000 as measured by gel filtration on 
UltroPac TSK column (7.5x600 mm, G2000 SW, purchased from LKB, 
Bromma, Sweden). The presence of more than one active site in 
the macromolecule cannot be excluded; also the possibility that 
the enzyme is in an aggregation state cannot be ruled out. In 
these respects, it is of interest to recall that several plant 
and animal serine proteinases, as human urokinase, either with 
similar or higher molecular weights, are composed of a single 
polypeptide chain with only one active site (Ryan and Walker- 
Simmons, 1981; Ascenzi et al., 1982).
Serine and sulfydryl plant proteinases: a brief comparison
All known animal and plant serine proteinases are thought 
to employ a charge relay system to hydrolyze both natural and 
Synthetic substrates, although this is not entirely accepted 
(Kraut, 1 977; Steitz and Shulman, 1 982). In this system, Seri 95 
hydroxyl group becomes highly nucleophilic through hydrogen 
bonding with the side chain of His57 which is also hydrogen- 
bonded with the carboxyl of Asp102. During catalysis the appro­
priate side chain of an internal amino acid at the site of 
the substrate fits into the principal specificity site (or 
pocket or cleft) or the enzyme near Ser195 and the nucleophilic 
serine oxygen attacks the carbonyl carbon of the scissile pep­
tide bond. A tetrahedral intermediate results that is subse­
quently converted to an acyl enzyme and finally hydrolyzed to 
products (see: Kraut, 1977; Steitz and Shulman, 1982).
Also plant sulfydryl proteinases employ a charge relay 
system to hydrolyze substrates (see: Lowe, 1977; Ryan and 
Walker-Simmons, 1981; and references cited therein). In this 
system Ser195, present in serine proteinases, is replaced by 
the highly nucleophilic Cys25 which is in a grove close to the 
imidazole ring of His159. The negative charge of the side 
chain of Asp158 promotes removal of the charged products of 
hydrolysis.
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As expected from the presence of different nucleophilic 
residues at the active site of serine and thiol proteinases, 
these enzymes show different reactivities towards specific sul- 
fydryl and hydroxyl reagents. On the other hand, they show the 
same reactivity towards histidyl reagents.
In general, three classes of specificities are ascribed 
to serine proteinases: trypsin-like enzymes that split proteins 
at internal peptide bonds where lysine or arginine occupy the 
residue of the substrate; chymotrypsin-like proteinases that 
cleave at bulky hydrophobic residues of the substrate (i.e., 
tyrosine, phenylalanine and tryptophan); and elastase-like pro­
teinases that cleave the alanine residue if present at the P^  
site. In this respect, the spinach leaf leucine specific serine 
proteinase should be considered the prototype of a new class of 
specificity among serine proteinases.
Papain, ficin and bromelains show a broader specificity as 
compared to that of serine proteinases. In this respect papain 
hydrolyzes amides of N-a-benzoxyl-L-arginine and L-lysine readi­
ly and those of glutamine, histidine, glycine and tyrosine at 
reduced rates (see: Lowe, 1977; and references cited therein). 
However, the enzyme splits peptide bonds having a wide variety 
of amino acids at the carboxyl, or P^, site of the scissile 
peptide bond, including alanine, asparagine, serine, glycine, 
histidine, aspartic acid and leucine. Different specificities 
of serine and thiol proteinases are also reflected in the dif­
ferent binding of natural and synthetic inhibitors (Ryan, 1981; 
Laskowski and Kato, 1980).
In spite of different specificities, serine proteinases 
exhibit generally pH optima around 8 (Kraut, 1977; Steitz and 
Shulman, 1982). On the other hand, thiol proteinases show a 
broad pH optimum, ranging between 5 and 8 (Lowe, 1977). Dif­
ferent effects of pH on the catalytic steps for the serine and 
thiol proteinase catalyzed hydrolysis of synthetic substrates 
are known. In this framework, the acylation step (k^) is rate 
limiting in the serine proteinase catalyzed hydrolysis of syn­
thetic substrates at pH values higher than 5. On the other hand, 
in thiol proteinases the deacylation step (k+ )^ seems to be 
rate limiting in catalysis around neutrality. Thus, in the
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ficin-catalyzed hydrolysis of N-a-benzoylglycine p-nitrophenyl 
ester, k+2 is rate limiting at acid pH values (3.9-5.9) whereas, 
at pH values higher than 5.9, k+  ^becomes rate limiting in ca­
talysis (Hollaway et al., 1971). Since, the effect of the side 
chain of (L-)amino acids on the proteinase catalyzed hydrolysis 
of synthetic and natural substrates can only be detected under 
conditions where k+2 is rate limiting in catalysis, the find­
ings reported above suggest that serine and thiol plant pro- 
teinases could be differently distributed in the same plant 
tissue. In this respect, it is known that in plant cells areas 
at different pH values (vacuole and cytoplasm) are present and 
must play a role in the regulation of metabolism, as many en­
zymatic activities are so sensitive to pH (Smith and Raven, 
1979).
A direct study of the relations between proteinase com- 
partmentation and different pH vaLues of cell organelles should 
be of wide interest for a better knowledge of the role of both 
serine and thiol proteinases in cellular processes and plant 
metabolism.
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DISCUSSION
STEPANOV:
Was the used spinach leaf proteinase purified?
ADUCCI:
The leucine specific spinach leaf proteinase has only been 
partially purified by ion exchange chromatography. The 
data presented have been obtained either with the crude 
juice or with the partially purified enzyme.
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